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Abstract 
Using an i n t e r v i e w - q u e s t i o n n a i r e technique,the frequency 
of i n s u l i n - t a k i n g d i a b e t i c s i n the f a m i l i e s of n o n - i n s u l i n - t a k i n g 
diabetics,and v i c e - v e r s a , i s compared w i t h the frequencies i n c o n t r o l 
f a m i l i e s and i n the general population. The r e s u l t s suggest t h a t these 
two forms of diabetes are not g e n e t i c a l l y d i s t i n c t . Early-onset, 
insulin-dependent d i a b e t i c s show i n d i c a t i o n s of dominant i n h e r i t a n c e 
i n t h e i r f a m i l i e s more o f t e n than do d i a b e t i c s of other types. 
Cardiovascular complications,at l e a s t i n l a t e - o n s e t , i n s u l i n - t a k i n g 
d i a b e t i c s , a r e found t o occur more rapidly,and t o be more severe,in 
i n d i v i d u a l s w i t h a s t r o n g f a m i l y h i s t o r y . 
D iabetics and c o n t r o l s are examined f o r a range of red and 
white c e l l polymorphisms,serum p r o t e i n s and isoenzymes. I n some of 
these systems,the c o n t r o l group e x h i b i t s s i g n i f i c a n t heterogeneity 
w i t h regard t o age. Comparison of the d i a b e t i c p o p u l a t i o n w i t h 
matched c o n t r o l s shows no s i g n i f i c a n t a ssociations except i n the 
case of the ABO system,where ol d e r d i a b e t i c s , e s p e c i a l l y males,show a 
higher frequency of group A^,and i n the HLA system,where i n s u l i n - t a k i n g 
d i a b e t i c s show higher frequencies of the B8 and Bwl5 a l l e l e s . I t i s 
suggested t h a t the apparent a s s o c i a t i o n w i t h ABO i s the r e s u l t of 
d i f f e r e n t i a l m o r t a l i t y amongst non-diabetics r a t h e r than any increased 
l i a b i l i t y t o the disease of group A^ i n d i v i d u a l s . Associations w i t h 
the HLA system show a r e l a t i o n s h i p w i t h age a l diagnosis which may 
e x p l a i n c e r t a i n i n c o n s i s t e n c i e s i n p r e v i o u s l y published r e p o r t s . 
The prevalence of c l i n i c a l l y diagnosed diabetes i n the 
Durham area i n 1975 exceeds t h a t reported p r e v i o u s l y f o r other B r i t i s h 
populations. The p r e s e n t a t i o n of new cases of i n s u l i n - r e q u i r i n g d i a b e t i c s 
has a marked peak i n February. 
Preface 
Diabetes m e l l i t u s i s a group of dis o r d e r s whose a e t i o l o g y 
and i n t e r - r e l a t i o n s h i p are not f u l l y understood. The work of t h i s 
t h e s i s was commenced w i t h two major o b j e c t i v e s - t o employ pedigree 
i n f o r m a t i o n t o c l a r i f y the genetic i n t e r - r e l a t i o n s h i p between various 
sub-types of the disease and,secondly,to explore associations between 
these and c e r t a i n genetic polymorphisms t a k i n g f u l l account of the 
inf l u e n c e o f f a c t o r s such as age and place o f b i r t h . 
As so o f t e n happens i n studies of diabetes,the major 
d i f f i c u l t i e s encountered were those of d e f i n i t i o n . The d i a b e t i c 
group i s d i v i d e d mainly by curr e n t treatment and,to a c e r t a i n e x t e n t , 
t h i s method of s u b d i v i s i o n has been superseded by developments i n the 
immunological study of these diseases over the past two years. Apart 
from being unavailable i n t h i s case,these immunological techniques are, 
at present,unsuitable f o r the c l a s s i f i c a t i o n of an e x i s t i n g d i a b e t i c 
population,although they have done much t o increase our understanding. 
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1.1 I n t r o d u c t i o n . 
The r e a l i s a t i o n t h a t diabetes runs i n f a m i l i e s may 
be almost as ancient as awareness of the disease i t s e l f . Hindu 
physicians of the f i r s t century A.D. recognised the c o n d i t i o n 
of mahumeha (honey urine),which seems l i k e l y t o have been 
diabetes m e l l i t u s , a n d mention t h a t i t could be t r a n s m i t t e d from 
f a t h e r t o son (see Simpson,1976,for t r a n s l a t i o n ) . 
Cammidge (1928) considers Rondolet,a s i x t e e n t h 
century physician,to have been the f i r s t Western author t o suggest 
the h e r e d i t a r y transmission of diabetes. I n the next century, 
Richard Morton,an English physician,reported a f a m i l y w i t h f o u r 
out of seven sibs a f f e c t e d by the disease (Morton,1696). 
Other e a r l y w r i t e r s on the subject do not seem to 
have been impressed by f a m i l i a l aggregation. Thomas W i l l i s , 
f o r example,in h i s volume 'Pharmaceutice R a t i o n a l i s or an 
E x e r c i t a t i o n of the Operations of Medicines i n Human Bodies', 
published i n 1679»attributes the disease t o 'good f e l l o w s h i p 
and g u s l i n g down c h i e f l y o f unallayed wine 1 ( e x t r a c t i n Major, 
1959). 
W r i t e r s of the present century were convinced of the 
importance of h e r e d i t y i n diabetes from t h e i r own observations. 
Heredity was,to Naunyn (19O6) a 'red thread which i s i n t e r t w i n e d 
i n diabetes from youth t o o l d age'. J o s l i n (1947) wondered 
whether 'heredity would not be demonstrable i n every case i f 
we had the f a c t s ' . 
This f i r s t chapter i s a review of the extensive body 
of l i t e r a t u r e concerned w i t h the speculat i o n t h a t diabetes,or a 
p r e d i s p o s i t i o n t o diabetes, i s i n h e r i t e d . 
7 
1.2 Proposed h e r e d i t a r y mechanisms f o r diabetes m e l l i t u s . 
Estimates of the percentages of d i a b e t i c s g i v i n g 
a p o s i t i v e f a m i l y h i s t o r y of the disease were published by 
many physicians i n the f i r s t three decades of t h i s century. 
Wright (1931) provides a u s e f u l l i s t of these papers. The 
f i r s t demonstration,however,that the r e l a t i v e s of d i a b e t i c s 
were s i g n i f i c a n t l y more o f t e n a f f e c t e d than the r e l a t i v e s of 
non-diabetic c o n t r o l s was made by Gregory Pincus and P r i s c i l l a 
White i n 1933« Although t h e i r conclusion t h a t the disease 
was i n h e r i t e d as an autosomal recessive was not new,Pincus 
and White were the f i r s t t o consider the question of the 
v a r i a b l e age a t onset of the c o n d i t i o n by the comparison of 
age-matched i n d i v i d u a l s . 
The concept of a recessive mode of i n h e r i t a n c e f o r 
diabetes was supported by several subsequent papers,including 
an important review by Steinberg (1959)• Other p u b l i c a t i o n s 
advocated alternatives,however,and soon every known mode of 
in h e r i t a n c e had been proposed. Table 1.1 l i s t s the most important 
of these p u b l i c a t i o n s . 
(a) Recessive i n h e r i t a n c e . 
Not a l l d i a b e t i c s have a f f e c t e d parents or a f f e c t e d 
children,though they may have a f f e c t e d grandparents or a f f e c t e d 
grandchildren. This phenomenon of the disease 'skipping a 
generation' suggested t h a t diabetes was not due t o a simple 
autosomal dominant gene and t h a t i t might be due t o a recessive. 
Assuming t h a t the disease i s due t o a s i n g l e 
recessive a l l e l e (m) segregating a t an autosomal locus w i t h 
Table 1.1 Pedigree a n a l y s i s i n diabetes m e l l i t u s 
(a) Autosomal recessive i n h e r i t a n c e 
A l l a n (1933) 
Pincus and White (1933) 
Pincus and White (1934) 
Steinberg and Wilder (1952) 
Thompson and Watson (1952) 
Grunnet (1957) 
(b) Autosomal dominant i n h e r i t a n c e 
L e v i t and Pessikova (1934) 
Burnstein and Patterson (1949) 
von Kries (1953) 
Vallance-Owen (1964) 
( c ) Sex-linked i n h e r i t a n c e 
Penrose and Watson (1954) 
(d) Autosomal co-dominant 
Cammidge (1934) 
H a r r i s (1950) 
Post (1962) 
N i l s s o n (1962) 
Nilsson (1964) 
B a r r a i and Cann (1965) 
Steinberg (1968) 
Pavel and Pieptea (1966) 
Roy e t a l (1966) 
O'Brien e t a l (1967) 
Stimmler and E l l i o t t (1964) 
E h r l i c h and M a r t i n (1966) 
(e) One ma.jor gene and n o n - a l l e l i c m o d i f i e r s 
Lamy e t a l (l96l) 
( f ) Polygenic 
Keen (1957) 
Simpson (1964) 
Thompson (1965) 
Neel e t a l (1965) 
Falconer (1967) 
Smith e t a l (1972) 
(g) E f f e c t of a s i n g l e dose of a gene which,in the homozygous s t a t e . 
gives a recognised,rare abnormality 
S w i f t e t a l (1972) Fraser (1973) 
(h) Early-onset diabetes the r e s u l t of a major gene,late-onset diabetes 
e i t h e r u n i f a c t o r i a l or m u l t i f a c t o r i a l 
Goodman and Chung (1975) 
i t s normal counterpart (M),then a l l d i a b e t i c i n d i v i d u a l s must 
be g e n e t i c a l l y mm,and,discounting any mut a t i o n a l events of M 
to m,all d i a b e t i c s have parents who are e i t h e r Mm or mm. Thus, 
d i a b e t i c s r e s u l t from the mating Mm x Mm,where n e i t h e r parent 
i s affected,from the mating Mm x mm.where one parent i s a f f e c t e d 
and from the mating nam x ram,where both parents are a f f e c t e d . 
These three i n f o r m a t i v e matings w i l l produce 
d i f f e r e n t frequencies of a f f e c t e d sibs of a d i a b e t i c propositus 
and i t was the a n a l y s i s of these frequencies which formed the 
corner-stone of the argument f o r the recessive gene hypothesis. 
Pincus and White (1933) included data from 523 
f a m i l i e s of d i a b e t i c p r o p o s i t i and from 153 c o n t r o l s ("non-
d i a b e t i c p a t i e n t s ' ) . The numbers of a f f e c t e d and unaffected 
r e l a t i v e s were ascertained by i n t e r v i e w - q u e s t i o n n a i r e . The age 
a t onset of the a f f e c t e d r e l a t i v e s and d e t a i l s of the current 
age or age a t death of a f f e c t e d and unaffected r e l a t i v e s were 
also recorded. They compared the incidence of the disease by 
decade of cu r r e n t age ( o r age a t death) i n parents and sibs of 
the d i a b e t i c and of the non-diabetic p r o p o s i t i , f i n d i n g t h a t i n 
no decade d i d the incidence of the disease i n the r e l a t i v e s of 
the non-diabetics exceed t h a t i n the r e l a t i v e s o f d i a b e t i c s . 
I n t e s t i n g the data against the p r e d i c t i o n s of a 
recessive a l l e l e hypothesis they ignored the only two f a m i l i e s 
they had of the mm x mm mating and considered 440 sibships 
from the h y p o t h e t i c a l Mm x Mm mating and 81 from the Mm x mm 
type. The p o s s i b i l i t y o f mm parents being m i s c l a s s i f i e d as 
Mm was mentioned but ignored i n the a n a l y s i s . 
Since ascertainment was through an mm c h i l d , t h e 
expectation of mm among the sibs of the propositus i s -
P 
1 - ( q ) n 
where p i s the p r o b a b i l i t y of an mm i n d i v i d u a l 
appearing (0.25 i n the Mm x Mm mating),q i s the p r o b a b i l i t y 
of an mm i n d i v i d u a l not appearing ( l - p) and n i s the number 
of c h i l d r e n per f a m i l y . 
I n a l l the various sized f a m i l i e s the expected numbers 
of nun individuals,assuming a recessive a l l e l e hypothesis,may 
thus be c a l c u l a t e d and,ignoring the p r o p o s i t i , t h e expected 
numbers of mm sibs may be a l l o t e d t o decades according t o the 
observed numbers of sibs present. By summing across the f a m i l i e s 
the expected numbers of mm sibs i n each decade may be obtained. 
These mm s i b s , a r e , g e n e t i c a l l y , p o t e n t i a l d i a b e t i c s , i n order t o 
c a l c u l a t e the expected number ma n i f e s t i n g the c o n d i t i o n i n each 
successive decade,age incidence t a b l e s from d i a b e t i c c l i n i c s 
and percentage s u r v i v a l t a b l e s f o r the general popul a t i o n were 
used. 
Two assumptions were necessary f o r t h i s c a l c u l a t i o n -
f i r s t l y , t h a t p o t e n t i a l d i a b e t i c s , b e f o r e the development of the 
disease,are subject t o the same chances of death as other members 
of the popula t i o n and,secondly,that a l l mm i n d i v i d u a l s w i l l 
manifest the c o n d i t i o n by the end of the n i n t h decade. 
By means of these c a l c u l a t i o n s the authors derived 
expected numbers of i d e n t i f i a b l y d i a b e t i c s i b l i n g s i n each 
decade. Summation of these expected numbers over a l l decades 
produced close agreement w i t h the numbers observed (64.98 
expected a f f e c t e d s i b l i n g s i n the Mm x Mm mating compared 
II 
w i t h 64 observed,and 52.85 expected a f f e c t e d s i b l i n g s i n the 
Mm x mm mating compared w i t h 32 observed). 
The authors expressed some s u r p r i s e a t t h i s close 
agreement and were c r i t i c a l of the i n t e r v i e w - q u e s t i o n n a i r e 
approach they had used. I n a l a t e r r e p o r t of the use of glucose 
tolerance t e s t s i n close r e l a t i v e s of diabetics,however,(Pincus 
and White,1934),they r e i t e r a t e d t h e i r b e l i e f t h a t diabetes was 
r e c e s s i v e l y i n h e r i t e d , a l t h o u g h they conceded t h a t the r e s u l t s 
were i n accordance w i t h a dominant mode of i n h e r i t a n c e w i t h 
' l i m i t e d expression' of the gene. 
Thompson and Watson (1952) also compared the r a t i o 
of a f f e c t e d o f f s p r i n g from Mm x Mm matings and Mm x mm matings 
and found good agreement w i t h the 1:2 values p r e d i c t e d by the 
recessive a l l e l e hypothesis. 
The review of the subject published by Steinberg 
i n 1959 supported the concept of recessive i n h e r i t a n c e and r e -
analysed the data of advocates of other modes of i n h e r i t a n c e 
t o show t h a t they were not incompatible w i t h t h i s view. There 
are many c r i t i c i s m s which can be l e v e l l e d against the recessive 
a l l e l e hypothesis,however,and i t i s no longer tenable. 
F i r s t l y , i t i s d i f f i c u l t to e x p l a i n the d i f f e r e n c e 
between e a r l y - o n s e t , i n s u l i n - r e q u i r i n g diabetes and l a t e - o n s e t , 
insulin-independent diabetes on the basis of t h e i r both being 
due to the same genotype,without i n t r o d u c i n g a d d i t i o n a l modifying 
factors,environmental or genetic. With the i n t r o d u c t i o n of these 
f a c t o r s the hypothesis moves away from the simple recessive gene 
idea. 
I n a d d i t i o n , a l t h o u g h the m a j o r i t y of f a m i l i e s do 
not show transmission o f the disease through consecutive 
generations,there are some published pedigrees w i t h a f f e c t e d 
persons i n three and f o u r generations ( Pavel and Pieptea,1966) 
and even i n f i v e generations (Burnstein and Patterson,1949)• 
I f these r e p o r t s are t o be believed t h e n , c l e a r l y , s i m p l e recessive 
i n h e r i t a n c e i s u n l i k e l y or diabetes i s a g e n e t i c a l l y heterogeneous 
group of d i s o r d e r s . 
T h i r d l y , a c c o r d i n g to the recessive a l l e l e hypothesis, 
a l l the c h i l d r e n of conjugal d i a b e t i c s w i l l be of the genotype 
mm so t h a t they should a l l develop diabetes. They do not,however, 
a phenomenon J o s l i n a t t r i b u t e d t o t h e i r dying 'too soon of other 
causes' (Joslin,1947)• Other authors (e.g. Nilsson,1962) concede 
t h a t i t i s d i f f i c u l t t o e x p l a i n t h i s d e f i c i t w ithout i n v o k i n g 
a d d i t i o n a l modifying mechanisms. 
Post (1962) considered t h i s unnecessary and t h a t the 
observed number of a f f e c t e d progeny from such marriages was not 
s i g n i f i c a n t l y d i f f e r e n t from t h a t expected when appropriate 
c o r r e c t i o n s were made f o r the age-structure of the group of 
o f f s p r i n g and f o r the p r o b a b i l i t y of death before diagnosis. 
I t has been observed (Neel,1976) t h a t the numbers of o f f s p r i n g 
from these unusual matings i s so small t h a t i t i s d i f f i c u l t t o 
d i s t i n g u i s h w i t h any accuracy one genetic hypothesis from 
another. 
I n some cases (Nilsson,1962;Barrai and Cann,1965) 
a n a l y s i s of segregation data was considered t o be compatible 
w i t h more than one genetic hypothesis. N i l s s o n s t a t e d t h a t 
'the values f i t i n best w i t h an autosomal recessive hypothesis, 
though the r e s u l t s of the a n a l y s i s are also to a c e r t a i n degree 
compatible w i t h a dominant gene of low penetrance'. Further 
i n v e s t i g a t i o n w i t h a l a r g e r sample (Nilsson,1964) was unable 
r 
t o produce a f i r m e r conclusion. Barai and Cann were able to 
f i t the data they analysed (taken from Simpson,1962) to recessive 
and polygenic models. 
(b) Dominant i n h e r i t a n c e . 
The advocates of dominant i n h e r i t a n c e have the 
problem o f e x p l a i n i n g the large numbers of parents and c h i l d r e n 
of d i a b e t i c s who are not a f f e c t e d themselves. The only way t o 
do t h i s i s t o p o s t u l a t e a g r e a t l y reduced penetrance f o r the a l l e l e 
i n question. L e v i t and Pessikova (1934) suggested t h a t only 
lO/o of i n d i v i d u a l s c a r r y i n g the gene a c t u a l l y develop diabetes. 
Once one r e s o r t s t o t h i s 'escape clause' (Edwards, 
1969) the hypothesis i s no longer one of a simple dominant gene. 
There are only two possible reasons f o r the r e d u c t i o n of 
penetrance - the a c t i o n o f the environment or the i n f l u e n c e 
of other genes. I n the case of the f i r s t , t h e mechanism i s then 
m u l t i f a c t o r i a l , w i t h the second,a major gene w i t h m o d i f i e r s . At 
the l e v e l of penetrance proposed by L e v i t and Pessikova the 
hypothesis i s i n d i s t i n g u i s h a b l e from m u l t i f a c t o r i a l i n h e r i t a n c e . 
I n t h e i r a n a l y s i s of f a m i l y data von K r i e s (1953) 
and L e v i t and Pessikova (1934) considered dominant i n h e r i t a n c e 
more l i k e l y than recessive because the prevalence of the 
disease among parents of the probands i n t h e i r sample was as 
great as t h a t amongst s i b s . I t was pointed out,however,(Steinberg, 
1959) t h a t the ages of these i n d i v i d u a l s had not been taken i n t o 
account and t h a t the frequency of a f f e c t e d s i b l i n g s would 
increase w i t h time and be great e r than t h a t amongst the p a r e n t a l 
group when these two groups were comparable i n terms of age. 
The most appealing suggestion f o r the dominant 
i n h e r i t a n c e of diabetes came w i t h the d e s c r i p t i o n o f 'synalbumin 
antagonist' (Vallance Owen,1964). Here was a s i n g l e f a c t o r , 
dominantly i n h e r i t e d , w h i c h i n t e r f e r e d w i t h the p h y s i o l o g i c a l 
a c t i o n of i n s u l i n and explained the pathogenesis of carbohydrate 
i n t o l e r a n c e and i t s i n h e r i t a n c e i n an elegant manner. U n f o r t u n a t e l y 
the i d e n t i f i c a t i o n of t h i s i n s u l i n antagonist i n es t a b l i s h e d 
d i a b e t i c s was not u n i v e r s a l l y reproducible (Keen,1963;Cameron 
et al,1964 and Levin and Recant,1967) and synalbumin-positive 
i n d i v i d u a l s without diabetes have been reported (Levin and 
Recant,1967). 
( c ) Sex-linked i n h e r i t a n c e . 
I n t h e i r a n a l y s i s of the f a m i l i e s of 500 d i a b e t i c s , 
Penrose and Watson (1945) found a s i g n i f i c a n t d e f i c i t of brot h e r 
s i s t e r d i a b e t i c p a i r s compared-with p a i r s of a f f e c t e d , l i k e - s e x e d 
s i b l i n g s . This f i n d i n g prompted them to suggest a sex-linked 
element i n the i n h e r i t a n c e of the c o n d i t i o n . 
I f diabetes were due t o a major gene and t h i s were 
present on the X chromosome,there would be no i n h e r i t a n c e of the 
c o n d i t i o n by a son from h i s f a t h e r . This was not the c a s e , r a i s i n g 
the p o s s i b i l i t y t h a t the major genetic determinant was autosomal 
but t h a t sex-linked modifying genes were present. I f p a r t of the 
a c t i o n o f these m o d i f i e r s was i n terms of age a t o n s e t , t h i s age 
should be more h i g h l y c o r r e l a t e d i n like-sexed p a r e n t - o f f s p r i n g 
combinations than i n unlike-sexed p a r e n t - o f f s p r i n g combinations. 
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Penrose and V/atson's i n i t i a l report suggested t h i s . 
A further report from the same centre (Thompson 
and V/atson,1952) analysing data on 1,631 families of diabetics 
which included the o r i g i n a l 500»failed to confirm a si g n i f i c a n t 
d e f i c i t of^like-sexed affected sib pairs,and the authors considered 
the small discrepancy with respect to sex was due to d i f f e r e n t i a l 
prevalence of the condition i n the two sexes. The hypothesis of 
sex-linked inheritance of diabetes has,therefore,been abandoned. 
(d) Co-dominant inheritance. 
Following e a r l i e r suggestions (Cammidge 1928 and 
1934)*Harris (1950) tackled the problem of c l i n i c a l heterogeneity 
i n the disease by considering that the early-onset form of the 
disease (diagnosed before the age of thirty)was due to the presence 
of an abnormal a l l e l e i n the homozygous state. The late-onset 
form of the disease was considered to be the result of the 
inheritance of t h i s same a l l e l e with i t s normal counterpart. 
Harris studied family h i s t o r i e s from 1,241 diabetics and found 
that 7$ of the sibs of early-onset propositi had developed the 
disease by the time they were forty,whereas only 1.3$ of the sibs 
of late-onset propositi had become diabetic by t h i s age. 
This hypothesis was supported by the f i n d i n g of 
greater consanguinity among the parents of early-onset propositi 
than among the parents of late-onset p r o p o s i t i . A similar 
f i n d i n g was reported by Thompson and Watson (1952) who found 
that 0.88$ of the parents of early-onset diabetics were f i r s t 
cousins and 0.43$ of the parents of late-onset p r o p o s i t i . The 
number of f i r s t cousin marriages i n the whole sample was,however, 
only nine. 
I t haB been pointed out (Steinberg,1959) that, 
according to Harris 1 hypothesis,the disease should be more frequent 
among the parents of early-onset cases than among the parents of 
late-onset patients. This prediction was not supported i n the 
analysis of the data of Steinberg and Wilder (1952) nor i n the 
analysis of Harris' data by these authors. 
Steinberg also points out (Steinberg,1959) that the 
frequencies of the affected sibs of diabetics should be greater 
when the disease i n the propositus i s early-onset than when i t 
i s late and that t h i s tendency should be independent of the 
a f f e c t i o n status of the parent. I n an analysis of three sets 
of data,however,(that of Harris,1950;Thompson and Watson,1952, 
and Steinberg and Wilder,1952),Steinberg demonstrates that, 
although frequency of affected sibs is,indeed,dependent upon 
the age at onset i n the propositus,it i s also dependent upon 
whether one or neither parent i s diabetic. I n t h i s analysis 
Steinberg did not consider the current ages of siblings or parents 
and was considering c l i n i c a l l y diagnosed diabetics rather than 
indivdiduals assessed by a glucose tolerance t e s t . 
Following the lead of Vallance-Owen,Ehrlich and Martin 
(1966) studied the plasma of non-diabetic sibs of diabetic children, 
a small sample of t h e i r parents and ten controls ('children with 
no obvious endocrine disorder selected at random from the wards 
of the Hospital f o r Sick Children'). The number of individuals 
positive f o r synalbumin antagonist i n each group suggested that 
the phenomenon was inherited as an autosomal co-dominant. 
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(e) One major gene with non-allelic modifiers. 
I t was suggested by Lamy et a l (l96l) t h a t , i n the 
majority of cases,the diabetic phenotype i s the result of the 
action of a major gene with non-allelic modifiers but t h a t , i n 
some instances,if enough modifiers are present,the major gene 
i s unnecessary. I n the l a t t e r instance the modifying genes are 
acting as components i n a polygenic system. The d i s t i n c t i o n 
between t h i s hypothesis and that of polygenic inheritance i s 
largely a matter of semantics. 
( f ) Polygenic inheritance. 
The terms 'polygenic' and ' m u l t i f a c t o r i a l ' are 
often used synonymously. I t i s useful,however,to d i f f e r e n t i a t e 
between the two terms i n the manner suggested by Carter (1969). 
He uses the term 'polygenic' to refer to a genetic component 
involving a l l e l e s at more than one locus and reserves 
' m u l t i f a c t o r i a l ' to include environmental as well as genetic 
factors. 
Advocates of single gene inheritance tended to 
view diabetes as a qu a l i t a t i v e t r a i t with the abnormal clearly 
d i f f e r e n t i a t e d from the normal. I f glucose tolerance i s taken 
to be the indicator of the diabetic state,however,diabetics 
are recognised as individuals i n that portion of the population 
beyond an a r b i t r a r y threshold imposed upon a continuously 
varying character. Edwards (1960) has pointed out that such 
quasi-continuous traits,when common and familial,may simulate 
single factor inheritance so i t i s hardly surprising that 
family data are compatible with several simple genetic models. 
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This continuous d i s t r i b u t i o n of glucose tolerance 
has been demonstrated by Neel et a l (1965) and by Thompson 
(1965),who performed glucose tolerance tests on the f i r s t degree 
rela t i v e s of diabetics (Thompson) and on individuals without 
a positive family history of diabetes (both groups). I t was 
suggested that t h i s a t t r i b u t e was influenced by a large number 
of factors,genetic as well as environmental,in much the same 
way as height or I.Q. 
This f i n d i n g has been challenged by Steinberg et 
a l (1970) and by Rushforth et a l (1971) who considered that, 
even i f the d i s t r i b u t i o n were b i - or tri-modal,the number of 
abnormal individuals,even i n a sample of f i r s t degree relatives 
of diabetics,would be so small that any discontinuity would be 
l o s t . Accordingly,they directed t h e i r attention to groups with a 
very high prevalence of glucose tolerance abnormalities - the 
Pima Indians of Arizona and Asiatic Indians resident i n South 
Africa (the l a t t e r from unpublished data of Jackson and 
Campbell). In both populations,individuals over the age of 45 
showed a bimodal d i s t r i b u t i o n of the l o & ^ o v a ^ u e s °^ blood 
sugar two hours a f t e r the loading dose. 
This bimodality of response does not necessarily 
indicate the effe c t of a major gene,however,but merely s i g n i f i e s 
the presence of two clearly i d e n t i f i a b l e phenotypes. This could 
be accounted f o r by an environmental difference and i t i s only 
when environmental variables have been standardised over the 
whole population that a bimodal d i s t r i b u t i o n i s indicative of 
a major gene ef f e c t (Thompson,1965). 
A m u l t i f a c t o r i a l aetiology,with a polygenic hereditary 
component has proved a useful working hypothesis f o r diabetes 
since the concept of h e r i t a b i l i t y can be applied to estimate 
the magnitude of the genetic contribution (Falconer,1965 and 
1967)»to predict the risks of recurrence i n relatives (Falconer, 
1967;Darlow et al,1973;Smith,1971 and 1972) and f o r the 
investigation of genetic heterogeneity w i t h i n the disease 
(Smith,1976). Some observations on the occurrence of diabetes 
within families can best be explained i n terms of t h i s type of 
inheritance. The f i r s t degree r e l a t i v e s of propositi who develop 
t h e i r diabetes before the age of 20 are more l i k e l y to be 
affected by the disease than the r e l a t i v e s of propositi with 
diabetes of l a t e r onset (Harris,1950,and Simpson,1964). This 
effec t can be explained i f i t i s assumed that early-onset cases 
have inherited a larger number of 'risk factors' so that f i r s t 
degree rel a t i v e s w i l l also tend to have a larger number of such 
factors and thus be at a greater r i s k of developing the disease. 
(g) Effect of a single dose of a gene which,in the homozygous 
state,gives a recognised,rare abnormality. 
There are many conditions,apparently determined by 
single genes,which give r i s e to syndromes with diabetes mellitus 
as a component part. A f u l l l i s t of these would be out of place 
i n t h i s account but may be found i n the review by Rimoin and 
Schimke (1971),together with the references to the o r i g i n a l 
descriptions. I t i s not an unreasonable hypothesis that the 
heterozygotes f o r these genes are at a greater r i s k with regard 
to developing diabetes. 
H a l l e t t et a l (1965) investigated the diabetics 
amongst 132 parents of children with cystic f i b r o s i s . They 
compared the prevalence of the disease i n t h i s group with that 
i n 118 parents of unaffected children (neighbours of the affected 
i n d i v i d u a l s ) . They found three diabetics amongst the cystic 
f i b r o s i s gene carriers and none amongst the controls but concluded 
that there was no s t a t i s t i c a l l y s i g n i f i c a n t excess of diabetics 
i n the c a r r i e r group. 
Swift et a l (1974) pointed out that,assuming a 
prevalence of l^o f o r diabetes i n the United States i n individuals 
of the same age group as the control parents used by H a l l e t t et 
al,about one affected individual would be expected i n a group 
of 118. I f the carriers of the cystic f i b r o s i s gene were three 
times more susceptible to diabetes then the observed number of 
cases i n the c a r r i e r group would be the res u l t expected. That 
t h i s result was not s i g n i f i c a n t was only the result of the small 
sample considered. Restriction of sample size i s inevitable i f 
only obligatory heterozygotes are used and the group can be 
enlarged by the inclusion of more distant r e l a t i v e s who have a 
certain,calculable p r o b a b i l i t y of being heterozygotes. 
Swift had already done t h i s (Swift,1971 and 1972) 
by considering the prevalence of neoplastic disease and of 
c l i n i c a l l y diagnosed diabetes i n a l l r e l a t i v e s whose prob a b i l i t y 
of being heterozygote f o r the gene f o r Panconi's anaemia was 
greater than 0.123. The result of t h i s investigation was the claim 
that the females had a s i x - f o l d r i s k of developing diabetes 
compared with age-matched controls from the general population. 
Panconi's anaemia i s not one of the conditions known to be 
associated with diabetes i n the homozygous state but Swift 
suggested that the affected individuals died before diabetes 
became manifest. 
Edwards (1973) f e l t that the increased incidence of 
diabetes i n these female relatives was solely a consequence of 
the fact that the r i s k of becoming diabetic and of being included 
as the parent of a c h i l d with a rare recessive condition are both 
related to p a r i t y . Praser (1973) f e l t that the point was v a l i d 
though the magnitude of the bias exaggerated. He suggested 
that Swift's results be compared,not with the prevalence 
figures f o r the general population,but with data from the 
rel a t i v e s of normal children. Swift (1973) pointed out that 
the sample of female r e l a t i v e s found to have an increased r i s k 
of diabetes included,not only mothers,grandmothers and great-
grandmothers but also s i s t e r s , a u n t s , f i r s t cousins,grandparents' 
sisters and female f i r s t cousins once removed. The p r o b a b i l i t y 
of ascertaining these r e l a t i v e s was independent of t h e i r own 
p a r i t y . 
This l i n e of investigation i s i n t r i g u i n g and i s 
of p r a c t i c a l as well as theoretical importance,for such hetero-
zygotes make up a s i g n i f i c a n t proportion of the general population. 
The frequency of heterozygotes f o r cystic f i b r o s i s amongst white 
residents of the United States,for example,is estimated at about 
4% (Ha l l e t t et al,1965). The question is,as yet,unresolved. 
(h) Early-onset diabetes the res u l t of a ma.jor gene,late-onset 
diabetes either u n i f a c t o r i a l or m u l t i f a c t o r i a l . 
Using the technique of complex segregation analysis, 
claimed to d i f f e r e n t i a t e between inheritance by a single gene and 
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by a polygenic system (Rao et al,1975),Goodman and Chung (1975) 
studied questionnaire information on the f i r s t degree rel a t i v e s 
of 6,559 diabetic p r o p o s i t i . The families were grouped,according 
to the propositus' age at diagnosis,into early-onset (0 - 19 y r s ) , 
middle-onset (20 - 39 yrs) and late-onset (over 40 y r s ) . The 
estimate of h e r i t a b i l i t y i n the early-onset group was so high 
(0.99) t h a t , i n accordance with the views of previous writers 
(Morton,1967,and Smith,1971(b)),they considered that the condition 
was due to the segregation of a major gene. The considerably 
lower h e r i t a b i l i t y estimates f o r the two later-onset groups 
allowed them to f i t either a single locus hypothesis,with 
penetrance qualifications,or a m u l t i f a c t o r i a l hypothesis. 
Despite considerable e f f o r t i n the f i e l d of pedigree 
analysis a single mode of inheritance f o r diabetes has never 
been convincingly demonstrated. The main reasons f o r t h i s 
f a i l u r e are:-
( i ) Lack of recognition of the genetic 
heterogeneity of the group of individuals labelled 'diabetic', 
or the use of sub-divisional c r i t e r i a which are not v a l i d 
genetically. 
( i i ) Ignorance of the fundamental lesion responsible 
f o r the various sub-types of the disease and the influence of 
environmental factors on the phenotype. 
( i i i ) Failure to agree upon d e f i n i t i o n s of 
abnormality. 
( i v ) The analysis of pedigree data based on the 
assumption that dibetes i s a q u a l i t a t i v e t r a i t . 
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(v) Failure to take i n t o account the variable age 
at onset of the disease. 
1.5 The d e f i n i t i o n of diabetes. 
Although other features of the disease,especially 
cardiovascular abnormalities,are currently of prime importance 
with regard to the morbidity and mortality of diabetes,and 
other metabolic disturbances are as marked as that of the control 
of blood glucose,it i s on the basis of abnormality of blood 
glucose control that diabetes i s customarily defined. 
glucose tolerance test but,despite wide use of t h i s investigation, 
there i s l i t t l e conformity either i n the d e f i n i t i o n of abnormality 
or i n the standardisation of factors which may influence the 
r e s u l t . 
the B r i t i s h Diabetic Association by Fitzgerald and Keen (1964) 
and endorsed by the World Health Organisation (W.H.O.,1965) 
are that c a p i l l a r y blood glucose at two hours a f t e r the oral 
administration of 50 grams of glucose should not exceed 6.7mmol/l 
and that the peak of blood glucose should not be greater than 
10.0mmol/l. The suggested upper l i m i t of normality at two hours 
has been raised to 7«5n™°l/l as a resu l t of follow-up of 
borderline cases i n the Birmingham diabetes survey (FitzGerald, 
1976). Different upper l i m i t s of(abnormality have been used 
by other workers (e.g.Kobberling et al,1969). 
Several single figure indices which describe 
characteristics of the glucose tolerance curve have been 
This control i s most conveniently measured by the 
The standards of lormality suggested on behalf of 
> 
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advocated. These have several advantages i n that they eliminate 
the ambiguity of individuals abnormal with regard to one c r i t e r i o n 
blood value but normal with regard to the other,make graphical 
display of the d i s t r i b u t i o n of response i n a population 
considerably easier and simplify the consideration of change 
i n the glucose tolerance of an individual with time. 
The simplest of these - the two hour blood glucose 
value (Steinberg et al,1970,and Rushforth et al,197l) conveys 
nothing about the shape of the curve and has l i t t l e , o t h e r than 
s i m p l i c i t y , t o recommend i t . 
J a r r e t t and Graver (1968) measured the area under 
the curve by means of a formula:-
area = a + 2b + 2c + 2d + e 
where a i s the f a s t i n g blood sugar and b,c,d and e 
are subsequent half hour measurements. As pointed out by Billewicz 
et a l (1973)tthis figure i s disproportioately influenced by the 
absolute value of the f a s t i n g blood glucose. 
The H index (Billewicz et al,1973) i s an expression 
of the shape of the curve taking two of i t s most important 
features i n t o consideration - the time taken to reach the peak 
and the degree to which f a s t i n g blood sugar level i s regained 
withi n the two-hour test period. I t i s independent of the absolute 
value of blood glucose at the peak and the f a s t i n g blood glucose. 
Comparison with assessments by other c r i t e r i a (those 
of PitzGerald and Keen,1964) show that i t gives c l i n i c a l l y 
useful results. I t s main advantage,however,is not greater 
accuracy of diagnosis but the fact that i t i s independent of 
the absolute level of f a s t i n g blood glucose,site of sampling, 
as. 
method of measurement of blood glucose,loading dose and absolute 
value of peak blood glucose. The value of H correlates quite 
well ( r = 0.68) with the mathematically more complex estimate 
of the ef f i c i e n c y of homeostatic control of blood glucose 
derived by Ackerman et a l (1964). 
Stringent rules f o r the conduct of the oral glucose 
tolerance test are l a i d down by FitzGerald and Keen (1964) but 
i t i s not often emphasised i n family and epidemiological studies 
that these are adhered t o . I n addition,many other factors,age, 
time of day,current medication etc.,are known to influence the 
result (Jarret,1973) but are often paid scant attention. 
1.4 Heterogeneity and lack of precise knowledge of pathogenesis. 
Before the immunological and immunogenetic studies of 
the past few years,the major sub-division of diabetes was on the 
basis of age at onset and treatment. Two major forms were thus 
defined. Juvenile-onset diabetes (J.0.D.,juvenile diabetes 
mellitus (j.D.M.),early-onset diabetes,or classical diabetes) 
was recognised as that form of the disease which presented before 
a certain age (from 20 to 45,depending on the author concerned), 
was rapid i n onset,with symptoms of polyuria,polydypsia and 
weight loss,a tendency to ketoacidosis and a requirement f o r 
treatment with i n s u l i n . The other major sub-type - maturity-
onset diabetes (M.O.D.,adult- or late-onset diabetes) - was 
diabetes presenting a f t e r t h i s age,with mild or absent symptoms, 
often associated with obesity without the requirement f o r i n s u l i n . 
The implication from t h i s c l a s s i f i c a t i o n was that juvenile-onset and 
X\o. 
maturity-onset diabetes were genetically and ae t i o l o g i c a l l y 
d i f f e r e n t . 
This sub-division was unsatisfactory i n many ways. 
An a r b i t r a r y age limit,wherever i t i s set,is unlikely to 
distinguish e f f e c t i v e l y between two diseases and some individuals 
diagnosed a f t e r the c r i t i c a l age may require i n s u l i n therapy 
whereas other individuals diagnosed before t h i s age may be 
treated perfectly well without i t . 
I n addition,the treatment of diabetes i s not 
immutable and may be the result of the preferences of the 
physician i n charge. Individuals may commence t h e i r treatment 
with diet or oral hypoglycaemics and progress to i n s u l i n or 
vice versa and other patients,adequately controlled without i n s u l i n 
f o r the greater part of the time may require i n s u l i n during times 
of stress,such as in f e c t i o n . 
Techniques fo r the detection of c i r c u l a t i n g a n t i -
bodies directed against the insulin-producing c e l l s and the 
study of the major histocompatibility locus antigens i n diabetics 
have contributed to our understanding of the sub-division of 
diabetes although the s i t u a t i o n i s s t i l l f l u i d with many 
unresolved questions. The possible sub-types of diabetes w i l l 
be discussed i n the order i n which they appear i n table 1.2. 
This i s a suggested working c l a s s i f i c a t i o n of diabetes based, 
with some modification,on that given by Cudworth (1976). 
(a) Congenital diabetes. 
I t i s uncertain whether t r u l y congenital diabetes 
exists although Laurence and Dodge (1975) report an infant who 
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Table 1.2 Genetic and aetiolo g i c a l c l a s s i f i c a t i o n of diabetes. 
PRIMARY DIABETES 
(a) Congenital diabetes 
(b) Diabetes associated with recognised genetic 
syndromes. 
(c) Maturity-onset diabetes i n young people (M.O.D.Y.) 
(d) Type I diabetes mellitus 
(e) Type I I diabetes mellitus 
SECONDARY DIABETES 
Diabetes associated with obesity,pancreatitis or as a 
result of medication,acromegaly etc. 
a 6 
died shortly a f t e r b i r t h i n diabetic coma and i n whom autopsy 
revealed a complete absence of the i s l e t s of Langerhans. One 
of the child's brothers had died i n similar circumstances although 
no post-mortem evidence was available i n t h i s case. 
MacDonald (1974) has written on the subject of 
diabetes i n the f i r s t month of l i f e giving references to 32 case 
i 
reports. He concludes that i n the affected cases small f o r 
i 
dates there was mention of neonatal diabetes amongst siblings 
or cousins i n four out of eight cases f o r whom family information 
• i was available. Affected cases not small f o r dates were found 
not to have a family history of the condition. 
Diabetes was not permanent i n every case and those 
of normal birth-weight or above tended to have transient diabetes. 
Whether t h i s diabetes of early l i f e i s a d i s t i n c t genetic e n t i t y 
or whether i t i s related to intra-uterine i n f e c t i o n i s unknown. 
(b) Diabetes associated with recognised genetic syndromes. 
Several syndromes,with recognised genetic or chromosomal 
aetiology,have been described as associated with abnormalities of 
glucose tolerance,with or without symptoms of diabetes. These 
comprise about Vfo of c l i n i c a l cases of dia.betes (Neel,1976),and 
have been mentioned before (section 1.2(g)). 
I t i s d i f f i c u l t to draw any f i r m conclusions as to 
the relationship between the basic genetic defect and the 
development of diabetes i n these conditions. I n some cases,ataxia 
telangiectasia,for example,there i s i n s u l i n resistance similar to 
that found i n some cases of type I I diabetes (see below),in others 
i n s u l i n deficiency seems to be the resul t of secondary pancreatic 
degeneration,cystic f i b r o s i s , f o r example (Rimoin,1976). The 
mechanism of glucose intolerance i n chromosomal aberations i s 
not clear,(Schbffling and Schade,1976). 
(c) Maturity-onset diabetes i n young people. 
In 1974 T a t t e r s a l l described and named a rare form 
of diabetes characterised by clear autosomal inheritance and 
'mildness' ( i n that i n s u l i n i s rarely required and affected 
individuals seem to escape cardiovascular and neurological 
complications no matter how long the duration of t h e i r disease). 
The name given to t h i s condition was 'maturity-onset diabetes 
of young people' (M.O.D.Y.) since i t was defined as presenting 
before the age of twenty-five. A subsequent report ( T a t t e r s a l l 
and Fajans,1975) confirmed that the inheritance of the disease 
was clearly d i f f e r e n t from that of insulin-dependent diabetes 
presenting i n the same age group. M.O.D.Y. i s an unfortunate 
name since available information indicates that the condition 
i s different,not only from the juvenile-onset,insulin-dependent 
form of the disease but also,in i t s dominant inheritance and 
lack of complications,from maturity-onset,insulin-independent 
diabetes. 
Although the f i r s t to give the condition a name, 
Tat t e r s a l l was not the f i r s t to describe the condition since 
i t i s mentioned i n several early reports (Charles,1907,and 
Cammidge,1928) and may have been the disease segregating through 
several generations i n the families described by Bernstein and 
Patterson (1949) and Pavel and Pieptea (1966). 
The relationship of the condition to other forms 
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of diabetes i s not wholly clear. A recent reviewer (Cudworth, 
1976) included i t i n the same genetic category as type I I 
diabetes,as did I r v i n e (1977) i n his aetiological c l a s s i f i c a t i o n . 
There seems l i t t l e j u s t i f i c a t i o n f o r t h i s . Barbosa (1977) 
suggests a tentative designation of 'type I I I ' diabetes but, 
since an important component of the syndrome - the cardiovascular 
complications - i s lacking,there i s some j u s t i f i c a t i o n f o r not 
regarding i t as diabetes at a l l but using his alternative suggestion 
'maturity-onset type of hyperglycaemia i n the young' (Barbosa,1977)• 
(d) Type I diabetes me l l i t u s . 
Early-onset,insulin-requiring diabetes has long been 
known to be accompanied i n many cases by lymphocytic i n f i l t r a t i o n 
of the I s l e t s of Langerhans (Warren and Root,1925,and Gepts,1965). 
These observations are derived from post-mortem examinations of 
individuals dying as a result of keto-acidotic episodes at the onset 
of t h e i r diabetes. A suggestion that the same process occurs i n 
insulin-requiring diabetics with presentation a f t e r the age of 30 
comes from the report of LeCompte and Legg (1972). 
Significant associations between known auto-immune 
diseases and insulin-dependent diabetes (Ungar et al,1968,and Masi 
et al,1965) have strengthened the b e l i e f that cases of t h i s type of 
diabetes are a e t i o l o g i c a l l y related and that they involve some 
abnormality of the immune response. 
The d e f i n i t i o n of type I diabetes and the exact 
pathological processes involved are s t i l l not t o t a l l y clear 
31 
but the study of the human leucocyte antigen (H.L.A.) frequencies 
of diabetic subjects and the development of immunochemical 
techniques f o r the vis u a l i s a t i o n of pancreatic i s l e t c e l l 
antibodies are contributing greatly. 
The HLA system w i l l be discussed i n d e t a i l i n the next 
chapter but,briefly,evidence has been presented (Cudworth and 
Woodrow,1976) t h a t , i n agreement with the evidence from post-
mortem studies described above,insulin-requiring diabetics,at 
whatever age they are diagnosed,seem to have been subject to the 
same disease process and that they are diff e r e n t , g e n e t i c a l l y , 
from non-insulin-requiring diabetics. 
Several groups have reported the detection of 
ci r c u l a t i n g IgG directed against pancreatic i s l e t c e l l s i n 
insulin-requiring diabetics (Bottazzo et al,1974;MacCuish et a l , 
1974;Lendrum et al,1975,and Lendrum et al,1976). At f i r s t i t 
was considered that these pancreatic i s l e t - c e l l antibodies 
(P.I.C.A.) were only present i n those diabetics with concomitant 
auto-immune disease of other organs (Bottazzo et al,1974>and 
MacCuish et al,1974) but i t was l a t e r realised that the 
phenomenon i s more generalised with detectable antibodies i n 
a l l i nsulin-requiring diabetics immediately a f t e r the onset 
of the disease. With increasing duration of disease the t i t r e 
declines i n most individuals (Lendrum et al,1976). Type I 
diabetes was taken to be the result of auto-immune destruction 
of the insulin-producing c e l l s i n genetically predisposed 
individuals as a result of contact with an unknown environmental 
trigger factor or factors and corresponded,very largely,with 
the previous category of insulin-requiring diabetes (Cudworth, 
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1976). 
Bottazzo and Doniach (1976) suggested a further 
sub-division of t h i s group into a type IA and IB. The former, 
numerically the larger group,was considered to have transient 
c i r c u l a t i n g P.I.C.A. and to be the result of the environmentally 
triggered auto-immune reaction described above. Type IB had 
permanent P.I.C.A. and the propensity f o r the development of 
auto-immune disease of other endocrine organs. 
Irvine (1977) has put forward evidence f o r the 
presence of P.I.C.A. i n some individuals i n i t i a l l y treated with 
oral hypoglycaemics who eventually progress to i n s u l i n therapy. 
These individuals are,therefore,in the same aetiological,and, 
presumably,genetic category as the type I diabetics who commence 
th e i r treatment with i n s u l i n . Irvine (1977) further suggests 
that three sub-groups of the type I diabetes may be recognised -
type la,a rare variety i n which the disease i s the result of auto-
immune destruction of the beta c e l l s as a resul t of a genetic 
diathesis,type Ic,also rare i n which the diathesis i s towards 
direct v i r a l destruction of the beta cel l s with no auto-immune 
reaction and a commoner type l b , i n which both dir e c t v i r a l 
action and subsequent auto-immune destruction take place. 
There has been no demonstration to date of a n t i -
bodies directed s p e c i f i c a l l y against the beta c e l l . The reports 
refered to above have been concerned with antibodies directed 
at a l l i s l e t c e l l s . The demonstration (Bottazzo and Lendrum, 
1976) of antibodies specific to the glucagon- and somatostatin-
producing c e l l s (alpha and delta) suggests that anti-beta c e l l 
antibodies may soon be isolated. 
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P.I.C.A. has been demonstrated i n 1.7$ of the general 
population (Lendrum et al,1976),the significance of t h i s i s 
unknown. 
For some time circumstantial evidence has been available 
suggestive that the environmental t r i g g e r f o r type I diabetes may 
be a virus or one of several viruses. New cases of i n s u l i n -
dependent diabetes are more common i n the autumn and winter months 
(Adams,1926;Gamble and Taylor,1969;Gamble et al,1973,and Bloom et 
al,1975)« This pattern of incidence corresponds with the 
epidemiology of Coxsackie type B4 vi r u s . Gamble et a l (1973) 
reprted neutralising antibodies to Coxsackie types Bl to B5 i n 
the sera of newly-diagnosed insulin-requiring diabetics. 
A disease indistinguishable from human diabetes 
can be produced i n genetically susceptible mice by the i n t r a -
peritoneal i n j e c t i o n of Coxsackie B4 virus (Coleman et al,1973)« 
A prospective study (Dippe et al,1975) f a i l e d to 
support the hypothesis that i n f e c t i o n with the Coxsackie B4 led 
to the development of diabetes although,in choosing an Eskimo 
community f o r t h i s study,lack of genetically susceptible 
individuals may have accounted f o r the f a i l u r e of any infected 
individuals to develop diabetes. 
Other viruses,such as mumps (Khakpour and Nik-Akhtar, 
1975) and rubella (Menser et al,1974),have been implicated i n the 
pathogenesis of type I diabetes and the fact that the disease 
may be produced i n mice by inf e c t i o n with encephalomyocarditis 
virus (Hayashi et al,1974»&nd Bloucher et al,1973) suggests 
that more than one virus may be involved. 
I n a study of 110 early-onset insulin-requiring 
newly-diagnosed diabetics (Cudworth et al,1977) antibody t i t r e s 
to Coxsackie types Bl to B5 were found to be higher i n diabetics 
with certain HLA s p e c i f i c i t i e s (Bwl5 and B8/Bwl5) BW15 positive 
individuals tended to present i n the months of January,February 
and March. There was no correlation of HLA phenotypes or a n t i -
body t i t r e s with c i r c u l a t i n g P.I.C.A. levels. 
The d e f i n i t i o n of type I diabetes rests with the 
demonstration of c i r c u l a t i n g P.I.C.A. but,since t h i s phenomenon 
i s t r a n s i t o r y i n most cases,it i s not possible to cl a s s i f y a l l 
established diabetics i n t h i s manner. I t seems t h a t , i n any 
population of diabetics,the overwhelming majority of i n s u l i n -
taking diabetics and some of those treated with oral hypoglycaemics 
w i l l belong to t h i s category. 
(e) Type I I diabetes. 
There i s very l i t t l e evidence concerning the fundamental 
lesion responsible f o r type I I diabetes and there are some 
indications that i t may be a repository f o r several sub-types. 
Early investigations by Himsworth (1949) suggested 
that there was a group of diabetics who were insensitive to 
exogenous i n s u l i n and whose disease might be the resu l t of the 
lack of effective action of t h e i r own i n s u l i n . The introduction 
of radio-immunoas8ay techniques f o r the measurement of endogenous 
in s u l i n confirmed t h i s view by demonstrating normal or increased 
amounts of c i r c u l a t i n g i n s u l i n i n non-ketosis-prone diabetics 
(Yalow and Berson,1960;Berson and Yalow,196l,and Chiles and 
Tzagournis,1970). 
The f i n d i n g of abnormally elevated serum i n s u l i n 
levels a f t e r a glucose load i n chemically diabetic subjects 
(Jackson et al,1972,and Reaven et al,1972) prompted the 
suggestion that the i n i t i a l lesion i n maturity-onset diabetes 
might be peripheral i n s e n s i t i v i t y to c i r c u l a t i n g i n s u l i n 
(Jackson et al.1972) and that the cardiovascular complications 
seen i n t h i s disease might be the consequence of the resultant 
hyperinsulinaemia (Reaven et al,1972). Although further work 
(Reaven et al,1976) confirmed t h i s feature of chemical diabetes 
and borderline c l i n i c a l diabetes,insulin deficiency was found i n 
some individuals with f l o r i d maturity-onset non-insulin-
requiring diabetes with f a s t i n g hyperglycaemia. Whether t h i s 
represents the normal progression i n t h i s type of diabetes -
from i n s u l i n i n s e n s i t i v i t y to i n s u l i n deficiency by way of beta 
c e l l exhaustion - or whether the type I I category includes at 
least two groups of individuals with regard to i n s u l i n 
effectiveness and i n s u l i n secretion i s not clear. 
I n - v i t r o experiments (Rosenbloom et al,1976) have 
demonstrated that the number of i n s u l i n molecules required to 
activate c e l l receptor sites increases with age and i s also 
greater i n individuals with hereditary conditions characterised 
by precocious ageing (Rothmund's syndrome and progeira). The 
molecular basis f o r t h i s change i s unknown but the work does 
suggest t h a t , i n at least some of,the type I I diabetics,hyper-
glycaemia may be the resul t of accelerated c e l l u l a r ageing 
processes r e s u l t i n g i n peripheral i n s e n s i t i v i t y to c i r c u l a t i n g 
i n s u l i n . 
There i s considerable epidemiological evidence that 
diet contributes to the development of diabetes,especially type 
I I diabetes. The prevalence of the disease d i f f e r s i n groups 
of the same ethnic background l i v i n g under d i f f e r e n t dietary 
circumstances (West and Kalbfleisch,1971;West,1974;Prior, 
1974»and West,1974(a)),and the incidence and mor t a l i t y rates 
i n t h i s country declined during the dietary r e s t r i c t i o n s 
necessitated by the two world wars (Trowell,1974)• I t i s 
uncertain whether increase i n carbohydrate,fat or protein i s 
the major contributor or whether t o t a l c a l o r i f i c intake irrespective 
of source i s the most important factor (West,1975)* Reduction i n 
the vegetable f i b r e content of the diet with increase i n the 
quantity of refined carbohydrate has also been implicated. I t 
i s l i k e l y that several of these factors are involved simultaneously. 
The rapid absorption of refined carbohydrate has been cited as 
antagonistic to c i r c u l a t i n g i n s u l i n (Kiehm et al,1976) whereas a 
die t i n which 75$ of the calories are i n the form of carbohydrate 
but accompanied by a high f i b r e content leads to a lowering of 
fas t i n g blood glucose i n established diabetics and a reduction 
i n i n s u l i n and oral-hypoglycaemic requirements (Kiehm et al,1976). 
I t has been suggested (Jenkins et al,1976) that the addition of 
certain forms of dietary f i b r e to iso-caloric test meals reduces 
post-prandial hypoglycaemia i n established diabetics. 
The implication of dietary factors i n the pathogenesis 
of diabetes does not diminish the role of heredity. Faced with a 
given dietary regime individuals react d i f f e r e n t l y and i t i s 
overwhelmingly l i k e l y that some of these differences w i l l have 
been inherited. Neel (1962) has introduced the concept of the ' t h r i f y 
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genotype1 to r e f e r to those individuals genetically better 
adapted to some n u t r i t i o n a l situations and has suggested that 
the genetically potential diabetic individuals may have been 
selectively favoured before the large-scale a v a i l a b i l i t y of 
refined carbohydrate foods and the increase of life-expectancy. 
I t i s possible that trace elements i n the d i e t , 
p a r t i c u l a r l y chromium,may be related to i n s u l i n effectiveness. 
Impaired glucose tolerance can be produced i n experimental animals 
by the reduction of t r i v a l e n t chromium (Cr^ +) levels i n the diet 
(Mertz and Schwarz,1959)• Normal glucose tolerance can be 
restored i n these animals by the administration of Cr^ + or of 
'glucose tolerance factor' which contains chromium i n t h i s form 
(Schwarz and Mertz,1959). In addition to Cr^ + glucose tolerance 
factor (G.T.F.) contains n i c o t i n i c acid as i t s active component 
(Doisy et al,1976) and,certainly i n vitro,seems to be necessary 
for maximum c e l l u l a r response to i n s u l i n . (Mertz,1969). I n 
humans the ingestion of Cr^ + improves glucose tolerance i n l a t e -
onset diabetics (Glinsmann and Mertz,1966),elderly subjects 
(Levine et al,1968),and young adults (Doisy et al,1976). I t i s 
possible that low chromium levels,either due to dietary deficiency 
or inadequate absorption,may contribute to the i n s u l i n i n s e n s i t i v i t y 
of type I I diabetes by reducing the amount of c i r c u l a t i n g G.T.P. 
1.5 The contribution of twin studies. 
Early twin studies i n diabetes (Then Berg,1938;Harvald 
and Hauge,1963,and Gottlieb and Root,1968) tended to emphasise 
the fact that high concordance rates i n monozygotic twin pairs 
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was evidence f o r an inherited component i n diabetes. More recently, 
the study of twins has been less popular and the emphasis has 
shifted with the r e a l i s a t i o n that twins concordant f o r diabetes 
may be concordant because of environmental factors,whereas discordant 
pairs are discordant because the action of the environment has been 
di f f e r e n t on the two individuals concerned. Modern studies of 
diabetes i n twins tend to reveal what i s not inherited rather 
than what i s (Pyke and Nelson,1976). 
In an analysis of 106 pairs of monozygotic twins 
from the United Kingdom,Pyke and Nelson (1976) found 71 pairs 
to be concordant (both individuals diabetic) and 35 discordant 
(one individual d i a b e t i c ) . A family history of diabetes was 
found i n 45$ of the concordant pairs but only 17$ of the 
discordant pairs,suggesting t h a t , i n the discordant pairs the disease 
i n the affected individual was less influenced by genotype than 
the disease i n the concordant pairs. The discordance rates 
di f f e r e d markedly when age at diagnosis of the index twin was 
considered. When t h i s age was less than f o r t y years the dis-
cordance rate was 50$ (32 pairs discordant out of 64),when the age 
at diagnosis was greater than f o r t y the discordance rate was 
7.1$ (3 discordant pairs out of 42). The age at diagnosis 
i s strongly p o s i t i v e l y correlated i n concordant twins (Pyke and 
Nelson,1976),with most pairs becoming concordant with i n three 
years of the diagnosis of the disease i n the index tv/in so that 
t h i s difference i n concordance rates with age at diagnosis of the 
index case i s unlikely to be the result of late-onset pairs 
having been followed up f o r longer than early-onset pairs. 
This f i n d i n g i s i n agreement with e a r l i e r studies 
(Then Berg,1938;Harvald and Hauge,1963;Gottlieb and Root,1968) 
but the deduction which must be made,namely,that hereditary 
factors are more important i n late-onset diabetes than i n early-
onset, i s at variance with the estimates of higher h e r i t a b i l i t y 
i n early-onset disease than i n late-onset disease (Goodman and 
Chung,1975tSimpson,1964). There i s no conflict,however, 
between t h i s f i n d i n g and the hypothesis that type I diabetes 
(most of the twins with onset before the age of f o r t y must have 
been of t h i s variety although there i s no immunological 
confirmation of t h i s ) i s the result of beta c e l l destruction 
i n genetically predisposed individuals following an environmental 
stimulus. The non-diabetic twins of the pairs i n which the 
index twin had early-onset diabetes presumably remained unaffected 
because,although they possessed the appropriate genotype,they did 
not encounter the relevant environmental stimulus. The present 
twin data suggest t h a t , i n early-onset diabetes,genetic factors 
are necessary f o r the p r e c i p i t a t i o n of the disease but are probably 
not s u f f i c i e n t alone,whereas,in late-onset diabetes,genetic 
factors are necessary and,in most cases,are s u f f i c i e n t , o r the 
environmental factors,whatever they are,are ubiquitous. I f the 
non-diabetic twins of the pairs with early-onset index twins 
remain unaffected,as i s proposed,it suggests that there i s a 
c r i t i c a l period i n the normal life—span,outside of which exposure 
to the environmental t r i g g e r i n g mechanism i s unlikely to lead 
to the development of diabetes. 
1.6 Animal models. 
Diabetes mellitus has been reported i n many laboratory 
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and domesticated animals. The d i v e r s i t y of the pathological 
processes involved i n animal diabetes and the several genetic 
mechanisms proposed r e f l e c t the heterogeneity and,to a certain 
extent,the confusion seen i n human diabetes. 
Diabetes i n animals may be induced (by various 
substances toxic to the i s l e t s of Langerhans,such as alloxan) 
or may be spontaneous. The chemical induction of diabetes forms 
a convenient laboratory model f o r the study of the biochemistry 
of i n s u l i n lack,although i t would seem more analagous to the 
diabetes induced i n humans by pancreatectomy or pancreatitis 
rather than the primary diabetic syndromes where hereditary factors 
are involved. 
Diabetes occurring spontaneously i n animals has been 
reviewed (Dickie,1970,and Herberg and Coleman,1977). As i n the 
human disease,the factors responsible are environmental and 
hereditary,and instances of simple and complex inheritance may be 
found. Changing the d i e t of some strains of sheep (Warren et a l , 
1966) and the Egyptian sand r a t (Dickie,1970) leads to the 
pre c i p i t a t i o n of diabetes. In the Chinese hamster (Gerritsen 
and Dulin,1967) diabetes occurs spontaneously and inheritance 
of the condition seems to be polygenic,depending on the action 
of at least four l o c i (Butler,1967)• In t h i s animal the disease 
seems similar to that of type I diabetes i n humans i n that plasma 
i n s u l i n levels are below normal and plasma free f a t t y acid and 
ketone levels are elevated. I n addition,small blood vessel 
changes develop that are indistinguishable from those found i n 
human type I (and type Il)diabetes. 
I n the mouse,several d i f f e r e n t conditions are known 
i n which animals become diabetic,with or without concurrent 
obesity (Herberg and Coleman,1977). The Japanese KK mouse,in 
addition to hyperphagia and obesity,has diabetes characterised 
by hyperinsulinaemia and,therefore,presumably,peripheral i n s u l i n 
resistance. The genetics of t h i s condition has been explained 
as being polygenic (iwatsuka and Shino,1970) although Butler 
and Gerritsen (1970),using d i f f e r e n t criteria,suggested a 
dominant gene with 25$ penetrance,coupled with a recessive 
modifier which raised the penetrance to 75$- This c o n f l i c t i s 
rather reminiscent of human diabetes research. 
Single gene models i n mice include the 'diabetes 
mouse' where an autosomal recessive gene (db) i s segregating 
at a chromosome 4 locus and i n which the disease appears similar 
to human type I I diabetes i n that hyperglycaemia i s the resul t 
of i n s u l i n resistance (Dickie,1970). Several other animal models 
exist and serve a useful p/rpose i n the elucidation of biochemical 
aspects of diabetes although no clear understanding of the 
genetics of human diabetes has been gained from t h e i r study. 
1.7 Complications and the concept of premature ageing. 
The a b i l i t y to maintain diabetics f o r many years 
on i n s u l i n and other supportive therapy has meant that cardio-
vascular complications contribute substantially to the mo r t a l i t y 
and morbidity of the disease. Type I and type I I diabetics are 
equally l i k e l y to develop these changes given an equal duration 
of the disease (Tattersall,1974)• Lamentably,there i s l i t t l e 
d i rect proof that good control of diabetes,in so f a r as t h i s 
i s judged by blood glucose estimates,can prevent or reverse 
these complications (Fajans,1972;Keen and Jarrett,1975»and B.M.J., 
1976) although some studies,both retrospective (Knowle3,1964) 
and prospective ( P i r a r t et al,1975) suggest that s t r i c t control 
of blood glucose from the time of diagnosis can delay t h e i r onset. 
The major problem i n t h i s f i e l d i s lack of agreement on the 
d e f i n i t i o n and assessment of 'good control' i n the diabetic. 
The mechanisms responsible f o r cardiovascular 
complications i n the diabetic are largely obscure. Their absence 
i n the M.O.D.Y. sub-type (Tattersall,1974iand T a t t e r s a l l and 
Fajans,1975) tends to argue against the view that they are due 
to elevated blood glucose alone and t h e i r presence i n both type 
I and type I I diabetes suggests that absolute blood i n s u l i n 
levels are not responsible,though they may be due to lack of 
effective i n s u l i n action. Plasma tr i g l y c e r i d e s are elevated 
i n diabetics even when control i s judged satisfactory i n terms 
of blood glucose (Keiding et al,1952) and i t i s possible that 
elevated blood l i p i d s are contributory. I t would seem that the 
study of the M.O.D.Y. phenotype would be f r u i t f u l i n the 
assessment of the contribution of various metabolic derangements 
to the pathogenesis of diabetic angiopathy. 
Genetic factors have been said to be important i n the 
production of cardiovascular complications. The study of i d e n t i c a l 
twins concordant f o r diabetes (Pyke and Tattersallj1973 >and Pyke 
and Nelson,1976) has shown that related individuals are similar 
i n the rate of development and nature of these complications 
even when l i v i n g apart and treated at d i f f e r e n t centres. 
Superficially i t would seem that the observation of 
retinopathy and glomerulosclerosis i n the 'secondary diabetes' 
associated w i t h chronic p a n c r e a t i t i s (Duncan et al,1958,and 
Sevel et al,197l) was against t h i s view. I t has been shown,however, 
(Verdonk e t al,1975) t h a t the frequency of these complications 
i n such p a t i e n t s i s g r e a t e r i n those who a lso have a f a m i l y 
h i s t o r y of diabetes. The " p o t e n t i a l d i a b e t i c ' , j u d g e d from f a m i l y 
h i s t o r y may be more susceptible t o p a n c r e a t i t i s and more 
susceptible t o the complications of the r e s u l t i n g diabetes. 
There can be l i t t l e c o n f l i c t as t o whether cardiovascular 
changes are genetic or metabolic i n o r i g i n . I t i s l i k e l y t h a t , 
given a c e r t a i n h e r e d i t a r y c a p a b i l i t y , o n e or several of the 
metabolic derangements seen i n diabetes act as exacerbating 
f a c t o r s i n t h e i r development. Having come t o terms w i t h the 
p o s s i b i l i t y t h a t both environmental and h e r e d i t a r y f a c t o r s are 
a c t i n g t o produce the disease s t a t e i n the f i r s t p l a c e , i t demands 
very l i t t l e e x t r a p o l a t i o n to suggest t h a t the same i s t r u e of 
other manifestations of the disease. 
The physico-chemical p r o p e r t i e s of collagen i n young, 
insulin-dependent d i a b e t i c s have been shown to resemble those of 
collagen from ol d e r i n d i v i d u a l s . 
Work discussed above (Rosenbloom e t al,1976) has shown 
t h a t the i n s u l i n resistance of m a t u r i t y onset diabetes resembles 
t h a t seen i n older,non-diabetic i n d i v i d u a l s , a t l e a s t i n v i t r o . 
The p o s s i b i l i t y t h a t g e n e t i c a l l y determined a c c e l e r a t i o n 
of c e l l u l a r ageing processes u n d e r l i e s the pathogenic process i n 
a l l d i a b e t i c s has been expounded by Vracko and B e n d i t t (1972). 
These workers considered t h a t the t h i c k e n i n g of the c a p i l l a r y 
basement membrane c h a r a c t e r i s t i c of d i a b e t i c micro-angiopathy 
was due t o abnormally r a p i d c e l l turnover and the subsequent 
accumulation of c e l l u l a r debris at these s i t e s . That the same 
process might be responsible f o r the changes seen i n macro-angiopathy 
was suggested by Martin and Sprague (1975). 
Skin fibroblasts,when grown i n culture,have a potential 
number of replications which i s inversely proportional to the age 
of the donor (Martin et al,1970). Fibroblasts from diabetics 
exhibit about half the number of replications compared with age-
matched controls (Vracko and Benditt,1975)»a f i n d i n g taken to 
indicate increased s u s c e p t i b i l i t y of diabetics' c e l l s to i n j u r y . 
Beta c e l l s reach the l i m i t a t i o n of r e p l i c a t i o n i n v i t r o a f t e r 
only a few generations (Logothetopoulos,1972). 
Vracko and Benditt's hypothesis i s appealing i n that 
one genetic abnormality i s responsible f o r a l l the manifestations 
of diabetes i n i t s several forms. I t has come under some c r i t i c i s m 
(Williamson and Kilo,1977) and there are several incongruities. 
The laminar nature of the thickened c a p i l l a r y basement membrane 
which Vracko and Benditt took to be due to the successive deposition 
of c e l l u l a r material has not been reported i n a l l anatomical s i t e s . 
In a d d i t i o n , i t i s d i f f i c u l t to incorporate the suggestion that type 
I diabetes i s due to an abnormal response to v i r a l i n f e c t i o n i n 
individuals genetically d i s t i n c t , a t least i n some respects,from 
the type I I diabetic,and that diet and obesity seem to influence 
the development of the l a t t e r disease. 
A hypothesis concerning the pathogenesis of the type 
I and type I I diabetes suggesting a genetic relationship between 
them i s developed i n chapter three. The intervening chapter 
deals more s p e c i f i c a l l y with the evidence f o r 'genetic markers' 
f o r diabetes. 
Chapter 2 
Genetic polymorphisms and diabetes mellitus. 
¥-b-
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2.1 Introduction. 
2.2 Red c e l l antigen systems. 
(a) The ABO system. 
(b) The MNSs system. 
(c) The P system. 
(d) The Rhesus system. 
(e) The Kell system. 
( f ) The Lewis system and secretor status. 
(g) The Duffy system. 
2.3 Serum proteins and iso-enzymes. 
(a) Haptoglobin. 
(b) Acid phosphatase. 
(c) Phosphoglucomutase. 
(d) Adenylate kinase. 
(e) Adenosine deaminase. 
( f ) Esterase D. 
(g) Other polymorphisms. 
2.4 The a b i l i t y to taste phenylthiourea. 
2.5 The major histocompatibility complex. 
2.6 Methodological and s t a t i s t i c a l d i f f i c u l t i e s i n the search f o r 
associations. 
(a) Selection of patients. 
(b) Selection of controls. 
(c) S t a t i s t i c a l significance. 
2.7 The bio l o g i c a l significance of associations with disease. 
2.1 Introduction. 
There are two major j u s t i f i c a t i o n s f o r the 
investigation of associations between genetic polymorphisms 
and disease. Firstly,knowledge of such associations i d e n t i f i e s 
genetic factors important i n the aetiology of the condition. 
Secondly,the demonstration of d i f f e r e n t i a l s u s c e p t i b i l i t y to 
disease,on the basis of genotype,may reveal mechanisms whereby 
balanced polymorphisms are maintained by selection. 
There i s considerable published material on t h i s 
aspect of medical genetics. Before 1970 most investigators were 
concerned with the ABO polymorphism and several convincing 
associations were demonstrated such as that between carcinoma 
of the stomach and blood group A (Aird et al,1953) but t h i s 
extensive investigation contributed l i t t l e to our understanding 
of the pathology of individual diseases and less to the elucidation 
of the factors maintaining the ABO polymorphism and influencing 
the world-wide d i s t r i b u t i o n of the A,B and 0 a l l e l e s . 
Since 1970,however,the intensely polymorphic major 
histocompatibility complex (M.H.C.) has been studied and has 
increased our understanding of hereditary aspects of some disorders 
of obscure aetiology,among them diabetes. 
This chapter reviews the studies concerned with 
associations between genetic polymorphisms and diabetes. A b r i e f 
description of the polymorphism and some h i s t o r i c a l notes are 
included. The chromosome assignments f o r various l o c i are a l l 
taken from a series of a r t i c l e s i n Cytogenetics and Cell Genetics, 
(1976),l6,Nos. 1 - 5»which are reports from the 1975 International 
Congress on Cytogenetics. 
H-8. 
2.2 Red c e l l antigen systems. 
(a) The ABO system. 
The ABO system was discovered by Landsteiner (1900). 
Pour common alleles,designated A^jAgjB and 0 segregate at a locus 
on chromosome 9« The A-^Ag and B a l l e l e s are dominant to the 0 
and co-dominant with respect to eachother,except i n the case of 
A^ and A^,where A^ i s dominant to A^ . This system i s the only 
one described so f a r with 'naturally occurring 1 antibodies -
anti-A and anti-B i n group 0 persons,anti-A i n group B persons 
and anti-B i n group A persons. Group AB persons have neither 
anti-A nor anti-B. 
Available data on the d i s t r i b u t i o n of the ABO blood 
group phenotypes i n diabetic individuals are summarised i n Table 
2 • 19 
Several of the studies have revealed a si g n i f i c a n t 
excess of group A individuals amongst the diabetics taken as a 
whole,although i n no case i s t h i s excess very great. Some have 
f a i l e d to f i n d associations,others have found associations with 
phenotypes other than A. 
A readily appreciated numerical representation of 
the result i s the r e l a t i v e incidence (x),which,in the case of 
the A/0 comparison i s calculated as follows:-
x = n, / x. JN 0 /„ l / n 2 2/N1 
where n^ and are the numbers of A and 0 individuals 
i n the diabetic group and and Ng the same categories f o r the 
control group. This r a t i o i s an estimate of the r e l a t i v e r i s k , 
or the increased r i s k of the disease developing i n group A persons 
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compared with that i n group 0 persons. 
The r e l a t i v e incidence has the further advantage that 
data from numerous centres may be amalgamated by the method of 
V/oolf (1955)»resulting i n a weighted mean re l a t i v e incidence and 
a chi squared value which may be divided into two parts,the f i r s t 
(with one degree of freedom) gives the probability that the mean 
re l a t i v e incidence deviates from unity by chance alone,the second 
gives the significance of heterogeneity between the pooled samples. 
Table 2.2 shows the results of these investigations 
i n the form of A/0 r a t i o s . The data of Tedeschi and Cavazzutti 
(1958) are taken from McConnell (1966). 
In some cases i t has been necessary to calculate the 
components of the A/0 r a t i o from phenotype frequencies where only 
these and the t o t a l sample sizes are given. These are indicated 
(*). Series which form part of l a t e r reports (e.g. McConnell,1955) 
are omitted,as are those i n which the necessary data are not given 
(e.g. Ksenofontor,1974)• The raw data from which the r a t i o s are 
calculated are given i n table 1 of Appendix A. 
Transforming the value of x into i t s logarithm avoids 
d i f f i c u l t i e s due to asymmetry (V/oolf,1955)• I f y = log gx,then 
the sampling variance of y i s given as:-
V = l / i ^ + l / n 2 + l/N 1 + l/N 2 
where n^,n2,N^ and have the same designation as 
i n the equation f o r x given above. The weight (w) of y i s given 
by the reciprocal of V. 
I f x i s u n i t y , i . e . there i s no association of blood 
groups with the diseased state,y i s zero. The chi squared value 
(with one degree of freedom) fo r the significance of the 
5*. 
Table 2-2 ABO results i n diabetics 
Reference X chi squared p 
Craig & Wang' (1955) 1*12 1-98 <• 0*20 > 0«10 
McConnell et a l (1956) ( l ) 
(2) 
(3) 
1-12 
1-19 
1-11 
1-60 
1.18 
1-13 
* 0.30 ^ 0«20 
< 0«30 ••> 0*20 
-t 0«30 > 0«20 
Zeytinoglu (1956 1*03 0*08 -c 0«80 ^ 0«70 
Tedeschi & Cavazzutti (1958) 1.28 4-53 -s- 0*05 0.025 
Speiser (1958) 1-11 0*40 0*60 0-50 
Otto-Servais et a l (1958) 1*02 0*08 <. 0-80 > 0«70 
Mahr (1959) * 1-03 0-15 ^ C 7 0 > 0.275 
Anderson & Lauritzen (1960)* 0'83 7*31 <£ 0*01 > 0«005 
Cornil & P i r a r t ( l96l) * 1*30 8.31 <. 0-005 > 0*001 
Bibawi & Khatwa ( l96l) * 1-34 12-93 <. 0.0005 
Doll et a l (1961) 1*20 0«60 ^ o«50 > 0-40 
Simpson et a l (1962) + 0-97 0.02 < 0«90 > 0*80 
Sauer et a l (1963) + 1-08 1*83 <. 0«20 • 0*10 
Macafee (1964) * 0*91 1-50 -t 0«30 > 0.20 
Serra et a l (1964) 1-34 8-69 < 0«005 r 0*001 
Buckwalter (1964) + 1*02 0*12 < 0*80 0*70 
Berg et a l (1967) 1.04 0.06 < 0-90 > 0-80 
Scholz et a l (1975) * 1-08 0.90 ^ 0.40 ?• 0.30 
X (weighted mean r e l a t i v e incidence) = 1*08 
Chi squared (significance) = 17'08 (d.f. = l ) p < 0*0005 
Chi squared (heterogeneity) = 36*32 (d.f. = 19) p<0«01 
* calculated from frequencies 
+ control series combined 
65 
deviation of y from zero i n each case i s given by y /V or wy . 
Combination of data from various centres yields a 
weighted mean,Y,given bySwy/2w. I t s antilogarithm,X,is the 
weighted mean r e l a t i v e incidence. Chi squared (with one degree 
of freedom) f o r the significance of the deviation of Y from zero 
2 2 
i s given by ( X w y ) / Z w or Y Z w and heterogeneity between samples 
2 2 
i s tested f o r by chi squared given by iE wy - ( Z w y ) / Z w or 
2 2 
Zwy - Y Z w . Degrees of freedom are given by (N - l ) where 
N i s the number of data sets. 
From table 2.2 i t i s evident that the weighted mean 
rel a t i v e incidence,X,(1.08) d i f f e r s s i g n i f i c a n t l y from unity,but 
that the data sets are heterogeneous (chi squared,with 19 degrees 
of freedom = 36.32). 
This heterogeneity i s hardly surprising f o r a disease 
group such as diabetes. Several disease e n t i t i e s are included i n 
the term and,presumably,these sub-groups are being included to 
d i f f e r i n g degrees i n the various populations studied. 
Many of the published reports have t r i e d to take t h i s 
c l i n i c a l heterogeneity into account,sub-dividing the sample on 
various c r i t e r i a and examining them separately f o r associations 
(see table 2 .3) . 
The sub-division of the diabetic population on the 
basis of presence or absence of a family history of the nondition 
r e f l e c t s the once-favoured d i s t i n c t i o n between 'hereditary' and 
'acquired' diabetes and i s of l i t t l e u t i l i t y . Of more potential 
merit i s the d i s t i n c t i o n between early- and late-onset cases 
(the t h i r t i e t h birthday i s usually taken as the d i v i s i o n between 
them). Even more useful i s a sub-division on the grounds of 
5b 
Table 2-3 C r i t e r i a used f o r the sub-division of diabetic samples 
Reference Method of sub-division 
McConnell (1955) By mode of inheritance - 'recessive gene 1, 
•dominant gene1 and 'unclassifiable 1, 
By age at diagnosis ( d i v i s i o n at 30 yrs.) 
Craig and Wang (1955) By sex. By presence of family history of 
diabetes or obesity. By presence or absence 
of obesity. By age at diagnosis ( d i v i s i o n at 
30 years.) 
McConnell et a l (1956) By sex. By age at diagnosis ( d i v i s i o n at 
30.) By treatment*. By presence or absense 
of family h i s t o r y . 
Zeytinoglu (1956) With and without 'Kimmelsteil-Wilson syndrome1. 
Tedeschi and Cavazzutti (1958) By sex. 
Speiser (1958) By sex. 
Otto-Servais et a l (1958) By sex. 
I/iahr (1959) By sex. 
Anderson and Lauritzen (1960) By sex. By age at diagnosis ( d i v i s i o n at 
30 years.) By presence or absence of family 
history. By current age. 
Henry and Poon King ( l96l) By sex. By race (East Indian and 'mixed'). 
Cornil and P i r a r t ( l96l) By sex. Presence or a.bsence of family 
his t o r y . Age at dia^osis ( d i v i s i o n at 30). 
Bibawi and Khatwa (1961) By sex. 
Doll et a l (1961) By sex. 
Simpson et a l (1962) A l l 'juvenile diabetics'. 
Sauer et a l (1963) By sex. 
Macafee (1964) By sex (data f o r sexes separate not given). 
By age at onset ( c r i t e r i a not given). 
By presence or absence of family history. 
Serra et a l (1964) By sex. By age at diagnosis ( d i v i s i o n at 
20 years). By presence or absence of family 
history 
* Classification 'by treatment' i n a l l cases except Scholz et a l (1975)» 
involves d i v i s i o n into i n s u l i n - taking and non - i n s u l i n - taking diabetics. 
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Table 2«3 continued. 
Reference Method of sub-division 
Buckwalter (1964) By sex. 
Berg et a l (1967) None 
Revai and Konig (1968) By sex (percentage f o r controls do not add 
up to 100 - no further analysis possible). 
Kaenofontor (1974) None 
Scholz et a l (1975) By sex. By current age. By treatment. 
By age at diagnosis ( d i v i s i o n at 40)« 
By body type (Rohrer index). 
5%. 
insulin-taking or non-insulin-taking since t h i s approximates to 
the currently favoured type I and type I I aetiological sub-
divisions. These sub-divisions of the diabetic sample reveal no 
clear-cut differences with regard to ABO phenotype frequencies. 
The data as published do not allow detailed consideration 
of current age or age at diagnosis. Anderson and Lauritzen (196O) 
found an excess of group 0 individuals amongst the early-onset 
diabetics and a more detailed analysis of t h i s data (Mourant,1977» 
personal communication) shows a steady rise of the A/0 r a t i o 
throughout l i f e so that the adult diabetics show a s i g n i f i c a n t 
excess of group A. 
Most workers sub-divide t h e i r diabetics by sex. I n 
general,the A/0 r a t i o d i f f e r s more markedly from unity i n male 
diabetics than i t does i n females. Tables 2.4 and 2.5 show the 
results f o r males and females respectively i n those reports where 
data are given f o r the sexes separately. The raw data used f o r 
these calculations are given i n Appendix A,tables 5 and 4« I n 
each case,male and female diabetics are compared with the t o t a l 
control group. The weighted mean r e l a t i v e incidence f o r male 
diabetics i s 1.12 compared with 1.08 f o r females. The deviation 
of t h i s incidence from unity i s more si g n i f i c a n t i n males than i n 
females although the data sets f o r the male diabetics are hetero-
geneous. These values compare well with those computed,from an 
augmented set of reports,by Mourant (1977)» 
although the heterogeneity found by him amongst the male data sets 
was non-significant. 
This difference between the sexes does not imply a 
difference i n the mechanism of hereditary transmission of 
sq. 
Table 2-4 ABO results f o r male diabetics only 
Reference X chi squared P 
Craig & Wang (1955) 0-95 0«29 < 0-60 0-50 
McConnell et a l (1956) ( l ) 1*32 3-57 < 0-10 •>• 0-05 
(2) l * 6 l 3*86 ^0-05 ^0.025 
(3) 1-25 1*98 < 0-20 •>• 0-10 
Tedeschi & Cavazzutti 
(1958) 
1-23 1.60 < 0-30 -s- 0-20 
Speiser (1958) 1-13 0-35 < 0-60 s- 0-50 
Otto-Servais et a l 
(1958) 
1*09 0*60 < 0*50 O.4O 
Mahr (1959) * 1.01 0-01 <0«95 =• O.90 
Anderson & Lauritzen * + 
(1960) 
0-79 0«06 < 0*90 ?- 0«80 
Cornil & P i r a r t ( l96l) * 1'43 5*68 < 0.025 > 0«01 
Bibawi & Khatwa ( l96l) * 1-81 18-35 < 0.0005 
Doll et a l (1961) 1*56 1*56 < 0*30 >• 0*20 
Sauer et a l (1963) + 1*09 1-17 < 0-30 > 0*20 
Serra et a l (1964) 1.60 12-47 < 0.0005 
Buckwalter (1964) + I.04 0-20 0.70 > 0*60 
Scholz et a l (1975) * 1.09 0.58 -:0.50 0.40 
X (weighted mean r e l a t i v e incidence) = 1*12 
Chi squared (significance =14*52 (d.f. = l ) P < 0*0005 
Chi squared (heterogeneity) = 37*81 (d.f. = 13) P < 0*0005 
* calculated from frequencies 
+ control series combined 
to 
Table 2*5 ABO results f o r female diabetics only 
Reference X chi squared P 
Craig & V/ang (1955) 1*21 3-85 < 0«05 •> 0*025 
McConnell et a l (1956) ( l ) 
(2) 
(5) 
1.05 
0-97 
1«04 
0-07 
0.02 
0.10 
< 0«80 > 0«70 
< 0.90 0.80 
< 0*80 7- 0*70 
Tedeschi & Cavazzutti 
(1958) 
1-32 3-34 < 0.10 ^ 0*05 
Speiser (1958) I . 09 0.13 < 0*80 ^ 0«70 
Otto-Servais et a l 
(1958) 
0*98 0'05 < 0«90 •> 0.80 
Mahr (1959) * 1*04 0.18 < 0*70 > 0*60 
Anderson & Lauritzen * + 
(1960) 
0*87 0-02 < 0.90 > 0*80 
Cornil & P i r a r t (1961) * 1-24 3-53 •< o»io > 0.05 
Bibawi & Khatwa * 
(1961) 
1.15 2-02 < 0«20 > 0-10 
Doll et a l (1961) 1-00 O'OO -
Sauer et a l (1963) + 1*06 0*58 < 0»50 > 0-40 
Serra et a l (1964) 1»19 2'28 -s.0.20 > 0-10 
Buckwalter (1964) + 1-01 0*02 <. 0«90 > 0*80 
Scholz et a l (1975) * 1-07 O.46 <: 0*50 -y, 0*40 
X (weighted mean r e l a t i v e incidence) = 1*08 
Chi squared (significance = 7'99 (d.f. = l ) p < 0*005 
Chi squared (heterogeneity) = 8*66 (d.f. =13) p<0'8 :> 0*7 
* calculated from frequencies 
+ control series combined 
predisposition i n males and females. I f the A,B and 0 a l l e l e s 
influence the development of diabetes they do so i n both sexes 
but t h e i r effect i s less discernible i n the female presumably 
because of the greater influence of non-genetic factors such as 
parity and obesity. Studies of h e r i t a b i l i t y of l i a b i l i t y 
(Falconer,1967) have shown that h e r i t a b i l i t y i s lower i n the 
female. 
Four series have presented results f o r the sub-types 
of A - Sauer et a l (1963).Buckwalter (l964),Berg et a l (1967) 
and Scholz et a l (1975)• In no case were the r e l a t i v e frequencies 
of A^  and A^.and A^ B and A^ B di f f e r e n t i n diabetics compared with 
controls. 
Vogel and Kriiger (1968),amalgamating twenty studies 
of ABO d i s t r i b u t i o n i n diabetics,found a sig n i f i c a n t excess of the 
B phenotype over the 0 phenotype,although,again,there was si g n i f i c a n t 
heterogeneity between samples. This tended to suggest that r e l a t i v e 
resistance to the disease of the 0 phenotype,rather than s u s c e p t i b i l i t y 
of the A phenotype,was responsible f o r the associations. Analysis 
of the twenty sets of data i n table 2.2 f a i l s to confirm t h i s with 
a weighted mean re l a t i v e incidence of the B/O r a t i o of 1.01,which 
i s i n s i g n i f i c a n t l y d i f f e r e n t from zero (chi squared,with one degree 
of freedom = 0.215). 
The results of various comparisons using the data from 
these reports are shown i n table 2.6. 
(b) The MNSs system. 
In 1927 the discovery of the M and N antigens was 
announced (Landsteiner and Levine,1927 ). These were 
Table 2.6. The Results of various comparisons using data from reports quoted 
i n table 2.2. (male and female diabetics combined). 
Comparison X Chi square (sig) P Chi square (het) P 
A/O 1-08 17-08 < 0*0005 36*32 *0*0>0*005 
B/O 1*01 0*21 N.S. 77-76 < o*ooo5 
A/not A 1-07 12'30 < 0*0005 41-35 < 0*005 
A+AB/B+O 1*07 11*86 <• 0*001 >0*0005 90*65 <o*ooo5 
N.S. = non-significant 
considered to be determined by two co-dominant a l l e l e s M and N. 
The p o s s i b i l i t y that N i s a precursor substance acted upon by one 
a l l e l e M with an a l l e l i c amorph m is,as yet,unresolved (Race and 
Sanger,1975)• The discovery of another antigen,S (Walsh and 
Montgomery,1947),added interest since,although the corresponding 
gene,S,was not a l l e l i c to M and N,it was associated,being found 
more often with M than with N (Sanger and Race,1947»and Sanger et 
al,1948)« The s antigen,product of the ja gene,the a l l e l i c partner 
of S_,was detected by Levine et a l (l95l)« I t i s suggested that M 
and N,and S_ and ss segregate at two closely linked l o c i on chromosome 
No.2. 
Table 2.7 shows the results of investigations on diabetics 
using anti-M and anti-N antisera. No si g n i f i c a n t association has 
been found,except i n the series reported by Ksenofontor (1974)» 
where the diabetic group show a higher frequency of the N phenotype 
and a lower frequency of heterozygotes. Although not giving the data 
i n full,Scholz et a l (1975) state that the M phenotype i s more 
common i n diabetics diagnosed before the age of f o r t y compared with 
those diagnosed a f t e r t h i s age. This difference was not s i g n i f i c a n t . 
The only series to test f o r antigens of the Ss system i s 
that of Scholz et a l (1975) i n which testing was only performed 
with anti-S. The data are not given but no association was found. 
(c) The P system. 
In the same report as they developed the MN system, 
Landsteiner and Levine described another individual difference i n 
human blood (Landsteiner and Levine,1927(a)). Some individuals' 
red c e l l s were agglutinated by the sera of immunised rabbits i n 
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a way which cut across the previously described ABO and MN 
d i s t i n c t i o n s . Those individuals whose ce l l s were agglutinated were 
designated P+,those whose c e l l s were unaffected,P-. The antiserum 
was called anti-P. 
The discovery that Tj(a-) individuals were also 
negative with anti-P (Sanger,1955) suggested that the T j a antigen 
belonged to the P system. The outlined scheme f o r the system (Race 
and Sanger, 1975) suggests three a l l e l e s E^tEq 8 1 1 ( 1 £» w it n £ being a 
possible amorph. Individuals possessing at least one P^  a l l e l e 
correspond to those previously designated P+,in that they show 
agglutination with anti-P^ (previously anti-P). Varying strengths 
of reaction to anti-P^ have been shown to be inherited. 
The exact chromosomal assignment of the P locus i s i n 
doubt,there i s evidence f o r linkage with the HLA locus (chromosome 
6) and with the ADA (adenosine deaminase) locus of chromosome 20. 
Ksenofontor (1974) and Scholz et a l (1975) performed 
P system grouping on t h e i r subjects. Scholz et a l did not detect 
a s i g n i f i c a n t association but do not give t h e i r data. Ksenofontor 
gives neither conclusions nor results f o r t h i s system. 
(d) The Rhesus system. 
Soon a f t e r the discovery of the Rh system (Landsteiner 
and Weiner,1940) i t s complexity was realised. Fisher's synthesis 
(Fisher,1947) c l a r i f i e d the position considerably and his suggestions 
and nomenclature w i l l be used here. Three loci,closely linked and 
now known to be situated on chromosome No.1,were postulated with 
the a l l e l e s £ and c at one,D and d at the second and E and e at the 
t h i r d . Antisera corresponding to the gene products of f i v e of these 
lob 
six a l l e l e s are currently i n use,anti-d alone has not been found. 
In view of the r e l a t i v e frequencies of rhesus haplotypes i t was 
postulated (Fisher and Race,1946»and Fisher,1947) that the order 
of these l o c i on the chromosome was D,C,E. A l l populations so f a r 
studied show linkage disequilibrium between the a l l e l e s of t h i s 
system,similar to that found i n the MNSs and the HLA systems,in 
that the t h e o r e t i c a l l y possible chromosome combinations do not 
occur with equal frequency. In English populations three orders 
of haplotype frequencies are found - CDe,cde and cDE which occur 
at frequencies of 12$ or greater,cDe,cdE,Cde and CPE at less than 
yfo and the rare CdE (Race and Sanger,1975) • The mechanisms 
responsible f o r this,presumably selective,have never been demonstrated. 
There are often more than one Rh genotype which can,in 
t h e o r y , f i t the results of an individual tested with anti-C,anti-c, 
anti-D,anti-E and anti-e. I n practice the 'most l i k e l y genotype', 
based on previous knowledge of r e l a t i v e haplotype frequencies i n the 
population to which the individual belongs,is suggested. 
The results of investigations of diabetics with anti-D 
alone are given i n table 2.8. No si g n i f i c a n t associations are 
demonstrated. 
Testing f o r a l l e l e s at the other two l o c i and the 
assignment of probable genotypes has been performed by Buckwalter 
and Tweed (1962),Berg et a l (1967) and Scholz et a l (1975). D+ve 
and J)-ve frequencies cannot be calculated from the data given by 
Berg et a l (1967) and Scholz et a l (1975) due to the inclusion of 
a category termed'other'. 
Berg et a l (1967) found a si g n i f i c a n t excess of the R^  
haplotype (cTE) amongst diabetics,the chi squared value,with f i v e 
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degrees of freedom being 18.53 (p-<0.015-0.001). Scholz et a l 
(1975) found the opposite - an excess of (CDe) and r (cde) 
amongst the diabetics with a deficiency of Rg,although t h i s was 
not s i g n i f i c a n t , Buckwalter and Tweed (1962) did not f i n d any 
sig n i f i c a n t differences between diabetics and controls. 
(e) The Kell system. 
The elucidation of the Ke l l system began i n 1946 with 
the discovery of an antibody responsible f o r haemolytic disease of 
the newborn and which was not anti-D (Coombs et al,1946). This was 
named a n t i - K e l l (anti-K) a f t e r the o r i g i n a l family and i t was not 
long before the a n t i t h e t i c a l antibody,anti-k,was found (Levine et 
al,1949)» I t seemed that the system consisted of two allele,K and 
a b 
k. Later came the detection of the Kp and Kp antigens and the 
rea l i s a t i o n that the corresponding a l l e l e s (Kp_a and Kp^) were 
associated with K and k but not a l l e l i c to them (Allen and Lewis, 
1957). I n 1965 the a l l e l e s of the Sutter system ( J s a and J a3) were 
seen to be part of the same complex (Stroup et al,1965). I t i s now 
suggested that the l o c i involved are situated on chromosome 6. 
Three groups from those l i s t e d i n table 2.2 tested t h e i r 
subjects with anti-K. No s i g n i f i c a n t differences were found between 
diabetics and controls. The data from Simpson et a l (1962) and Berg 
et a l (1967) i s summarised i n table 2.9. The data of Scholz et a l 
are not given i n t h e i r paper. There are no results available f o r 
81 "fa Si 
diabetics tested with anti-Kp and anti-Kp ,nor with anti-Js and 
anti-Js* 5. 
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( f ) The Lewis system and secretor status. 
There are two features which distinguish the Lewis 
blood group system from those considered so f a r . Firstly,Le and 
Le^ substances are not produced by the red c e l l s as in t e g r a l parts 
of the membrane but are passively acquired from the surrounding 
plasma (Grubb,1951»Sneath and Sneath,1955 and 1959). Secondly,the 
Lewis system,ABO and sectretor systems are in t e r - r e l a t e d . 
3. to Anti-Le was found i n 1946 (Mourant,1946) and anti-Le 
two years l a t e r (Andreson,1948)• At f i r s t , f a m i l y studies suggested 
a 4 that the Le antigen was recessively inherited (Andre5^,1948) but 
i t was soon realised that Le (a+b-) individuals were always non-
secretors of ABH (Grubb,1948). I n fact,individuals homozygous f o r 
the h a l l e l e at the H locus (the rare 'Bombay' phenotype) have Le a 
substance on t h e i r red c e l l s even when they are secretors but t h i s 
does not affec t the consideration of European populations. 
At the Lewis locus (as yet not assigned to a par t i c u l a r 
chromosome) two alleles,Le and le,are segregating. The le_ gene i s 
inactive but under the influence of the Le gene Le substance i s 
produced. I n the presence of the dominant secretor allele,Se,and 
at least one H a l l e l e at the H locus,most of th i s Le substance i s 
b a converted to Le leaving weakly detectable Le i n secretions but not 
on red c e l l s . The secretor locus i s also unassigned but i s known 
not to be closely linked to the Lewis locus (Race and Sanger,1975). 
Anderson and Lauritzen (1960) found a si g n i f i c a n t 
excess of Le a +ve individuals amongst t h e i r diabetics (chi squared 
17.15 f o r one degree of freedom,p less than 0.0005). They took t h e i r 
control data from Jordal (1975) and these subjects were grouped by 
a d i f f e r e n t technique and,presumably,by a d i f f e r e n t antibody,from 
7V. 
the diabetics. This f i n d i n g suggested a l i n k between diabetes and 
secretor status but the four series shown i n table 2.10 f a i l e d to 
confirm t h i s . 
(g) The Duffy system. 
The Duffy locus has been assigned to chromosome No.l. 
a b 
The two common European a l l e l e s , ^ and Py_ are co-dominant. A 
t h i r d s i l e n t allele,Fy_,extremely rare i n Caucasians,is very common 
in Negroes giving the phenotype Fy(a-b-) when i n the homozygous 
state. Anti-Fy a was i n i t i a l l y reported i n 1950 (Cutbush et a l , 
1950) and anti-Fy* 5 the following year ( i k i n et al,195l)» 
Only one of the studies referred to i n table 2.2 tested 
fo r the Duffy system (Scholz et al,1975) and only anti-Fy a was used. 
Results are not given but no significant difference between diabetics 
and controls was found. 
2.3 Serum proteins and i3Q-enzymes. 
(a) Haptoglobin. 
This alpha-2 glycoprotein present i n the serum and 
capable of binding haemoglobin was f i r s t shown to have phenotypic 
variants i n starch-gel electrophoresis by Smithies (1955»and 
1 2 
Smithies and Walker,1956). The two common alleles,Hp and Hp , 
segregate at an,as yet,unassigned autosomal locus. 
Several groups have studied t h i s polymorphism i n 
diabetics with c o n f l i c t i n g results. Simpson et a l (l962),in t h e i r 
study of 98 early-onset diabetics,found a reduction i n the 2-1 
phenotype and an increase i n the 2-2 amongst diabetics. The results 
of Jb'rgensen and Hopfer (1967) showed a si g n i f i c a n t reduction i n 
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the frequency of the Hp_ a l l e l e i n the diseased group. Berg et a l 
(1969) found an increase of a similar nature though t h i s was only 
marginally s i g n i f i c a n t . No si g n i f i c a n t differences could be 
demonstrated by Scholz et a l (1975). 
The most si g n i f i c a n t demonstration of an association 
was by Ksenofontor (1974). His series showed a reduction of 2-2 
individuals amongst the diabetics and an increase of the frequency 
of heterozygotes. This paper gives a combined analysis f o r the 
haptoglobin and MN l o c i and shows a s i g n i f i c a n t excess of diabetic 
individuals heterozygote f o r the two systems (39?° compared with 
18.25$ of controls). These studies are summarised i n table 2.11. 
(b) Acid phosphatase. 
Hopkinson et a l (1963) f i r s t reported electrophoretically 
d i s t i n c t phenotypes of the phosphotransferase enzyme red c e l l acid 
phosphatase. The f i v e phenotypes were designated A,BA,B,CA and CB, 
a b c 
determined by three co-dominant a l l e l e s P ,P , and P . The predicted 
sixth phenotype,C,was soon reported (Lai et al,1964). The P*5 a l l e l e 
i s the most common i n almost a l l groups studied to date. Populations 
of European o r i g i n tend to show higher P frequencies than those of 
non-Europeans and the P allele,though rare i n Europeans i s commoner 
than amongst Europeans. 
There has been no study of red-cell acid phosphatase 
phenotype frequencies amongst diabetics. 
(c) Phosphoglucomutase. 
Phosphoglucomutase (PGM),which reversibly catalyses the 
transfer of phosphate from the f i r s t to the s i x t h position of the 
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glucose molecule,was found to show inherited,electrophoretically 
detectable variation by Spencer et a l (1964). At least three l o c i 
code f o r t h i s enzyme - PGM.^  (chromosome l),PGM2 (chromosome 4) and 
PGMj (chromosome 6). The placenta i s the most satisfactory tissue 
f o r the study of the PGM^  locus variants and i t i s the products of 
the PGM^  and PGMg l o c i that may be seen i n the electrophoresis of 
red-cell preparations. Starch-gel electrophoresis demonstrates 
seven bands,designated a,b,c,d,e,f and g. I n the three common 
phenotypes,the e,f and g bands,representing the products of the 
PGM2 locus do not vary. At the PGM^  locus there are two common 
1 2 
co-dominant alleles,PGM^and PGM„ whose products are represented by 
the a and c,and the b and d bands respectively. The PGM^  a l l e l e i s 
the commoner i n most populations so f a r documented except f o r some 
Jewish groups and Finnish Lapps (Mourant et al,1976). There have 
been no reports of PGM^  locus frequencies i n diabetics. 
(d) Adenylate kinase. 
Adenylate kinase (AK) i s a red c e l l enzyme catalysing 
the reversible conversion of two molecules of adenosine diphosphate 
to a molecule of adenosine triphosphate and a molecule of adenosine 
monophosphate. Electrophoretic variants of t h i s enzyme were f i r s t 
demonstrated by Pildes and Harris (1966). Two co-dominant a l l e l e s , 
1 2 m Ak and Ak segregate at a locus on chromosome 9• The former a l l e l e 
i s the commoner i n a l l populations so f a r studied. Nothing i s known 
of the d i s t r i b u t i o n of t h i s polymorphism i n diabetics. 
(e) Adenosine deaminase. 
The enzyme adenosine deaminase (ADA) i s an aminohydrolase 
7b 
catalysing the deamination of adenosine to inosine. Electrophoretic 
variants were discovered by Spencer et a l (1968) and two co-dominant 
1 2 
al l e l e s AM and ADA ,segregating at a locus on chromosome 20,give 
three recognised phenotypes. The ADA phenotype frequencies of 
diabetics have not been reported. 
( f ) Esterase D. 
The f i r s t demonstration that the red-cell enzyme esterase 
D (EsD) was polymorphic was by Hopkinson et a l (1973)- Two co-
1 2 
dominant alleles,EsD and EsD ,segregate at a chromosome 13 locus 
and,of these,the EsD''" a l l e l e i s the commoner i n the populations 
2 
reported on so far,although EsD i s commoner i n Asian populations 
than i t i s i n European (Hopkinson et al,1973; Welch and Lee, 
1974jan<l Cartwright et a l , 1976). There has been no previous 
report of EsD phenotype frequencies amongst diabetics. 
(g) Other polymorphisms. 
Diabetic patients have been investigated with regard 
to the Gm system (Berg et al,1969;Scholz et al,1975)»the C3 
component of complement (Farhud et al,1972),Gc (Berg et al,1969; 
Cleave,1966;Jorgensen and Hopfer,1976(a),and Scholz et al,1975) 
and f o r the beta-lipoprotein systems Ag (Blumberg,1964;Berg et a l , 
I969),Ld (Berg et al,1969) and Lp (Berg et al,1969) i Significant 
associations were detected f o r Gm and Ag,although those f o r Gm 
were c o n f l i c t i n g and that found by Blumberg (1964) f o r Ag was not 
confirmed by Berg et a l (1969). 
77. 
2.4 The a b i l i t y to taste phenylthiourea. 
The polymorphism fo r the a b i l i t y to taste the substance 
phenylthiourea (also known as phenylthiocarbamide,or P.T.C.) was 
discovered i n 1932 (Fox,1932). I t i s considered to be determined 
by the a l l e l e s T and t segregating at an,as yet,unassigned locus. 
The a l l e l e T,which confers the a b i l i t y to taste the substance,is 
dominant to t. 
Two studies,summarised i n table 2.12,have shown a 
s i g n i f i c a n t d e f i c i t of tasters i n diabetics. This has been found 
i n Caucasians (Terry and Segall,1947) and i n Negroes (Terry,1950). 
The series of Harris et a l (l949)»drawn from a Caucasian population, 
f a i l e d to confirm t h i s . An association between P.T.C. tas t i n g and 
diabetes has never been s a t i s f a c t o r i l y explained and there has been 
no study on a sample of diabetics sub-divided on meaningful c l i n i c a l 
grounds. The p o s s i b i l i t y exists that diabetics have an altered 
perception of taste leading to a misclassification of TT and Tt 
individuals as non-tasters. 
2.5 The ma.jor histocompatibility complex. 
Stimulated by the needs of transplant surgery and by the 
intensive study of the analogous system i n the mouse,knowledge of 
the major histocompatibility complex (M.H.C.) i n humans has increased 
enormously i n the past two decades. The linkage relationships of 
the complex (situated on the short arm of chromosome 6) and the 
large number of a l l e l e s segregating at the human leucocyte antigen 
(HLA) loci,which are a part of the complex,are shown i n figure 2.1. 
These a l l e l e s code f o r glycoprotein molecules which are 
integral parts of the c e l l surface of most ce l l s (Colombani and Degos, 
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Figure 2.1 Linkage relationships of HLA l o c i (adapted from Bodmer,1976) 
GLO ? 
PGM D-B-C-A 
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Key: o = centromere, PGM^  = phophoglucomutase locus 3, GLO = glyoxylase, 
D,B,C,A, = HLA l o c i , Pg = Pepsinogen, C2,C4,C8 = complement l o c i , Bf = 
Properdin factor B, Ch,Rg = Chido and Rodgers blood group l o c i . 
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1972) and which seem to play a role i n the recognition of self and 
the co-ordination of the immune response (Katz and Benacerraf f1975)• 
Several features of the system are worth noting. F i r s t l y , 
the extent of the polymorphism at each locus i s prodigious. The A 
and B l o c i have the greatest number of recognised a l l e l e s but t h i s 
i s probably a consequence of the fact that they have been most 
intensively studied to date. The number of possible haplotypes at 
these four l o c i i s very large indeed. There has been considerable 
speculation on the reasons fo r t h i s degree of pf!|ojymorphism. I t 
may be the result of frequency-dependent selection i n that individuals 
possessing the rarer s p e c i f i c i t i e s may be favoured i f pathogens and 
parasites are able to mimic the commoner s p e c i f i c i t i e s . Under 
such a system there would be continual pressure f o r the production 
of new a l l e l e s i n higher animals and continual pressure f o r t h e i r 
copying i n parasites and pathogens. 
A further characteristic of the system i s the linkage 
disequilibrium present between a l l e l e s at d i f f e r e n t l o c i . The 
a l l e l e s HLA-A1 and HLA-B8,for example,both occur commonly i n 
European populations. The theoretical frequency of occurrence of 
the two a l l e l e s on the same chromosome (the 1 - 8*haplotype) i s 
the product of t h e i r separate gene frequencies. This haplotype 
occurs much more commonly than t h i s prediction,however,at least i n 
European populations. The magnitude of t h i s linkage disequilibrium 
i s given by the difference between the observed haplotype frequency 
and the expected haplotype frequency and i s known as delta. The 
value of delta may thus be positive or negative depending on whether 
the two a l l e l e s are associated more or less often than expected. 
Al l e l e frequencies,haplotype frequencies and delta values exhibit 
SI 
considerable geographic v a r i a t i o n . 
The reasons f o r t h i s linkage disequilibrium and 
geographic vari a t i o n are not clear. New a l l e l e s may have originated 
i n a particular population and the linkage disequilibrium between 
these new a l l e l e s and other a l l e l e s characteristic of those 
populations may be the r e s u l t of l i m i t e d d i f f u s i o n away from t h i s 
centre. Alternatively,and more probably,selective forces,as yet 
undefined,make i t advantageous,under certain conditions,to possess 
certain combinations of these a l l e l e s i n the cis rather than the 
trans position (Thomson et al,1976). 
Since the f i r s t tentative description of an association 
between a disease and a l l e l e s at the HLA l o c i (Amiel,1967) a large 
number of such associations have been suggested and subsequently 
confirmed. I n general these associations are more s t r i k i n g than 
those with the ABO polymorphism. 
Several studies have examined the d i s t r i b u t i o n of HLA 
a l l e l e s i n diabetics,complete agreement has not been achieved. 
The f i r s t series (Finkelstein et al,1972) could detect 
no s i g n i f i c a n t association. A group of 44 diabetic individuals 
were considered,all insulin-taking. With hindsight i t i s possible 
to see that the a l l e l e s implicated i n the disease (B8 and Bwl5) were 
both present at increased frequencies i n the diabetic group. The 
small sample size probably accounts f o r the negative r e s u l t . 
The next report (Singal and Blajchman,1973) showed a 
si g n i f i c a n t excess of Bwl5 individuals amongst the diabetic group 
although serological d i f f i c u l t i e s made t h i s conclusion suspect. 
In 1974 Cudworth and Woodrow and Nerup et a l using larger populations 
of diabetics were able to demonstrate convincing associations 
between insulin-dependent diabetes and the a l l e l e s B8 and Bwl5 . 
The r e l a t i v e r i s k s were 2.0,for B8,and 2.8,for Bwl5 (Nerup et a l , 
1974). A sample of Austrian diabetics (Schemthaner et al,1975) 
confirmed these associations and suggested an excess of the C 
locus a l l e l e Cw3 i n the diabetics. 
Expansion of the Liverpool series (Cudworth and Woodrow, 
1976) suggested further associations,a positive association between 
insulin-dependent diabetes and B18 and a negative association with 
B7. The l a t t e r has also been found by Ludwig et a l (1976). 
An investigation of 75 insulin-taking diabetics by 
Cathelineau et a l (1975) found a si g n i f i c a n t excess of B8 positive 
individuals amongst the diseased group but was unable to confirm the 
association with Bwl5. 
Most of these insulin-taking diabetics had presented 
before the age of 30. The only series i n which a substantial 
number of insulin-taking diabetics presenting a f t e r t h i s age was 
studied i s that of Cudworth and Woodrow (1976) they were able to 
report t h a t , i n these individuals,the frequency of the B8 a l l e l e 
was s i g n i f i c a n t l y increased and that of Bwl5,though suggesting an 
association did not reach significance. Cathelineau et a l (1975) 
found no increase i n either antigen i n t h e i r cases presenting 
a f t e r 35 though there were only 20 of them. 
X x i o U X i n ^ i i G l l c 1T1^ Ci.XSliDG'tiICS XTl OtheJ? pOputj-EL"tions G 
also been subject to scrutiny. Wakisaka et a l (1976) showed a 
positive association between the disease and Bw22J,a specific 
Japanese variant of Bw22. The Japanese do not possess the B8 
a l l e l e but they do possess the Bwl5 a l l e l e . I n t e r e s t i n g l y , i n the 
series of Japanese diabetics reported by these authors there were 
R3 
fewer,though not s t a t i s t i c a l l y s i g n i f i c a n t l y fewer,Bwl5 positive 
individuals amongst the diabetics than amongst the controls. 
Patel et a l (1977) report frequencies of the HLA-A 
and HLA-B locus a l l e l e s amongst Caucasian,Mexican-American and 
Negro diabetics i n the United States. The frequencies of B8 and 
Bwl5 were both raised amongst a l l three r a c i a l groups though the 
sizes of the samples were not s u f f i c i e n t to withstand correction 
f o r the number of al l e l e s tested f o r (see below). 
The HLA typing of 100 non-insulin-taking diabetics 
(Cudworth and V/oodrow,1976) showed no association with any of the 
HLA a l l e l e s . 
On the basis of a small series (Nelson and Pyke,1976) 
i t has been claimed that M.O.D.Y. i s not associated with the HLA 
system. This finding has been disputed i n a preliminary report 
(Barbosa,1977) which claims an association with the haplotype 3 -
wl5. 
At the A locus s i g n i f i c a n t associations have been 
demonstrated between early-onset insulin-dependent diabetes and 
the Al and A l l a l l e l e s (Cudworth and Woodrow,1976). The association 
with Al was shown to be a consequence of the positive linkage d i s -
equilibrium with B8. The association with A l l was si g n i f i c a n t 
a f t e r correction f o r the number of s p e c i f i c i t i e s studied and was 
also present a f t e r pooling the Liverpool data with that of two 
other centres - Copenhagen (Nerup et al,1975) and Montpelier 
(Seignalet et al,1975)» The weighted mean re l a t i v e incidences of 
selected HLA al l e l e s from these populations are shown i n table 2.14 
which has kindly been supplied by Dr.J.C.Woodrow. 
Prospective reports on the HLA frequencies i n diabetics 
in-. 
• • • • • 
GO CO CO CO CO to • • • • • • 
- p 
OJ 
II CM "Si" O rH o CT\ • rH O a* • • • • • • • CM rH CM rH o • •H <d 
o 
CM 1 f -
1 
rH 
1 1 
VO 
PH VO o O o o O O rH rH rH rH rH 
O 
e kj n »n KA r~i K « o 00 r-rv 
• • • • • CM r O 
'bo 
•H 00 rH 
^ s rH CTs a\ (TV t o II US CM CO VO 
• • • • • • • a1 • t— CM vo CO CM rH rH CM rH CM 
• •H -ci 
6 
rH r — CM O o • • • • • • •H o o rvi CM CM 
o> 
rH 
d) ITV 
rH rH CO rH 
rH rH rH r — CO rH 
« i PP pq pq m 
K5. 
are published by Cudworth et a l (1977) and Garavoy et a l (1977). 
They have the advantage over the above reports,which are a l l 
retrospective,in that they r e f l e c t d i f f e r e n t i a l s u s c e p t i b i l i t y 
and are free of any bias possibly r e s u l t i n g from d i f f e r e n t i a l 
survival. The series reported by Garavoy et a l was able to confirm 
the positive association with B8,though not that with Bwl5,and 
demonstrated the seasonal v a r i a t i o n i n the presentation of new 
cases of juvenile diabetes. There was no difference i n the frequency 
of new diabetics positive f o r B8 at any season of the year. The 
110 cases reported by Cudworth et a l showed an increase of both 
B8 and Bwl5 and suggested clustering of the Bwl5 positive individuals 
i n the f i r s t three months of 1976. I n addition,subjects with t h i s 
specificity,especially i f accompanied by B8,showed higher t i t r e s 
of antibodies to Coxsackie Bl - B4 viruses immediately a f t e r 
diagnosis. There was no correlation between HLA phenotype and the 
presence of P.I.C.A. 
Jansen et a l (1975) have suggested that the production 
of antibodies to exogenous i n s u l i n i s related to HLA phenotype. 
They found that the frequencies of both B8 and Bwl5 were increased 
i n diabetics taking i n s u l i n but that the increase of Bwl5 was 
confined to the group shown to have high levels of a n t i - i n s u l i n 
antibodies and that the increase of B8 was confined to those 
diabetics with low levels of antibodies. 
H1A-D locus antigens show associations with i n s u l i n -
dependent diabetes. Thomsen et a l (1975) found a s i g n i f i c a n t 
excess of insulin-taking diabetics positive f o r the D locus antigen 
LD-8a (now called HLA-Dw3). This a l l e l e i s known to be i n positive 
linkage disequilibrium with B8 and the r e l a t i v e r i s k f o r developing 
the disease considering the D locus a l l e l e was considerably higher 
than that f o r the B locus a l l e l e . There was also an association 
with LD-wl5a (now called Dw6),a D locus a l l e l e i n positive linkage 
disequilibrium with Bwl5,but the association with t h i s D locus a l l e l e 
was considered to be secondary to that with Bwl5. 
Control populations i n most of the above studies were 
composed of blood donors,often supplemented by laboratory s t a f f and 
medical students. The controls were usually stated to be resident 
i n the same geographical area as the patients. I n some cases (e.g. 
Nerup et al,1974,and Wakisaka et al,1976) the exact source of the 
controls i s not given. 
2.6 Methodological and s t a t i s t i c a l d i f f i c u l t i e s i n the search f o r 
associations. 
The underlying rationale and methodology employed i n the 
search f o r associations has been severely c r i t i c i s e d by Warier (1956, 
and 1970). Many of the points raised i n t h i s c r i t i c i s m are of great 
importance,they are concerned with the choice of patients,the 
selection of controls and the s t a t i s t i c a l and biological significance 
of the r e s u l t s . 
(a) Selection of patients. 
The series l i s t e d i n table ?,? and indeed most of the 
series concerned with other diseases report frequencies i n patients 
collected retrospectively,after the diagnosis has been made. The 
practical advantages of t h i s approach outweighed,in the minds of 
the investigators,the theoretical advantages of the prospective 
approach. 
a?. 
One c r i t i c i s m of the retrospective study i s that i t 
introduces unacceptable bias with regard to the selection of patients. 
More severe cases attending hospital may be included,omitting the less 
severe cases managed by the general practitioner. Peptic ulcers,for 
example,that bleed,perforate or give intractable pain w i l l tend to 
be p r e f e r e n t i a l l y included i n a retrospective sample of hospital 
patients. 
Several workers have attempted to minimise t h i s problem 
by including a l l the patients with a p a r t i c u l a r disease attending an 
out-patient department i n a set period of time ( f o r diabetics,Craig 
and Wang,1955;Serra et al,1964,for example) or by taking a 'random 
sample1 of such a population (McConnell et al,1956). The inclusion 
of individuals i n such samples,however,is heavily dependent upon the 
frequency of attendance. There i s no series i n the l i t e r a t u r e on 
diabetics which includes a l l the known cases,irrespective of hospital 
attendance,within a defined geographical area. 
I n addition,retrospective studies may give a completely 
false representation of the relationship between a genetic factor and 
a disease. An increased frequency i n the l i v i n g patients with a 
certain condition may give the impression that a p a r t i c u l a r genotype 
or phenotype i s predisposed to the development of the disease when, 
i n f a c t , i t i s associated with survival. 
Uncertainty with regard to the d e f i n i t i o n of the disease 
also creates d i f f i c u l t i e s and t h i s i s especially true f o r type I I 
diabetes where the d e f i n i t i o n of abnormality r e l i e s upon an arbitary 
point i n a continuous d i s t r i b u t i o n . 
Unrecognised heterogeneity within a disease may mask a 
real association. Two equally common sub-types,for example,both 
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associated to an equal degree with the 0 phenotype,one p o s i t i v e l y 
and one negatively,would y i e l d a normal ABO d i s t r i b u t i o n i f they were 
both taken together. An association between a polymorphism and a 
rare sub-type of a disease would be masked by amalgamation with a 
numerically superior category with no association. Subjectivity i n 
the process of c l i n i c a l subdivision of peptic ulcer patients has 
been suggested by Weiner (1956) as influencing the results of 
investigations concerning the ABO polymorphism. 
(b) Selection of controls. 
The blood donors commonly used as controls have many 
advantages. Data on a large number of r e l i a b l y typed individuals 
are available f o r most countries of the world (Kopec,1970,and 
Mourantet al,1976). Regional v a r i a t i o n i s defined to a very f i n e 
degree,particularly f o r the ABO system i n the United Kingdom 
(Kope6,1970). This obviates the need f o r typing large numbers of 
'normal' people,a category d i f f i c u l t to define and even more 
d i f f i c u l t to locate. 
Since the variance of a gene frequency estimate i s 
inversely proportional to the sample size,large samples give 
better estimates than small samples although the gene frequencies 
being estimated by the use of donors are the frequencies i n the 
donor population of the region. Whether these are the same as the 
frequencies i n the general population i s a matter f o r speculation 
at the present state of knowledge. 
Buckwalter and Knowler (1958) have claimed that the 
presence of professional donors s i g n i f i c a n t l y increases the 
frequency of blood group 0 i n t h i s type of sample. Although t h i s 
does not apply to t h i s country i t may be influencing the frequencies 
quoted f o r other countries. I t has also been suggested (Seeff et a l , 
1975) that blood donors,especially females,show a sig n i f i c a n t excess 
of rhesus negative individuals when compared with persons grouped fo r 
paternity cases. Kopec (1970) found that blood donors,at least f o r 
ABO and Rh(D) frequencies,did not d i f f e r s i g n i f i c a n t l y from a large 
number of Royal Air Force recruits,though t h i s does not mean that 
either group i s representative of the general population. 
There are several factors which might be considered 
important i n the matching of controls to diseased persons. The 
factors which w i l l be considered here are age,sex,area of b i r t h and 
social class. 
Age. 
There are few data available on the question of whether 
gene frequencies change i n a population as i t ages. The question 
has been considered from a theoretical standpoint (Hiorns and 
Harrison,1970) though the model they considered was not d i r e c t l y 
applicable to blood group data. Most of the data available are 
concerned with the ABO system and some of them are c o n f l i c t i n g . 
The ideal study - the collecti o n of frequencies f o r a cohort of 
bir t h s and the prospective examination of these individuals f o r 
d i f f e r e n t i a l mortality on the basis of genotype —..has not been 
carried out f o r reasons of practicality,although a study of t h i s 
type on a lim i t e d scale i s currently being attempted (Beardmore, 
personal communication). The nearest substitute f o r t h i s ideal 
study i s to sample d i f f e r e n t age groups of an existing population 
and see whether they d i f f e r with regard to phenotype frequencies. 
I f t h i s difference cannot be a t t r i b u t e d to other factors they are 
indicative of d i f f e r e n t i a l survival of individuals on the basis of 
phenotype. 
Jorgensen and Schwartz (1968) have suggested that 
healthy individuals over the age of 75 years have a s i g n i f i c a n t l y 
higher frequency of 0 individuals than a population of donors from 
the same region. They suggest that the 0 phenotype i s selectively 
favoured by way of resistance to disease,notably neoplasms,which 
select against the bearers of the A a l l e l e . 
This f i n d i n g has been confirmed by van Hoote and 
Kesteloot (1972) who,in a survey of 42,804 male soldiers between 
the ages of 16 and 60,found a s i g n i f i c a n t l y higher frequency of 0 
and a s i g n i f i c a n t l y lower frequency of A i n the 55 - 60 year age 
group than i n a l l the younger age groups. They a t t r i b u t e d t h i s 
to d i f f e r e n t i a l mortality and showed t h a t , i n men aged 50 - 54» 
s i g n i f i c a n t l y more individuals of the A and AB blood groups had 
parents who had died before the age of 60,irrespective of cause, 
compared with the men of the 0 and B blood groups. They found 
that serum cholesterol levels tended to be higher i n blood group 
A men and these individuals are known to be more often subject to 
cardiac i n f a r c t i o n (Mourant et al,197l). However,van Houte and 
Kesteloot (1972) f e l t that d i f f e r e n t i a l mortality from coronary 
artery disease alone was un l i k e l y to explain these differences. 
On the basis of these findings i t was recommended (Kesteloot et 
al,1977) that age should be taken into account whenever blood 
group d i s t r i b u t i o n s are compared. 
On the other hand,Roberts (1948),in an analysis of 
30,000 war-time donors from the south-western counties of England, 
found no sig n i f i c a n t differences i n either sex between the mean 
ages f o r the four blood groups A,B,0 and AB. He concluded t h a t , i f 
membership of any group did confer a selective advantage,as judged 
by l o n g e v i t y , i t was either small or effective outside the age range 
covered by the data (18 - 60 years). 
Buckwalier and Knowler (1958) found no change i n the 
ABO phenotype frequencies with age and concluded that,although 
some diseases may seem to favour the 0 phenotype,others select 
against i t making the net effect zero. Since t h e i r analysis was 
confined to individuals under 65 years of age they may have missed 
changes which occur l a t e r i n l i f e . 
Bennett and Walker (1956) i n an analysis of 3>028 
East Anglian donors between the ages of 50 and 65 years could 
show no sig n i f i c a n t heterogeneity with regard to the A/(0+A) 
r a t i o with age although there was a trend f o r an increase of 
t h i s r a t i o with increase i n age of the sub-sample. 
I f blood group frequencies are related to age then the 
comparison of donor populations with diabetic populations i s 
unsatisfactory. Few data are available f o r the age d i s t r i b u t i o n 
of blood donors. The standard text f o r t h i s country (Kopec,1970) 
does not break down the data i n terms of age since t h i s would make 
an already complex analysis impossibly unwieldy. The age d i s t r i b u t i o n 
of 1,517 unselected I s l e of Wight donors (Smith,1977),shown i n table 
2 . 1 5 ,reveals that the commonest age group i s 25 - 29 and that 50% 
of them are below the age of 35« This i s very d i f f e r e n t indeed from 
the age structure of a diabetic population (to be discussed i n 
chapter 4)« 
There are some data on t h i s problem f o r the HLA system 
Table 2*15 Age d i s t r i b u t i o n i n a sample of 1517 I s l e of Y/ight donors 
Age No. Cumulative $ 
under 20 91 6-00 6*00 
20 - 25 209 13*78 19*78 
25 - 30 258 17*01 36*78 
30 - 35 222 14*63 51*42 
35 - 40 191 12*59 64-01 
40 - 45 149 9*82 73*83 
45 - 50 123 8*11 81*94 
50 - 55 107 7*05 88*99 
55 - 60 93 6*13 95*12 
60 - 65 74 4.88 100*00 
ft 
although,again,there are contradictions. A preliminary report 
(Bender et al,1973) suggested that individuals heterozygous at 
both the A and the B l o c i were more frequent i n older people 
than i n controls. Gerkins et a l (1974)»in an analysis of healthy 
aged individuals,aged individuals with neoplasms,healthy young 
individuals and young individuals with neoplasms,found that the 
healthy aged individuals were more frequently heterozygous at the 
A and B l o c i than healthy young individuals and that,when matched 
f o r age,healthy individuals were more frequently doubly heterozygous 
than patients with neoplasms. This was disputed i n a second report 
from the West German group (Bender et al ,1976) who could f i n d no 
sig n i f i c a n t differences with regard to heterozygosity i n t h e i r 
enlarged samples. No convincing differences i n the frequencies of 
individual a l l e l e s with age has been reported. 
The remarks of Svejgaard et a l (1974) on th i s point 
are worth quoting i n f u l l since,although they refer s p e c i f i c a l l y 
to the HLA system,they could also be taken as relevant to other 
polymorphi sms:-
'Very few studies have,as y e t , t r i e d to match 
patients and controls i n respect of a l l 
possible variables which might influence 
the d i s t r i b u t i o n of HLA antigens e.g. age 
and geographic o r i g i n . Race differences 
are usually taken i n t o account,but considerable 
vari a t i o n i n HLA antigen frequencies have been 
found within races (Bodmer,1973)• L i t t l e i s 
known about age va r i a t i o n i n the HLA antigen 
frequencies. In many studies the control series 
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included individuals suffering from diseases 
other than those under 3tudy. Often cadaveric 
kidney donors are included and i t i s as yet 
unknown whether brain tumours ( i n contrast to 
i n j u r i e s ) f o r example are associated with HLA 
antigens. Even healthy blood donors may not 
r e f l e c t the true d i s t r i b u t i o n of HLA antigens i n 
the population. In most European areas the effect 
of the above variables might be small (but needs 
investigating) and large differences between 
patients and controls would be r e a l . 1 
Sex. 
Suggested sex differences i n the ABO frequencies 
(Fisher and Roberts,1943iand Allan,1953) may be related to the 
phenomenon of age specific mortality. Although donor records 
register sex,many studies do not include t h i s i n t h e i r analysis 
and the question of the relationship between sex,age and poly-
morphisms remains unanswered. 
Area of b i r t h . 
For the ABO system,analysis has been carried out on 
a regional basis i n the United Kingdom although the area of 
residence i s considered rather than the area of b i r t h of the donor 
or his antecedants (Kopec,1970). As Mourant has pointed out i n 
his foreword to t h i s publication,this has the effect of describing 
a population a generation l a t e r than that described on the basis 
of b i r t h place. The magnitude of the difference between the 
d i s t r i b u t i o n of a polymorphism on the basis of residence and that 
on the basis of b i r t h place depends on the degree of migration in t o 
and out of the area and the l o c a l i t i e s from which the migrants are 
drawn. Whether t h i s affects the study of associations with diseases 
depends on whether the diseased group and the control group are 
d i f f e r e n t enough with regard to t h e i r geographical and r a c i a l 
origins to show differences i n t h e i r phenotype frequencies. This 
p o s s i b i l i t y seems unlikely at f i r s t sight but may apply i f the 
diseased and control groups d i f f e r markedly i n terms of age or 
social class both of which are undoubtedly related to social 
mobility. There are no data to suggest that blood donors form a 
representative sample of the population with regard to social 
class. 
The variations i n the HLA system on a regional basis 
within national boundaries i s almost t o t a l l y unknown,although,as 
stated above i t i s known that antigen frequencies i n t h i s system 
vary considerably within races. U n t i l these variations have been 
qu a n t i f i e d , i t seems unwise to compare the frequencies of diseased 
individuals with the mean frequencies f o r t h e i r race. 
(c) S t a t i s t i c a l significance. 
I t has been pointed out (Weiner,1970) that an 'association' 
said to be s i g n i f i c a n t at the 20$ level w i l l occur by chance once i n 
20 t r i a l s and that,with many groups working on polymorphisms and 
diseases,and positive findings being published i n preference to 
negative,chance associations w i l l be taken f o r real relationships. 
Vogel (1970) thought t h i s objection u n l i k e l y . The acid test of a 
disease association i s that i t can be repeated i n several centres 
with d i f f e r e n t series of patients and controls• 
The consideration of several genetic factors simultaneously 
may lead to the demonstration of a spurious association. This has 
been s p e c i f i c a l l y mentioned i n the case of the HLA system where a 
large number of a l l e l e s are studied at the same time (Svejgaard et 
al , 1 9 7 4 ) but i t i s none the less true of other investigations where 
a number of polymorphisms are examined i n the same population. 
Several means of circumventing t h i s d i f f i c u l t y , a t least f o r HLA, 
have been suggested (Svejgaard et al , 1 9 7 4 ) although none take into 
account the fact that the factors studied are not t o t a l l y independent 
(there being linkage disequilibrium between some of the A and B 
locus a l l e l e s ) . The most convenient (and most widely employed) 
method f o r correcting f o r t h i s i s to multiply the p value f o r each 
a l l e l e by the number of a l l e l e s tested f o r . This means that only 
highly s i g n i f i c a n t associations w i l l be revealed and some r e a l , 
though less marked associations w i l l be l o s t . This d i f f i c u l t y i s 
overcome by the f i n d i n g of the same associations i n other independent 
series. 
2.7 The biological significance of associations with disease. 
There has been no satisfactory explanation of the 
biological significance of the associations between the ABO system 
and disease. I t would be satisf y i n g i f a convincing theory 
explaining the whole phenomenon were available rather than one 
explanation f o r every association. 
The nearest thing to t h i s i s a theory expounded by 
Lennes ( l96 l ),which,although intended to explain the association 
with duodenal u l c e r , i s capable of explaining a l l ABO - disease 
associations on the same p r i n c i p l e . Lennes suggested that the 
development of duodenal ulcer had nothing to do with the ABO 
phenotype of the individual but that an interaction between the 
"ulcer genotype1 and the phenomenon of feto-maternal ABO 
incompatibility was responsible f o r the association. The presence 
of the 'ulcer genotype' i n the fetus was suggested to make the 
abortion or f a i l u r e of implantation of an embryo already incompatible 
with i t s mother more l i k e l y . Since ABO incompatibility affects 0 
fetuses less often than i t does A,B or AB fetuses,the result w i l l 
be that,of those individuals bom with the 'ulcer genotype1,more 
w i l l be 0 than A,B or AB. After b i r t h the ABO locus has no e f f e c t . 
By extrapolation,the same phenomenon could account f o r associations 
with blood groups A or B by postulating a protective effe c t of 
the relevant disease genotype with regard to the effects of f e t o -
maternal incompatibility. 
I t has been pointed out (McConnell,1966) that a 
prediction of t h i s theory i s that associations with ABO should 
be less marked i n those areas where the frequency of the 0 gene 
i s highest (and feto-maternal incompatibility lowest). I n f a c t , 
t h i s i s not bourne out by the data on diabetes taken from the 
reports l i s t e d i n table 2 . 2 , When x,the value of the A/0 r a t i o , 
i s plotted against the value of 0/w/o f o r each corresponding 
control group there i s no significant, negative correlation 
demonstrated ( r = - 0 . 0 7 2 ) . This i s also true for the comparison 
of y ( l o g g x ) against 0/N$. 
The biological significance of the HLA associations 
i s easier to comprehend. By analogy with the mouse,there i s 
l i k e l y to be a region of chromosome 6 ,not f a r from the HLA l o c i , 
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which contains the immune response ( i r ) genes (McDevitt and Bodmer, 
1974)• I f t h i s i s the case then the associations observed between 
the HLA al l e l e s and,for example,diabetes,may be due to linkage 
disequilibrium between the B locus a l l e l e s and pa r t i c u l a r I r genes 
which render the individual more l i k e l y to develop diabetes. I t 
has been suggested (Nerup et al , 1 9 7 6 ) that the I r gene associated 
with the B8 a l l e l e may code f o r an abnormal T lymphocyte response 
to certain infections and that t h i s abnormal response results i n 
the auto-immune destruction of insulin-producing c e l l s . The 
fi n d i n g of a greater association with the D locus a l l e l e Dw3 
(Thomsen et al , 1 9 7 6 ) supports t h i s general theory since the D 
locus i s nearer the hypothetical I r genes than the A,B or C l o c i . 
Family studies (Cudworth and Woodrow,1975(a)) support 
the contention that i t i s not the HLA a l l e l e s themselves that are 
responsible since sib pairs,both of whom are diabetic,share HLA 
haplotypes more often than would be expected by chance even though 
these haplotypes may not include the B8,Bwl5 or B18 a l l e l e s . 
I t i s evident from twin studies (Nelson et al , 1 9 7 5 ) 
that d i f f e r e n t mechanisms are responsible f o r the association with 
Bwl5. This i s supported by the work with the D locus a l l e l e Dw6 
and the fact that the r e l a t i v e r i s k f o r individuals possessing 
both B8 and Bwl5 a l l e l e s i s equal to the sum of the two individual 
r e l a t i v e risks (Svejgaard et "-1,1975) whereas the risks foT being 
homozygous B8 or homozygous Bwl5 are no d i f f e r e n t from having one 
B8 or Bwl5 a l l e l e i n combination with something else. I t has been 
suggested (Nerup et al , 1 9 7 6 ) that the Bwl5 positive unaffected sibs 
of diabetic individuals have lower levels of i n s u l i n response than 
do the Bwl5 negative unaffected sibs of the same diabetics. I t may 
be that the Bwl5 a l l e l e i t s e l f i s connected with beta c e l l function. 
A considerable amount of data has been presented 
concerning associations between diabetes and polymorphisms. I t 
i s evident,though,that,despite t h i s volume of work,some systems 
have been examined inadequately,with c o n f l i c t i n g results,or not at 
a l l . More important,however,is the f a i l u r e of reported series to 
explore any effect of age,sex or area of o r i g i n i n the d i s t r i b u t i o n 
of phenotype frequencies i n the general population which may be 
exaggerating or masking associations with diabetes. 
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3.1 Introduction. 
The conclusions from the evidence reviewed i n the 
previous chapter are that the major genetic determinants f o r type I 
diabetes are present somewhere i n the major histocompatibility 
complex on chromosome 6 and that these are non-contributory i n the 
genetic predisposition to type I I diabetes. Although d i f f e r e n t 
genetic factors are,therfore,responsible f o r these two diseases i t 
does not necessarily follow that they are genetically independent and, 
indeed,the evidence on t h i s i s contradictory. 
Two things suggest that type I and type I I diabetes may 
be i n t e r - r e l a t e d genetically. F i r s t l y , t h e f i n d i n g of families i n 
which both diseases are present,though data of t h i s nature must be 
subject to rigorous analysis to determine whether such events are 
commoner than would occur by chance. Secondly,both types of diabetic 
suffer from cardiovascular complications of the same c l i n i c a l and 
hi s t o l o g i c a l type,and,if there are genetic factors involved i n these 
changes,it seems possible that type I and type I I diabetics share 
some of these components. 
I f these sub-types of diabetes are genetically related 
then i t follows that the chromosome 6 determinants involved i n type 
I diabetes are not the only hereditary material contributing to the 
disease. This p o s s i b i l i t y has been suggested before (Cudworth and 
Woodrow,1975»and. 1976) ,to explain the f a i l u r e of sibs of diabetics 
to develop the disease when they were exposed to the environmental 
tr i g g e r at the same time as t h e i r HLA-identical affected brothers 
and s i s t e r s . 
3.2 Family studies. 
There have been no studies of the frequencies of type I 
and type I I diabetes i n families using an immunological c r i t e r i o n -
the presence of P.I.C.A. The d i f f i c u l t i e s involved i n such a study 
would be considerable,mainly because of the transient nature of these 
antibodies i n the c i r c u l a t i o n . The closest approaches have been the 
consideration i n families of disease subdivided on the basis of age 
at diagnosis or current treatment. Of the two the l a t t e r i s the 
more acceptable since insulin-taking diabetics are largely type I , 
although the insulin-independent category may include some diabetics 
of t h i s type (Irvine, 1 9 7 7 ) . 
Analysis of the family data from these studies has been 
of two types - the consideration of frequencies of affected 
relatives i n families of diabetics and controls and the use of 
more complex techniques such as h e r i t a b i l i t y of l i a b i l i t y . 
(a) Frequencies of affected r e l a t i v e s . 
MacDonald (1974(a)) analysed family data,obtained by 
questionnaire,from the rela t i v e s of 118 insulin-taking diabetics 
diagnosed before the age of sixteen and of 108 non-diabetic 
children admitted to hospital f o r minor surgery. I n the f i n a l 
analysis he used grandparental data only,since he considered 
t h i s group to be the most l i k e l y to manifest the condition i f they 
were genetically predisposed. There was information on 423 grand-
parents of diabetics and 395 grandparents of non-diabetics. The 
groups were of comparable age. 
Considering diabetics diagnosed over the age of 45 and 
irrespective of treatment,the prevalence i n the grandparents of 
diabetic children was 0.078,that i n the granparents of non-diabetic 
children 0.071,an i n s i g n i f i c a n t difference. 
This late threshold of diagnosis was chosen to exclude 
cases which might have been ambiguous i n the c l a s s i f i c a t i o n i n t o 
early- and late-onset types. Curiously,MacDonald excluded from the 
control group any children with a r e l a t i v e of any type diagnosed as 
diabetic before the age of t h i r t y - 'To reduce the incidence of 
genes which could lead to juvenile diabetes among the families of 
the controls'. I t i s unfortunate that the prevalence of non-insulin-
taking diabetics amongst the grandparents was not considered rather 
that the prevalence of late-onset diabetes irrespective of 
treatment. 
Lestradet et a l (1972) considered insulin-independent 
and insulin-dependent subdivisions of diabetes. They studied the 
prevalences of these sub-types i n selected r e l a t i v e s (fathers, 
mothers,grandparents and parents' sibs) of 1,000 insulin-dependent 
c h i l d diabetics and those of 1,000 controls (paediatric patients 
without diabetes). They found that 1.55$ of the rel a t i v e s of the 
diabetic propositi and 1 .42$ of the rel a t i v e s of controls had 
insulin-independent diabetes,concluding that these two sub-types 
of the disease were genetically independent. I n t h i s study the 
relatives considered were not shown to be of comparable ages 
and sibs were eliminated from the analysis. 
Kobberling ( 1969) ,using a d i f f e r e n t approach,concluded that 
early- and late-onset were genetically d i s t i n c t because the prevalence 
of the former disease amongst the sibs of early-onset diabetics was 
twenty-five times that amongst siblings of late-onset diabetics. 
Similarly,Cudworth (1976) concluded that type I and type I I diabetes 
were 'genetically heterogeneous1 because the prevalence of type I I 
diabetics amongst the sibs of type I I propositi was 4• 59^  compared 
with O.lfc f o r the prevalence of type I diabetes i n these siblings, 
whereas the prevalence of type I I diabetes i n the sibs of type I 
propositi was O.&fo compared with 8 .6$ f o r type I siblings of type I 
propo s i t i . Such statements are meaningless when,as Cudworth himself 
points out,unexpired r i s k i n these relatives i s not considered and 
the prevalence i n the general population i s not used f o r comparison. 
(b) Studies of h e r i t a b i l i t y of l i a b i l i t y . 
The application of techniques f o r the estimation of 
h e r i t a b i l i t y of l i a b i l i t y to early- and late-onset diabetes has 
produced ambiguous resu l t s . Analysing data from an Edinburgh 
population,Smith et a l (1972) considered that these subdivisions 
of diabetes were genetically related,in that the 'genetic correlation' 
between them was O.65 (Smith,1976). The l i m i t i n g values f o r t h i s 
correlation being zero f o r no relationship and uni t y f o r the same 
genetic disease. 
Analysing a larger body of Canadian data by the same 
methods,Simpson (1969) reached the opposite conclusion,namely that 
early- and late-onset diabetes were d i s t i n c t genetic diseases. 
I f the methodology i s v a l i d i t would seem that the only 
way of explaining these conclusions are that the data sets were 
d i f f e r e n t (Simpson,1976). On the other hand,the c l a s s i f i c a t i o n of 
diabetes i n t h i s way i s unsatisfactory,since,using diagnosis at 
30 years as the div i s i o n between early- and late-onset diabetes, 
as w i l l be shown i n chapter 8,nearly half of the insulin-taking 
diabetics i n a population w i l l be c l a s s i f i e d as late-onset cases 
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along with the non-insulin-taking diabetics. A spurious genetic 
relationship between the early- and late-onset categories could 
result from t h i s alone. As suggested by Smith et a l (1972) and 
MacDonald (1974)»the model of m u l t i f a c t o r i a l inheritance with an 
ar b i t r a r y threshold may be inappropriate f o r early-onset diabetes. 
3.5 A hypothesis f o r genetic predisposition to type I and type I I 
diabetes. 
The basis of t h i s hypothesis i s that the auto-immune 
reaction to the pancreatic beta c e l l s triggered by the relevant 
environmental factor i n an individual carrying the appropriate 
I r genotype,varies i n severity and only produces the insulinopaenia 
characteristic of the type I disease i n the most severely affected 
individuals. The severity of t h i s beta c e l l i n j u r y i s determined 
by genes at other l o c i which are concerned with the response of a l l 
c e l l s of the body to i n j u r y . Furthermore,these same genes comprise 
the whole,or the major part,of the genetic determinants of type I I 
diabetes and of the cardiovascular changes characteristic of diabetic 
complications. 
(a) Propositions. 
I t i s proposed that a polygenic system determines the 
v u l n e r a b i l i t y of c e l l s to local injurious factors - traumatic, 
immunological and metabolic - so that individuals at one end of the 
consequent normal d i s t r i b u t i o n of genotypes have vulnerable c e l l s 
with a rapid rate of c e l l death and a resultant rapid rate of c e l l u l a r 
replacement. Individuals at the other end of the range have c e l l s 
r e l a t i v e l y resistant to injury,a slow rate of c e l l death and a slow 
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rate of c e l l replacement. Most people are intermediate (see figure 
5 . 1 ) . 
There i s evidence from tissue culture (Logethetopoulos, 
1972,and Martin et al , 1 9 7 0 ) that cel l s have a l i m i t e d number of 
regenerative cycles at t h e i r disposal,at least i n v i t r o . I f t h i s 
also applies i n vivo then individuals with rapid rates of c e l l death 
would approach t h i s theoretical l i m i t faster than those with slower 
rates of c e l l death. 
In the individuals with a high turnover of cel l s the 
accumulation of debris around c a p i l l a r i e s leads to basement 
membrane changes i n the manner envisaged by Vracko and Benditt 
(1972) . The development of i n s u l i n resistance i n the type I I 
diabetics i s seen as another manifestation of t h i s genetic make-up, 
either through the s e n s i t i v i t y of cell-surface receptor sites to 
i n j u r y or the presence of large numbers of 'aged' c e l l s - i n the 
sense that they are further removed from t h e i r stem c e l l i n terms 
of mitotic divisions. Thus the major components of type I I diabetes, 
micro-angiopathy and i n s u l i n resistance are considered the res u l t of 
the possession of certain extreme combinations of genes i n t h i s 
polygenic system. 
This proposition does not preclude the influence of 
environmental factors,both acceleratory and retardatory,in the 
pathogenesis of type I I diabetes,given the required genetic make-
up. Acceleratory changes may be a diet high i n refined carbo-
hydrate with a consequent metabolic i n s u l t to the c e l l s i n the form 
of rapid and extreme fluctuations i n blood glucose. The development 
of obesity,frequent pregnancies or r e l a t i v e dietary chromium 
deficiency are also possible acceleratory environmental influences. 
Figure 3»1 Schematic representation of hypothesis f o r genetic 
predisposition to type I and type I I diabetes. 
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Deceleratory changes might include near starvation,diets low i n 
refined carbohydrate and high i n dietary fibre,low p a r i t y and diets 
adequate with regard chromium intake. 
The proposition of such a m u l t i f a c t o r i a l aetiology 
for type I I diabetes f i t s well with the observed f a m i l i a l incidence 
of the disease. Groups with an unusually high prevalence of the 
disease,such as the Pima Indians of North America ( M i l l e r et a l , 
I965) show t h i s prevalence because of t h e i r possession of a large 
number of the appropriate polygenes (perhaps,because,under certain 
circumstances,they are selectively favoured,or by chance) and 
because acceleratory environmental influences ( i n t h i s case the 
recent adoption of a high carbohydrate,low f i b r e d i e t ) . 
The pathogenesis of type I diabetes i s more complex 
i n that i t involves the simultaneous influence of both the poly-
genic system outlined above,the relevant I r genotype and the 
environmental components of each. When an in f e c t i o n of the 
appropriate type i s experienced by an individual with the required 
I r genotype and with 'vulnerable' c e l l s an auto-immune reaction 
occurs which i s s u f f i c i e n t to produce complete,or almost complete, 
i n s u l i n lack either immediately or af t e r a.n initial,unsuccessful 
period of compensatory beta c e l l r e p l i c a t i o n . The i n i t i a l c e l l u l a r 
i n s u l t i s severe because the beta c e l l s are p a r t i c u l a r l y vulnerable 
to immunological i n j u r y and the recovery process i s unsuccesful 
because the beta c e l l s have already undergone a number of 
regenerative c e l l divisions and have a f i n i t e number available to 
them. 
When an infection i s encountered by an individual not 
at t h i s extreme end of the polygenic d i s t r i b u t i o n but who,neverthele 
carries the relevant I r genotype,there i s a reaction against beta 
cells,with a transient appearance of P.I.C.A. and,perhaps,a short-
li v e d deterioration of glucose tolerance. In these individuals, 
however,either because the c e l l s are less vulnerable to i n j u r y , 
or because they have a greater regenerative capacity,or both,beta 
c e l l function i s regained either permanently or f o r a considerable 
time,depending on where,precisely,the genotype of the person f i t s 
on the polygenic d i s t r i b u t i o n . I n the individuals whose recovery 
i s only temporary,glucose tolerance w i l l deteriorate with the 
insidious onset of insulin-dependent diabetes l a t e r i n l i f e . 
The insulinopaenia and other metabolic derangements 
of type I diabetes are envisaged as acceleratory contributions 
to the development of cardiovascular changes but these changes are 
not possible without the appropriate polygenic background. 
(b) Predictions. 
The following predictions are generated by t h i s 
hypothesis and some of them w i l l be tested with family data:-
( i ) There should be more individuals with type I 
diabetes i n the families of type I I diabetic propositi (and vice 
versa) than would be expected by chance. Because these two types 
of diabetes share certain genetic factors v i z . the genes f o r 
'vulnerable' c e l l s . 
( i i ) The frequency of the occurrence of cardiovascular 
complications i n diabetics should be d i r e c t l y related to the 
family h i s t o r y . The more affected r e l a t i v e s there are and the 
more closely they are related to the propositus,the more common 
and the more rapid should be the complications i n the index case. 
'Q. 
This i s "because both the density of family history and the development 
of complications are related to the number of deleterious c e l l u l a r 
ageing polygenes present. 
( i i i ) There should be a higher incidence of diabetic 
individuals i n the families of type I and type I I diabetics whose 
disease occurred early i n l i f e compared with those index cases 
whose disease was diagnosed l a t e r . 
( i v ) The hypothesis suggests that there are at least 
two types of late-onset insulin-dependent diabetic - those with 
sudden onset who are experiencing the environmental t r i g g e r agent 
for the f i r s t time and those with an insidious onset,perhaps with 
a period of i n i t i a l insulin-independence,who have experienced the 
trig g e r at some time i n the past but made a temporary recovery. 
Both of these types w i l l show an increased frequency of certain 
HLA-B and HLA-D locus a l l e l e s but those of sudden onset should 
show the seasonal fluctuations characteristic of early-onset i n s u l i n -
dependent diabetics,have a higher incidence of cardiovascular 
complications and a greater number of affected r e l a t i v e s . This 
follows from the fact that those with an insidious onset recovered 
i n i t i a l l y because they possessed fewer c e l l u l a r i n j u r y genes. 
(v) Sibs of newly-diagnosed diabetics who share 
i d e n t i c a l HLA haplotypes with t h e i r affected sibs w i l l show a 
transient, appearance of P.T.fi.A, and a short-lived phase of 
glucose intolerance at the time of the onset of the disease i n 
th e i r affected sib. Recovery w i l l follow i f t h e i r component of 
polygenes i s d i f f e r e n t from that of t h e i r sib with diabetes. 
( v i ) At any one time a certain number of the general 
population w i l l show positive c i r c u l a t i n g P.I.C.A.,not a l l w i l l 
become insulin-requiring diabetics. 
This hypothesis i s similar to that expounded by Lamy 
et a l ( l 9 6 l ) i n that predisposition to type I diabetes i s considered 
to be the result of a major gene with non-allelic modifiers. 
I t has the disadvantage that i t proposes a whole new series of, 
as yet,unidentified polygenes but there i s the advantage that these 
genes are the same i n both types of diabetes. 
Chapter 4 
The populations studied. 
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4 .1 Introduction. 
The c o l l e c t i o n of data fo r t h i s study took place with 
the following major objectives i n view:-
( i ) To compare the d i s t r i b u t i o n of some genetic 
polymorphisms i n a sample of c l i n i c a l l y diagnosed diabetics with 
that i n an appropriately matched control group for the sake of 
c l a r i f i c a t i o n i n systems already studied and to search f o r new 
associations i n those hitherto unexplored. 
( i i ) To test some of the predictions of the hypothesis 
outlined i n the previous chapter using pedigree data from diabetics 
and controls. 
( i i i ) To examine the pattern of occurrence of new 
cases of the disease with regard to time of onset,area of residence 
at diagnosis and the genetic make-up of newly-diagnosed diabetics. 
The information on diabetic individuals was collected 
from those attending the out-patient department of Dryburn hospital, 
Durham. A group of non-diabetic controls was assembled from 
several sources. 
4 .2 Diabetic subjects. 
At Dryburn hospital,diabetic out-patients are seen at 
one of three c l i n i c s - during the course of a paediatric out-
patient session and at one of tv/o specific adult diabetic c l i n i c s , 
one f o r individuals up to the age of 6 5 ,the other f o r g e r i a t r i c 
patients. 
This particular hospital offers several advantages 
f o r the conduction of such a survey. F i r s t l y , i t i s situated near 
the geographical centre of i t s catchment area which considerably 
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eases the l o g i s t i c s of v i s i t i n g patients at t h e i r homes a f t e r a 
preliminary interview at the c l i n i c . 
Secondly,the diabetic patients are reviewed unselectively, 
i. e . there i s no tendency to follow up only those patients on 
in s u l i n or those with poor control,for example,and to discharge 
others to the care of the general pr a c t i t i o n e r s . 
Thirdly,diabetics are gathered together at one c l i n i c 
and not seen at general medical sessions with other types of 
patient. 
Fourthly,the co-operation of the consultant s t a f f at 
Dryburn had been secured,both f o r the study of the diabetic 
patients and f o r the study of controls. This l a s t consideration, 
of course,was the most important of a l l . 
The only disadvantage of the diabetic c l i n i c s at t h i s 
hospital was the lack of separate diabetic notes,which would have 
f a c i l i t a t e d some aspects of the study and lack of accurate figures 
on the size of the current diabetic population. Using the estimate 
of 0.64?£ f o r the prevalence of c l i n i c a l l y diagnosed diabetes 
(Malins,1968) and estimating the population of the catchment area 
to be somewhere around 186,000 (Sutherland,1974)»it was calculated 
that j u s t over a thousand diabetics should be resident i n the area, 
a large number of these would be attending the local hospital. 
I t was o r i g i n a l l y intended that a l l c l i n i c a l l y 
diagnosed diabetics resident i n the area should be investigated. 
Time and resources did not allow f o r t h i s . A l l c l i n i c a l l y 
diagnosed diabetics i n the area i n 1975 were,in fact,located 
(see chapter 8) but they were not a l l contacted. 
Diabetics were interviewed at the out-patient c l i n i c s 
from November,19741"to June 1976. The d e f i n i t i o n of diabetes 
employed was that they should have been diagnosed as such by the 
physicians i n charge and that they should be currently receiving 
treatment. Diagnosis had been made either on the basis of a 
glucose tolerance test or on the basis of a random blood sugar. 
Glucose tolerance tests had been judged on the basis of published 
c r i t e r i a (PitzGerald and Keen,1962). 
At the beginning of the interview the diabetics were 
t o l d of the nature and purpose of the investigation. Venous blood 
was taken from those wishing to participate and name,address,date 
of b i r t h and current treatment noted. Arrangement were made to see 
as large a number as possible of these individuals at t h e i r homes 
when,during a longer interview,details of family history,mode of 
onset of the disease,place of residence at the time of diagnosis, 
past treatment,place of b i r t h of the patient,his parents,spouse and 
grandparents and detai l s of occupation were ascertained. For each 
patient the date at which the diagnosis of diabetes v/as made was 
the date on the i n i t i a l r e f e r r a l l e t t e r from the general p r a c t i t i o n e r . 
For patients whose date of diagnosis was unrecorded t h i s date v/as 
ascertained by asking the individual when he had f i r s t been t o l d 
he was diabetic. For individuals not v i s i t e d at home,the place of 
residence at the time of diagnosis was noted from the r e f e r r a l 
l e t t e r . 
During the home interview,each diabetic was asked to 
f i n d an acquaintance suitable f o r study as a control. I f necessary, 
a second sample of blood was taken at t h i s time. 
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(a) Diabetics from the 1975 out-patient population. 
During the course of 1 9 7 5i9 3 6 c l i n i c a l l y diagnosed 
diabetics were seen as out-patients at Dryburn hospital. Of these, 
577 ( 4 0 . 3 $ ) were male and 559 ( 5 9 . 7 $ ) were female (sex r a t i o O .67) . 
By the f i r s t of January,1976,251 ( 2 6 . 8 $ ) of them were being treated 
with insulin,3 3 6 ( 3 5 « 9 $ ) with a combination of oral hypoglycaemic 
drugs and dietary therapy and 349 (37.3%) with dietary r e s t r i c t i o n 
alone. Their age d i s t r i b u t i o n ( i n terms of age on the f i r s t of 
January,1976) i s given i n table 4»1» 
Of these 936 individuals,6 9 3 (74.0%) participated i n 
the study,32 (3«5%) were asked but refused and the remaining 211 
( 2 2 . 5 $ ) were not contacted. These tended to be patients attending 
infrequently who happened to be missed on the days they were 
present at the c l i n i c . 
Table 4 » 1 also shows the age d i s t r i b u t i o n of those 
individuals included i n the sample,together with the percentage 
sampled of those available f o r each five-year group. 
The percentage sampled of those available ranged from 
100% (0 - 4 age group) to 52.9% (75 - 79 age group). This was 
partl y a resul t of the frequency of attendance and part l y of the 
t o t a l number available i n each age group. Despite this,however, 
the 693 individuals represent a random sample of the t o t a l out-
patient population i n terms of current age i n these categories. 
After amalgamation of the 0 - 4 and 5 - 9 age groups and the 90 -
94 and 85 - 89 age groups,the chi squared f o r the comparison of 
age group membership between diabetics available and diabetics 
sampled i s 10 .36 which,for 16 degrees of freedom,gives p between 
0 .9 and 0 . 8 . 
Table 4*1 Age d i s t r i b u t i o n (on 1 . 1 . 7 6 ) of diabetics attending: ; out-patients 
i n 1975 and det a i l s of sampling of each age group. 
Ages (yrs) Number 
available 
frequency number 
sampled 
io sampled 
of those available 
i» of t o t a l 
sample 
0-4 4 0*4 4 100 '0 0*6 
5-9 6 0*6 5 83-3 C 7 
10-14 11 1-2 9 81 .8 1-3 
15-19 20 2-1 19 95.O 2-7 
20-24 22 2-4 20 9O.9 2-9 
25-29 13 1.4 10 76-9 1-4 
30-34 18 1-9 16 8 8 « 9 2-3 
35-39 23 2 -5 21 91-3 3 '0 
40-44 40 4 . 3 34 85.O 4 .9 
45-49 45 4 . 8 39 86 .7 5.6 
50-54 60 6 . 4 50 83-3 7-2 
55-59 89 9 . 5 77 8 6 . 5 1 1 « 1 
60-64 130 13-9 94 72-3 13 .6 
65-69 150 16*0 112 74-7 16*2 
70-74 146 15 '6 96 65*7 13'9 
75-79 104 11-1 55 52-9 7 .9 1 
8O-84 35 3-7 21 6 0 . 0 3 .0 
85-89 17 1*8 10 5 8 « 8 1-4 
90-94 3 0-3 1 33-3 0 .1 
TOTALS 936 100 693 74-0 100 
Mean age ( t o t a l population) = 60 .38 
Minimum, 3»07 Maximum, 9 2 . 2 3 
( ± 0 - 5 7 ) years (sample) = 58.08 (+O.67) 
years 
Minimum, 3 .07 Maximum, 91*59 
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Of the diabetics sampled,297 ( 4 2 . 9 $ ) were male and 396 
( 5 7 . 1 $ ) were female (sex r a t i o 0 . 7 5 )|S0 that the sample i s s l i g h t l y 
biased towards males,although t h i s i s i n s i g n i f i c a n t when compared 
with the t o t a l out-patient group (chi squared,with one degree of 
freedom = 1 . 0 9 ) . 
The numbers i n each treatment sub-group i n the sample 
and i n the t o t a l population are given i n table 4*2 . Although the 
sample i s biased towards insulin-taking diabetics (who were the more 
frequent attenders),at the expense of the diet-controlled patients, 
t h i s difference i s non-significant (chi squared = 4•35 f o r 2 
degrees of freedom). 
(b) Diabetics from other sources. 
I n addition to these 693 individuals,28 other diabetics 
were included,bringing the t o t a l to 721 . 27 of these were new-
comers to the c l i n i c i n 1976 and one was a local medical p r a c t i t i o n e r 
interested i n the venture. 
(c) The t o t a l diabetic sample. 
Table 4 . 3 shows the t o t a l diabetic sample sub-divided 
into 5 year age groups. Compared with the age d i s t r i b u t i o n of the 
1975 out-patient population,there are more young diabetics i n the 
sample. The mean age of these 721 diabetics,on the f i r s t of 
January,1976,was 57.56 ( + 0 . 6 8 ) years. 
There were 314 male and 407 females (sex r a t i o 0 .77 -
i n s i g n i f i c a n t l y d i f f e r e n t from the complete 1975 diabetic c l i n i c ) . 
Insulin-taking diabetics comprised 31 .9$ of the sample (230 
individuals,1 2 9 male and 101 female),there were 252 (34*9$) treated 
Table 4*2 Treatment of diabetics i n sample and diabetica i n 
the out - patient population 
Treatment Whole group sample 
I n s u l i n 251 (26'Bfo) 215 ( 5 1 , 0 » / 0 ) 
Oral hypoglycaemics 
+ diet 
336 (35-9%) 248 (35*896) 
Diet alone 349 ( 3 7 - 3 $ ) 230 (33-296) 
Table 4 » 3 Age d i s t r i b u t i o n (on 1 . 1 . 7 6 ) of a l l diabetics 
i n the sample 
(age) Number Frequency ($) Cumulative frequency (%) 
0-4 5 0-7 0-7 
5-9 6 0*8 1-5 
10-14 12 1-7 3-2 
15-19 20 2*8 6-0 
20-24 22 3-1 9-0 
25-29 11 1'5 10*5 
30-34 16 2'2 12 '8 
35-39 23 3-2 16*0 
40-44 37 5-1 21-1 
45-49 42 5 .8 2 6 « 9 
50-54 50 6 .9 33-8 
55-59 79 l l ' O 4 4 . 8 
60-64 95 13-2 58 .0 
65-69 115 16-0 73*9 
70-74 98 13*6 8 7 . 5 
75-79 56 7 .8 95-3 
8O-84 22 3-1 98-3 
85-89 11 1-5 99 .9 
90-94 1 0-1 100 .0 
Total - 721 
Mean age = 57-55 St.dev 18'13 
Minimum 3*07 years Maximum 9 1 # 5 9 years 
with oral hypoglycaemics (81 males and 171 females) and 239 
patients ( 3 3 . 2 $ ) treated with diet alone (104 males,135 females). 
This d i s t r i b u t i o n with regard treatment i s i n s i g n i f i c a n t l y d i f f e r e n t 
from that i n the 1975 diabetic c l i n i c (chi squared = 5.69 f o r 2 
degrees of freedom). 
Time and resources permitted 433 of these 721 individuals 
( 6 0 . 0 $ ) to be v i s i t e d at home f o r further questioning. This 
represented between 40 and 50$ of the current out-patient population 
i n 1976. 
4 .3 Control subjects. 
Control data f o r such studies as t h i s are often d i f f i c u l t 
to obtain. Kopec (1970) gives ABO and Rhesus (D.) results f o r donors 
from t h i s region but there are few such samples for other systems. 
Besides,theoretical disadvantages i n using donors f o r comparison 
with diabetics have been raised i n chapter 2 . Accordingly,it was 
decided to col l e c t blood samples from non-donor,non-diabetic 
individuals resident i n the area fo r comparison with previously 
published material,investigation f o r the e f f e c t of sex,age and other 
factors and f o r comparison with the diabetics. 
(a) Neighbour controls. 
I t was the o r i g i n a l intention that the entire control 
sample should consist of individuals chosen by the diabetic subjects 
from amongst t h e i r acquaintances. By specifying that the diabetics 
should choose a non-diabetic friend of the same sex,within f i v e years 
of t h e i r own age and l i v i n g within the same pa r i s h , i t was hoped that 
a control sample,matched with the diabetics i n terms of age,sex, 
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social class and area of residence should be b u i l t up. The diabetic 
was to contact a suitable person and report the address of the 
individual,who would be contacted with a view to a home v i s i t . 
I n practice t h i s exercise was not a succes since only 
74 (17.1%) of the 433 individuals asked were able to f i n d a 
suitable individual who would co-operate. These 74 people were 
v i s i t e d at home and information taken on t h e i r date of b i r t h , 
occupation.family history of diabetes and place of b i r t h of 
themselves and t h e i r antecedants. Of these 74f68 agreed to have 
blood drawn. A urine sample taken between one and two hours a f t e r 
the largest meal of the day was tested f o r glucose and,in fact,one 
individual was found to have glycosuria. Diabetes was confirmed 
with a glucose tolerance test and he was referred to the diabetic 
c l i n i c leaving 73 neighbour controls. 
There are several reasons f o r the f a i l u r e of t h i s part 
of the exercise. I t may be that many diabetics did not appreciate 
the importance of studying normal individuals f o r comparison,or 
were unable,or unwilling,to persuade a suitable individual to 
take part. Alternatively,some individuals may not have known 
a suitable person s u f f i c i e n t l y intimately. 
(b) Controls from the orthopaedic wards. 
As soon as i t became obvious that the neighbours of 
the diabetics would be i n s u f f i c i e n t f o r a control population other 
sources of non-diabetics were considered. Many authors have r i g h t l y 
c r i t i c i s e d the use of hospital in-patients as controls. They are 
a highly selected group and may include sufferers from diseases 
strongly associated with the polymorphisms under study. I t was 
considered justified,however,to use a sample of patients from the 
orthopaedic wards i f the reasons f o r admission were traumatic 
conditions or minor orthopaedic surgery. The reasons f o r admission 
of these subjects were mostly head,injuries,fractures etc. (see 
table 4 « 4 ) » Care was taken to exclude patients whose current 
admission was the result of a chronic i l l n e s s . A l l patients with 
rheumatoid a r t h r i t i s , f o r example,if t h i s was the reason f o r t h e i r 
current admission,were excluded,similarly with pathological fractures. 
Cases of chronic back pain were also excluded. 
From these patients d e t a i l s of name,address,date of b i r t h , 
place of b i r t h and the b i r t h s of ancestors was taken,together with 
a sample of venous blood and,in some cases,a family history. 
I t i s the policy of the orthopaedic v/ards to test a l l 
patients f o r glycosuria and a l l those included i n t h i s 3tudy were 
negative i n t h i s respect. 
(c) Student controls. 
I t soon became clear that the controls showed some 
interesting trends with rega.rd to age,but that i n s u f f i c i e n t numbers 
were available i n the younger age groups f o r v a l i d s t a t i s t i c a l 
comparison. As a result,students at the University were asked to 
volunteer as controls and data were collected from them i n collaboration 
with Paul Converse,an M.Sc. student i n the anthropology department. 
The only s t i p u l a t i o n was that the volunteers should not be diabetic 
and that they should be permanently resident i n the county of Durham. 
Forty six controls were collected i n t h i s way. Information on date 
of birth,place of b i r t h of self,parents and grandparents and father's 
occupation was taken at the same time as 10 mis of venous blood. 
Table 4*4 Reasons f o r admission of orthopaedic controls 
Diagnosis Number Frequency ($) 
Head i n j u r y 109 28»oS 
Fractured Femur (neck or shaft) 60 15#«tfc 
Keller's operation 44 11-34 
Medical meniscectomy * 40 10 '30 
Lacerations 21 5-4.1 
Back i n j u r i e s 17 4-3* 
Amputation of d i g i t * 14 3 ' 6 l 
Removal of ganglion 12 5-©5 
Fractured radius and/or ulna 12 3-09 
Fractured t i b i a 10 2 « 5 7 
Fractured pelvis 8 2*06 
Repair of tendon * 7 1*80 
Removal of toe n a i l 6 1-55 
Fractured f i b u l a 6 1-55 
Patellectomy * 5 1*29 
Fractured Ribs 5 1*29 
Fractured nasal bones 3 0-77 
Eye i n j u r y 2 0*52 
Dislocated shoulder 2 0 '52 
Bruising to foot 2 0 .52 
Removal of bursa 2 0 .52 
Fractured humerus 1 0*26 
Total 386 
Following trauma 
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A l l these students had been screened f o r glycosuria 
at t h e i r entrance medical,though,in some cases,this was two and a 
half years p r i o r to the interview. 
(d) The t o t a l control sample. 
The entire control sample from the three sources -
neighbours,orthopaedic patients and students - amounted to 507 
individuals. Of these,262 (51.7$) were male and 245 (48.3$) 
female (sex r a t i o 1.06). Their age d i s t r i b u t i o n (calculated, 
as of the f i r s t of January,1976) i s shown i n table 4»5« As can 
be seen,when compared with the diabetics (table 4»3) there i s a 
deficiency of individuals i n the older age groups. This was 
because the numbers of suitable orthopaedic in-patients i n these 
groups were r e l a t i v e l y few. The numbers of controls from each 
source are summarised i n table 4»6. 
4.7 Characteristics of the diabetic and control populations taken 
as a whole. 
(a) Place of residence. 
Throughout t h i s study,'old 1 County Durham i s taken as 
the area of reference as are the 'old* counties of the rest of the 
United Kingdom. These areas refer to the counties before the 
reorganisation which took effect i n April.1974• The reason f o r 
using 'old'counties i s simply that people s t i l l think i n terms of 
these boundaries rather than i n terms of 'new' county boundaries. 
A l l individuals i n the control group were resident 
within 'old' County Durham. A l l but four of the diabetics were. 
Table 4*5 Ages (on 1.1.76) of a l l controls 
Ages (yrs) Number Frequency (fo) Cumulative frequency (fo) 
0-4 3 0*6 0-6 
5-9 2 0-4 1.0 
10-14 1 0*2 1-2 
15-19 69 13*6 I4.8 
20-24 57 11-2 26.0 
25-29 32 6-3 32-3 
30-54 24 4-7 37-1 
35-39 25 4*9 42-0 
40-44 26 5*1 47-1 
45-49 28 5-5 52.7 
50-54 31 6-1 58*8 
53-59 40 7-9 66-7 
6O-64 45 8-9 75-5 
65-69 33 6-5 82*1 
70-74 31 6-1 88»2 
75-79 29 5-7 93-9 
80-84 22 4-3 98-9 
85-89 6 1-2 99.4 
90-94 2 0.4 99.8 
95-99 0 0*0 99.8 
IOO-104 1 0*2 100.0 
Table 4»6 Source of controls 
Source No $ of t o t a l Sex No <fo of t o t a l 
Neighbours 73 14*40 Male 21 4*14 
Female 52 10«26 
Orthopaedic 
patients 
388 76-53 Male 217 42.80 
Female 171 33-73 
Students 
46 9-07 Male 24 4-73 
Female 22 4-34 
Total 507 
(b) Place of b i r t h . 
The place of b i r t h (by county) was only ascertained 
from 391 (54.2$)of the sample of diabeti cs,since the question was 
only asked of the 433 who were v i s i t e d at home and 42 of those asked 
were unsure. There i s no reason to think that t h i s group i s 
unrepresentative i n terms of b i r t h place. Of the 507 controls, 
476 were asked t h e i r place of b i r t h and information was obtained from 
420 of them. The places of b i r t h of diabetics and controls are 
summarised i n table 4*7. The differences between the two samples 
are i n s i g n i f i c a n t (chi squared = 0.188 f o r 2 degrees of freedom). 
This large proportion of native-born Durham inhabitants has been 
noted before (Teasdale,personal communication). 
Tables 4»8f4»9 and 4»10 show information on the 
place of b i r t h of parents,grandparents and the six immediate ancestors 
of controls and diabetics. There are no sig n i f i c a n t differences 
with regard to the parents or grandparents (chi squared values,with 
2 degrees of freedom,are 4»2 and 4»7 respectively). With consideration 
of parents and grandparents simultaneously,there i s a si g n i f i c a n t 
difference between the two samples with chi squared,for 3 degrees of 
freedom,equal to 14.03 (p between 0,005 and 0.001). 
4.4 Data analysis. 
Most of the analysis wan performed with the assistance 
of the I.B.M. 370/167 computer available to researchers at the 
University of Durham. The raw data were stored i n two files,one 
f o r c l i n i c a l and polymorphism data on individuals,the other f o r 
pedigree information. Polymorphism data v/ere analysed largely by 
means of the S t a t i s t i c a l Package f o r the Social Sciences (S.P.S.S) 
1*3-
Table 4*7 Place of b i r t h of diabetic and control samples 
Place of b i r t h Diabetics Controls 
County Durham 326 346 
(83-4%) (82-4$) 
Neighbouring counties 
31 34 (Northumberland, Westmorland, 
Cumberland and Yorkshire) (7-9%) (8-l/o) 
Other parts of the 34 40 
United Kingdom (8-7%) (9*5/°) 
Total 391 420 
Table 4*8 Comparison of parental birth-place of diabetics and controls. 
No.of parents born i n Co.Durham Diabetics Controls 
0 59 (16-5%) 73 (18.00) 
1 67 (18*70) 54 (13*50) 
2 232 (64*80) 279 (68-70) 
358 406 
Table 4*9 Comparison of grand-parental birth-places i n diabetica 
and controls. 
No. of g.parents born i n Co.Durham Diabetics Controls 
None or 1 51 (21-5$) 70 (21«2#) 
2 52 (21-9$) 50 (15*20) 
3 or 4 134 (56-90) 210 (63*6$) 
237 330 
Table 4*10 Comparison of places of b i r t h of six direct ancestors 
of diabetics and controls 
No. of ancestors born i n Co.Durham Diabetics Controls 
None or 1 40 (17-02$) 54 (16-51$) 
2 or 3 42 (17-87$) 46 (14-07$) 
4 or 5 46 (19-57$) 34 (10-40$) 
6 107 (45-53$) 193 (59-02$) 
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with a small number of Fortran programmes f o r the calculation of 
gene frequencies etc. The family data were analysed with Fortran 
programmes written f o r the purpose. Programmes supplied by other 
workers f o r various aspects of the analysis are acknowledged i n 
the appropriate sections. 
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5.1 Introduction. 
Analysis of pedigree data,the mainstay of classical 
human genetic studies,has hitherto,revealed l i t t l e of the mechanism 
of the inheritance of diabetes except i n the case of M.O.D.Y. and 
the study of HLA haplotype frequencies amongst affected members 
of sibships. There i s a continuing role f o r pedigree analysis, 
however,since such an approach may answer several relevant questions 
notably whether diabetes,subdivided on the basis of current 
treatment,for example,is a group of d i s t i n c t genetic disorders 
or a group of genetically i n t e r - r e l a t e d conditions. 
Pedigree data were collected,by the technique of 
interview questionnaire,from a number of diabetic propositi and 
a number of non-diabetic controls. The prevalence of the various 
sub-types i n the general population was also assessed. The analysis 
of the results and a c r i t i c a l discussion of the methodology form 
the substance of t h i s chapter. 
5.2 The col l e c t i o n of data. 
Pedigree information was collected during an interview 
with the propositus or informant conducted by the same interviewer. 
Diabetic and non-diabetic propositi were seen,in most cases,once 
and once only between January,1975»and January,1977.using the same 
technique of questioning. Information was recorded f o r each 
re l a t i v e working from the propositus and taking relatives i n the 
same order each time - spouse,parents,children,grandchildren,grand-
parents, sibs,sibs' children,sibs' grandchildren,parents' sibs,parents 
children and grandparents' sibs. I f information was available f o r 
more d i s t a n t l y related individuals t h i s was also recorded. 
For each r e l a t i v e the following data were noted -
sex,relationship to propositus,whether ali v e or dead,current age 
or age at death (to w i t h i n f i v e years),whether affected by diabetes 
and,if affected,current treatment and age at diagnosis (again to 
within f i v e years). For each l i v i n g affected r e l a t i v e the centre 
at which t h e i r diabetes was managed was recorded and,if t h i s proved 
to be Dryburn hospital,the name and address of the individual were 
noted. 
I n the case of children,the informant was always the 
parent,usually the mother. I n these cases a second interview was 
often required i f the necessary information on the relatives of 
the father could not be furnished. 
At each interview the informant was asked to n o t i f y 
the investigator i f any previously unsuspected diabetes came to 
l i g h t . Four pedigrees were l a t e r ammended because of t h i s . 
The information from each family was coded f o r computer 
analysis i n the method detailed i n Appendix B. Relatives were 
omitted i f the current age or age at death were unknown or i f 
there were any doubt about whether they were alive or dead,it was 
f e l t t h a t , i n these cases,information on the disease state of that 
pa r t i c u l a r individual was not r e l i a b l e . Using a l i b r a r y of Fortran 
programmes w r i t t e n f o r the purpose,statistical analysis was 
performed on various aspects of the data. 
5.3 Methodological considerations. 
The accuracy of family data obtained on diabetes by 
the technique of interview questionnaire has been c r i t i c i s e d 
(ft 
elsewhere (see,for example,MacDonald,1974)• The presence of the 
J O . 
interviewer,however impartial he may believe himself to be,may 
influence the resu l t of the interview by assisting the informant 
i n a particular d i r e c t i o n . I n a d d i t i o n , i t may well be,as MacDonald 
(1974) suggests,that diabetics are very much more aware of the 
A 
disease i n t h e i r r e l a t i v e s than are non-diabetics and that t h i s 
i s s u f f i c i e n t to bias the results s i g n i f i c a n t l y . 
The findings of the Edinburgh group (Smith et al,1973) 
are encouraging i n t h i s respect. They checked the information 
obtained on rel a t i v e s by contacting a sub-sample d i r e c t l y and 
re-recording the information d i r e c t l y from the individual 
concerned. They found that diabetic propositi gave accurate 
information on the current age and disease status of relatives 
and tha t , f o r the diabetic relatives,age at diagnosis was also 
r e l i a b l e . As f a r as treatment was concerned,all those said to be 
on i n s u l i n were,although tv/o (out of 25) said to be on dietary 
therapy alone were also being treated with oral hypoglycaemics. 
There has been no assessment of the information given on diabetic 
relatives by non-diabetic propositi,however,and t h i s might be 
expected to be less accurate. 
Any mis-recording of affected re l a t i v e s as unaffected 
w i l l produce an underestimate of the frequency of the disease. The 
magnitude of t h i s error w i l l be greater i n more d i s t a n t l y related 
individuals with whom contact i s less intimate,and,since diabetics 
may be more aware of the disease i n t h e i r relatives,of greater 
magnitude i n the families of non-diabetics than i n the families 
of diabetics. Different types of diabetes may suffer from t h i s 
phenomenon to d i f f e r i n g extents i n that insulin-taking diabetic 
relatives,especially when diagnosed at an early age w i l l be a greater 
t a l k i n g point i n a family,with a consequently greater chance of 
being reported,than older diabetics with less dramatic presentation 
and treatment. In addition,diabetic propositi with a long history 
of the disease w i l l have accumulated family information on the 
condition f o r a much greater period and may thus be expected to 
possess greater knowledge of t h i s aspect of t h e i r families. 
The omission of relatives for whom complete information 
has not been obtained w i l l lead to the exclusion of proportionally 
greater numbers of d i s t a n t l y related individuals than close 
r e l a t i v e s . The effect of t h i s may well be to overestimate the 
frequency of affected individuals i n the more d i s t a n t l y related 
groups i f there i s a tendency to report information on affected 
individuals more assiduously than that on unaffected individuals. 
Many diabetics,after the diagnosis of t h e i r own disease w i l l 
actively seek information about s i m i l a r l y affected individuals 
i n the family and,since they are interested,not i n the frequency 
of affected relatives,but i n individual instances,they may not 
be given,or not retain,the information about unaffected relatives 
of a similar degree of relationship. 
The very nature of diabetes leads to the p o s s i b i l i t y 
that affected relatives,with no symptoms,may be undetected. 
Several populations have been investigated, to assess the extent 
of t h i s phenomenon and,regardless of the methods used to detect 
undiagnosed diabetes,have consistently shown two things - that 
the prevalence of undiagnosed disease i s approximately equal to 
that of diagnosed disease (Malins,1968) and that the prevalence 
of undiagnosed diabetes rises with age. I t i s reasonable to 
assume that,at any one time,the cases of undiagnosed diabetes 
w i l l be of type I I and not type I . 
to 
MacDonald (1974) has suggested t h a t the immediate 
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f a m i l i e s of d i a b e t i c p r o p o s i t i w i l l c ontain fewer undiagnosed 
d i a b e t i c s than the immediate f a m i l i e s of c o n t r o l p r o p o s i t i since 
g r e a t e r awareness of the disease i n the former group w i l l have 
r e s u l t e d i n the screening of r e l a t i v e s f o r the presence of the 
disease. I n h i s sample of d i a b e t i c s and t h e i r f a m i l i e s r e s i d e n t 
i n the United States,twice the percentage of parents of d i a b e t i c 
c h i l d r e n had been pr e v i o u s l y i n v e s t i g a t e d f o r the disease than the 
parents of non-diabetic c o n t r o l s . This i s less l i k e l y i n t h i s 
country where there i s less emphasis on r o u t i n e screening of 
r e l a t i v e s . 
5»4 Families of i n d i v i d u a l s a t t e n d i n g the d i a b e t i c c l i n i c . 
The number of i n d i v i d u a l s a t t e n d i n g the d i a b e t i c c l i n i c 
f o r whom pedigree i n f o r m a t i o n was obtained t o t a l l e d 433• Of these, 
180 were male and 253 female. Adult d i a b e t i c s were a l l i n t e r v i e w e d 
at home a f t e r a p r e l i m i n a r y encounter i n the c l i n i c . C hildren 
were seen together w i t h a parent i n the p a e d i a t r i c c l i n i c although, 
i f a second i n t e r v i e w were necessary,this u s u a l l y took place a t 
home. The t o t a l number of r e l a t i v e s of a l l types f o r whom 
s u f f i c i e n t i n f o r m a t i o n was obtained f o r i n c l u s i o n i n the a n a l y s i s 
was 13,811. These i n d i v i d u a l s - p r o p o s i t i d i v i d e d according t o sex 
cur r e n t treatment and age a t d i a g n o s i s , r e l a t i v e s d i v i d e d according 
to sex - are shown i n t a b l e 5»1« 
Of these 433 p r o p o s i t i two were c l a s s i f i e d as l a t e n t 
d i a b e t i c . One of these was shown t o have g l y c o s u r i a d u r i n g her 
f i r s t pregnancy w i t h r e v e r s i o n t o normal glucose tolerance a f t e r 
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d e l i v e r y . The other was shown t o have g l y c o s u r i a a t a r o u t i n e 
medical examination but t h i s could not be confirmed and h i s glucose 
tolerance t e s t was normal. These two f a m i l i e s c o n s t i t u t e d too 
small a group t o be considered separately and,since they could not 
be amalgamated s a t i s f a c t o r i l y w i t h any other group,were e l i m i n a t e d 
from f u r t h e r a n a l y s i s . 
The remaining 451 f a m i l i e s y i e l d e d i n f o r m a t i o n on 
13,730 r e l a t i v e s . F i r s t degree r e l a t i v e s ( p a r e n t s , o f f s p r i n g and 
sib s ) comprised 3>H4 i n d i v i d u a l s . Second degree r e l a t i v e s (grand-
parents,grandchildren,parents' sibs and s i b s 1 c h i l d r e n ) amounted t o 
5,847 and t h i r d degree r e l a t i v e s (great-grandparents,great-grand-
c h i l d r e n , parents' s i b s ' c h i l d r e n and s i b s 1 grandchildren) ^,1^8. 
There were 344 spouses,35 h a l f - s i b s and 1,242 i n d i v i d u a l s more 
d i s t a n t l y r e l a t e d than t h i r d degree. Tables 5*2,5•3 and. 5»4 show 
the numbers of various types o f r e l a t i v e s amongst the f a m i l i e s o f 
various categories of propositus. 
The p o l i c y of o m i t t i n g r e l a t i v e s f o r whom adequate 
i n f o r m a t i o n has not been obtained leads t o the a r t i f i c i a l r e d u c t i o n 
i n the numbers of r e l a t i v e s more d i s t a n t l y r e l a t e d than second 
degree. This i s l e a s t marked i n the f a m i l i e s of i n s u l i n - t a k i n g 
d i a b e t i c s presenting before the age of t h i r t y , s i n c e , i n the m a j o r i t y 
of cases,the informant was the parent,to whom the propositus' t h i r d 
and f o u r t h degree r e l a t i v e s were second and t h i r d degree r e l a t i v e s . 
I n most other cases,however,the l a c k of i n f o r m a t i o n about these more 
d i s t a n t l y r e l a t e d i n d i v i d u a l s r e s u l t e d i n a small p r o p o r t i o n only 
being s u i t a b l e f o r i n c l u s i o n . I n the f i n a l analysis,the r e l a t i v e s 
i n these more d i s t a n t categories were discounted,as explained below. 
The spouses of p r o p o s i t i o n theory an a t t r a c t i v e source 
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of controls,had t o be omitted from the analysis,since there was a 
tendency f o r conjugal d i a b e t i c p a i r s t o be v i s i t e d i n preference t o 
f a m i l i e s where o n l y one spouse was a f f e c t e d . S i m i l a r l y , t h e group 
of 35 h a l f - s i b s were i g n o r e d , s i n c e , g e n e t i c a l l y speaking,these have 
to be considered i n a separate category,between f i r s t and second 
degree r e l a t i v e s and there were too few f o r separate treatment. 
5.5 The use of c o n t r o l data. 
The occurrence of diabetes i n the f a m i l i e s of d i a b e t i c 
p r o p o s i t i may be compared e i t h e r w i t h the occurrence of the disease 
i n the f a m i l i e s o f non-diabetic c o n t r o l s (as i n the studies of 
Lestradet e t al ( l 9 7 2)and MacDonald ( 1 9 7 4(a))iOr w i t h estimates 
of the prevalence of the disease i n the general p o p u l a t i o n (see,for 
example,Simpson ( l 964),and Smith et a l ( 1 9 7 3 ) ) . The former permits 
the c o n s i d e r a t i o n of l i v i n g and dead r e l a t i v e s , u s i n g the age a t death 
as equivalent t o the cur r e n t age. I n the comparison of the disease 
i n a f f e c t e d r e l a t i v e s w i t h the prevalence i n the general p o p u l a t i o n , 
l i v i n g r e l a t i v e s o nly may be considered,since the general p o p u l a t i o n 
f i g u r e s deal only w i t h l i v i n g i n d i v i d u a l s . This method e l i m i n a t e s 
any inaccuracies due t o changing a t t a c k and d e t e c t i o n r a t e s inherent 
i n the former method,in which three or f o u r successive generations 
are regarded as contemporaneous,but i t i s l i m i t e d by the laboriousness 
and p o t e n t i a l inaccuracies involved i n a large-scale e s t i m a t i o n of the 
numbers of d i a b e t i c s i n the community. I n t h i s account both of these 
methods are employed and the r e s u l t s compared. 
A d i s t i n c t i o n w i l l be drawn between the term 'frequency' 
of a f f e c t e d i n d i v i d u a l s i n the sample o f l i v i n g and dead r e l a t i v e s 
and the term 'prevalence' which has the conventional meaning o f the 
p r o p o r t i o n of the l i v i n g p opulation t h a t are c u r r e n t l y a f f e c t e d . 
5.6 The f a m i l i e s of non-diabetic p r o p o s i t i . 
I t was intended t h a t a l l c o n t r o l data should be 
c o l l e c t e d from the neighbours of the d i a b e t i c p r o p o s i t i . I n 
practice,however,only 66 such f a m i l i e s presented themselves and the 
group was supplemented by pedigrees of 35 orthopaedic p a t i e n t s 
g i v i n g a t o t a l of 101 c o n t r o l f a m i l i e s . Of these,the p r o p o s i t i 
i n 43 were male,in 58 females. The age d i s t r i b u t i o n of the 
p r o p o s i t i i s given i n t a b l e 5»5 and the reasons f o r admission of the 
35 orthopaedic p a t i e n t s i n t a b l e 5.6. 
These 101 p r o p o s i t i gave i n f o r m a t i o n on 3i520 r e l a t i v e s . 
The number of r e l a t i v e s i n each category i s shown i n t a b l e 5«7. 
The f a l l - o f f i n the numbers of r e l a t i v e s more d i s t a n t than second 
degree i s seen again i n the case of these c o n t r o l f a m i l i e s and i s 
again the r e s u l t of omission of d i s t a n t r e l a t i v e s w i t h i n s u f f i c i e n t 
i n f o r m a t i o n . I n the case of controls,spouses were a u s e f u l a d d i t i o n 
to the group and both these and h a l f - s i b s were u t i l i s e d when the 
r e l a t i v e s of a l l types were pooled. 
5.7 'Doubtful d i a b e t i c s ' amongst r e l a t i v e s . 
During the i n t e r v i e w s a number o f r e l a t i v e s were 
discussed whose d i a b e t i c status was u n c e r t a i n . These included 
r e l a t i v e s shown to have g l y c o s u r i a of pregnancy whose curr e n t 
disease s t a t u s was unknown,or r e l a t i v e s thought to have g l y c o s u r i a 
detected d u r i n g a te r m i n a l i l l n e s s but i n whom d e t a i l s of the disease 
or treatment were unknown. These i n d i v i d u a l s (39 i n "the f a m i l i e s 
of d i a b e t i c p r o p o s i t i and 3 i n the f a m i l i e s of c o n t r o l s ) posed 
Table 5. 5 Age and sex d i s t r i b u t i o n of p r o p o s i t i of c o n t r o l f a m i l i e s 
Age group No. of p r o p o s i t i 
Male Female 
0 - 1 9 5 5 
20 - 39 14 18 
40 - 59 18 17 
60 and over 6 18 
Tot a l s 43 58 
Table 5.6 Reasons f o r admission o f orthopaedic p a t i e n t s 
Diagnosis Number 
Medial meniscectomy 9 
Head i n j u r y 7 
K e l l e r ' s o p e r a t i o n 4 
Amputation o f d i g i t * 4 
Lacerations 3 
Patellectomy* 2 
Fracture of t i b i a 2 
Removal of ganglion 1 
Removal of toe n a i l 1 
Repair of tendon* 1 
Back i n j u r y 1 
T o t a l 35 
* Fol l o w i n g trauma 
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something of a problem. I n the end they were ignored completely 
i n the analyses because t h e i r status was so i l l - d e f i n e d so t h a t , 
i f a number o f them were indeed c l i n i c a l l y diagnosed d i a b e t i c s , t h e 
estimates of prevalence given are s l i g h t l y under-estimates. 
5.8 I n d i v i d u a l s ascertained through two p r o p o s i t i . 
The p r a c t i c e of reco r d i n g the names and addresses of 
l i v i n g , a f f e c t e d r e l a t i v e s being t r e a t e d at Dryburn H o s p i t a l enabled 
the number of r e l a t i o n s h i p s between the 532 (431 d i a b e t i c and 101 
non-diabetic) p r o p o s i t i t o be determined. There were twelve p a i r s 
who were r e l a t e d . I n ten of these cases d i a b e t i c p r o p o s i t i were 
r e l a t e d t o other d i a b e t i c p r o p o s i t i . I n two cases non-diabetic, 
p r o p o s i t i were r e l a t e d to d i a b e t i c p r o p o s i t i . The number of p a i r s 
present f o r each degree of r e l a t i o n s h i p i s shown i n t a b l e 5«8» 
Examination of the pedigrees of these 24 i n d i v i d u a l s 
revealed t h a t , f o r 188 r e l a t i v e s , i n f o r m a t i o n had been obtained t w i c e , 
once from each propositus. This a f f o r d e d the o p p o r t u n i t y f o r 
assessing the measure of agreement between the i n f o r m a t i o n 
obtained f o r the same persons through two informants but also posed 
the proDiem of whether these i n d i v i d u a l s should be included once 
or twice i n the a n a l y s i s . 
(a) Measure o f agreement i n i n f o r m a t i o n obtained. 
I n 142 instances (75• 59^ ) the i n f o r m a t i o n derived 
from both informants on these common r e l a t i v e s was i d e n t i c a l . 
When the disagreement regarded current age or age a t death,in a l l 
but one case the estimates of age were v / i t h i n f i v e years of eachother. 
I n one instance ( 0 . 7$ ) there was disagreement on the disease s t a t e 
Table 5*8 Numbers of p a i r s of r e l a t e d p r o p o s i t i f o r each degree of 
r e l a t i o n s h i p 
Degree of 
r e l a t i o n s h i p 
Number 
of p a i r s 
F i r s t degree 4 
Second degree 3 
T h i r d degree 4 
Fourth degree 1 
T o t a l 12 
'51 
of a r e l a t i v e and,in t h i s case,a genuine diabetic had been reported 
as non-diabetic by one propositus. There were 23 cases i n which 
common relatives were reported as affected by both propositi and, 
i n a l l but two,there was agreement on the age at diagnosis,and,in 
a l l but three,agreement on the current treatment. I n the three 
cases of disagreement regarding treatment the debate was between 
oral hypoglycaemics and diet not regarding insulin-taking or non-
i n s u l i n - taking. This accords with the findings of Smith et a l (1972) 
i n that information gained from diabetic propositi on the disease 
status i s reliable,especially i f age and age at diagnosis are 
considered only to the nearest f i v e years and treatment i s considered 
as either insulin-taking or non-insulin-taking. 
(b) The case f o r double inclusion of common re l a t i v e s . 
I n cases where ascertainment of related propositi i s 
independent,i.e. the ascertainment of the second case i s not the 
result of t h e i r relationship with the first,Falconer (1967) has 
advocated that common rel a t i v e s be included twice. Since,in t h i s 
instance,ascertainment of the second propositus was by v i r t u e of 
th e i r attendance at Dryburn Hospital and not the r e s u l t of the 
relationship with the other propositus,it was f e l t j u s t i f i a b l e to 
include these 188 common rela t i v e s twice i n the analyses. 
5.9 The frequency of diabetes of a l l types i n the families of 
diabetics and i n the families of non-diabetics. 
Ignoring the doubtful diabetics,the frequencies of 
diabetics of a l l types i n the various relatives of diabetic and 
non-diabetic propositi are summarised i n table 5.9(a) and table 
Table 5 . 9(a) D i a b e t i c s i n the f a m i l i e s o f d i a b e t i c p r o p o s i t i 
Type of r e l a t i v e No. a f f e c t e d T o t a l r e l a t i v e s Frequency ($) 
F i r s t degree 153 3098 4.94 ( + . 3 9 ) 
Second degree 128 5837 2.19 ( + . 1 9 ) 
T h i r d degree 57 3141 1.81 (+ .24) 
Fourth degree e t c . 42 1236 3.40 (+ .51) 
A l l r e l a t i v e s 380 13312 2.85 (+ .14 ) 
Table 5 . 9(h) D i a b e t i c s i n the f a m i l i e s of c o n t r o l p r o p o s i t i 
Type o f r e l a t i v e No. a f f e c t e d T o t a l r e l a t i v e s Frequency ($) 
F i r s t degree 8 678 1.18 (+ .41 ) 
Second degree 16 1416 1.13 (+.28) 
T h i r d degree 6 958 0 .63 (+ .26) 
Fourth degree e t c . 3 377 0.80 (+ .46) 
A l l r e l a t i v e s 33 3429 0 .94 (+ .17) 
5 . 9(b) r e s p e c t i v e l y . Sex and unexpired r i s k are not taken i n t o 
account. These frequencies are represented g r a p h i c a l l y i n f i g u r e s 
5 . 1(a) and 5 . 1 ( b ) . The standard e r r o r s of these and a l l other 
frequencies quoted i n t h i s chapter are c a l c u l a t e d from the 
formula:-
where p i s the frequency and N the number of i n d i v i d u a l s 
on which i t i s based. 
The f a m i l i e s of d i a b e t i c p r o p o s i t i have s i g n i f i c a n t l y 
higher frequencies of a f f e c t e d r e l a t i v e s i n a l l f o u r categories of 
r e l a t i o n s h i p a t t h i s crude l e v e l of a n a l y s i s . For f i r s t degree 
r e l a t i v e s , c h i squared i s 19.25 (p < 0 . 0 0 0 5 ),for second degree 
r e l a t i v e s 6.63 (p -<0 .025) and f o r t h i r d degree r e l a t i v e s 6,85 
( p < 0 . 0 l ) - a l l c h i squared values are f o r one degree of freedom. 
The frequency of a f f e c t e d r e l a t i v e s of d i a b e t i c p r o p o s i t i i n the 
f o u r t h and subsequent degrees of r e l a t i o n s h i p i s also s i g n i f i c a n t l y 
g r e a t e r than t h a t i n c o n t r o l s . The frequency of a f f e c t e d r e l a t i v e s 
i n these more d i s t a n t r e l a t i v e s of d i a b e t i c p r opositi,however,is 
s i g n i f i c a n t l y g r e a t e r than t h a t i n second and t h i r d degree r e l a t i v e s . 
This increase i n frequency i n the d i s t a n t r e l a t i v e s i s i n e x p l i c a b l e 
i n genetic terms and may be the r e s u l t e i t h e r of the small number of 
such r e l a t i v e s (1 ,236) or the consequence of the i n c l u s i o n of 
a f f e c t e d d i s t a n t r e l a t i v e s i n preference t o u n a f f e c t e d because of 
l a c k of i n f o r m a t i o n on the l a t t e r . These more d i s t a n t l y r e l a t e d 
i n d i v i d u a l s i n the f a m i l i e s of d i a b e t i c p r o p o s i t i are excluded 
from f u r t h e r a n a l y s i s . 
standard e r r o r 
\/ N 
I n the f a m i l i e s of non-diabetic p r o p o s i t i the degree of 
Figure 5.1(a) Frequencies of diabetics in the families of diabetics 
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Figure 5«l(b) Frequencies of diabetics in the families of controls 
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/6»: 
r e l a t i o n s h i p t o the propositus makes no detectable d i f f e r e n c e to 
the p r o p o r t i o n of i n d i v i d u a l s t h a t are a f f e c t e d . I n f i g u r e 5«l(b), 
f o r example,the f o u r categories of r e l a t i v e s , d i v i d e d according t o 
degree of r e l a t i o n s h i p , a r e homogeneous w i t h regard t o t h e i r 
frequencies of a f f e c t e d i n d i v i d u a l s ( c h i squared = 2 . 0 0 f o r three 
degrees of freedom). The p o s s i b i l i t y t h a t the close r e l a t i v e s o f 
i n d i v i d u a l s chosen because they are non-diabetic should show a 
reduced frequency of a f f e c t e d i n d i v i d u a l s ( F a lconer, I 9 6 7 ) i s not 
demonstrated i n t h i s sample. I n the subsequent an a l y s i s the 
c o n t r o l population considered i s the pooled sample of a l l l i v i n g 
and dead r e l a t i v e s of the non-diabetic p r o p o s i t i i n c l u d i n g t h e i r 
spouses and h a l f - s i b s . This group consists of 3»517 i n d i v i d u a l s , 
33 of whom were af f e c t e d , a frequency of 0.94/J* This f i g u r e i s 
higher than the prevalence i n the general p o p u l a t i o n quoted by 
Malins (1968) and t h a t found i n t h i s study (0.77$) because of the 
i n c l u s i o n of dead r e l a t i v e s . 
5*10 Diabetics diagnosed before the age of t h i r t y and not t a k i n g 
i n s u l i n . 
Out of the 936 d i a b e t i c i n d i v i d u a l s a t t e n d i n g Dryburn 
o u t - p a t i e n t departments d u r i n g 1975>nine ( 0 . 9 6 % ) had been diagnosed 
before the age of t h i r t y and were not being t r e a t e d w i t h i n s u l i n . 
This group represents 6.9^ of the t o t a l number diagnosed before 
t h i s age and 1.4$ of n o n - i n s u l i n - t a k i n g d i a b e t i c s i n the sample. 
I n view of the p o s s i b i l i t y t h a t some of these i n d i v i d u a l s might 
correspond to the M.O.D.Y. type of d i a b e t i c , a p a r t i c u l a r i n t e r e s t 
was taken i n t h i s group. 
Seven of these nine were contacted and a f u l l f a m i l y 
h i s t o r y obtained,one refused t o p a r t i c i p a t e and one had l e f t the 
area by the time she was contacted f o r a home v i s i t . A f u r t h e r 
f a m i l y was added t o t h i s group i n 1 9 7 6 making e i g h t pedigrees which 
can be analysed i n d e t a i l . I n every case but one the proband through 
whom the f a m i l y was ascertained was female. The one male index case 
had been diagnosed i n 1 9 7 3 and had been t r e a t e d w i t h o r a l hypo-
glycaemic agents since then. Six of the female index cases had 
been known d i a b e t i c s f o r a t l e a s t f o u r years and had been t r e a t e d 
w i t h d i e t a r y r e s t r i c t i o n alone since diagnosis. I n the seventh 
female,diagnosed i n February, 1 9 7 6 ,there has been no need f o r i n s u l i n 
or o r a l hypoglycaemic treatment,at l e a s t u n t i l the time o f w r i t i n g 
( J u l y , 1 9 7 7 ) . I t was considered that,although some o f these f a m i l i e s 
might correspond t o the M.O.D.Y. type of di a b e t e s , i n others,the 
proband could be of the type I I v a r i e t y w i t h a p a r t i c u l a r l y e a r l y 
onset or a type I d i a b e t i c c o n t r o l l e d on o r a l hypoglycaemics. 
Figure 5 » 2 shows the pedigree of the only male propositus 
i n t h i s group. Presenting i n June,1973>with t h i r s t and polyuria,he 
has been t r e a t e d so f a r w i t h tolbutamide. There are no other 
recorded cases of diabetes of any type v / i t h i n the f a m i l y . I n view 
of the mode of pr e s e n t a t i o n and the absence of f a m i l y h i s t o r y , i t i s 
l i k e l y t h a t t h i s i n d i v i d u a l i s of the type I v a r i e t y i n i t i a l l y 
c o n t r o l l e d w i t h o r a l hypoglycaemics. I f t h i s i s c o r r e c t he should 
progress t o i n s u l i n treatment at some stage. 
Two of the female cases d i d not have a f f e c t e d parents or 
grandparents,their pedigrees are shown i n f i g u r e s 5^3 and 5 « 4 » 
The proband of the f a m i l y shown i n f i g u r e 5 . 3 "as found 
to be d i a b e t i c i n August 1 9 7 2 when she was being i n v e s t i g a t e d f o r 
a rash b y her general p r a c t i t i o n e r . She had no symptoms of diabetes 
Legend f o r f i g u r e s 5 « 2 t o 5*9 and f i g u r e 5.1^. 
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Unaffected,male and female 
Proband 
Affected,male and female 
Glycosuria found on a t l e a s t one occasion, 
not c l i n i c a l l y d i a b e t i c a t present 
Dia b e t i c on i n s u l i n 
D i a b e t i c on o r a l hypoglycaemic agents 
D i a b e t i c on d i e t a r y therapy alone 
D e t a i l s unknown 
Current age or age at death f o r each i n d i v i d u a l included 
i s known but not displayed i n the f i g u r e s . D e t a i l s considered t o be 
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For ease of drawing,the b i r t h order of sibs has not been 
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but showed a d i a b e t i c response i n the glucose tolerance t e s t 
performed on r e f e r a l t o h o s p i t a l . She has no a f f e c t e d sibs and 
her one pregnancy was u n e v e n t f u l . The sta t u s of the f a t h e r i s 
unknown but the mother has been i n v e s t i g a t e d f o r the disease 
(by u r i n a l y s i s ) by the general p r a c t i t i o n e r d u r i n g the l a s t year 
and found t o be negative. There i s no r e l i a b l e evidence concerning 
the h e a l t h of the grandparents when they were a l i v e but n e i t h e r i s 
there any d e f i n i t e evidence of diabetes i n them,or,for t h a t matter, 
i n any other r e l a t i v e except a maternal aunt. Discounting the 
p o s s i b i l i t y t h a t the f a t h e r and a pat e r n a l grandparent were a f f e c t e d 
but undetected,this pedigree does not f u l f i l l the c r i t e r i a f o r the 
M.O.D.Y. type of diabetes. 
The proband of the f a m i l y shown i n f i g u r e 5»4 was found 
to have g l y c o s u r i a d u r i n g her f i r s t pregnancy i n February 1970. 
The subsequent glucose tolerance t e s t was abnormal and she has been 
t r e a t e d w i t h d i e t a r y r e s t r i c t i o n alone since diagnosis. This has 
provided s u f f i c i e n t c o n t r o l f o r two uneventful pregnancies. I n 
t h i s case,both the parents have been t e s t e d w i t h i n the l a s t tv/o 
years and are known not t o have g l y c o s u r i a . One s i b of the 
p r o p o s i t a has had g l y c o s u r i a of pregnancy w i t h a normal glucose 
tolerance t e s t and a maternal f i r s t cousin has had diabetes since the 
age of f o u r years,treated w i t h i n s u l i n throughout. There i s no 
evidence t h a t t h i s i n d i v i d u a l i s of the M.O.D.Y. type excepting 
the p o s s i b i l i t i e s of a mutation i n her or of the non-manifestation 
of the c o n d i t i o n i n one of the parents,a p o s s i b i l i t y which runs 
counter to the published r e p o r t s of the disease. 
I t i s suggested t h a t , i n these two cases,the disease i s 
not of the M.O.D.Y. v a r i e t y but may be type I I diabetes of p a r t i c u l a r l y -
e a r l y onset. 
I n the other f i v e f a m i l i e s i n t h i s group there was 
evidence suggestive of M.O.D.Y. type i n h e r i t a n c e . Their pedigrees 
are shown i n f i g u r e s 5«5 t o 5»9» 
On the p a t e r n a l side of the f a m i l y shown i n f i g u r e 5»5 
there i s an a f f e c t e d r e l a t i v e i n each of three successive generations. 
The p r o p o s i t a was diagnosed as d i a b e t i c f o l l o w i n g a r o u t i n e medical 
examination f o r e n t r y i n t o Durham U n i v e r s i t y when she was aged 18. 
There were no symptoms a t t h a t time and she has been adequately 
c o n t r o l l e d on d i e t a r y r e s t r i c t i o n alone f o r the l a s t three years. 
Her f a t h e r and p a t e r n a l grandfather are both d i a b e t i c and both are 
t r e a t e d by d i e t a r y means. They were detected i n a s i m i l a r f a s h i o n 
w i t h symptomless g l y c o s u r i a though at r a t h e r g r e a t e r ages than the 
proband ( f a t h e r 35 years,grandfather 67). There are no other 
members of the f a m i l y a f f e c t e d though the only others s p e c i f i c a l l y 
i n v e s t i g a t e d (by u r i n a l y s i s ) have been the sibs of the proband. 
I n the f a m i l y shown i n f i g u r e 5»6 there i s again an 
a f f e c t e d member i n three cosecutive generations. The proband v/as 
found to have g l y c o s u r i a of pregnancy w i t h a d i a b e t i c glucose 
tolerance t e s t . There were no symptoms and c o n t r o l has been 
s a t i s f a c t o r y f o r two years without i n s u l i n or o r a l hypoglycaemics. 
Her f a t h e r and p a t e r n a l grandmother were both detected w i t h 
symptomless g l y c o s u r i a a t the age of 47 smd 60 r e s p e c t i v e l y . They 
were both i n i t i a l l y t r e a t e d w i t h d i e t alone but the f a t h e r received 
o r a l hypoglycaemic treatment two years a f t e r diagnosis, He died a t 
the age of 52 w i t h coronary a r t e r y disease. The status of the 
p a t e r n a l grandfather i s unclear,he was found to have g l y c o s u r i a 
d u r i n g h i s t e r m i n a l i l l n e s s . There i s no evidence t h a t e i t h e r of 
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the p a t e r n a l grandmother's parents had diabetes. 
The p r o p o s i t a of the f a m i l y shown i n f i g u r e 5.7 was 
found t o have g l y c o s u r i a a t a school medical examination at the 
age of twelve ( i n February,1976). She was r e f e r e d to the h o s p i t a l 
where diabetes was confirmed w i t h a glucose tolerance t e s t and has 
been t r e a t e d w i t h d i e t a r y therapy alone since t h a t time. Her mother, 
also a p a t i e n t a t Dryburn,was diagnosed a t the age of 31 and i s 
managed w i t h d i e t alone. Ther i s no evidence of diabetes i n e i t h e r 
of the mother's parents,both of whom are deceased,though the 
mother's maternal grandfather was known t o be diabetic,diagnosed 
a t the age of 37. He preceeded the i n t r o d u c t i o n of both i n s u l i n 
and o r a l hypoglycaemic agents and was managed f o r twenty years 
v/ithout them. 
I n these f a m i l i e s there i s suggestive evidence of the 
presence of the M.O.D.Y. gene though i t i s conceded that,as pointed 
out by Edwards ( l960),the occurrence of a f f e c t e d r e l a t i v e s i n three 
generations does not neces s a r i l y imply causation by a s i n g l e 
dominant gene. I n a l l three f a m i l i e s the r a t i o o f a f f e c t e d t o 
unaffected sibs i s too low to accord comfortably w i t h the p r e d i c t i o n s 
of dominant i n h e r i t a n c e . Assuming t h a t i n d i v i d u a l I I . 8 of f i g u r e 
5.7 was a f f e c t e d but undetected,there are 10 a f f e c t e d c h i l d r e n of 
a f f e c t e d parents and 25 unaffected c h i l d r e n ( l : 2 . 3 ) . The published 
r e p o r t s of M.O.D.Y..where the a f f e c t e d t u n a f f e c t e d s i b r a t i o has been 
close t o the p r e d i c t e d 1:1 have been based upon f a m i l i e s i n which 
r e l a t i v e s were s p e c i f i c a l l y i n v e s t i g a t e d and i t may be that,were 
the l i v i n g and apparently unaffected sibs i n these f a m i l i e s to be 
inv e s t i g a t e d , t h e y would also be shown to have the c o n d i t i o n . 
The s t a t u s of the f a m i l i e s shown i n f i g u r e 5«8 and 
5.9 are l e s s c l e a r . Both of the prbands were discovered t o have 
symptomless g l y c o s u r i a before the age of t h i r t y and both have never 
received i n s u l i n or o r a l hypoglycaemics. I n the f a m i l y shown i n 
f i g u r e 5«8>the p i c t u r e i s complicated by the proposita being the 
o f f s p r i n g of a conjugal d i a b e t i c p a i r . Her diabetes was detected at 
a r o u t i n e medical i n 1974 and she has been t r e a t e d w i t h d i e t a r y 
r e s t r i c t i o n since diagnosis. The mother's diabetes came on 
suddenly i n 1965 when she was aged 44>with c h a r a c t e r i s t i c symptoms 
of t h i r s t and weight l o s s . I n s u l i n therapy was commenced a t once 
and has continued since. The f a t h e r was found t o have symptomless 
g l y c o s u r i a a t the age of 40 and was t r e a t e d w i t h o r a l hypoglycaemics 
throughout. He died of a coronary a t the age of 49• Both of the 
c r u c i a l p a t e r n a l grandparents are dead though there i s no p o s i t i v e 
evidence t h a t e i t h e r had the disease. 
I n the f a m i l y shown i n f i g u r e 5»9 the proband was found 
to have g l y c o s u r i a i n 1962 (she was then aged 28). There were no 
symptoms of diabetes and d i e t a r y r e s t r i c t i o n has been s u f f i c i e n t 
treatment f o r 12 years. The mother was a f f e c t e d though d e t a i l s o f 
her- disease are unclear. Diagnosis was a t the age of 50 and she was 
tr e a t e d w i t h i n s u l i n f o r a time,the cause of death i s unknown. The 
maternal grandparents died a t a young age and there i s n o t h i n g t o 
suggest t h a t they were a f f e c t e d . One s i b of the p r o p o s i t a was 
found to have g l y c o s u r i a a t the age o f 44»though a glucose tolerance 
t e s t proved normal. I t i s impossible to be c e r t a i n about these two 
f a m i l i e s . 
T a t t e r s a l l (1974) has commented t h a t M.O.D.Y. i n d i v i d u a l s 
are predominantly female and,in t h i s population,the three index cases 
who are most l i k e l y t o be of t h i s type are a l l female,though there 
are male affected relatives i n every family. Five male rel a t i v e s are 
known to be affected and f i v e female,in f a c t . 
A l l these families show the phenomenon of 'anticipation' 
i n that the disease i s diagnosed e a r l i e r i n each generation. This 
has been reported before (Tattersall,1974). I t may be simply a 
consequence of changing patterns of health care with more emphasis 
on routine u r i n a l y s i s i n medical examinations and during pregnancy. 
The affected parents and grandparents i n these families were a l l 
diagnosed a f t e r the age of t h i r t y . None of these individuals were 
attending the Dryburn clinic,except i n the case of the mother of the 
family shown i n figure 5«7»but,if they had been,and t h e i r offspring 
were not considered,they would have been c l a s s i f i e d as type I I 
diabetics and not M.O.D.Y. This raises the p o s s i b i l i t y that several 
individuals,bearers of t h i s gene,are being misclassified by v i r t u e 
of the late detection of t h e i r glycosuria and that M.O.D.Y. may be 
much commoner than published reports imply. 
The condition deserves considerable attention i n population 
studies as a useful model f o r the investigation of the pathogenesis 
of cardiovascular complications. None of the propositi i n the families 
suggested as examples of the condition had any recorded evidence of 
complications,though the duration of the disease was so short that 
t h i s was hardly remarkable. I t would be inst r u c t i v e to follow up 
such a group with appropriate controls. 
I t i s int e r e s t i n g that the individual treated with i n s u l i n 
f o r the longest time amongst the diabetic patients at Dryburn has 
a family history suggestive of M.O.D.Y. This patient was found to 
be diabetic i n 1928 when he was aged 24 and has been treated with 
i n s u l i n f o r the past 49 years with no recorded cardiovascular 
complications. His s i s t e r i s also diabetic treated with d i e t and 
his father and paternal grandfather were also affected. I t i s 
suggested that t h i s individual i s not a type I diabetic as would 
be assumed from his current treatment but a M.O.D.Y. individual 
commenced on i n s u l i n i n the early days of that therapy and i n 
whom endogenous i n s u l i n secretion has been almost t o t a l l y suppressed. 
The f i v e families (figures 5«5 to 5»9) suggested as 
examples of M.O.D.Y. or of unclear designation were eliminated 
from further analysis. The propositus of the family i l l u s t r a t e d 
i n figure 5«2 was included with the insulin-taking diabetics and the 
families of figures 5»3 and. 5»4 were included with the non-insulin-
taking diabetics. 
5.11 Unexpired r i s k . 
I n a disease with variable age of onset such as diabetes 
i t i s important to consider the unexpired r i s k to r e l a t i v e s . This 
may be accounted f o r by the matching of r e l a t i v e s f o r age using age 
at death or current age. Most conveniently these matched groups 
may be obtained by s p e c i f i c a l l y matching affected and non-affected 
propositi f o r age,over a large sample i t should follow that t h e i r 
r e l a t i v e s ' ages w i l l be comparable. Altern a t i v e l y , r e l a t i v e s may be 
contrasted w i t h i n specific age groups. 
5.12 The consideration of unexpired r i s k with diabetes of a l l types. 
The number and frequency of affected relatives ( l i v i n g 
and dead) of non-diabetic p r o p o s i t i , f o r each 20 year age group,are 
shown i n table 5*10 together with the affected individuals i n 
comparable age groups of the first,second and t h i r d degree rel a t i v e s 
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of diabetics. The control group i s numerically i n s u f f i c i e n t to 
allow separate consideration of the sexes* I n a l l 15 comparisons 
between the relatives of diabetics and the r e l a t i v e s of controls 
the frequency of affected individuals i n the families of diabetics 
i s greater than that i n the relatives of controls. The prob a b i l i t y 
of t h i s occurring by chance i s very low. This analysis i s similar 
to that of Pincus and White (1933) but extended to second and t h i r d 
degree r e l a t i v e s . For some comparisons the numbers of affected individuals 
are too small f o r the chi squared test to be appropriate. I n the cases 
where i t i s appropriate,and the frequency i n r e l a t i v e s of diabetics i s 
s i g n i f i c a n t l y greater than that i n the r e l a t i v e s of controls,the 
frequency i s marked (*). Where the chi squared test i s appropriate 
but there i s no si g n i f i c a n t difference i s also indicated ( + ) . 
5.15 Subdivision of diabetes with regard to age at diagnosis. 
When diabetes i s subdivided according to age at diagnosis, 
two questions may be asked - f i r s t l y , d o late-onset diabetics occur 
i n the families of early-onset diabetic propositi more often than 
would be expected by chance and,conversely,do early-onset diabetics 
occur more often i n the families of late-onset propositi? The 
previous negative answer to the f i r s t question (Lestradet et a l , 
1972,and MacDonald,1974(a)) are at odds with the findings of Smith 
et a l (1972) and Smith (l976),who f i n d that early- and late-onset 
diabetes are genetically related diseases. 
Firstly,considering the comparison made by MacDonald (1974(a)), 
v i z . that of grandparents of early-onset diabetics (age at diagnosis 
less than 30 years) with the grandparents of non-diabetic controls. 
MacDonald1s propositi consisted of insulin-taking diabetics only, 
the numbers of late-onset diabetic grandparents of these patients 
i n MacDonald's study and i n the present study,together with the 
frequencies fo r the control groups,are shown i n table 5.H. The 
findings from County Durham confirm those of MacDonald i n that the 
frequency of affected grandparents of diabetics i s greater than 
that i n the grandparents of controls but that t h i s excess i s non-
si g n i f i c a n t (chi squared,with one degree of freedom,in the present 
sample = 2.13). The studies show widely d i f f e r i n g frequencies 
of affected individuals which could be the r e s u l t of a large 
number of factors - interview technique,greater awareness of diabetes 
i n family members i n the United States,the use of screening,regional 
va r i a t i o n i n genetic and environmental factors or d i f f e r e n t 
d e f i n i t i o n s of the disease. 
The frequencies of late-onset diabetics i n relatives of 
early-onset diabetic propositi and i n the relatives of controls i n 
various age groups are seen i n table 5.12. The numbers of affected 
individuals again l i m i t the number of comparisons which can be 
tested with chi squared. I t i s appropriate i n second degree 
relatives and shows that the frequency of late-onset diabetics 
i n the younger (30 - 59) age group i s s i g n i f i c a n t l y greater i n 
the families of diabetics (chi squared = 9»48»wi"th one degree of 
freedom p^O.0005). the excess i n the older age group of these 
relatives i s non-significant (chi squared = 2.59,with one degree 
of freedom). Comparison of frequencies and t h e i r standard errors 
reveals that the excess frequency of affected individuals i n f i r s t 
degree relatives and i n the older t h i r d degree relatives i s non-
s i g n i f i c a n t . 
The frequency of early-onset diabetes i n the relatives 
Table 5.11 Late-onset diabetics amongst the grandparents of early-
onset insulin-taking diabetics. 
Status Present study MacDonald (1974) 
Grandparents 
of diabetics 
Grandparents 
of controls 
Grandparents 
of diabetics 
Grandparents 
of controls 
Affected 17 
(5.4#) 
8 
(3.01%) 
39 
(8.26%) 
33 
(7.64%) 
Not 
Affected 
295 258 433 399 
Total 310 266 472 432 
eg
re
e 
CO 
CO N"\ 
K S • 
d ? l 
* ' 
*—s 
os 
C— LfN 
OS • 
rTS + | 
+ K S 
osvo 
vo • 
A% 
XJ 
T5 
H 
• H 
J3 
EH 
• +> o 
EH 
•** 
VO 
CM 
rH 
ITS 
rH 
ITS 
rH 
• 
<H 
««! 
rH VO 
CO 
di
ab
et
ic
 
0) 
(D 
B> 
CO 
"d 
s s— * CO r— CM • 
CM ? | 
+ t— 
rH OS 
CM • 
4 ? , 
—. * 
rH VO 
fTN • 
• O 
K S + | 
v—-* 
Re
la
ti
ve
s 
of
 
o 
u 
CD 
CO 
• +> 
O 
EH 
f~ 
ITS 
N"\ 
CO 
CM 
ITS 
CO 
r— 
Re
la
ti
ve
s 
of
 
• 
CM 
«w 
<< 
GO CO 
rH 
VO 
CM 
0) 
0) 
T J 
s r—^ vo r -o • -3 
O 
O rH 
t— • 
» CM 
KN + | 
CM 
ITS CO 
CO • 
+> 
to 
r l 
• H 
« 
+» 
O 
EH 
ON 
CO 
rH 
H 
GO 
o r— 
CM 
• 
«H 
««S 
CM rTS LfS 
co
nt
ro
ls
 
s 0.50 (+0.2
0)
 
OS 
rH • 
CM " ? | 
«—•» 
ITS 
VO CM 
hfS • 
,t
iv
es
 o
f 
,t
iv
es
 o
f 
• +> 
C 
EH 
CO 
o 
r\ i 
rH 
OS 
W * 
CM 
O 
CM 
CM 
Re
la
 
• 
<iH 
«»i 
VO 
CM 
O rrs 
0) 
• 
OS 
ITS 
1 
o 
rTN 
T3 U 
9 5 O o vo 
CO 
rH 
cd 
+» 
O 
EH 
of late-onset diabetic propositi has not,so f a r been reported. 
Table 5.13 shows these frequencies f o r t h i s sample. Early-onset 
diabetes i s not a common disease and only three affected relatives 
were encountered i n the control population. The frequency of 
affected relatives i n the families of diabetics exceeds that i n 
the r e l a t i v e s of the controls i n a l l cases though i n no instance 
i s t h i s s i g n i f i c a n t . Early-onset may,indeed,be more common i n the 
relatives of late-onset diabetics than i n the relatives of controls, 
though a much larger number of families are required to demonstrate 
t h i s conclusively. 
5.14 Subdivision of diabetes on the basis of current treatment. 
Information was available on the treatment of most of 
the affected r e l a t i v e s i n the families considered although,in some 
instances,particularly f o r the more distant r e l a t i v e s , t h i s information 
was lacking. These individuals posed something of a problem - they 
could not be ignored since they were d e f i n i t e l y affected and yet 
they could not be assigned unambiguously to current treatment groups. 
I n a l l , t h e r e were 81 such relatives,61 i n the families of controls 
and 28 i n the families of diabetics. 
I t was decided to assign these individuals to treatment 
groups according to the d i s t r i b u t i o n of affected r e l a t i v e s of 
known current treatment i n the same age group of re l a t i v e s of the 
same type of propositus. I f , f o r example,the 30 - 59 year old 
affected relatives (whose treatment was known) of diabetic propositi 
treated with diet were distr i b u t e d between the three treatment groups 
(insulin-taking:oral-hypoglycaemic-treated:diet-controlled) i n the 
r a t i o of l:3:2,then the affected relatives of t h i s age,for whom 
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treatment was unknown would be d i s t r i b u t e d between these three 
treatment groups i n the same r a t i o , w i t h rounding o f f to the 
nearest whole number of individuals. 
Oral-hypoglycaemic-treated and diet-controlled 
patients are i n i t i a l l y amalgamated as non-insulin-taking diabetics. 
5.15 Insulin-taking and non-insulin-taking diabetics. 
Table 5.14 shows the frequencies of non-insulin-taking 
diabetics i n the families of control propositi and i n the families 
of insulin-taking diabetics. The numbers of affected individuals 
are small and so the relatives have been amalgamated int o two 
age groups only - under 60 years and 60 and over. There are 
s i g n i f i c a n t l y more affected individuals i n the t o t a l f i r s t and 
second degree relatives of diabetics but not i n t h i r d degree 
r e l a t i v e s . Chi squared tests are only applicable i n the older 
age group and the affected f i r s t degree r e l a t i v e s of diabetics 
are s i g n i f i c a n t l y more frequent than those of controls. The numbers 
are small i n the other age sub-groups making the chi squared test 
i n v a l i d . The frequency of affected r e l a t i v e s i n the diabetics' 
families i s greater than those i n controls' families f o r f i r s t and 
second degree rel a t i v e s though comparison of these frequencies using 
t h e i r standard errors i s unconvincing. 
The results of the reciprocal comparison,the frequency 
of insulin-taking diabetics i n the families of non-insulin-taking 
diabetics and i n the families of controls,may be seen i n table 5.15• 
I n t h i s case,the paucity of affected individuals i n the families of 
controls has necessitated the subdivision of the r e l a t i v e s i n t o 
two age groups only. The frequency of affected individuals i n 
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the f i r s t degree rel a t i v e s of diabetics i s s i g n i f i c a n t l y greater 
than that i n controls i n both age groups. Other s i g n i f i c a n t 
comparisons are marked (*). 
Within the numerical inadequacies of these data,the 
suggestion that these two forms of diabetes are genetically 
related i s supported. This w i l l be discussed further at the end 
of t h i s chapter. 
5.16 The separate consideration of oral-hypoglycaemic and d i e t -
treated groups. 
The f i n d i n g by I r v i n e (1977) that some individuals 
i n i t i a l l y treated with oral-hypoglycaemics are F.I.C.A. positive 
(and,therefore,type I diabetics) recommends that the di e t and o r a l -
hypoglycaemic treated groups be treated separately. There i s also 
an implication from t h i s work that insulin-taking diabetic r e l a t i v e s 
may be more common i n the families of oral-hypoglycaemic-treated 
propositi than i n the families of diabetics controlled with d i e t , 
although t h i s i s dependent upon the proportion of oral-hypoglycaemic-
treated patients that are type I . Tables 5.16(a) and 5.16(b) show 
the frequencies of insulin-taking diabetic relatives i n the families 
of oral-hypoglycaemic-treated propositi,diet-treated propositi and 
controls. There are no s t a t i s t i c a l l y s i g n i f i c a n t excesses of 
insulin-taking relatives i n the families of oral-hypoglycaemic-
treated propositi compared with diet-managed p r o p o s i t i . 
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5.17 Comparison of the prevalence of diabetes i n the relatives of 
diabetics and i n the general population. 
The method f o r the determination of the prevalence of 
diabetes i n the general population using 1971 census data w i l l be 
described i n d e t a i l i n chapter 8. Table 5.17 shows these figures 
f o r a l l types of diabetes i n both sexes,considering the area 
immediately surrounding Durham c i t y . The prevalences are expressed 
i n percentages. Also present i n t h i s table are the prevalences of 
affected individuals i n the families of diabetics ( l i v i n g relatives 
only are considered). 
Thir t y comparisons are possible between the rela t i v e s 
of diabetics and the general population. The prevalence i n the 
diabetics' r e l a t i v e s exceeds that i n the general population i n 
25 of these,in four cases the prevalence i s zero i n the families 
of diabetics and i n one case the prevalence i n the general population 
i s the greater. The numbers of affected r e l a t i v e s i n the families 
of diabetics are too small f o r the chi squared te s t to be v a l i d 
except i n the cases of individuals between 60 and 69 years old, 
those 70 years of age and over and the t o t a l samples irrespective 
of age. The comparisons f o r which the prevalence of affected 
re l a t i v e s i n the families of diabetics i s s i g n i f i c a n t l y greater 
than that i n the general population are marked. 
Table 5.18 shows the prevalence of non-insulin-taking 
diabetics i n the l i v i n g r e l a t i v e s of insulin-taking diabetic 
propositi and the prevalence of t h i s type of diabetes i n the 
general population. Table 5.19 shows the prevalence of i n s u l i n -
taking diabetics i n the families of non-insulin-taking diabetic 
propositi and that i n the general population. 
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Although,in most instances,the prevalence of both types 
of diabetes i s more common i n the relatives of diabetic propositi of 
the other t y p e , i t i s impossible to be categorical with such small 
numbers of affected r e l a t i v e s . 
5.18 Correlations between pairs of f i r s t degree r e l a t i v e s . 
Information was available on 1J4 pairs of affected f i r s t 
degree relatives,one of whom being,in each case,a propositus. Of 
these pairs,72 were sib-sib combinations,the remaining 62 were 
parent-offspring pairs. They were examined f o r the correlation 
with regard to age at diagnosis and current treatment. I n the sib-
sib pair group there were ten brother-brother pairs,38 s i s t e r - s i s t e r 
pairs and 24 brother-sister pairs,twice as many like-sexed pairs as 
unlike-sexed pairs,an eff e c t previously noticed by Penrose and 
Watson.(1945)• There are s i g n i f i c a n t l y more females amongst these 
sib-sib pairs when they are compared with the sex r a t i o i n the t o t a l 
1975 out-patient population (44 males to 100 females compared with 
377 males to 559 females,chi squared = 4.95 f o r one degree of freedom, 
p* 0.05>0.025). I n the parent-offspring combinations there were 
seven father-son pairs,ten father-daughter pairs,15 mother-son pairs 
and 30 mother-daughter pairs (like-sexed pairs/unlike-sexed pairs 
37/25). 
(a) Age at diagnosis. 
Age at diagnosis was s i g n i f i c a n t l y correlated i n the sib-
sib pairs ( r = 0.68,p = 0.00001). This i s shown i n figure 5.10 f o r 
70 pairs,the age at diagnosis being unknown f o r one member of a pair. 
The age at diagnosis i n the parent-offspring pairs was not s i g n i f i c a n t l y 
1% 
Figure 5.10 Age at diagnosis i n sib-sib pairs 
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Figure 5.11 Age at diagnosis i n parent-offspring pairs 
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correlated ( r = 0.21,p = 0.05). The value f o r the 61 pairs i n which 
age at diagnosis was known for both members are shown i n figure 5»H« 
The higher correlation i n the sib-sib pairs implies that common 
environmental effects,not present i n the parent-offspring pairs,are 
contributing considerably to the determination of time of onset of 
the disease. 
Age at diagnosis i s more highly correlated ( r = 0.78, 
p = O.OOOOl)if sib-sib pairs i n which both members are i n the same 
treatment group (insulin-taking or non-insulin-taking) are 
considered (figure 5*12). The lower cluster of points (with age 
at diagnosis less than about 40 years) consists,predominantly,of the 
pairs i n which both members are insulin-taking diabetics. When 
these 13 pairs are considered alone (figure 5*13) age at diagnosis 
i s s i g n i f i c a n t l y correlated ( r = 0.67,p = 0.006). There i s no 
sig n i f i c a n t correlation demonstrable i n the 24 sib-sib pairs i n 
which both members are non-insulin-taking diabetics ( r = 0.34» 
p = 0.05). This d i s t r i b u t i o n i s shown i n figure 5»14» 
Like-treatment parent-offspring pairs (figure 5«15) 
show a si g n i f i c a n t correlation f o r age at diagnosis ( r = O.34, 
p = 0.02). There are too few parent-offspring pairs i n which 
both members are insulin-taking but analysis of the parent-offspring 
pairs i n which both are non-insulin-taking (figure 5*16) shows a 
sig n i f i c a n t correlation with regard to age at diagnosis ( r = 0.40, 
p = 0.02). 
(b) Current treatment. 
Tables 5*20 (a) and 5*20(h) show the correlation of 
current treatment i n sib-sib and parent-offspring pairs respectively. 
Figure 5.12 Age at diagnosis i n like-treatment sib pairs. 
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Figure 5.13 Age at diagnosis i n ins u l i n - t a k i n g sib pairs, 
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Figure 5»14 Age at diagnosis i n non-insulin-taking sib pairs. 
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Figure 5.15 Age at diagnosis i n like-treatment parent-offspring 
~~ pairs. 
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Figure 5.16 Age at diagnosis i n non-insulin-taking parent-offspring 
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Table 5.20(a) Current treatment of sib-sib pairs. 
(1) Propositus insulin-taking,sib insulin-taking - 13 (23*2%) 
(2) Propositus insulin-taking,sib non-insulin-taking - 8 (14*3%) 
(3) Propositus non-insulin-taking,sib insulin-taking - 10 (17.9%) 
(4) Propositus non-insulin-taking,sib non-insulin-taking - 25 (44*6%) 
Total number of pairs - 56 
Concordant - 38 (67.9%) Discordant - 18 (32.1%) 
Table 5•20(b) Current treatment of parent-offspring pairs. 
(1) Propositus insulin-taking,parent or offspring _ ^ Q „ ^ \ 
insulin-taking " \ ?• 7°) 
(2) Propositus insulin-taking,parent or offspring , / ,. 
non-insulin-taking ~ 5 \ J»7/°) 
(3) Propositus non-insulin-taking,parent or offspring ^ /g, aa\ 
insulin-taking " * s*Jr>) 
(4) Propositus non-insulin-taking,parent or offspring ^* 
non-insulin-taking ~ ^ '°' 
Total number of pairs - 51 
Concordant - 36 (70.6%) Discordant - 15 (29.4%) 
As would be expected,there are more pairs concordant 
f o r current treatment than discordant,and t h i s excess i s s i g n i f i c a n t . 
5.19 Correlation between family history and phenotype. 
I t i s a prediction of the hypothesis outlined i n chapter 
3 t h a t , i n affected individuals with a strong family history of the 
disease,cardiovascular complications should develop more rapidly 
than i n diabetics with a less marked family history. This follows 
because the proportion of affected individuals i n a pedigree i s an 
indication of the number of deleterious'rapid ageing'genes segregating 
i n the family and affected individuals,on average,will tend to have 
a larger number of these genes,and w i l l be subjected to more rapid 
complications than diabetics with fewer deleterious genes and 
fewer affected r e l a t i v e s . 
Hereditary factors determining the rate of development 
of diabetic complications and t h e i r type i n twins have been suggested 
before (Pyke and Tattersall , 1973) although there has been no investigation 
of other types of r e l a t i v e s . Such factors are one possible explanation 
f o r the differences i n the nature and speed of development of these 
changes i n r a c i a l l y d i s t i n c t groups. 
Two major d i f f i c u l t i e s are apparent - the measurement 
of the severity of family history so that diabetic propositi can be 
ranked f o r t h i s a t t r i b u t e i n a meaningful way,and,secondly,some 
means of assessing the rate of development of complications. 
(a) The measurement of the severity of family history. 
Smith (1972) has reported the use of a computer 
programme (RISKMF) f o r the calculation of recurrence risks of 
m u l t i f a c t o r i a l conditions i n families. With some adaptation t h i s 
programme may be used to give a pro b a b i l i t y f o r the l i k e l i h o o d of 
the propositus developing the disease i n a p a r t i c u l a r age group, 
based on the consideration of his family hi s t o r y . This depends,not 
only upon the frequency of affected r e l a t i v e s but on t h e i r sex,the 
age at which they became affected,the h e r i t a b i l i t y of the disease 
i n both sexes,its prevalence i n the general population and the 
current ages or ages at death of unaffected r e l a t i v e s . The RISKMF 
programme,by taking these factors i n t o account,gives the pro b a b i l i t y 
of an unborn c h i l d developing the disease i n each of four successive 
age groups (0 - 19f20 - 39»40 - 59 and 60 years and over),or the 
prob a b i l i t y of an individual already born developing the disease i n 
the present and subsequent age groups. The input requires the coded 
family history,the prevalence of the disease i n the general population 
f o r each sex f o r the four age groups and the h e r i t a b i l i t y of l i a b i l i t y 
to the disease again f o r each sex and f o r each age class. The family 
history required are the sex of each relative,the relationship to the 
propositus and the disease status ( i . e . affected or unaffected). I f 
the r e l a t i v e i s unaffected the programme uses the current age,if 
affected,the age at diagnosis. The programme assumes that the 
inheritance of the disease i s polygenic and that diabetes diagnosed 
at a l l ages i s genetically one disease,an assumption which i s not 
wholly j u s t i f i e d . 
By inputing the coded family history of any diabetic 
propositus,but coding the propositus as unaffected and currently i n 
the age group i n which diabetes was diagnosed,the output gives the 
probability,based on the family history and on the above assumptions, 
that the propositus would develop the disease i n the age group i n 
which i t was diagnosed. The probability figure f o r the oldest age 
group i s the probability,based on the present family history,that 
the propositus w i l l develop the disease eventually. A specimen 
coded pedigree f o r the programme i s shown i n Appendix C. 
In order to analyse the pedigrees collected i n t h i s 
way i t was necessary to write a Fortran programme which would 
recode the family data and present i t i n a form suitable f o r the 
RISKMF programme (supplied by Dr.C.Smith and Miss S.Holloway). 
This programme i s not able to deal with information on rela t i v e s 
more d i s t a n t l y related from the propositus than those shown i n 
Appendix C so that only the most immediate r e l a t i v e s f o r each 
family were included. The d i s t r i b u t i o n of ri s k s f o r the development 
of the disease i n diabetic and non-diabetic propositi are shown i n 
figures 5*17(a) and 5«17(b) respectively. For the diabetics,this 
i s the r i s k of developing the disease i n the age group i n which 
they were diagnosed,for the controls i t i s the r i s k of developing 
the disease i n t h e i r current age group. These figures are 
calculated using the population prevalence estimates and the 
h e r i t a b i l i t y figures supplied with the RISKMF programme. 
The r i s k of developing the disease i s greatly influenced 
by age so that a more meaningful comparison i s the r i s k of being 
diagnosed as diabetic i n the f i n a l age group,i.e. the p r o b a b i l i t y 
of becoming diabetic eventually,assessed from the present family 
history. This i s shown,for diabetics,in figure 5*18(a) and,for 
controls,in figure 5.18(b). 
The highest value f o r t h i s figure i s 0.3021 f o r the 
diabetic propositus i n figure 5.19,shown f o r the purpose of i l l u s t r a t i o n . 
This individual also had the highest r i s k of developing the disease 
Figure 5.17 Probability of becoming diabetic,based on family history, 
(a) Diabetic propositi ( p r o b a b i l i t y at age of diagnosis) 
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Figure 5.18 Probability of becoming diabetic,based on family h i s t o r y , 
(a) Diabetic propositi (probability i n f i n a l age group) 
IBOT 
100 
in 
~n 
3 
TO 
> •5 c 
e 
6 ao 
•OOS .03 
Probability 
(b) Control propositi ( p r o b a b i l i t y i n f i n a l age group) 
801 
« 
cfl 
3 
V 
> 
•a 
c 
o 
Z Ik-
•005 • OS 
Probability 
r-O O 
r-n 
o -o 
-o -o 
o -o-Q -Q-Q —• Lo -o 
-a • 
-o 
o n 
i n the age c l a s s of diagnosis (O.1727 i n figure 5»l7(a))» 
(b) The assessment of complications. 
The evaluation of the development of cardiovascular 
complications present i n the whole diabetic group for whom family 
history was known and a value for the probability calculated (418 
individuals,excluding the M.O.D.Y. propositi) was rejected as 
being too time consuming. Instead,the complications noted throughout 
the course of the disease i n 20 insulin-taking individuals were 
noted from the hospital records. The individuals were chosen, 10 
from those diagnosed before the age of 30, 10 from those diagnosed 
a f t e r t h i s age,according to t h e i r position i n the d i s t r i b u t i o n of 
probabilities for becoming affected at the age at which they were 
diagnosed. For each age at onset category,the f i v e with the highest 
value of t h i s probability and f i v e randomly chosen from the group 
with the lowest value of t h i s probability. 
For insulin-taking diabetics diagnosed before the age of 
30,cardiovascular complications attributable to diabetes,together 
with the period af t e r diagnosis of the disease at which they were 
f i r s t noted are shown i n table 5«22(a) and. 5«22(b), The complications 
developed to date are more severe i n the diabetics with the greatest 
family history (table 5.22(a)) but the two groups are not comparable 
i n that the duration of the disease i n the former group i s much 
longer,on average,than that i n the l a t t e r . 
Tables 5»23(a) and (b) show the same information for 
insulin-taking diabetics diagnosed a f t e r the age of 30* Although 
the patients with the high values for the probability of developing 
diabetes (table 5«23(a)) have been diagnosed as diabetic for l e s s 
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time than those with a low probability of developing the disease, 
the recorded cardiovascular complications i n the former group are 
more severe and developed more rapidly a f t e r the onset of diabetes 
i n these individuals. 
5.22 Summary and discussion. 
Investigation of cases of insulin-independent diabetes 
diagnosed before the age of 30 supports the suggestion ( T a t t e r s a l l , 
1974»and T a t t e r s a l l and Fajans,1975) that many w i l l show features 
suggestive of dominant inheritance. Out of eight such cases 
investigated i n t h i s diabetic population,three (37.5$) showed a 
family history with affected parents and offspring i n successive 
generations. The affected sibs were too few i n number to accord 
with the predictions of dominant inheritance but active investigation 
of their glucose tolerance might well have revealed further cases of 
mild,non-insulin-requiring diabetes. I n the 425 other families of 
diabetics investigated only nine (2fo) suggested dominant inheritance 
i n the same fashion. I t i s suggested that some of these may have 
been examples of M.O.D.Y. missed as a r e s u l t of the propositus being 
diagnosed a f t e r the a r b i t r a r y age of 30. Further investigation of 
t h i s sub-type of diabetes i s urged since i t presents a potentially 
useful model for the investigation of the pathogenesis of cardiovascular 
complications. 
The investigation of the occurrence of diabetes i n families 
by the interview questionnaire technique becomes progressively l e s s 
r e l i a b l e with more d i s t a n t l y related individuals since lack of 
information leads to the exclusion of many of these r e l a t i v e s , e s p e c i a l l y 
those unaffected by the disease. 
0 m-. 
The data presented here on the occurrence of diabetes i n 
the grandparents of insulin-taking early-onset diabetics agree with 
the findings of MacDonald (1974(a)) i n that the frequency of affected 
individuals amongst the grandparents of diabetics i s greater than that 
amongst the grandparents of controls but that t h i s difference i s non-
si g n i f i c a n t . This strongly suggests that the difference may be a 
re a l one but that a larger sample of families than i s presented either 
here or by MacDonald (1974(a)) i s required to demonstrate t h i s with 
confidence. 
When the numbers of individuals are augmented by the 
inclusion of other relatives,the data strongly suggest that non-insulin-
taking diabetics are found i n the families s£ insulin-taking diabetics 
more often than i n the families of non-diabetics and that i n s u l i n -
taking diabetics are,similarly,more common i n the families of non-
i n s u l i n - taking diabetics than i n those of controls. These findings 
are supported i n the examination of prevalence figures for the 
general population although i n no case does the number of affected 
individuals i n a l l age groups for any type of r e l a t i v e reach a high 
enough value for t h i s contention to be supported by s t a t i s t i c a l t e s t s . 
A larger number of families than has been studied here i s required to 
substantiate t h i s suggestion. I f i t i s true then the findings of 
Smith et a l (1972) and Smith (1976) are supported rather than those 
of MacDonald (1974(a)),Lestradet et a l (1972) and Simpson (1969). 
Age at diagnosis i s p o s i t i v e l y correlated i n pairs of 
affected sibs and i s most highly correlated when pairs currently on 
the same treatment are considered. The higher correlation i n sibs 
than i n parent-offspring pairs suggests the action of environmental 
agents which are more commonly shared i n the case of sibs than i n 
parents and offspring. 
The development of cardiovascular complications i n i n s u l i n -
taking diabetics has been investigated i n r e l a t i o n to the family 
history of the disease. Although twins have been investigated for 
genetic factors causing the development of these complications (Fyke 
and Tattersall,1973)iiio investigation has,so far,been directed at the 
question of whether diabetics with a large number of affected r e l a t i v e s 
develop complications more rapidly and more severely than those with 
fewer affected r e l a t i v e s , a prediction which follows l o g i c a l l y from 
the suggestions of the hypothesis i n chapter 3- Within the limitations 
of the methods employed here there i s suggestive evidence,especially 
i n the group of late-onset insulin-taking diabetics,that there i s , 
indeed,a correlation between family history of diabetes and the tendency 
to develop severe cardiovascular complications i n the propositus. 
This finding,which needs further investigation with a 
prospective type of study,gives some meaning to the question asked of 
each new diabetic - ' I s there any diabetes i n the family?'. 
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6.1 Introduction. 
The r e s u l t s of the study of genetic polymorphisms in 
diabetics and i n non-diabetic controls are described i n the present 
chapter and in the following chapter. A description of the materials 
and methods,together with a discussion of the r e s u l t s for controls 
are dealt with i n t h i s chapter,the comparisons between diabetics and 
controls are discussed i n chapter T. Specific descriptions of 
soultions and d e t a i l s of sources of antisera are relegated to 
Appendix D. The discussion of r e s u l t s i n the control subjects takes 
the same form for each system,- f i r s t l y a description of the r e s u l t s 
for the t o t a l sample i s presented,together with a comparison with 
previously published data. Comparative ser i e s have been selected for 
th e i r geographical s i m i l a r i t y to the present sample,and for as large a 
sample size as possible. Most are derived from data given i n Kopec 
(1970) or Mourant et a l (1976). 
Secondly,the control sample i s examined for differences 
i n the phenotype frequencies r e s u l t i n g from the sex,area of origin 
and source of the subjects. Regarding area of origin,individuals 
have been divided i n two ways - according to the county of t h e i r 
own b i r t h (either County Durham or elsewhere i n the United Kingdom),and 
according to place of granparental b i r t h (contrasting those subjects 
with three or four grandparents born within the County with those 
with one or none). The three sources of controls considered are 
neighbours of diabetics,trauma patients and students. Data are not 
given for these comparisons except where s i g n i f i c a n t differences have 
been found. 
Lastly,the control data are examined for e f f e c t s related 
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to the current age of individuals i n the sample. This has been 
carried out i n several ways. Phenotype frequencies for different 
combinations of five-year age groups have been analysed for 
differences using the standard chi squared t e s t . The mean ages 
of different categories of individuals (homozygotes vs. heterozygotes, 
for example) have been compared using the Student's t-test,and 
analysis for trends i n proportions using various age groupings has 
been performed using the method suggested by Cox (1970). In general, 
where a s i g n i f i c a n t trend i n frequencies has been found,the data are 
given for the four sub-divisions 0 - 1 9 years,20 - 39 years,40 - 59 
years and 60 years and over (ages at l a s t birthday). Although these 
sub-divisions are a r b i t r a r y they have the advantage i n that they give 
equal periods of time (there are few subjects over 80),which i s 
required by the method for analysis of trends i n proportions. The 
d e t a i l s of t h i s method i s given i n the f i r s t section of analysis 
devoted to the ABO system. 
i s by the method of gene counting and populations have been tested 
for accordance with the predictions of the Hardy-Weinberg law i n 
the standard way. The standard errors of the gene frequency 
estimates,again unless otherwise stated,have been computed according 
to the formula:-
where p i s the gene frequency concerned and H i s the 
t o t a l sample s i z e . 
Unless otherwise stated,the computation of gene frequencies 
H i J st»nriard error 
N 
Not a l l individuals have been tested for a l l systems. 
Beneath each table of gene frequencies the chi squared 
for the deviation of each group from Hardy-Weinberg prediction and 
the chi squared value for the comparison of the present control 
sample with the previously published sample are given. P values 
are only given when they are l e s s than,or close to,0.05. 
6.2 Methods. 
(a) Preparation of samples. 
From each subject,10 mis of venous blood were taken into 
two 5 ml heparinised containers. The contents of one were used for 
the HLA antigen determination,the other 5 mis for the erythrocyte 
grouping and for electrophoresis. 
Within twelve hours of the blood being taken,the red c e l l s 
for grouping and electrophoresis were separated by centrifugation at 
2,000 r.p.m. for 10 minutes,the serum was decanted and frozen 
immediately to -80*C. The remaining red c e l l s were washed twice with 
saline (kept at 4"C) and a 4$ suspension of the c e l l s i n saline 
prepared for red c e l l grouping. The remaining erythrocytes were 
immediately frozen and kept for the preparation of haemolysates 
i n batches. I n a l l cases,red c e l l grouping was completed within 
24 hours of the blood samples being taken. 
Haemolysates were prepared by thawing the lysed c e l l 
specimens and adding 6 mis of carbon tetrachloride solution. This 
mixture was spun at 1,500 r.p.m. for 1-g- hours. The supernatant 
was decanted and kept at -80*C u n t i l required for electrophoresis. 
(b) Red- c e l l grouping methods. 
Red c e l l grouping was performed,with antisera derived from 
a variety of sources,either by a t i l e technique,by tube technique or 
indirect Coombs. Control c e l l s were unavailable for the typing 
of the f i r s t 378 specimens owing to f i n a n c i a l constraints but, 
aft e r this,regular supplies of Ortho 'Identigen* were obtained and 
appropriate controls (homozygous positive,heterozygote and homo-
zygous negative) were set up with each run. In the case of testing 
with anti-Kp ,no suitable controls were ever available. Of these 
f i r s t 378 specimens tested without controls,260 were retested 
(when a second sample of blood was collected for tissue typing) 
and,for these individuals,the r e s u l t s of the second testing were 
used. 
I n the case of unusual phenotypes (for the rhesus and 
K e l l systems) corroboration was obtained with the use of commercial 
antisera. 
anti-A 
anti-B 
anti A+B 
10 mins. 
at room temp. 
anti-P, 
anti-N 
T i l e technique. 
Used for testing with:-
anti-A, | 10 mins. 
at 4*C. 
30 mins. 
at 4*C. 
anti-A(hel) - 1 minute 
at room temp. 
Aliquots of antiserum and c e l l suspension were placed 
on a scored glass t i l e and the r e s u l t read a f t e r the appropriate 
time i n t e r v a l . The t i l e was intermittently rotated to mix the c e l l s 
and antiserum. For investigations carried out at 4"C,the t i l e had 
previously been cooled to t h i s temperature. 
Tube technique. 
Used for t e s t s with: 
anti-M 
anti-N 
saline,room 
temp. 2 hours 
anti-e - Papain method, 
37*C,1 hour. 
anti-Le(a) - saline,16'C anti-C A 
2 hours. anti-c Albumen 
anti-D / displacement, 
anti-E 37*C,2 hours. 
anti-C j 
One drop of c e l l suspension was incubated with one drop 
of the appropriate antiserum in a p r e c i p i t i n tube. In the case of 
anti-M,anti-N and anti-Le(a) ,a Vfo saline suspension of the c e l l s 
was used i n the place of the usual Hf/o solution. The anti-Le(a) 
serum used contained anti-B,so that the r e s u l t s quoted for t h i s 
system are for A and 0 individuals only. 
For the papain method used with anti-e,the red c e l l s 
were i n i t i a l l y sensitized with Vfo papain solution by aggitating one 
drop of the Affo saline suspension with 2 drops of the papain solution. 
The r e s u l t i n g suspension was spun so that the excess papain could 
be removed and the sensitized c e l l s were re-suspended i n two drops 
of sa l i n e . One drop of anti-e was added and the test read a f t e r 
incubation for 1 hour at 37*C. 
method,the albumen (30$ i n the case of anti-C,anti-c,anti-D and 
of the p r e c i p i t i n tube a f t e r the c e l l suspension had been incubated 
with the antiserum for 1^ - hours. The t e s t was read af t e r a further 
incubation period of ^ hour. 
For the antisera requiring an albumen di splacfiment 
w anti-E,20yo in the case of anti-C ) was run gently down the inside 
Coombs technique. 
Used with:-
anti-Py anti-K 
anti-Fy* 5 anti-k 
3. 
anti-S anti-Kp 
anti-s anti-Kp*3 
a l l 1 hour techniques. 
After one hour of incubation at 37 "C the excess a n t i -
serum was removed by washing four times with saline. The r e s u l t i n g 
cells,resuspended i n a drop of saline,were mixed with an equal volume 
of anti-human globulin f o r 10 minutes at room temperature on a 
scored t i l e . When available,Coombs control c e l l s (Ortho) were used 
to corroborate negative res u l t s . 
The sources from which the various antisera were 
obtained are shown i n Appendix D. 
(c) Electrophoresis. 
A l l systems were investigated with starch-gel techniques. 
The haptoglobin and red c e l l acid phosphatase systems were run i n 
5 mm thick gels,the remaining systems (phosphoglucomutase,adenylate 
kinase,adenosine deaminase and esterase ]}) were run i n 1 mm gels. 
The details of gel manufacture,buffers,staining solutions and the 
conditions f o r each run are described i n d e t a i l i n Appendix D. 
(d) HLA antigen determination. 
Tissue typing was performed by the method advocated 
J 
by the National I n s t i t u t e / o f Health (N.I.H.),which has now largely 
superseded the Trypan blue v i t a l staining method of Kissmeyer-
Nielsdn. The N.I.H. method consists of separation of lymphocytes, 
successive incubation with antiserum alone and then with a mixture 
of antiserum and complement and the reading of the test under phase-
contrast with Eosin counter-staining. The antisera used were largely 
commercially produced,the prohibitive cost of these and the l i m i t e d 
range available account f o r the reduced range of s p e c i f i c i t i e s 
tested f o r . 
Separation of lymphocytes. 
Where possible,the test was commenced within three 
hours of taking the blood samples. Where t h i s was not possible 
i t was found acceptable to store the heparinized blood samples f o r 
up to twelve hours at 4'C when,although the appearance of the 
lymphocytes was satisfactory,the reading of the test was made 
somewhat d i f f i c u l t by the presence of red c e l l s i n the test wells. 
I t i s suggested that stored red cells,by v i r t u e of some change i n 
t h e i r surface charge,possibly,are not removed as e f f i c i e n t l y by 
centrifugation with F i c o l l as are fresh c e l l s . 
About 10 yg of carbonyl iron powder was f i r s t added to 
the blood i n the heparinized containers and t h i s mixture was 
rotated gently at room temperature to enable the i r o n particles 
to adhere to the macrophages. Standing f o r f i v e minutes on a 
magnet brought the iron particles and these c e l l s to the bottom 
of the tube and the supernatant was carefully layered onto 5 mis 
of a F i c o l l - T r i o s i l mixture (composition given i n Appendix D) 
i n a p l a s t i c centrifuge tube. This was spun fo r 15 minutes at 
2,000 r.p.m. and the result was that the erythrocytes,embedded i n 
the F i c o l l were contained i n the lowest layer,and the white c e l l s 
(lymphocytes and p l a t e l e t s ) could be removed by careful p i p e t t i n g 
P2b 
from a zone between a layer of T r i o s i l and the uppermost layer of 
serum. These c e l l s were placed i n 5 mis of culture medium (R.P.M.I. 
I64O - Gibco-Biocult) and centrifugation f o r 10 minutes at 1,000 
r.p.m. produced a plug of lymphocytes and a suspension of platelets 
i n culture medium which could be discarded. The lymphocytes were 
re-suspended i n 10 drops of culture medium. 
Incubation with antiserum. 
The concentration of the lymphocytes was adjusted to 
about one m i l l i o n c e l l s per ml. 
Terasaki test plates had previously been prepared by 
introducing 1 j * . l of antiserum in t o each well. An equal quantity 
of the c e l l suspension was introduced into each antiserum aliquot 
with a Hamilton dispenser. The antiserum - lymphocyte mixture was 
then incubated at room temperature f o r one hour. Controls were 
set up with each plate - anti-lymphocyte serum (Biotest) as the 
positive control and a suspension of lymphocytes i n the individual's 
own serum f o r a negative control. After t h i s 1-jy hours had elapsed 
5 j * l of rabbit complement were added to each well and incubation 
was continued f o r a further -g- hour,when,after counter-staining 
each well with 5 j * l °f Eosin,the tests were read under phase 
contrast. 
Reading the t e s t . 
The N.I.H. method r e l i e s upon the cyto-toxic action 
of the antisera i n the presence of complement so that a positive 
result i s one i n which a si g n i f i c a n t number of the lymphocytes 
have been k i l l e d . Dead lymphocytes are readily distinguishable 
from l i v e c e l l s under phase contrast i n that the l a t t e r are smaller 
and denser than the former with characteristic 'haloes' of bright 
l i g h t . Counting the number of dead c e l l s i n a representative f i e l d 
enabled the resu l t to be scored according to the percentage of dead 
ce l l s present:-
less than 20$ dead c e l l s - negative 
2 1 - 4 0 $ + 
4 1 - 6 0 $ - ++ 
6 1 - 80$ - +++ 
81 - 100$ - ++++ 
Most antisera gave consistent 81 - 100$ ' k i l l s ' . I n the 
cases of weaker antisera,the presence of more than one f o r each 
s p e c i f i c i t y enabled a determination to be made with confidence i n 
nearly every case. 
The sources of antisera are l i s t e d i n Appendix D. 
6.5 The ABO system. 
(a) V/ith subdivision of group A. 
Results f o r t h i s system are shown i n table 6.1 together 
with comparative data f o r English donors given by Sanger and Race 
(1951)• No sign i f i c a n t differences can be demonstrated between the 
two samples (groups A^ B and A^ B have been combined f o r the calculation 
of chi squared). The gene frequencies f o r the two populations are 
given i n table 6.2. Formulae given by Mourant et a l (1976) and 
at t r i b u t a b l e to BUrnstein have been used to calculate these frequencies. 
The formulae are:-
P l = 1 J (0 + A 2 + B + A^B) 
Table 6.1 Results f o r the ABO system,with subdivision of group A. 
Phenotype Number and frequency ($) 
(l)Present study (2)Sanger and Race ( l 9 5 l ) 
A l 161 (31.3) 66 (28.8) 
A 2 36 ( 7.0) 19 ( 8.3) 
0 255 (49.5) 115 (50.2) 
B 47 ( 9.D 18 ( 7.9) 
A-jB 12 ( 2.3) 9 ( 3.9) 
A2B 4 ( 0.8) 2 ( 0.9) 
Totals 515 229 
Chi squared ( ( l ) vs. (2)) = 2.23 (d.f.=4),N.S. 
Table 6.2 Gene frequencies f o r ABO system,with subdivision of group A. 
Gene Frequency 
Present sample Sanger and Race (1951) 
A l 0.1855 0.1793 
A 2 0.0492 0.0573 
B 0.0633 0.0650 
0 0.7020 0.6984 
(+.02) (+.03) 
p' = s/ (0 + A 2 + B + A2B) - j ( 0 + B) 
1 = 1 -\/ (0 + A) 
where pj,p 2,q' and r' are i n i t i a l estimates of the A^, 
A_2,B and 0 gene frequencies respectively. 
From these i n i t i a l estimates can be calculated a 
correction factor,D:-
D = 1 - ( p j + p 2 + q' + r') 
and f i n a l values are given byt-
Px = P{ (1 + i») 
P 2 = P 2 (1 + *D) 
q = q' (1 + iD) 
r = ( r + j ^ 5 (1 + ^ K 1 
These f i n a l values of p^,P2,q and r approximate to the 
maximum lik e l i h o o d estimates f o r the gene frequencies. I n practice 
the value of r was calculated from:-
r = 1 - ( p x + P 2 + q) 
as i n Mourant et a l (1976). 
No s i g n i f i c a n t differences with regard to sex,area of 
o r i g i n or source of controls could be demonstrated. 
The results f o r the ABO system i n controls subdivided 
by current age are shown i n table 6.3« Although the suggested trend 
i n the decrease of the A^  frequency with increasing age i s not 
s i g n i f i c a n t . The data are given f i r s t l y to i l l u s t r a t e the method 
used to assess the significance of such trends and,secondly,because 
the results are pertinent to the arguments used i n the next chapter. 
2?. 3-
Table 6.3 ABO phenotypes of controls subdivided by age. 
Fhenotype Number and frequency (%) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
A l 29 42 42 48 
(37 .7) (29 .6) (32 .8) (28.6) 
A2 9 8 7 12 
(11.7) ( 5.6) ( 5.5) ( 7.D 
0 33 73 61 88 
(42.9) (51 .4) (47.7) (52 .4) 
B 3 14 14 16 
( 3.9) ( 9.9) (10.9) ( 9.5) 
A^ 3 2 3 4 
( 5.9) ( 1.4) ( 2.3) (2.4) 
A2B 0 3 1 0 
( o) ( 2.1) ( 0.8) ( o) 
Totals 77 142 128 168 
Mean age of A^^ subjects = 44.05 (+1.7) years. 
Mean age of 0 subjects = 47.76 (+1.8) years. 
t (A. vs. r e s t ) = 1.022 (p=0.15) 
The assessment of the significance of trends i n 
proportions as advocated by Cox (1970) r e l i e s on the calculation 
of z i n the following manner:-
age group 0 - 1 9 2 0 - 3 9 40 - 59 60 and over Totals 
coded age (x^) 1 2 3 4 
Aj_ ( r . ) 29 42 42 48 161 
not Ax ( r ^ - r . ) 48 100 86 120 354 
group t o t a l ( n ± ) 77 142 128 168 515 
the figures i n the above table denote the absolute 
number of individuals i n each group,thence:-
r = ^ r ± = 161 
n = £ n. = 515 
t =2x.r. = 431 
x =2n.x./n = 1417/515 = 2.75 
nS x = [ ( 2 n . x ^ - ( S n . x . ) 2 / i i ) ] = (4485 - ((l417) 2/515)) 
= 586.19 
E(T) = rx" = 442.75 
var(T) = r (n-r) S x = 126.21 
(n-1) 
z = 1 1 - E ( T ) 1 - k = 11.25 = 1.00 
y/ var(T) 126.21 
The p r o b a b i l i t y of the value of z exceeding 1.00 
by chance alone i s given by the table f o r the d i s t r i b u t i o n of the 
normal probability i n t e g r a l (Fisher and Yates,1974) and i s equal 
to 0.16,i.e. i t i s not s i g n i f i c a n t . 
(b) No subdivision of group A. 
The results f o r the ABO system without subdivision 
of group A are given i n table 6.4,together with regional blood donor 
results derived from Kope6 (1970),which may now be used f o r 
comparison. The gene frequencies f o r the two samples are given i n 
table 6.5. These have been calculated by the equations f o r three 
a l l e l e s given by Mourant et a l (1976) and are similar to those used 
f o r the calculation of p^,P2»q and r above. The derivation of the 
blood donor data from Kopec i s shown i n table 6.6. Frequencies f o r 
the twelve postal d i s t r i c t s from which control subjects were derived 
have been amalgamated without weighting f o r the numbers coming from 
each. There are no s i g n i f i c a n t differences between the present 
control sample and the donors. Standard errors f o r the frequencies 
are calculated by means of the forrmila given by Smith (1969)5-
where p i s the frequency of group A,for example, 
and n i s the t o t a l sample size. 
Sex,area of o r i g i n and source of controls reveal 
no s i g n i f i c a n t differences and there i s no s i g n i f i c a n t trend i n 
proportions with age although,as shown i n table 6.7»the downward 
trend of group A with age j u s t f a i l s to achieve t h i s . 
the data fo r a trend i n proportions with age w i l l reveal only l i n e a r 
trends. More complex associations w i l l not be demonstrated by t h i s 
method. 
standard error P(2 - P 
4n 
I t should be noted that the method used f o r examining 
• Table 6.4 Results f o r the ABO system,no subdivision of group A. 
Phenotype Number and frequency ($) 
(l)Present sample (2)Kopec (1970) 
A 197 (38.3) 1849 (38.3) 
0 255 (49.5) 2367 (49.0) 
B 47 ( 9.1) 443 ( 9.2) 
AB 16 ( 3.1) 174 ( 3.6) 
Totals 515 4833 
Chi squared ( ( l ) vs. (2)) = 0.13 (d.f.=3),N.S. 
Table 6.5 ABO gene frequencies,no subdivision of group A. 
Gene Frequency (+S.E.) 
Present sample Kopec (1970) 
A 0.2347 0.2379 
(+.014) (+.005) 
B 0.0633 0.0661 
(+.003) (+.003) 
0 Os7020 0.7026 
(+.021) (+.007) 
Table 6.6 Derivation of ABO phenotype data from blood donors 
resident i n the Durham area,taken from Kopec (1970). 
Kopec area 
No Name A 0 B AB N 
32 Stanley 203 248 43 12 506 
33 B i r t l e y 130 152 30 17 329 
34 Washington 46 75 14 6 141 
35 Chester-
le-Street 
88 122 21 12 243 
36 Houghton-
le-Spring 
136 169 31 13 349 
37 Seaham 130 163 24 8 325 
38 Easington 163 223 50 22 458 
39 Horden 201 231 50 11 493 
40 Durham 382 458 87 37 964 
41 Spennymoor 72 86 17 11 186 
43 P e r r y h i l l 231 335 57 21 644 
55 Crook 67 105 19 4 195 
Totals 1849 2367 443 174 4833 
Table 6.7 ABO phenotype frequencies and age in controls. 
Group Number and frequency (%) in each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
A 38 50 49 60 
(49.3) (35.2) (38.3) (35.7) 
not A 39 92 79 108 
(50.7) (64.8) (61.7) (64.3) 
Totals 77 142 128 168 
Z = 1.404 (p=0.08) 
6.5 The MNSs system. 
(a) The MN locus. 
Control subjects tested with anti-M and anti-N 
t o t a l l e d 488 individuals. The results,together with comparative 
data fo r a Hertfordshire sample used as controls i n a study of 
mental disorders (Thomas and Hewitt,1939) i s given i n table 6.8. 
The differences between the two samples are not s i g n i f i c a n t . The 
frequency of the heterozygote,MN,in the present sample i s greater 
than the theoretical maximum of 50?£ predicted by the Hardy-VVeinberg 
law. This i s probably the result of the mis-typing of some M 
individuals as MN because of agglutination with anti-N as discussed 
by Mourant et a l (1976). The deviation of the phenotype frequencies 
from that predicted has been considered u n l i k e l y to be due to 
heterozygote advantage i n t h i s system (Race and Sanger,1975)• 
The gene frequencies f o r the present sample and 
that of Thomas and Hewitt (1939) are given i n table 6.9. No 
signi f i c a n t differences with regard to sex,area of o r i g i n or source 
could be detected at t h i s locus and there were no si g n i f i c a n t trends 
with age. 
(b) The Ss locus. 
400 controls were tested with anti-S alone,the 
results,together with those from 359 B r i t i s h and European subjects 
from London (Giles,1964) are shown i n table 6.10. There i s no 
sign i f i c a n t difference between these samples. 
No si g n i f i c a n t sex differences are demonstrable 
within the present sample and,similarly,there are no differences 
with regard to area of o r i g i n or source. 
Table 6.8 Results for the UN locus,control subjects. 
Phenotype Number and frequency ($) 
(l)Present sample (2)Thomas and Hewitt (1939) 
M 136 (26.5) 279 (31.0) 
MN 266 (51.8) 436 (48.4) 
N 86 (16.7) 185 (20.6) 
Totals 488 900 
Chi squared (H.W.) ( l ) = 5.05 
Chi squared ( ( l ) vs. ( 2 ) ) = 4.72 (d.f.=2) N.S. 
Table 6.9 Gene frequencies for the MN locus,control subjects. 
Gene Frequency (+S.E.) 
Present sample Thomas and Hewitt (1939) 
M 0.5512 0.5522 
(+.023) (+.017) 
N 0.4488 0.4478 
Table 6.10 Results with anti-S,control subjects. 
Phenotype Number and frequency ($) 
(l)Pre8ent sample (2)Giles (1964) 
S+ve 209 (52-3) 201 (56.0) 
S-ve 191 (47.7) 158 (44.0) 
Totals 400 359 
Chi squared ( ( l ) vs. (2)) = 1.06 ( d . f . = l ) N.S. 
Of the 400 controls tested with anti-S,273 were also 
tested with anti-s. These results are shown i n table 6.11 together 
with comparative data from Germany (Wendt and Theile,1963),the only 
other published European population s i m i l a r l y tested. Table 6.12 
gives the gene frequencies f o r these populations. 
There were no s i g n i f i c a n t differences at t h i s locus with 
regard to sex,area of o r i g i n or source but table 6.13 demonstrates 
si g n i f i c a n t trends with age,the frequency of the heterozygote,Ss, 
increasing with age at the expense of the s homozygote. These 
trends are paralleled by changes i n gene frequencies (see table 6.14). 
(c) The MNSs complex. 
Results from the 386 control subjects tested with a n t i -
M,anti-N and antiS are shown i n table 6.15,together with comparative 
data from the largest published series of English subjects thus tested 
( i k i n et al,1952) and quoted i n Mourant et a l (1976). There are no 
si g n i f i c a n t differences between these two series. As i n other reported 
samples,linkage disequilibrium can be demonstrated i n t h i s system i n 
the present control sample with the S a l l e l e associated with the M 
a l l e l e s i g n i f i c a n t l y more often than i t i s with the N a l l e l e . 
The results f o r the 271 controls tested with anti-M, 
anti-N,anti-S and antics are given i n table 6.16,together with 
comparative data f o r 1,000 donors from the South East of England 
published by Cleghorn (1960). There are no s i g n i f i c a n t differences 
Table 6.11 Results for the Ss locus,control subjects. 
— 
Phenotype Number and frequency {$) 
(l)Present sample (2)Wendt and Theile (1963) 
S 29 (10.6) 18 (16 .7) 
Ss 117 (42.9) 39 (36.1) 
s 127 (46.5) 51 (47.2) 
Totals 273 108 
Chi squared (H.W.) ( l ) = 0.07 
Chi squared ( ( l ) vs. (2)) = 3.16 (d.f.=2) N.S. 
Table 6.12 Gene frequencies for the Ss locus,control subjects. 
Gene Frequency (+S.E.) 
Present sample Wendt and Theile (1963) 
S 0.3205 0.3472 
(+.028) (+.O46) 
s 0.6795 0.6528 
Table 6.13 Ss phenotypes of controls subdivided according to age. 
Phenotype Number and frequency ($) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
S 4 
( 8 .9) 
10 
(12.5) 
6 
( 9.4) 
9 
(10.7) 
Ss 16 
(35.6) 
30 
(37.5) 
29 
(45.3) 
42 
(50.0) 
s 25 
(55.6) 
40 
(50.0) 
29 
(45.3) 
33 
(39.3) 
Totals 45 80 64 84 
Z (heterozygotes vs. r e s t ) = 1.853 P = 0.03 
Z (s vs. r e s t ) = 1.854 P = 0.03 
Mean age S individuals = 43.19 (+4.0) years 
Mean age Ss individuals = 48.04 (+2.0) years 
Mean age s individuals = 43.47 (+1.9) years 
Table 6.14 Gene frequencies Ss locus of controls according to age. 
Gene Frequency (+S.E.) for each age group 
0 -19 20 - 39 40 - 59 60 and over 
S 0.2667 
(+.066) 
0.3125 
(+.052) 
0.3203 
(+.058) 
0.3571 
(±.052) 
s 0.7333 0.6875 0.6797 0.6429 
5«? 
Table 6.15 Results for the MNSs system,controls tested with anti-M, 
anti-N and anti-S. 
Phenotype Number and frequency ($) 
(l)Present sample ( 2)lkin et a l (1952) 
MS 67 (17.4) 250 (19.7) 
MNS 121 (51.5) 505 (26.0) 
NS 17 ( 4.4) 56 ( 4.8) 
Ms 57 ( 9.6) 115 ( 9.7) 
MNs 97 (25.1) 264 (22.6) 
Ns 47 (12.2) 200 (17.1) 
Totals 586 1166 
Chi squared ( ( l ) vs. (2)) = 9.27 (d.f.* 5) N.S. 
Table 6.16 Results for the MNSs system,controls tested with anti-M, 
anti-N,anti-S,and a n t i - s . 
Phenotype Number and frequency (°/o) 
(l)Present sample (2)Cleghorn (1960) 
MS 16 ( 5.9) 57 ( 5.7) 
MNS 12 ( 4.4) 39 ( 3.9) 
NS 1 ( 0.4) 3 ( 0.3) 
MSs 30 (11.1) 140 (14.0) 
MNSs 80 (29.5) 224 (22.4) 
NSs 7 ( 2.6) 54 ( 5.4) 
Ms 26 ( 9.6) 101 (10.1) 
MNs 66 (24.4) 226 (22.6) 
Ns 33 (12.2) 156 (15.6) 
Totals 271 1000 
Chi squared ( ( l ) vs. (2)) = 11.61 (d.f. = 7) N.S. 
, between the two samples (categories MNS and NS have been amalgamated 
for the calculation of chi squared). 
Figure 6.17 shows the relationship of phenotype 
requencies to age i n these 271 subjects. Although none of these 
trends are s i g n i f i c a n t the data are presented here as a preparation 
for the next chapter. Attention i s drawn to the frequencies of the 
double heterozygote (MNSs) i n the four age categories. 
6.4 The P system. 
A t o t a l of 509 controls were tested with anti-P^. 
The results,shown in table 6.18,were recorded as positive or negative 
with the positive category subdivided according to strength of 
agglutination. A l l readings were performed by one of two individuals. 
The c l a s s i f i c a t i o n on the basis of strength of reaction i s open to 
some c r i t i c i s m . Not only i s there room for considerable observer 
error,but there i s also a p o s s i b i l i t y that variations i n the strength 
of the antiserum might lead to variation i n the r e s u l t . A l l the e n t i -
re used i n t h i s study was from the same source and the same batch but 
continual freezing and thawing of the antiserum over the time i n t e r v a l 
of the study might have affected the t i t r e . Advantage was made of 
the fact that several blood samples were collected on two separate 
occasions,the second time s p e c i f i c a l l y for HLA typing. One hundred 
and twenty-two specimens (diabetic and control) were collected twice, 
and were able to be tested,on the second occasion,by the individual 
who had assessed the reaction with anti-P^ on the f i r s t occasion. 
The measure of agreement between the readings on these two occasions 
i s shown i n table 6.19. Only 63 (52$) of the samples gave the same 
res u l t on the second occasion as they had on the f i r s t . Of the 59 
Table 6.17 Results for the MNSs system,controls tested with anti-M, 
anti-N,anti-S and anti-s,subdivided according to age. 
Phenotype Number and frequency (fo) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
MS 
( 4?5) 
5 
( 6 .3) 
3 
( 4.7) 
6 
( 7.2) 
MSs 4 
( 9.1) 
6 
( 7.5) 
13 
(20 .3 ) 
7 
( 8 .4) 
Ms 
(6.8) 
11 
(13.8) 
5 
( 7.8) 
7 
( 8 .4) 
MNS 
( 4?5) 
5 
( 6.3) 
2 
( 3.1) ( 3^6) 
MNSs 11 
(25.0) 
23 
(28.8) 
16 
(25.0) 
30 
(36 .1) 
MNs 15 
(34.1) 
20 
(25.0) 
13 
(20 .3 ) 
18 
(21 .7) 
NS 0 0 
( i . f t ) 
0 
NSs 
( 2^5) ( 1*3) 
0 5 
( 6 .0) 
Ns 6 
(13.6) 
9 
(11.3) 
11 
(17.2) 
7 
( 8 .4) 
Totals 44 80 64 83 
Table 6.18 Results for control subjects tested with anti-P. 
Reaction with anti-P^^ Number and frequency ($) 
-ve 128 (25.1) 
1 185 (36.3) 
2 130 (25.5) 
3 65 (12.8) 
4 1 ( 0.2) 
Total 509 
.Table 6.19 Results for subjects tested with anti-P. on two occasions. 
Result on the second occasion 
-ve 1 2 3 
Result -ve 9 1 1 0 
on the 1 10 25 3 3 
f i r s t 2 5 14 15 4 
occasion 3 0 10 8 14 
Table 6.20 Results for subjects tested with anti-P^ on two occasions 
( c l a s s i f i c a t i o n into +ve and -ve only). 
Result on the second occasion 
Result on the 
f i r s t occasion 
-ve +ve 
-ve 
+ve 
9 2 
15 96 
samples (48$) that were c l a s s i f i e d d i f f e r e n t l y on the second occasion, 
12 (20$) of them were recorded as reacting more strongly and 47 (80%) 
as reacting more weakly than they did on the f i r s t occasion. 
I f the r e s u l t s are c l a s s i f i e d as either positive 
or negative without grading of strength of reaction 86$ of samples 
give the same r e s u l t twice (table 6.20). Although this l e v e l of 
agreement i s no reason for congratulation i t was f e l t j u s t i f i a b l e 
to consider positive and negative subdivisions of reaction but not, 
under these laboratory conditions,any f i n e r subdivisions. The 
direction of change,predominantly from a stronger to a weaker 
category,of these samples with time suggests that the strength of 
the antiserum was being progressively reduced. 
The present sample,classified as positive or 
negative,is shown in table 6.21 together with that of I k i n et a l 
(1954) composed of 1,166 English blood donors. There are no sig n i f i c a n t 
differences between these samples. Table 6.22 shows the gene frequencies 
for the two populations. 
There were no detectable differences between the 
sexes,individuals from different areas or source of controls. The 
P system showed no relationship with current age. 
6.5 The Rhesus system. 
The Rhesus phenotypes of 515 individuals from 
the control group were determined. These samples were a l l tested 
with anti-C,anti-c,anti-D and anti-E. Those positive with anti-E 
were also tested with anti-e. Unusual phenotypes were checked with 
the f u l l range of commercial antisera. Results are given f i r s t for 
the complete phenotypes and,secondly,considering the C,D and E l o c i 
Table 6.21 Results with anti-P.,control subjects. 
Phenotype Number and frequency ($) 
+ve 
(l)Present sample ( 2)lkin et a l (1954) 
581 (74.9) 893 (76.6) 
-ve 128 (25.1) 273 (23.4) 
Totals 509 1166 
Table 6.22 Gene frequencies for the P system,control subjects. 
Gene Frequency (+S.E.) 
Present sample I k i n et a l (1954) 
P l 0.4985 0.5161 
(+.022) (+.015) 
P 2 + P 0.5015 0.4839 
, separately. Gene frequencies i n the l a t t e r case are calculated by 
the method of gene counting,the haplotype frequencies are estimated 
from the phenotype data by means of a maximum likelihood computer 
programme. 
(a) Phenotype frequencies considering the three l o c i C,D and E. 
Table 6.23 shows the phenotype frequencies for 
the entire control sample compared with those given for 1,073 
English subjects by Race et a l (1948). Combining the categories 
R Qr.r'r.R^R^.r' 'r and HJ0i2 enables a chi squared to be calculated 
and t h i s shows no differences between the two samples. Table 6.24 
gives the haplotype frequencies for these two populations calculated 
by the same computer programme. 
There are no sign i f i c a n t differences attributable 
to sex,area of origin or source i n these frequencies but table 6.25 
shows that a sig n i f i c a n t relationship e x i s t s with age. The r r 
genotype increases i n frequency with increasing age of the subjects. 
Table 6.26 shows the relationship of age and haplotype frequency. 
The value of z for t h i s trend (considering r r vs not-rr) i s 1.998, 
p = 0.023. 
(b) Separate consideration of the C,D and E l o c i . 
Tables 6.27,6.28 and 6.29 show r e s u l t s for the 
C,D and E l o c i i n the present se r i e s and i n that of Race et a l (1948). 
There are no sig n i f i c a n t differences between the populations. Tables 
6.30 and 6.31 give the gene frequencies for the £,£,E and e_ a l l e l e s . 
The frequency of the Cc heterozygote i s greater than the 5096 
theoretical maximum. I f t h i s i s the r e s u l t of typing errors,as i s 
Table 6.23 Results for the Rhesus system,control subjects. 
Reaction with a n t i - Probable Number and frequency (*) 
C c D E e genotype (l)Present sample (2)Race et a l (1948) 
+ - + r r 81 (15.7) 170 (15.8) 
+ + + + V 194 (37.7) 363 (33.8) 
+ + + R 1 R 1 86 (16.7) 190 (17.7) 
+ + + V 4 ( 0.8) 19 ( 1.8) 
+ + + + R 2 r 53 (10.3) 137 (12.8) 
+ + + - 11 ( 2.1) 29 ( 2.7) 
+ + + + + R 1 R 2 77 (15.0) 144 (13.4) 
+ - + r ' r ' 0 0 
+ + - + r ' r 5 ( 1.0) 10 ( 0.9) 
+ + + + R z R l 0 4 ( 0.4) 
+ + + r ' r ^ 0 0 
+ + + + r " r ' 0 0 
+ + + r " r 2 ( 0.4) 7 ( 0.7) 
+ + + - R R 
z z 
0 0 
+ + + + - R z R 2 2 ( 0.4) 0 
+ + - 0 0 
+ + + - r ^ r " 0 0 
+ + - 0 0 
515 1073 
Chi squared ( ( l ) vs. (2)) = 6.0 (d.f.=6) N.S. 
Table 6.24 Rhesus haplotype frequencies,control subjects. 
Haplotype Present sample Race et a l (1948) 
r 0.4018 0.3973 
r ' 0.0119 0.0114 
r " O.OO44 0.0081 
0.0019 0 
Ro 0.0098 0.0262 
R l 0.4230 O.4O66 
R2 0.1470 0.1513 
R 
z 
0 0.0037 
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Table 6 .26 Rhesus haplotype frequencies,control subjects subdivided 
by age. 
Haplotype Frequency i n each age group 
r 
0 - 1 9 20 - 39 40 - 59 60 and over 
0.3247 0.3707 0.4257 0 .4458 
r 1 0.0195 0 0.0180 0.0131 
r " 0 0 0 0 .0133 
r ^ O.OO65 0 .0035 0 0 
R o 0 0.0096 0.0118 0.0125 
R l O .46IO 0.4789 0.3844 0.3887 
R 2 0.1883 0.1373 0.1602 0.1266 
R z 0 0 0 0 
No. 77 142 128 168 
Table 6.27 Results for control subjects tested with anti-C and a n t i -
Phenotype Number and frequency ($) 
C 
(l)Present sample (2)Race et a l (1948) 
86 (16.7) 194 (18 .1) 
Cc 278 (54.0) 517 (48 .2) 
c 151 (29.3) 362 (33.7) 
Totals 515 1073 
Chi squared ( ( l ) vs. (2)) = 4.81 (d.f.=2) N.S. 
Chi squared (H.W.) ( l ) = 4.85 
Table 6.28 Results for control subjects tested with anti-D. 
Phenotype Number and frequency ($) 
(l)Present sample (2)Race et a l (1948) 
d 88 (17.1) 187 (17.4) 
D 427 (82 .9 ) 886 (82.6) 
Totals 515 1073 
Table 6.29 Rhesus r e s u l t s for control subjects tested with anti-E 
and anti-e. 
Phenotype Number and frequency ($) 
E 
(l)Present sample (2)Race et a l (1948) 
13 ( 2.5) 29 ( 2.7) 
Ee 132 (25.6) 292 (27.2) 
e 370 (71.8) 752 (70.1) 
Total 515 1073 
Chi squared ( ( l ) vs. (2)) = 0.52 (d.f.=2) N.S. 
Chi squared (H.W.) ( l ) = 0.09 
Table 6.30 Gene frequencies for the C locus,control subjects. 
Gene Frequency (+S.E.) 
Present sample Race et a l (1948) 
C 0.4369 0.4217 
(+.022) (+.015) 
c 0.5631 0.5783 
Table 6.31 Gene frequencies for the E locus,control subjects. 
Gene Frequency (+S.E.) 
Present sample Race et a l (1948) 
E 0.1534 0.1631 
(+.016) (+.011) 
e_ O.8466 0.8369 
most l i k e l y , i t does not conform to the most usual error (c i t e d by 
Mourant et al,1976) - f a l s e negative r e s u l t s with anti-c which 
give an excess of CC homozygotes and a d e f i c i t of heterozygotes. 
Consideration of only the D and d a l l e l e s allows for 
comparison with regional blood donor data derived from Kopec (1970). 
Table 6.32 shows the derivation of these data from the same twelve 
postal d i s t r i c t s as were used for the ABO data. There i s no 
s i g n i f i c a n t difference between the D -ve frequency i n the present 
sample and that i n these donors. 
There i s a difference between the sexes i n the frequency 
of D -ve individuals. Although t h i s difference i s not s i g n i f i c a n t i n 
t h i s sample,the data are given (table 6.33) since they are pertinent 
to the argument concerning the relationship between the frequency of 
t h i s phenotype and age. No s i g n i f i c a n t differences between the 
sexes are detectable at the C and E loci,nor are there any differences 
at any of the three l o c i when area of origin and source are considered. 
Table 6.34 and table 6.35 show the influence of age 
on the phenotype frequencies considering the C and D l o c i respectively. 
There i s a s i g n i f i c a n t upward trend i n the frequency of the c 
phenotype with age and i n the frequency of the D -ve phenotype. The 
C locus gene frequencies in the various age sub-classes are shown i n 
table 6.36. 
If , i n s t e a d of categorisation into four age groups,the 
sample i s divided into two,under 55 years and 55 years and over, 
the difference i n the D -ve frequencies i s s i g n i f i c a n t by chi 
squared (table 6.37)• 
The mean age of the D -ve individuals i s 51.67 years 
(+ 2.4) and the mean age of the D +ve individuals i s 45•45 (+ 1.0) 
as* 
Table 6.32 Derivation of comparative data for Rhesus (D) from 
Kopec (1970). 
Kopec area No. Rh -ve N dd ^ 
No. Name 
102 506 20.16 32 Stanley 
33 B i r t l e y 58 329 17.63 
34 Washington 29 141 20.57 
35 Chester-le-
Street 
50 243 20.58 
36 Houghton-le 
Spring 
75 349 21.49 
37 Seaham 69 325 21.23 
38 Easington 83 458 18.12 
39 Horden 91 493 I8.46 
40 Durham 182 964 18.88 
41 Spennymoor 47 186 25.27 
43 P e r r y h i l l 108 644 16.77 
55 Crook 33 195 16.92 
Totals 927 4833 19.18 
Present 
sample 
88 515 17.1 
Chi squared (comparison of Kopec sample and present sample) = 1. 
(d.f. = 1) N.S. 
Table 6.33 Rhesus phenotype r e s u l t s (D only),controls subdivided 
by sex. 
Phenotype Number and frequency ($) 
Males Females 
d 38 50 
(14.2) (20.2) 
D 230 197 
(85.8) (79.8) 
Chi squared (comparison of males and females) = 3*34 (d.f.=l) N.S. 
Table 6.34 Results with anti-C and anti-c,controls subdivided by 
age. 
Phenotype Number and frequency ($) in each age group 
C 
0 - 1 9 20 - 39 40 - 59 60 and over 
12 (15.6) 33 (23.3) 17 (13.3) 24 (14.3) 
Cc 51 (66.2) 71 (50.0) 69 (53.9) 87 (51.8) 
c 14 (18.2) 38 (26.8) 42 (32.8) 57 (33.9) 
Totals 77 142 128 168 
Z (c vs. rest) = 2.541 (p = 0.005) 
Z (Cc vs. rest) = 1.358 (p = 0.09) 
Table 6.35 Results with anti-D,controls subdivided by age. 
Phenotype Number and frequency (' fo) in each age group 
d 
0 - 1 9 20 - 39 40 - 59 60 and over 
10 (13.0) 19 (13.4) 20 (15.6) 39 (23.2) 
D 67 (87.0) 123 (86.6) 108 (84.4) 129 (76.8) 
Totals 77 142 128 168 
Z = 2.343 (p = 0.0096) 
Table 6.36 Gene frequencies,C locus,for control subjects subdivided 
by age. 
Gene Frequencies (+S.E.) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
C 0.4870 
(+.057) 
0.4824 
(+.042) 
O.4023 
(+.043) 
O.4OI8 
(+.038) 
£ 0.5130 0.5176 0.5977 0.5982 
Table 6.37 Rhesus (D) frequencies i n controls subdivided by age, 
divisio n at 55 years. 
Phenotype Number and frequency ($) i n each age group 
d 
Under 55 55 and over 
43 (14.0) 45 (21.0) 
D 264 (86.0) 163 (78.4) 
Totals 307 208 
. years. This difference i s significant,the 2-tailed pooled variance 
estimate of Student's t i s 2.46 which,for 513 degrees of freedom, 
gives p = 0.014. 
The four age categories considered do not contain equal 
proportions of males and females (table 6 .38) . Since there i s a 
sex difference,albeit s t a t i s t i c a l l y i n s i g n i f i c a n t , i n the D -ve and 
D +ve frequencies (table 6.33) and there are more of the 
predominantly I) -ve females i n the oldest group,the question a r i s e s 
as to whether sex differences are producing a spurious relationship 
with age i n th i s system. Tables 6.39 and 6.4O show that the upward 
trend of D -ve frequencies with age i s present i n both males and 
females although i n neither of these small groups does i t reach 
acceptable l e v e l s of significance. 
6.6 The K e l l system. 
(a) Tests with anti-K and anti-k. 
Five hundred and fourteen control subjects were tested 
with anti-K. Those found to be positive were also tested with a n t i -
k. One individual of the genotype KK was found,this was confirmed 
with commercial anti-K and anti-k. Table 6 .4I shows the phenotype 
r e s u l t s for the present control sample together with those published 
by I k i n et a l (1954)• There are no s i g n i f i c a n t differences (K and 
Kk categories have been combined for the calculation of chi squared). 
Table 6.42 shows the gene frequencies for the two populations,neither 
show differences from Hardy-Weinberg expectation. 
There are no si g n i f i c a n t differences with regard to 
sex,area of origin or source for t h i s locus and,although the 
frequency of heterozygotes r i s e s with age,this trend i s not s i g n i f i c a n t . 
Table 6.38 Sex and age distr i b u t i o n of controls tested with anti-D. 
Sex Number and frequency ($) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
Male 46 95 72 55 
(59.7) (66.9) (56.3) (32 .7) 
Female 31 47 56 113 
(40 .3) (33.D (43.7) (67.3) 
"17 142 128 168 
Table 6.39 Rhesus (D) results,male controls subdivided by age. 
Phenotype Number and frequency ($) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
d 6 10 11 11 
(13 .0) (10.5) (15.3) (20.0) 
D 40 85 61 44 
(87.0) (89.5) (84.7) (80.0) 
Totals 46 95 72 55 
Z = 1.259 (p = 0.10) 
Table 6.40 Rhesus (D) resuits,female controls subdivided by age. 
Phenotype Number and frequency ($) i n each age group 
u 
0 - 1 9 20 - 39 40 - 59 60 and over 
A 4 
(12.9) (19.1) 
9 
(16.1) 
28 
(24.8) 
D 27 
(87.1) 
38 
(80.9) 
47 
(83.9) 
85 
(75.2) 
Totals 31 47 56 113 
Z = 1.514 (P = 0.07) 
Table 6.41 Results with anti-K and anti-k,control subjects. 
Phenotype Number and frequency ($) 
K 
(l)Present sample (2)lkin et a l (1954) 
1 ( 0.2) 1 ( 0.1) 
Kk 34 ( 6.6) 89 ( 7.6) 
k 479 (93.2) 1076 (92.3) 
Totals 514 1166 
Chi squared (H.W.) ( l ) = 0.23 
Chi squared ( ( l ) vs. (2)) = 0.42 (d.f.=2) N.S. 
Table 6.42 K e l l locus gene frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample I k i n et a l (1954) 
K 0.0350 0.0390 
(+.008) (+.006) 
0.9650 0.9610 
(b) Tests with anti-Kp a and anti-Kp . 
A t o t a l of 423 controls were tested with anti-Kp and the 
subjects positive with t h i s antiserum were also tested with anti-Kp* 3. 
No examples of the genotype Kp^p3- were found. Table 6.43 shows the 
data for the present control sample and that of the only other 
published sample s i m i l a r l y tested and with the Kp_ a l l e l e present. 
This i s the Canadian donor group of Dichupa et a l (1969) which shows 
a higher frequency of Kp +ve individuals than the present sample, 
although the difference i s not s i g n i f i c a n t . The gene frequencies 
for the two samples are given i n table 6.44» 
There are no differences with regard to sex,area of 
origin or age which are s t a t i s t i c a l l y s i g n i f i c a n t . 
(c) Tests with anti-K tanti-k tanti-Kp a and anti-Kp^. 
Table 6.45 shows the r e s u l t s for the 423 individuals 
tested with these antisera together with the frequencies i n a group 
of Michigan donors of West European orig i n ( S h r e f f l e r et a l (1971). 
No s i g n i f i c a n t differences can be demonstrated between these two 
populations. 
There are no differences with regard sex,area of origin, 
source or age demonstrable in t h i s sample. 
6.7 The Lewis system. 
The anti-Le (a) antiserum available contained anti-B and 
the r e s u l t s (table 6.46) are,consequently,for group A and group 0 
controls only. There was only s u f f i c i e n t antiserum for the testing 
of 108 non-diabetic individuals. The comparative data are derived 
from Race and Sanger (l968),no s i g n i f i c a n t differences were found 
Table 6.43 Results with anti-Kp a,control subjects. 
Phenotype Number and frequency {$>) 
Kp 
(l)Present sample (2)Bichupa et a l (1969) 
0 5 ( 0.04) 
Kp'V 6 ( 1.4) 269 ( 2.4) 
417 (98.6) 10965 (97.6) 
423 11239 
Chi squared (H.W.) ( l ) = 0.02 
Chi squared ( ( l ) vs. (2)) = 1.8 (d.f.=l) N.S. 
Table 6.44 Gene frequencies for Kp a locus,control subjects. 
Gene Frequency (+S.E.") 
Present sample Dichupa et a l (1969) 
0.0071 0.0124 
(+.004) (+.001) 
0.9929 0.9876 
Table 6.45 Results for the Kell-Kp complex,control subjects. 
Phenotype Number and frequency ($) 
KKp b 
(l)Present sample (2)Shreffler et a l (1971) 
1 ( 0.2) 6 ( 0.1) 
KkKp aKp b 0 5 ( 0.1) 
KkKp b 27 ( 6.4) 589 ( 7.0) 
kKp a 0 1 ( 0.01) 
kKp^p1* 6 ( 1.4) 125 ( 1.5) 
kKp b 389 (92.0) 7717 (91.4) 
Totals 423 8443 
Chi squared ( ( l ) vs. (2)) = 0.22 (d.f. = 2) N.S. 
Table 6.46 Results for control subjects tested with anti-Lewis ( a ) , 
group A and group 0 persons only. 
Reaction with 
anti-Lewis (a) 
Number and frequency ($) 
(l)Present sample (2)Race and Sanger (1968)* 
+ve 30 (27.8) 203 (21.9) 
-ve 78 (72.2) 725 (78.1) 
Totals 108 928 
Chi squared ( ( l ) vs. (2) = 1.94 (d.f. = l ) N.S. 
A l l ABO blood groups included i n t h i s sample. 
between the two samples. 
There were i n s u f f i c i e n t individuals to allow subdivision 
on the basis of sex,area of origin or age. 
6.9 The Duffy system. 
Testing with anti-Fy alone was performed on 507 control 
specimens. Table 6,47 shows the r e s u l t s for these and the sample 
reported by I k i n et a l (1954). There are no s i g n i f i c a n t differences 
between the samples. 
No si g n i f i c a n t trends were found with age neither were 
there any differences with regard to sex,area of origin nor source. 
Et 
Of the 507 individuals tested with anti-Fy ,289 were 
also tested with anti-Fy . Table 6.48 shows the r e s u l t s together 
with comparative data from Cleghorn (l965)« There are no s i g n i f i c a n t 
differences. Table 6.49 shows the gene frequencies for the two 
populations. I n neither case do the phenotype categories d i f f e r 
from Hardy-Weinberg prediction. 
There was no detectable difference when the sex,area of 
origin and source of controls were considered. There were no 
trends with age. 
6.10 Haptoglobin. 
Only 86 control subjects were typed for haptoglobin 
phenotype. The r e s u l t s are presented in table 6.50,together with 
the s e r i e s published by Harris et a l (1959). No s i g n i f i c a n t 
differences can be demonstrated between the two samples. Table 
6.51 shows the gene frequencies of these two groups. 
There were i n s i g n i f i c a n t numbers available for further 
Table 6 . 4 7 Results for control subjects tested with anti-Py . 
Reaction with Number and frequency (%) 
anti-Py (l)Present sample ( 2 ) l k i n et a l ( 1 9 5 4 ) 
+ve 326 ( 6 4 . 3 ) 764 ( 6 5 . 5 ) 
-ve 181 ( 3 5 . 7 ) 402 ( 3 4 . 5 ) 
Totals 507 1166 
Chi squared ( ( l ) vs. ( 2 ) ) = 0 . 2 3 (d.f. = l ) N.S. 
Table 6 . 4 8 Results for control subjects tested with anti-Py and 
anti-Py . 
Phenotype Number and frequency ($) 
(l)Present sample (2)Cleghorn ( I 9 6 5 ) 
Py a 55 ( 1 9 . 0 ) 130 (19.8) 
Py a Py b 126 ( 4 5 . 6 ) 321 (48 . 9 ) 
Py b 108 ( 3 7 . 4 ) 205 ( 3 1 . 3 ) 
Totals 289 656 
Chi squared (H.W.) ( l ) » 2 . 7 6 
Chi squared ( ( l ) vs. ( 2 ) ) = 3 .54 (d.f. = 2 ) N.S. 
Table 6 . 4 9 Duffy system gene frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample Cleghorn ( 1 9 6 5 ) 
Py.a O.4O83 0 . 4 4 2 8 
( + . 0 2 9 ) ( + . 0 1 9 ) 
_ b O .5917 0 .5572 
Table 6 . 5 0 Haptoglobin results,control subjects. 
Fhenotype Number and frequency (%) 
(l)Present sample ( 2)Harris et a l (1959) 
1-1 16 (18.6) 33 (18.4) 
2-1 44 ( 5 1 . 2 ) 88 (49 . 2 ) 
2-2 26 ( 3 0 . 2 ) 58 (32.4) 
Totals 86 179 
Chi squared (H.W.) ( l ) = 0 . 1 2 
Chi squared ( ( l ) vs. ( 2 ) ) = 0 . 1 3 (d.f. = 2 ) N.S. 
Table 6 . 5 1 Haptoglobin gene frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample Harris et a l ( 1 9 5 9 ) 
I * 1 0 .4419 0 .4302 
( ± • 3 3 6 ) ( + . 0 3 7 ) 
ft" 0 . 5 5 8 1 0 . 5 6 9 8 
' subdivision by sex,area of origin,source or age. 
6 . 1 1 Acid phosphatase. 
The acid phosphatase r e s u l t s for 229 controls are given 
i n table 6 . 5 2 . These d i f f e r s i g n i f i c a n t l y from the series of 
Hopkinson and Harris ( 1 9 6 9 ) i n having a higher frequency of the 
b c P a l l e l e and a lower frequency of P . There i s no way of t e l l i n g 
whether t h i s i s a regional effect (Hopkinson and Harris's sample 
was from the South of England) or the r e s u l t of technical errors 
leading to an under-representation of the CA phenotype and an over-
representation of the BA phenotype i n the present sample. The gene 
frequencies for the system are given i n table 6 . 5 5 . 
There are s i g n i f i c a n t differences with age i n that the 
A phenotype increases i n frequency with increasing age (table 6 . 5 5 ) 
No s i g n i f i c a n t differences are seen with regard to sex,area of 
origin or source. 
6 .12 Phosphoglucomutase. 
The r e s u l t s for the 115 controls examined for the PGM^  
locus are shown i n table 6 . 5 6 . This sample d i f f e r s s i g n i f i c a n t l y 
from that of Hopkinson and Harris ( 1 9 6 6 ) i n having a higher PGM^  
gene frequency. The 2 - 1 and 2 -2 categories were combined for the 
calculation of t h i s chi squared. Table 6 . 57 shows the gene 
frequencies for the two s e r i e s . Neither d i f f e r s s i g n i f i c a n t l y from 
Hardy Weinberg expectation. 
There are no s i g n i f i c a n t differences with regard to 
sex,area of o r i g i n or source i n t h i s system. Table 6 . 5 8 shows that 
when the sample i s subdivided by age,the numbers i n each group are 
Table 6 . 5 2 Acid phosphatase resuits,control subjects. 
Phenotype Number and frequency {%) 
(l)Present sample (2)Hopkinson and Harris ( 1 9 6 9 ) 
A 24 ( 1 0 . 5 ) 119 ( 1 3 . 5 ) 
BA 111 ( 4 8 . 5 ) 379 ( 4 3 . 1 ) 
B 80 ( 3 4 . 9 ) 282 ( 3 2 . 1 ) 
CA 4 ( 1.7) 39 ( 6 . 9 ) 
CB 10 ( 4 - 4 ) 39 ( 4 - 4 ) 
Totals 229 880 
Chi squared ( ( l ) vs. ( 2 ) ) = 7 .86 (d.f. = 3 ) P 0 . 0 5 
Table 6 . 5 3 Acid phosphatase gene frequencies,control subjects. 
Gene Frequency (+S,E.) 
Present sample Hopkinson and Harris ( 1 9 6 9 ) 
P a 0 .3559 0 .3727 
P b 0 .6135 0 .5705 
P c 0 .0306 O.O568 
Table 6 . 5 4 Acid phosphatase results,control subjects subdivided 
according to age. 
Phenotype Number and frequency ($) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
A 1 ( 6 . 3 ) 4 ( 4 . 2 ) 6 ( l l . l ) 13 ( 2 0 . 3 ) 
BA 11 ( 6 8 . 8 ) 44 ( 4 6 . 3 ) 25 ( 4 6 . 3 ) 31 ( 4 8 . 4 ) 
B 3 (18 . 8 ) 40 ( 4 2 . 1 ) 20 ( 3 7 . 0 ) 17 ( 2 6 . 6 ) 
CA 0 6 ( 6 . 3 ) 3 ( 5 . 6 ) 1 ( 1 -6 ) 
CB 1 ( 6 . 3 ) 1 ( 1 . 1 ) 0 2 ( 3 . 1 ) 
Totals 16 95 54 64 
Z (A vs. r e s t ) = 2 . 9 7 6 (p = 0 . 0 0 1 ) 
Table 6 . 5 5 Acid phosphatase gene frequencies,control subjects 
subdivided according to age. 
Gene Frequency i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
t O.4O63 0 .3053 0 .3704 0 . 4 5 3 1 
P b 0 .5625 0 .6579 0.6018 0 . 5 2 3 4 
P c 0.0312 0.0368 0.0278 0 . 0 2 3 4 
Table 6 .56 Phosphoglucomutase results,control subjects. 
Phenotype Number and frequency (fo) 
(l)Present sample (2)Hopkinson and Harris ( 1 9 6 6 ) 
1-1 79 ( 6 8 . 7 ) 1238 (58.7) 
2-1 32 (27.8) 754 (35.7) 
2-2 4 ( 3.5) 118 ( 5 . 6 ) 
Totals 115 2110 
Chi squared (H.W.) ( l ) = 0 . 1 1 (d.f. = 3 ) N.S. 
Chi squared ( ( l ) vs. ( 2 ) ) = 4 . 5 5 (d.f. = l ) p 0 . 0 5 
Table 6 .57 Phosphoglucomutase gene frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample Hopkinson and Harris ( 1 9 6 6 ) 
P.G.M.J 0.8261 0 . 7 6 4 1 
( + . 0 3 5 ) ( + . 0 0 9 ) 
P/G.M^ 0 .1739 O .2348 
Table 6 . 5 8 Phosphoglucomutase results,control subjects subdivided 
according to age. 
Phenotype Number and frequency ($) i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
1-1 2 ( 6 6 . 7 ) 29 ( 7 8 . 4 ) 23 ( 6 7 . 6 ) 25 ( 6 1 . 0 ) 
2 - 1 0 7 (18 . 9 ) 1 1 ( 3 2 . 4 ) 14 ( 3 4 . 1 ) 
2 -2 1 ( 3 3 . 3 ) 1 ( 2 . 7 ) 0 2 ( 4 . 9 ) 
Totals 3 37 34 4 1 
Z ( 2 - 1 vs. r e s t ) = 1.653 (p = 0 . 0 5 ) 
Mean age of heterozygotes = 54 65 ( + 3 * 7 ) years 
Mean age of homozygotes = 4 5 . 5 5 ( + 0 . 9 ) years 
small but the trend for increasing frequency of heterozygotes with 
increasing age almost reaches significance at the 0 . 0 5 l e v e l . 
6 .13 Adenylate kinase. 
Table 6 . 5 9 shows the r e s u l t s for 395 controls and a 
s e r i e s reported by Rapley et a l ( 1 9 6 7 ) . There are no si g n i f i c a n t 
differences between these samples and neither deviates s i g n i f i c a n t l y 
from Hardy-Weinberg expectation. 
No differences with regard to sex,area of origin or 
source can be found and there i s no s i g n i f i c a n t trend of adenylate 
kinase phenotype frequencies with age. 
6 . 1 4 Adenosine deaminase. 
Phenotype frequencies for the controls are shown i n table 
6 . 6 1 . The r e s u l t s do not d i f f e r s i g n i f i c a n t l y from those given for 
th i s system by Hopkinson et a l ( 1 9 6 9 ) . Gene frequencies are given 
i n table 6 . 6 2 . 
There are too few r e s u l t s for subdivision by sex,area of 
origin or age. 
6 .15 Esterase D. 
Table 6 . 63 shows the r e s u l t s for 390 controls typed for 
esterase D. They show no s i g n i f i c a n t differences from a sample 
reported by Hopkinson et a l ( 1 9 7 3 )• The gene frequencies for these 
samples are given i n table 6 . 6 4 . Phenotype frequencies accord with 
those predicted by the Hardy-Weinberg law. 
Table 6 . 5 9 Adenylate kinase results,control subjects. 
Phenotype Number and frequency ($) 
(l)Present sample (2)Rapley et a l (1967) 
1-1 363 (91.9) 1720 ( 9 1 . 1 ) 
2-1 30 ( 7.6) 165 ( 8 . 7 ) 
2-2 2 ( 0.5) 2 ( 0.1) 
Totals 395 1887 
Chi squared (H.W.) ( l ) = 2 . 4 0 
Chi squared ( ( l ) vs. ( 2 ) ) = 0 . 2 3 (d.f. = l ) N.S. 
Table 6 . 6 0 Adenylate kinase gene frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample Rapley et a l ( 1 9 6 7 ) 
A.K.1 0 . 9 5 7 0 0 .9552 
( + . 0 1 0 ) ( + . 0 0 5 ) 
A.K.2 0 . 0 4 3 0 0.0448 
Table 6.61 Adenosine deaminase results,control subjects. 
Phenotype Number and frequency ($) 
(l)Present sample (2)Hopkinson et a l (1969) 
1-1 96 (94.1) 1223 (9O.4) 
2-1 6 ( 5.9) 127 ( 9.4) 
2-2 0 3 ( 0.2) 
Totals 102 1353 
Chi squared (H.W.) ( l ) = 0.09 
Chi squared ( ( l ) vs. (2)) = I.55 (d.f. = l ) N.S. 
Table 6.62 Adenosine deaminase gene.frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample Hopkinson et a l (1969) 
ADA1 r\ r\nr\C 0.9508 
(+.017) (+.006) 
2 
ADA 0.0294 0.0492 
Table 6.63 Esterase D resuits,control subjects. 
Phenotype Number and frequency ($) 
(l)Present sample (2)Hopkinson et a l (1973) 
1-1 304 (77.9) 705 (81.3) 
2-1 82 (21.0) 154 (17.8) 
2-2 4 ( 1.0) 8 ( 0.9) 
Totals 390 867 
Chi squared (H.W.) ( l ) = 0.35 
Chi squared ( ( l ) vs. (2)) = 1.92 (d.f. = l ) N.S. 
Table 6.64 Esterase D gene frequencies,control subjects. 
Gene Frequency (+S.E.) 
Present sample Hopkinson et a l (1973) 
ESP 1 O.8846 0.9020 
(+.016) (+.010) 
ESD 2 0.1154 0.0980 
6.16 The HLA system. 
The absolute phenotype frequencies and the percentage 
frequencies for the HLA-A,HLA-B and HLA-C locus s p e c i f i c i t i e s 
considered are given i n table 6.65,together with comparative data 
(Murray et al,1976) of hospital s t a f f resident i n the Newcastle area. 
For each s p e c i f i c i t y , t h e chi squared value for the difference between 
the two samples i s calculated from the contingency table of the 
numbers of individuals positive for the s p e c i f i c i t y and the numbers 
negative for the s p e c i f i c i t y i n the two populations. 
The only s p e c i f i c i t y for which the value of p i s l e s s 
than 0.05 i s HLA-A9. When the large number of comparisons i s taken 
into account by multiplying the value of p by 15,the r e s u l t i s non-
sign i f i c a n t so that t h i s difference may be due to chance. The 
Newcastle sample was not tested with anti-HLA-Cw4. 
Each HLA locus i s analogous to the ABO system i n that a 
series of co-dominant a l l e l e s and one recessive a l l e l e (for the 
HLA system,the 'blank',for the AB0,the 0 a l l e l e ) segregate at each 
locus. A formula for the calculation of HLA gene frequencies,based 
on t h i s analogy i s given by Nam and Gart (1976). 
The f i r s t stage i s the calculation of an i n i t i a l 
estimate (p^) of the gene frequency of each allele,except 'blank', 
from the formula:-
„ I *i / "i / rt AT^ 
p: = ± A - vG./N, 
where G^ i s the number of individuals positive for each 
s p e c i f i c i t y and N i s the number of individuals tested. The i n i t i a l 
estimate of the 'blank' frequency i s given by:-
where f i s the frequency of individuals who are 
Table 6.65 HLA results,control subjects. 
Locus A l l e l e Number and frequency ($) Chi P 
Present sample Murray et a l squared 
n=427 (1976) n=246 (d.f.=l) 
HLA-A1 147 
( 5 4 . 4 ) 
91 
( 3 7 . 0 ) 
0 . 4 5 N.S. 
HLA-A2 207 
( 4 8 . 5 ) 
133 
( 5 4 . 0 ) 
1 .94 N.S. 
A 
HLA-A3 122 
(28 . 6 ) 
64 
( 2 6 . 0 ) 
0 .50 N.S. 
HLA-A9 57 
( 1 3 . 3 ) 
47 
( 1 9 . 0 ) 
3 .96 0 .05 
HLA-A10 48 
( 1 1 . 2 ) 
30 
( 1 2 . 0 ) 
0 .14 N.S. 
HLA-A11 40 
( 9 . 4 ) 
20 
( 8 . 0 ) 
0 .29 N.S. 
HLA-B5 43 
( 1 0 . 1 ) 
20 
( 8 . 0 ) 
0 .69 N.S. 
HLA-B7 119 
( 2 7 . 9 ) 
74 
( 3 0 . 0 ) 
0 . 38 N.S. 
HLA-B8 126 
( 2 9 . 5 ) 
69 
(28 . 0 ) 
0.16 N.S. 
HLA-B12 145 
( 3 4 . 0 ) 
81 
( 3 3 . 0 ) 
0.08 N.S. 
B HLA-B13 17 
( 4 . 0 ) 
7 
( 3 . 0 ) 
0 .59 N.S. 
HLA-B14 31 
( 7.^ 
20 
( f\.C\\ 
0 .17 N.S. 
HLA-B17 32 
( 7 . 5 ) 
26* 
( 1 2 . 0 ) 
3 .39 N.S. 
HLA-B27 35 
( 8 . 2 ) 
20 
( 8 . 0 ) 
0 N.S. 
HLA-Bwl5 53 
( 1 2 . 4 ) 
34* 
( 1 4 . 0 ) 
1 .21 N.S. 
C HLA-Cw4 2 3 + 
( 1 2 . 9 ) 
Not tested 
* n = 219 + n = 373 
homo zygou s 1blank 1. 
The following formula gives adjusted estimates of the 
gene frequencies which are close to the maximum likelihood estimates:-
3. = G. + p. / n. \ l _ i * i xf 1 J 
2N p£ + 2r' + D \ 2N / 
where D i s the correction factor calculated in exactly 
the same way for each HLA locus as i t i s for the ABO system and n^ 
i s the number of individuals homozygous for the a l l e l e under 
consideration. The f i n a l value of r,the frequency of 'blank 1, 
i s calculated from 1 - p . 
Table 6.66 shows the gene frequencies for the present 
sample,those of the Newcastle population (Murray et al,1976) cannot 
be computed because n^ i s unknown. 
Prom these gene frequencies,haplotype frequencies are 
calculated i n d i r e c t l y . The value of delta,the linkage disequilibrium, 
for each pair of A and B locus a l l e l e s i s given by:-
Delta = / d_ - / (b+d) (c+d) 
V ^ V N X N 
where b,c and d are,respectively,the numbers of individuals 
possessing the f i r s t only,the second only and both s p e c i f i c i t i e s 
under consideration. This formula i s taken from Mattiuz et a l (1970). 
V/ith the valueof delta known for each combination,the 
haplotype frequency i s calculated from the formula:-
haplotype frequency = (p^ x p^) + delta 
where p^ and p^ are the gene frequencies of the A and 
B locus a l l e l e s under consideration. 
The calculation of haplotype frequencies i n t h i s manner 
Table 6.66 HLA gene frequencies,control subjects. 
Locus A l l e l e Frequency 
HLA-A1 0.1882 
HLA-A2 0.2884 
HLA-A3 0.1547 
A HLA-A9 0.0691 
HLA-A10 0.0585 
HLA-A11 0.0480 
Blank 0.1931 
HLA-B5 0.0507 
HLA-B7 0.1498 
HLA-B8 0.1611 
HLA-B12 0.1892 
HLA-B13 0.0199 
B 
HLA-B14 0.0367 
HU-B17 0.0381 
HLA-B27 0.0421 
HLA-Bwl5 0.0635 
Blank 0.2489 
has been shown t o agree w e l l w i t h d i r e c t assessment from the study 
of f a m i l y data.(Svejgaard. et al,197l). 
The gene frequencies thus calculated,and,therefore,the 
haplotype frequencies,are i n f l u e n c e d by the range of s p e c i f i c i t i e s 
t e s t e d f o r i n t h a t , t h e fewer the s p e c i f i c i t i e s considered,the g r e a t e r 
w i l l be the number of i n d i v i d u a l s regarded as homozygous f o r any one 
a l l e l e (n^) above,and the great e r w i l l be the frequency of the 'blank' 
a l l e l e . Consequently these gene frequency estimates may not be 
compared w i t h those of other samples which have been t e s t e d against 
a d i f f e r e n t range of a n t i s e r a . They are,of course,valid f o r i n t e r n a l 
comparisons i n t h i s study between sub-samples t e s t e d w i t h the same 
a n t i s e r a . For the r e s u l t s i n the c o n t r o l group see t a b l e 6.67. 
The phenotype frequencies show two possible d i f f e r e n c e s 
when the sexes are compared. Table 6.68 shows t h a t HLA-A10 and 
HLA-B5 frequencies f o r males and females. These d i f f e r e n c e s may 
j u s t be the consequence of the number of s p e c i f i c i t i e s t e s t e d f o r 
since they are n o n - s i g n i f i c a n t a f t e r m u l t i p l i c a t i o n of the p values 
by the number of comparisons made. 
Haplotype frequencies do not d i f f e r s i g n i f i c a n t l y 
between the sexes or between the d i f f e r e n t groups w i t h respect t o 
sex,area of o r i g i n or source. 
The r e l a t i o n s h i p of HLA phenotype frequencies t o age 
i s shown i n t a b l e 6.69. There are no obvious trends,except t h a t 
of HLA-B12 which appears t o increase i n frequency w i t h age,although 
t h i s t r e n d i s n o n - s i g n i f i c a n t (z = 1.498»P = 0.07).-
Table 6.70,6.71 and 6.72 show the numbers and frequencies 
of i n d i v i d u a l s i n the f o u r age groups who are p o s i t i v e f o r two 
s p e c i f i c i t i e s a t the A and B l o c i ( t a b l e s 6.70 and 6.7l) and f o r 
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Table 6.68 HLA a l l e l e s d i f f e r i n g i n frequency between the sexes. 
A l l e l e Males Females Chi sq. 
(d.f.=l) 
P 
HLA-A10 32 16 6.90 0.0086 
(15.7*) ( 7.2^) 
HLA-B5 13 30 5.14 0.0234 
( 6.4*) (13.5%) 
6.69 HLA phenotype frequencies of controls subdivided according 
to age. 
Locus A l l e l e Number and frequency ($) i n each age group 
0-19 20-39 40-59 60 and over 
n=69 n=90 n=115 n=153 
HLA-A1 50 20 38 59 
( 4 3 . 5 ) ( 2 2 . 2 ) ( 3 3 . 0 ) ( 3 8 . 6 ) 
HLA-A2 28 58 47 74 
( 4 0 . 6 ) ( 6 4 . 4 ) ( 4 0 . 9 ) ( 4 8 . 4 ) 
HLA-A3 18 30 31 43 
( 2 6 . 1 ) ( 3 3 . 3 ) ( 2 7 . 0 ) ( 2 8 . 1 ) 
HLA-A9 8 14 16 19 A ( 1 1 . 6 ) ( 1 5 . 6 ) ( 1 3 . 6 ) ( 1 2 . 4 ) 
HLA-A10 6 6 17 19 
( 8 . 7 ) ( 6 . 7 ) ( 1 4 . 8 ) ( 1 2 . 4 ) HLA-A11 9 7 11 13 
( 1 3 . 0 ) ( 7 . 8 ) ( 9 . 6 ) ( 8 . 5 ) 
Blank 2 1 7 4 
( 2 . 9 ) ( 1 . 1 ) ( 6 . 1 ) ( 2 . 6 ) 
HLA-B5 10 6 9 18 
(14.5) ( 6 . 7 ) ( 7 . 8 ) ( 1 1 . 8 ) 
HLA-B7 20 24 35 40 
( 2 9 . 0 ) ( 2 6 . 7 ) ( 3 0 . 4 ) ( 2 6 . 1 ) 
HLA-B8 27 18 32 49 
( 3 9 . 1 ) ( 2 0 . 0 ) ( 2 7 . 8 ) ( 3 2 . 0 ) 
HLA-B12 17 31 41 56 
( 2 4 . 6 ) ( 3 4 . 4 ) ( 3 5 . 7 ) ( 3 6 . 6 ) 
B HLA-B1J 3 5 6 3 
( 4 . 3 ) ( 5 . 6 ) ( 5 . 2 ) ( 2 . 0 ) 
HLA-B14 3 9 7 12 
( 4 . 3 ) ( 1 0 . 0 ) ( 6 . 1 ) ( 7 . 8 ) 
HLA-B17 5 9 6 12 
( 7 . 2 ) ( 1 0 . 0 ) ( 5 . 2 ) ( 7 . 8 ) 
HLA-B27 6 7 9 13 
( 8 . 7 ) ( 7 . 8 ) ( 7 . 8 ) ( 8 . 5 ) 
HLA-Bwl5 7 13 18 15 
( 1 0 . 1 ) ( 1 4 . 4 ) ( 1 5 . 7 ) ( 9 . 8 ) 
Blank 3 5 5 12 
( 4 . 3 ) ( 5 . 6 ) ( 4 . 3 ) ( 7 . 8 ) 
C HLA-Cw4 8 10 13 17 
( 1 7 . 4 ) ( 1 2 . 3 ) ( 1 2 . 0 ) ( 1 2 . 3 ) 
(n - 4 6 ) (n= 8 l ) (n=108) (n=138) 
Table 6.70 Number of s p e c i f i c i t i e s detected at the HLA-A locus i n 
controls subdivided by age. 
No. of s p e c i f i c i t i e s 
detected at A locus 
Number & frequency (*) i n each group 
0-19 20-39 40-59 60 and over 
0 or 1 
2 
35 43 56 71 
(50.7) (47.8) (48.7) (46.4) 
34 47 59 82 
(49.3) (52.2) (51.3) (53.6) 
Totals 69 90 115 153 
Z = 0.488 (p = 0.31) 
Table 6.71 Number of s p e c i f i c i t i e s detected at the HLA-B locus i n 
controls subdivided by age. 
No. of s p e c i f i c i t i e s 
detected at B locus 
Number &, frequency (*) i n each group 
0-19 20-39 40-59 60 and over 
0 or 1 
2 
34 42 52 58 
(49.3) (46.7) (45.2) (37.9) 
35 48 63 95 
(50.7) (53.3) (54.8) (62.1) 
Totals 69 90 115 153 
Z = 1.687 (p = 0.05) 
/our s p e c i f i c i t i e s (table 6.72) at the two l o c i considered together. 
There i s a signifi c a n t trend for increase i n the frequency of hetero-
zygotes at the B locus with increasing age. This accords with the 
findings of Gerkins et a l (1974) i n suggesting that heterozygosity 
at t h i s locus i s associated with s u r v i v a l . 
There are no si g n i f i c a n t trends of haplotype frequencies 
with age. 
6.17 Summary and discussion. 
The analysis presented i n th i s chapter suggests a relationship 
with age i n the distribution of phenotypes of the Rhesus,MNSs,acid 
phosphatase,phosphoglucomutase and HLA polymorphisms. 
The data suggest that,in the Rhesus system,the d phenotype 
i s at a sel e c t i v e advantage i n that individuals of t h i s type make up 
a greater proportion of the older age groups than they do of the 
younger age groups. The ef f e c t s of sex ratio,area of bi r t h e t c. have 
been examined and found not to explain these r e s u l t s . Short of the 
polymorphism changing i n i t s composition rapidly i n these generations 
studied,the most l i k e l y conclusion i s some d i f f e r e n t i a l mortality with 
regard to the phenotypes i n t h i s system. 
S i m i l a r l y , i n the MNSs system,where the Ss heterozygote, 
and,consequently,the MNSs double heterozygote,seems s e l e c t i v e l y 
favoured,in the red c e l l acid phosphatase system,where the A phenotype 
i s at an advantage,the heterozygote i n the acid phosphatase system 
and the heterozygote at the HLA-B locus. 
These findings have two c o r o l l a r i e s - f i r s t l y that 
disease associations with the above systems must e x i s t and should be 
sought. An association between the MNSs system and breast cancer 
Table 6.72 Number of s p e c i f i c i t i e s detected at the HLA-A and HLA-B 
l o c i i n controls subdivided by age. 
No. of s p e c i f i c i t i e s 
detected at A & B l o c i 
Number & frequency ($) i n each group 
0-19 20-39 40-59 60 and over 
1,2 or 3 55 69 87 107 
(79.7) (76.7) (75.7) (69.9) 
4 14 21 28 46 
(20.3) (23.3) (24.3) (30.1) 
Totals 69 90 115 153 
Z = 1.594 (p = 0.06) 
has been suggested (Lancet,1971) and challenged (Morosini et al,1972) 
but t h i s association alone seems unlikely to explain the present 
findings. For the other systems mentioned above i t i s only i n the 
case of HLA that an association between longevity and heterozygosity 
has been suggested (Bender et al,1972,and Gerkins et al,1974)« 
The second corollary from these findings i s that any 
investigation which sets out to identify the mechanisms involved 
i n t h i s d i f f e r e n t i a l mortality must take age into account by matching 
diseased and control populations. 
Other systems suggest an association between heterozygosity 
and longevity though the numbers of individuals collected here are 
i n s u f f i c i e n t for s t a t i s t i c a l significance. I n the K e l l system,for 
example,the frequency of the heterozygote,Kk i s greater amongst older 
individuals. 
fo-Wo. 6.73 shows the relationship between age and hetero-
zygosity at s i x of the l o c i studied. These are MN,Ss,Kell,Kp ,HLA-A 
and HLA-B. The number of individuals typed for a l l s i x of these l o c i 
i s few but the r e s u l t s suggest that,in the older age groups,there are 
more individuals who are heterozygous at a greater number of these 
l o c i than in the younger groups. 
The relationship between heterosis and longevity requires 
careful study with a large cohort of new-born infants studied for 
a large number of l o c i and followed up for as long as i s practicable. 
Table 6.73 Heterozygosity at s i x l o c i (MN,Ss,Kell,Kpa,HLA-A and HLA-B) 
in controls subdivided by age. 
No. of l o c i at which 
individual i s 
heterozygous 
Number & frequency ($) i n each group 
0-19 20-39 40-59 60 and over 
1 3 7 7 4 
(11.5) (18.9) (17.D ( 8.2) 
2 15 12 19 18 
(57.7) (32.4) (46.3) (36.7) 
3 6 15 12 18 
(23.1) (40.5) (29.3) (36.7) 
4 2 3 3 7 
( 7.7) ( 8.1) ( 7.3) (14.3) 
5 0 0 0 2 
( 4.D 
Totals 26 37 41 49 
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7.2 The ABO system. 
(a) Group A subdivided. 
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. 7.16 Summary and discussion. 
7.1 Introduction. 
In the analysis of genetic polymorphism data from 
diabetic and non-diabetic populations many comparisons are possible 
depending on the ways i n which the groups are subdivided. The data 
for a l l possible comparisons i s not given here,to do so would have 
made t h i s chapter prohibitively long,but,following the example of 
the previous chapter,all possible comparisons are mentioned and,in 
general,data are given where si g n i f i c a n t differences have been found. 
The diabetic sample has been investigated for the effect 
of the following factors on each polymorphic system:- sex,area of 
origin (by county of the subject's b i r t h and by county of grand-
parental b i r t h as i n controls),current treatment,current age and 
age at diagnosis. The relationship between phenotype and month of 
diagnosis i s explored i n the following chapter. Regarding 
treatment,if no si g n i f i c a n t differences are found between o r a l -
hypoglycaemic-treated diabetics and diet-managed diabetics,these 
are amalgamated as non-insulin-taking diabetics for comparison 
with insulin-taking diabetics and controls. For systems i n which 
phenotype frequencies,in both controls and diabetics,show no 
relationship to age,comparisons are made without matching for age. 
For systems i n which an age effe c t , e i t h e r i n diabetics or i n controls, 
or both,has been demonstrated,diabetics and controls of comparable 
age are contrasted-
S t a t i s t i c a l comparison of diseased and control groups 
i s mostly by means of conventional chi squared t e s t s , r e l a t i v e 
incidence and chi squared by Woolf's method have been calculated 
where appropriate. The test for significance of trends i n 
proportions,described i n chapter 6,is also used. I n general,in t h i s 
chapter,the values of chi squared are not given unless significance i s 
reached at p = 0.05. 
7.2 The ABO system. 
(a) Group A subdivided. 
There are no si g n i f i c a n t differences i n the A^,A2,B, 
0,AjB and A^B frequencies i n diabetics with regard to sex or area 
of origin. Oral hypoglycaemic-treated diabetics and diet-treated 
diabetics are not s i g n i f i c a n t l y different,consequently,they have 
been amalgamated as non-insulin-taking diabetics. The phenotype 
frequencies for insulin-taking diabetics,non-insulin-taking diabetics 
the entire diabetic sample and the entire control sample are given 
i n table 7.1 with corresponding gene frequencies i n table 7.2. The 
gene frequencies are calculated i n the manner described i n the 
previous chapter. 
The frequency of group A^ individuals i s higher i n 
both insulin-taking diabetics and non-insulin-taking diabetics 
than i t i s i n controls. The r e l a t i v e incidences (A^/o),together 
with the chi squared values (Woolf's method) are given i n table 7.3* 
The r e l a t i v e incidence i s not s i g n i f i c a n t l y different 
from unity i n t h i s sample for the insulin-taking diabetics nor 
for the diabetic group as a whole,though i t i s for the non-insulin-
taking diabetics. 
ABO phenotype frequencies for diabetics subdivided 
into 20 year age groups i s given i n table 7.4* Although there 
are no s i g n i f i c a n t differences between these age groups and there 
i s no s i g n i f i c a n t trend of these frequencies with age,the data are 
given i n f u l l since they are pertinent to the argument which 
follows. 
Tables 7.5»7.6 and 7.7 show the comparisons between 
( d i a b e t i c s , i r r e s p e c t i v e of treatment,and controls for three age 
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Table 7 . 3 Relative incidence ( /O) i n diabetics and controls. 
Diabetics 
Group 
Relative incidence 
(x) 
Chi squared 
(wy 2)d.f=l 
P. 
I n s u l i n -
taking 1 . 1 3 0 . 4 5 6 5 < 0 . 5 0 > 0 . 4 0 
Non-insulin 
taking 1 . 3 7 4 . 9 1 5 9 < 0 . 0 5 > 0 . 0 2 5 
A l l 1 . 2 9 3 . 8 0 0 0 < 0 . 1 0 > 0 . 0 5 
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, groups,the two younger age groups i n table 7«4 having been 
amalgamated. The r e l a t i v e incidences (A J / O),together with the 
chi squared values f o r these age-specific comparisons are shown 
i n table 7 . 8 . 
I t i s evident from t h i s table that i t i s amongst the 
older subjects that the differences between diabetics and controls 
with regard to frequencies of A ^ lie,although i t i s not immediately 
apparent whether t h i s i s the result solely of current age (or age 
at diagnosis) or owing to the predominance of non-insulin-taking 
diabetics amongst t h i s older group. 
There i s no relationship between age at diagnosis and 
A B O phenotype w i t h i n the diabetic sample although i t i s amongst 
those diagnosed a f t e r the age of 60 that s i g n i f i c a n t deviations 
from the control frequencies may be detected. 
The biological significance of these apparent associations 
w i l l be discussed at the end of the next section. 
(b) Without subdivision of group A . 
Consideration of the A B O system without subdivision of 
group A enables a large sample of donors from the same region to be 
used f o r comparison (Kopec,1970). The A , B , 0 and A B phenotype 
frequencies f o r t h i s sample of donors,the present control sample and 
the diabetic samples are shown i n table 7«9»with the corresponding 
gene frequencies i n table 7.10. 
The excess of group A i s again confined to non-insulin-
taking diabetics,the r e l a t i v e incidences,together with the chi 
squared values,are given i n table 7»H(a) f o r the comparison with 
the present control sample,and 7«ll(h) f o r the comparison with the 
Table 7.8 Relative incidences ( /O) i n diabetics and subdivided 
by current age. 
Age group Relative incidence 
A l / 0 ( x ) 
Chi squared 
<d.f.=1) 
P. 
0-39 1.00 0 -
40-59 1.04 0.0239 <0.90>0.80 
60 and 
over 1.69 6.1627 <0.025>0.01 
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Table 7 .11(a) Relative incidences (A/0) in diabetics and 
controls from present study. 
Group of Relative incidence Chi squared 
diabetics (A/0) (x) (d.f.=1) P. 
I n s u l i n -
taking 1.09 0.25 <0.70>0.60 
Non-insulin 
taking 1.33 4.47 <0.05>0.025 
A l l 1.25 3.24 <0.10>0.05 
Table 7.11(b) Relative incidence (A/0) i n diabetics and donor 
controls (kopec, 1970) from the same region. 
Diabetic Relative incidence Chi squared n 
group (A/0) (x) (d.f.=1) r 
I n s u l i n -
taking 1.07 0.21 <0.70>0.60 
Non-insulin 
taking 1.31 7.18 <0.01>0.005 
A l l 1.23 5.86 <0.25>0.01 
donor controls. For insulin-taking diabetes,the r e l a t i v e incidence 
does not d i f f e r s i g n i f i c a n t l y from unity either compared with the 
present control sample or the donor controls. I n both comparisons 
non-insulin-taking diabetics have a s i g n i f i c a n t l y higher A/0 r a t i o 
than controls. V/ith consideration of the entire diabetic group, 
the r a t i o i s s i g n i f i c a n t l y raised only when comparison i s made with 
the numerically larger donor control group. 
Consideration of current age when group A i s not sub-
divided gives a similar r e s u l t to that given f o r A^ frequencies. 
The r e l a t i v e incidences (A/0) and t h e i r chi squared values are 
given i n table 7.12. Data f o r the calculation of these incidences 
may be obtained by appropriate amalgamation of the categories given 
i n tables 7•5»7•6 and 7«7. Similar consideration using the donor 
controls i s not possible since they are not subdivided with regard 
to current age. 
The numbers of individuals i n the samples i s 
i n s u f f i c i e n t to reveal whether the apparent association i s with 
the A^  group or with A. The r e l a t i v e incidence (A^/o) i s greater 
than that f o r (A / O ) and t h i s may si g n i f y that the differences between 
diabetics and controls l i e s i n the frequency of A^ rather than A. 
Prom the information collected i n t h i s study i t i s not 
possible to determine categorically whether the excess of group A^  
(or A) amongst the older diabetics i s primarily the resul t of t h e i r 
age,age at diagnosis or of the fact that they are mostly non-insulin-
taking diabetics. An indication that i t may be age,rather than 
treatment,is given by the fact that the A^/0 r e l a t i v e incidence i n 
insulin-taking diabetics currently aged 60 or above compared with 
Table 7.12 Relative incidences (A/0) i n diabetics and controls 
matched for age. 
Age group Relative incidence 
(A/0) 
Chi squared 
(d.f.=1 P. 
0-39 0.94 0.06 <0.80>0.70 
40-59 1.08 0.10 <0.80>0.70 
60 and 
over 1.58 5.29 <0.025>0.010 
.controls of the same age i s 1.35» This i s not demonstrably 
d i f f e r e n t from unity with t h i s small sample,however,there are only 
52 diabetics i n t h i s category,17 of group and 23 of group 0. A 
similar indication i s given by an A^/0 r a t i o of 1.06 f o r the non-
i n s u l i n - taking diabetics between the ages of 40 and 59 compared 
with controls of the same age. This i s s t a t i s t i c a l l y indistinguishable 
from unity,though again,the sample i s small (104 diabetics,44 of group 
A.^60 of group 0). 
On the basis of the resulta presented here i t i s 
apparent that diabetics,either non-insulin-taking or late-onset, 
have a higher frequency of A^ than a comparable sample of controls. 
This i s not necessarily evidence that individuals of t h i s blood 
group are genetically more susceptible to t h i s disease,on the 
contrary,it i s suggested that t h i s excess of A^ individuals may be 
a spurious association which i s the res u l t of d i f f e r e n t i a l mortality 
amongst non-diabetics with respect to the ABO phenotype and lack of 
th i s d i f f e r e n t i a l mortality i n diabetics. 
The studies of Jorgensen and Schwartz (1968) and van 
Houte and Kesteloot (1972) discussed i n chapter 2 have suggested 
that older individuals have lower frequencies of the A blood group 
(they did not sub-type f o r A^) than do younger age groups. This 
tendency,which i s best explained by greater mortality rates amongst 
A persons than amongst 0 persons i n certain age groups i s suggested 
by the control data presented here although the differences are not 
si g n i f i c a n t . The reduction i n the A^  frequency amongst older 
controls i s not seen i n the older diabetics and i t i s here that the 
sign i f i c a n t differences between diabetics and non-diabetics occur. 
This i s explained,either by suggesting that the disease processes 
'causing t h i s d i f f e r e n t i a l m o r t a l i t y are non-operational i n diabetics 
or,more plausibly,that that they are occurring and are such an 
int e g r a l part of the diabetic state that they are causing death 
independently of the ABO phenotype of the i n d i v i d u a l . 
I f , a s van Houte and Kesteloot (1972) suggest,the 
d i f f e r e n t i a l mortality i n non-diabetics i s , a t least partly,the 
re s u l t of coronary artery disease,this would explain the recurrent 
f i n d i n g by previous authors of a greater A/0 r e l a t i v e incidence i n 
male diabetics than i n female diabetics. The loss of A individuals 
i n older non-diabetic males should be proportionally greater than 
that i n females giving a greater difference between elderly male 
diabetics and male controls than between elderly female diabetics 
and female controls* This sex difference i s bourne out i n the present 
study with a higher value of the A^ /O r e l a t i v e incidence i n males 
than i n females (tables 7*13 a ^ d 7«14)« The greatest difference of 
a l l l i e s between male diabetics and male controls when both groups 
are over 60 years of age. 
7.3 The MNSs system. 
(a) The MM locus. 
Diabetics show no si g n i f i c a n t differences with regard to 
sex i n the phenotype frequencies at the MN locus,neither do they 
show differences with regard to area of o r i g i n . Table 7-15 shows 
the phenotype frequencies f o r t h i s locus f o r the entire diabetic 
sample,insulin-taking diabetics,non-insulin-taking diabetics (there 
being no differences between oral-hypoglycaemic-treated and d i e t -
managed diabetics) and the entire control sample. Since no 
differences with regard to age could be demonstrated i n the diabetic 
Table 7.13 A^ and 0 phenotype f r e q u e n c i e s i n d i a b e t i c s and c o n t r o l s 
sub-divided by sex. 
Group D i a b e t i c s C o n t r o l s 
Males Females Males Females 
A l 
117 145 80 81 
(37.3%) (35.6%) (29.9%) (32.8%) 
0 141 180 135 120 
(44.9%) (44.2%) (50.4%) (48.6%) 
T o t a l s 314 407 268 247 
Table 7.14 R e l a t i v e i n c i d e n c e ( /0) i n male and female d i a b e t i c s 
compared w i t h male and female c o n t r o l s . 
Sex R e l a t i v e i n c i d e n c e Ch i squared 
(d.f.=1) 
Male 1.40 3.18 <0.10>0.05 
Female 1.19 0.22 <0.70>0.60 
Table 7.15 
Results f o r the MN locus,diabetics and controls. 
Phenotype Number and frequency <*) 
Diabetics (3) A l l (4) A l l 
( l ) Ins.-taking (2) Non-ins.-taking Diabetics Controls 
M 63 128 191 136 
(27.9) (27.1) (27.3) (26.5) 
MN 117 257 374 266 
(51.8) (54.3) (53.5) (51.8) 
N 46 88 134 86 
(20.4) (18.6) (19.2) (16.7) 
Totals 226 473 699 488 
Table 7.16 MN gene frequencies,diabetics and controls. 
Gene Frequencies (+S.E.) 
Diabetics A l l A l l 
Ins.-taking Non-ins.-taking Diabetics Controls 
M 0.5376 0.5423 
(+.033) (+.023) 
0.5408 
(+.019) 
0.5512 
(+.023) 
N O.4624 0.4577 0.4592 0.4488 
sample.age matching has not been taken i n t o account. Gene frequencies 
f o r these samples are given i n table 7»l6. 
There are no si g n i f i c a n t differences between diabetics 
and controls and there are no differences between insulin-taking 
diabetics and non-insulin-taking diabetics. 
(b) The Ss locus. 
Tests with anti-S were performed on samples from 684 
diabetic individuals. No differences were found with regard to 
sex,area of origin,current age or age at diagnosis. There are no 
sig n i f i c a n t differences amongst the diabetics with regard to treatment 
and the phenotype frequencies of diabetics do not d i f f e r from those 
i n controls. These frequencies are set out i n table 7»17« 
Of the 684 individuals tested with anti-S,232 were also 
tested with a n t i - s . There were no detectable differences with 
regard to sex or area of o r i g i n but the same trend with regard to 
current age was found i n diabetics as i n controls. Table 7*18 
shows how the frequencies of heterozygotes increases with increasing 
age at the expense of the frequency of ss homozygotes. These trends 
have been tested f o r significance by the same method as was used i n 
chapter 6. The mean age of ss_ homozygotes i s s i g n i f i c a n t l y less 
than that of the heterozygotes. 
Tables 7.19 and 7»20 show Ss locus phenotype frequencies 
f o r insulin-taking and non-insulin-taking diabetics,together with 
age-matched controls. There are no s i g n i f i c a n t differences between 
diabetic and control groups,nor between the insulin-taking diabetics 
and the non-insulin-taking diabetics. Tables 7.21 and 7.22 show the 
Table 7.17 Results f o r diabetics and controls tested with anti-S. 
Phenotype Number and frequency (#) 
Diabetics (3) A l l (4) A l l 
( l ) Ins.-taking (2) Non-ins.-taking Diabetics Controls 
S+ve 105 256 361 209 
(48.2) (54.9) (52.8) (52.3) 
S-ve 113 210 323 191 
(51.8) (45.1) (47.2) (47.7) 
Totals 218 466 684 400 
Table 7.18 Ss phenotype results f o r diabetics subdivided according 
to age and irrespective of treatment. 
Phenotype Number and frequency i n each age group 
0 - 1 9 20 - 39 40 - 59 60 and over 
S 5 4 23 24 
(18 .5) ( 8.9) (19.0) (10.3) 
Ss 6 12 47 104 
(22.2) (26.7) (38.8) (44.8) 
s 16 29 51 104 
(59.3) (64.4) (42.1) (44.8) 
Totals 27 45 121 232 
Z (heterozygotes vs. rest) = 2.931 (p = .0017) 
Z (s homozygotes vs. rest) = 2.061 (p = .0197) 
Mean age of S individuals = 55.82 (+2 .5) years 
Mean age of Ss individuals = 60.01 (+1.2) years 
Mean age of s individuals = 54.59 (+1.4) years 
Table 7.19 Results f o r the Ss locus,diabetics and controls aged 0-45. 
Phenotype Number and frequency ($) 
Diabetics (3) (4) 
( l ) Ins.-taking (2) Non-ins.-taking Diabetics Controls 
S 8 3 11 14 
(10.4) (15.8) (11.5) (10.6) 
Ss 23 6 29 51 
(29.9) (31-6) (30.2) (38.6) 
s 46 10 56 67 
(59.7) (52.6) (58.3) (50.8) 
Totals 77 19 96 132 
Table 7.20 Results f o r the Ss locus,diabetics and controls aged 45 
and over. 
Phenotype Number and frequency (*) 
Diabetics (3) (4) 
( l ) Ins.-taking (2) Non-ins.-taking Diabetics Controls 
S 10 35 45 15 
(15.1) (13.3) (13.7) (10.6) 
Ss 23 117 140 66 
(34.9) (44.5) (42.5) (46.8) 
s 33 111 144 60 
(50.0) (42.2) (43.8) (42.5) 
Totals 66 263 329 141 
Table 7*21 Ss locus gene frequencies,diabetics and controls aged 
0 - 45. 
Gene Frequencies (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking Diabetics 
S 0.2532 0.3158 0.2656 0.2992 
(+.049) (+.229) (+.045) (+.040) 
0.7468 0.6842 0.7344 0.7008 
Table 7.22 Ss locus gene frequencies,diabetics and controls aged 
45 and over. 
Gene Frequencies (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking Diabetics 
S 0.3258 0.3555 0.3495 O.34O4 
(+.058) (+.030) (+.026) (+.040) 
8 0.6742 0.6445 0.6505 0.6596 
corresponding gene frequencies. 
(c) The MNSs complex. 
Table 7.23 shows the phenotype frequencies f o r the 662 
diabetic individuals tested with anti-M,anti-N and anti-S,together 
with the data f o r controls. There are no s i g n i f i c a n t differences 
revealed. 
When the results from the 454 diabetics tested with 
anti-M,anti-N,anti-S and anti-s are examined f o r age trends (table 
7.24(a)),a s i g n i f i c a n t upward trend of the frequency of the double 
heterozygote i s seen. This was suggested i n the control sample but 
was non-significant. This r e s u l t i s hardly surprising considering 
the si t u a t i o n already described i n the Ss locus alone. Table 7.24 
(b) and 7.24(c) show the phenotype frequencies f o r diabetics and 
age-matched controls. No significant differences can be demonstrated. 
7.4 The P system. 
For reasons given i n the previous chapter,resuits f o r 
the P system are given as positive or negative reactions with e n t i -
re antiserum without grading of the strength of agglutination of 
the positives. Amongst the 718 diabetics tested with t h i s a n t i -
serum, there were no s i g n i f i c a n t differences with regard to sex or 
area of o r i g i n and oral-hypoglycaemic-treated diabetics were 
indistinguishable from diet-treated diabetics. The phenotype 
frequencies f o r the entire diabetic group and f o r t h i s group sub-
divided by current treatment are given i n table 7.25 together with 
the results f o r the entire control sample. Gene frequencies are 
given i n table 7.26. Since there are no s i g n i f i c a n t age differences 
Table 7.23 Results f o r diabetics and controls tested with anti-M, 
anti-N and anti-S. 
Phenotype No. & frequency (%) 
Diabetics Controls 
MS 120 67 
(18 .1) (17.4) 
MNS 197 121 
(29.8) (31.3) 
NS 32 17 
( 4.8) ( 4.4) 
Ms 63 37 
( 9.5) ( 9.6) 
MNs 155 97 
(23.4) (25.D 
Ns 95 47 
(14.4) (12.2) 
Totals 662 386 
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Table 7.24(b) Phenotype frequencies f o r diabetics (irrespective of 
treatment) and controls tested with anti-M,anti-N, 
anti-S and anti- s . Individuals aged under 40. 
Phenotype Number and frequency ($) 
Diabetics Controls 
MS 4 ( 5.6) 7 ( 5.7) 
MSs 7 ( 9.9) 10 ( 8.1) 
Ms 10 (14.1) 14 (11.3) 
MNS 5 ( 7.0) 7 ( 5.6) 
MNSs 10 (14.I) 34 (27.4) 
MNs 23 (32.4) 35 (28 .2) 
NS 0 0 
NSs 1 ( 1.4) 2 ( 1.6) 
Ns 11 (15.5) 15 (12.1) 
Totals 71 124 
Table 7.24(c) Phenotype frequencies f o r diabetics (irrespective of 
treatment) and controls tested with anti-M,anti-N, 
anti-S and anti- s . Individuals aged 40 and over. 
Phenotype Number and frequency {"/<>) 
Diabetics Controls 
MS 20 ( 5.7) 9 ( 6.1) 
MSs 44 (12.5) 20 (13.6) 
Ms 34 ( 9.6) 12 ( 8.2) 
MNS 25 ( 7.1) 5 ( 3.4) 
MNSs 92 (26.1) 46 (31.3) 
MNs 73 (20.7) 31 (21.1) 
NS 2 ( 0.5) 1 ( 0.7) 
NSs 15 ( 4.2) 5 ( 3.4) 
Ns 48 (13.6) 18 (12.2) 
Totals 353 147 
Table 7.25 Results f o r diabetics and controls tested with anti-P. 
Phenotype Number and frequency (%) 
Diabetics (3) A l l (4) A l l 
( l ) Ins.-taking (2) Non-ins.-taking Diabetics Controls 
-ve 22 61 83 128 
( 9.6) (12.4) (11.6) (25.1) 
+ve 206 429 635 381 
(90.4) (87.6) (88.4) (74.9) 
Totals 228 490 718 509 
Chi squared ( ( l ) vs. (4)) = 23.33 (d.f. = l ) p < 0.001 
Chi squared ((2) vs. (4)) = 26.23 (d.f. = l ) p 0.001 
Chi squared ((3) vs. (4)) = 38.61 (d.f. = l ) p <. 0.001 
Chi squared ( ( l ) vs. (2)) = 1.19 (d.f. = l ) N.S. 
Table 7.26 Gene frequency results f o r the P system,diabetics and 
controls. 
Gene Frequencies (+S.E.) 
Diabetics A l l A l l 
. t - . i i 0 • ~ V t U V X l l g W « w > _ , 4- r - i n y\ ri> 4.1 V l l = J . i l O • = Uc*n--*-I*g W W I I U J . w x 0 
P l 0.6894 0.6472 0.6600 0.4985 
(+.031) (+.022) (+.018) (+.022) 
P 2 +P 0.3106 0.3528 0.3400 0.5015 
amongst diabetics,comparisons are made without matching f o r age. 
There i s no si g n i f i c a n t difference between the two 
diabetic sub-groups but both of these groups are s i g n i f i c a n t l y 
d i f f e r e n t from the controls,as i s the diabetic group as a whole,with 
a lower frequency of anti-P^ negative individuals amongst the 
diabetics. The rel a t i v e incidences (anti-P^ +ve/anti-P^ -ve) 
i n insulin-taking and non-insulin-taking diabetics compared with 
controls are 3.15 (chi squared = 21.67,p<0.0005) and 2.36 (chi 
squared = 25.28,p <• O.OOO5) respectively with a re l a t i v e incidence 
of 2.57 (chi squared = 37.03,p-«0.0005) i n the diabetic group 
taken as a whole. 
This apparent association with the P system i s e n t i r e l y 
spurious and i s the res u l t of deterioration i n the strength of the 
anti-P^ antiserum with time. The diabetic samples were obtained 
towards the beginning of the project and no control samples at a l l 
were obtained u n t i l about 25O diabetics had been studied. Prom 
t h i s p o i n t , u n t i l about the eight hundredth sample,diabetics and 
controls were obtained i n approximately equal numbers but,from 
there on,the specimens were mostly from non-diabetics. As a 
consequence,diabetics were tested with predominantly fresher 
antiserum than controls and the excess of positive reactions i n 
the former group can be at t r i b u t e d e n t i r e l y to t h i s . Table 7.27 
shows the relationship between the P phenotype and the series sample 
number i n diabetics. 
7.5 The Rhesus system. 
(a) Phenotype frequencies considering the three loci.CD and E. 
No sex differences can be detected i n the phenotype 
Table 7.27 Relationship of reaction with anti-P, to number of 
specimen,diabetics and controls. 
Reaction Number and frequency ($) 
with Nos. 1-249* Nos. 250-499 Nos. 500-649 Nos. 750 & over 
ant-P-^ 
+ve 223 (97.8) 150 (88.8) 137 (87.3) 125 (76.2) 
-ve 5 ( 2.2) 19 (H . 2 ) 20 (12.7) 39 (23.8) 
Totals 228 169 157 I64 
* Number refers to i d e n t i f i c a t i o n number of specimen i n series, 
collected chronologically from number 1. 
frequencies f o r t h i s system i n diabetics. Similarly,there are no 
sig n i f i c a n t differences with regard to area of o r i g i n . The age 
trends found i n non-diabetics were discussed i n chapter 6 and 
cannot be demonstrated i n the diabetic population. Since these 
age differences were present i n controls,however,comparisons are 
made between age-matched groups of individuals. 
Tables 7,28,7.29 and 7.30 show the phenotype frequencies 
i n diabetics and controls f o r the three age groups 0 - 3 9 years, 
40 - 59 years and 60 years and over. Tables 7*31»7.32 and 7.33 
give,for each of these age groups,the haplotype frequencies 
calculated by means of the maximum li k e l i h o o d computer programme. 
Oral-hypoglycaemic-treated diabetics do not d i f f e r 
s i g n i f i c a n t l y from diet-managed diabetics and the two groups have 
been amalgamated. There are too few of these non-insulin-taking 
diabetics i n the youngest age group to treat as a separate sample. 
Several of the less common s p e c i f i c i t i e s (probable 
genotypes R^R^r* 'r,r*r,R,,R,,,R,,r and R 0£) have been amalgamated 
f o r the calculation of chi squared. No sig n i f i c a n t differences 
are demonstrated i n any age group between insulin-taking diabetics 
and non-insulin-taking diabetics nor between either of these sub-
groups and the control group. There i s no si g n i f i c a n t difference 
i n any age-specific comparison between the t o t a l diabetic group 
and the control groups 
As discussed i n chapter 2,there have been c o n f l i c t i n g 
results i n the comparison of rhesus results from diabetic and 
control populations. The studies of Berg et a l (l967),Scholz et 
a l (1975) and Buckwalter and Tweed (1964) finding associations 
,with d i f f e r e n t haplotypes (Berg et a l and Scholz et a l ) or no 
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Table 7 .31 Rhesus haplotype frequencies i n diabetics and controls, 
aged under 40 years. 
Haplotype Diabetics Controls 
Ins.-taking A l l 
r 0.3725 O.3696 0 .3545 
r ' 0 0 O.OO64 
r " 0.0161 0 .0139 0 
0.0051 0 .0043 O.OO46 
Ro 0 0 O.OO63 
R l 0.4796 0 .4783 0 .4730 
R 2 0.1267 0 .1339 0.1552 
R 
z 
0 0 0 
3VI 
Table 7 .32 Rhesus haplotype frequencies i n diabetics and controls 
aged 40 - 59. 
Haplotype Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
r 0.3458 0.3846 0.3691 0 .4258 
r ' 0.0167 0 O.OO64 0.0180 
r " 0 0 0 0 
0 .0127 0.0078 0.0097 0 .0039 
R 
0 0.0275 
0.0099 0.0173 0 .0117 
R l 0.4453 O.4648 0 .4574 0 .3805 
R 2 0.1519 
0 .1328 0.1401 0.1602 
R 
z 
0. 0 0 0 
Table 7.33 Rhesus haplotype frequencies i n diabetics and controls 
aged 60 and over. 
Haplotype Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
r 0.3193 0.4056 0.3939 0.4487 
r 1 0 0.0107 O.OO95 0.0130 
r " 0 0 0 0.0129 
0 0.0029 0.0025 0 
Ro 0.0173 0.0034 0.0057 0.0126 
R l 0.4423 0.4286 0.4302 0.3858 
R 2 0.2211 0.1488 O.1583 0.1270 
R 
z 
0 0 0 0 
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. association at a l l (Buckwalter and Tweed). I t i s suggested that 
these c o n f l i c t i n g r e s u l t s have arisen by comparisons with control 
populations of different age structures with consequent variations 
i n haplotype frequencies. 
(b) Separate consideration of the C,D and E l o c i . 
The r e s u l t s for the C,D and E l o c i considered separately 
are given for the same age subdivisions i n tables 7.34 to 7.48. 
No si g n i f i c a n t differences can be detected either between the 
treatment sub-groups of the diabetics,between these sub-groups and 
controls nor between the diabetic groups as a whole and the 
controls. 
7.6 The K e l l system. 
(a) Tests with anti-K and anti-k. 
There are no s i g n i f i c a n t differences between the sexes 
for K e l l locus phenotypes. Similarly,area of origin,current age 
and age at diagnosis have no s i g n i f i c a n t e f f e c t . The r e s u l t s for 
insulin-taking and non-insulin-taking diabetics are given i n table 
7.49 together with those for the entire diabetic population and the 
controls. The K and Kk phenotypes have been amalgamated for the 
calculation of chi squared and the te s t s show no s i g n i f i c a n t 
differences either between the diabetics and the control group, 
within the diabetic group with regard to current treatment or 
between these treatment sub-groups and the controls. Gene 
frequency r e s u l t s for t h i s locus are given i n table 7.50* 
1.4.0 
Table 7»34 C locus phenotype frequencies for diabetics and controls 
aged under 40. 
Phenotype Number and frequency (*) 
Diabetics (3) Controls 
( l ) Ins.-taking (2) A l l 
C 24 27 45 
(24.5) (23.5) (20.5) 
Cc 47 57 122 
(48.0) (49.6) (55.7) 
c 27 31 52 
(27.5) (26.9) (23.7) 
Totals 98 115 219 
Table 7.35 C locus gene frequencies for diabetics and controls 
aged under 40. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking A l l 
_c 0.4847 0.4826 O.484O 
(+.051) (+.047) (+.034) 
_c 0.5153 0.5174 0.5159 
341 
Table 7.36 D locus phenotype frequencies for diabetics and control 
aged under 40. 
Phenotype Number and frequency (%) 
Diabetics (3) Controls 
( l ) Ins.-taking (2) A l l 
d 17 20 29 
(17.3) (17.4) (13.2) 
D 81 95 190 
(82.7) (82.6) (86.8) 
Totals 98 115 219 
Table 7-37 E locus phenotype frequencies for diabetics and controls 
aged under 40. 
Phenotype Number and frequency ($) 
Diabetics (3) Controls 
( l ) Ins.-taking (2) A l l 
£ 3 3 5 
( 3.0) ( 2.6) ( 2.3) 
Ee 23 29 60 
(23.5) (25.2) (27.4) 
e 72 83 154 
(73.5) (72.2) (70.3) 
Totals 98 115 219 
Table 7«38 E locus gene frequencies for diabetics and control 
aged under 40. 
Gene Pre quency (+S.E.) 
Diabetics Controls 
Ins.-taking A l l 
J . 0.1479 0.1522 0.1598 
(+.036) (+.033) (+.025) 
0.8521 0.8478 0.8402 
34.3. 
Table 7.39 C locus phenotype frequencies for diabetics and controls 
aged 40-59. 
Phenotype Number and frequency ($) 
Diabetics (3) (4) 
( l ) Ins-taking (2) Non-ins.-taking Diabetics Controls 
C 19 26 45 17 
(24.1) (20.3) (21.7) (13 .3) 
Cc 37 69 106 69 
(46.8) (53.9) (51 .2) (53.9) 
c 23 33 56 42 
(29.1) (27 .8) (27 .1) (32 .8) 
Totals 79 128 207 128 
Table 7.40 C locus gene frequencies,diabetics and controls 
aged 40-59. 
Gene Frequencies (+S.E.) 
Controls Diabetics 
Diabetics Ins.-taking Non-ins.-taking 
C 0.4747 0.4727 0.4734 0.4023 
(+.056) (+.044) (+.035) (+.043) 
£ 0.5253 0.5273 0.5266 0.5977 
34-4-
Table 7.41 D locus phenotype frequencies for diabetics and controls 
aged 40-59. 
Phenotype Number and frequency ($) 
Diabetics (3) 
Diabetics 
(4) 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
d 13 20 33 21 
(16 . 5 ) (15.6) (15.9) (16.4) 
D 66 108 174 107 
(83 . 5 ) (84.4) (84.1) (83.6) 
Totals 79 128 207 128 
Table 7.42 E locus phenotype frequencies for diabetics and controls 
aged 40-59. 
Phenotype Number and frequency <*> 
Diabetics (3) 
Diabetics 
(4) 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
E 3 1 4 5 
( 3.8) ( 0.8) ( 1.9) ( 3.9) 
Ee 20 34 54 32 
(25.3) (26.6) (26.1) (25.0) 
e 56 93 149 91 
(70.9) (72.7) (72.0) (71.1) 
Total8 79 128 207 128 
Table 7.43 E locus gene frequencies for diabetics and controls 
aged 40-59. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
JL 0.1645 0.1406 0.1498 O.I64I 
(+.042) (+.031) (+.025 (+.033) 
e 0.8355 0.8594 0.8502 0.8359 
Table 7.44 C locus phenotype frequencies for diabetics and controls 
aged 60 and over. 
Phenotype Number and frequency (*) 
Diabetics (3) 
Diabetics 
(4) 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
C 11 56 67 23 
(21.1) (16.2) (16.8) (13.7) 
Cc 24 194 218 88 
(46.2) (56.1) (54.8) (52.4) 
c 17 96 113 57 
(32.7) (27.7) (28.4) (33.9) 
Totals 52 346 398 168 
Table 7.45 C locus gene frequencies for diabetics and controls 
aged 60 and over. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
C 0.4423 0.4422 0.4422 0.3988 
(+.069) (+.027) ( ± . 0 2 5 ) (+.038) 
6.5577 0.5578 0.5578 0.6012 
34--/-
Table 7.46 D locua phenotype frequencies for diabetics and controls 
aged 60 and over. 
Phenotype Number and frequency ($) 
Diabetics (3) 
Diabetics 
(4) 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
d 9 64 73 39 
(17.3) (18 . 5 ) (18.3) (23.2) 
D 43 282 325 129 
(82.7) (81 . 5 ) (81.7) (76.8) 
Totals 52 346 398 168 
Table 7.47 E locus phenotype frequencies for diabetics and controls 
aged 60 and over. 
Phenotype Number and frequency ($) 
Diabetics (3) 
Diabetics 
(4) 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
E 3 6 9 3 
( 5.8) ( 1.7) ( 2 .3) ( 1.8) 
Ee 17 93 110 41 
(32.7) (26.9) (27.6) (24.4) 
e 32 247 279 124 
(61 . 5 ) (71.4) (70.1) (73.8) 
Totals 52 346 398 168 
Table 7.48 E locus gene frequencies for diabetics and controls 
aged 60 and over. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
E_ 0.2211 0.1517 0.1608 0.1399 
(+.057) (+.019) (+.018) (+.027) 
e. 0.7789 O.8483 0.8392 0.8601 
Table 7.49 Results for diabetics and controls tested with anti-K and 
anti-k. 
Phenotype Number and frequency ($) 
Diabetics (3) A l l (4) A l l 
( l ) Ins.-taking (2) Non-ins.-taking Diabetics Controls 
K 0 
( 0 .6) 
3 
( 0 .4) ( 0)2) 
Kk 23 44 67 34 
(10.0) ( 9 .1) ( 9 .4) ( 6.6) 
k 206 438 644 479 
(90.0) (90.3) (90.2) (93.2) 
Totals 229 485 714 514 
Table 7.50 Gene frequency r e s u l t s for diabetics tested with anti-K 
and anti-k. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
K 0.0502 0.0515 0.0511 0.0350 
(+.014) (+.010) (+.008) (+.008) 
k 0.9498 0.9485 0.9489 0.9650 
4 (b) Tests with anti-Kp and anti-Kp . 
Results for 699 diabetic individuals are given i n table 
7.51. There are no s i g n i f i c a n t differences amongst the diabetics 
with regard sex or area of o r i g i n . There i s a tendency for hetero-
zygotes to be more common amongst the older diabetics than amongst 
the younger although,with t h i s sample,the difference i s not 
s i g n i f i c a n t . Possibly as a r e s u l t of this,there i s a s i g n i f i c a n t 
difference between non-insulin-taking diabetics and the entire 
control sample. This difference i s not seen in the comparison 
between the entire diabetic group and the controls. There are 
i n s u f f i c i e n t insulin-taking diabetics for separate treatment. 
Gene frequencies are given i n table 7 .52. 
(c) Tests with anti-K tanti-k,anti-Kp a and anti-Kp^ 3. 
Table 7.53 shows the r e s u l t s for the individuals tested 
with these four antisera. There are no s i g n i f i c a n t differences either 
amongst diabetics or between diabetics and controls. 
7.7 The Lewis system. 
Table 7.54 shows the phenotype frequencies for diabetics 
and controls tested with a n t i - L e ( a ) . These r e s u l t s are for A and 0 
individuals only. The diabetic groups show a higher frequency of 
Le(a) positive individuals and t h i s i s i n agreement with Anderson 
and Lauritzen (1960).although the excess i s not s i g n i f i c a n t with 
such small samples. There are no s i g n i f i c a n t differences i n the 
diabetic group with regard to sex,area of origin,age or treatment. 
Table 7.51 Results for diabetics and controls tested with anti-Kp 
and anti-Kpk. 
Phenotype Number and frequency ($) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
KpV 2 17 19 6 
( 0 . 9 ) ( 3 .5) ( 2 .7) ( 1.4) 
Kp 218 462 680 417 
(99.1) (96.5) (97.3) (98.6) 
Totals 220 479 699 423 
Chi squared ( (2) vs. ( 4 ) ) = 4.12 (d.f. = l ) p< 0 . 0 5 > 0 . 0 2 
Chi squared ( (3 ) vs. ( 4 ) ) = 2.06 (d.f. = l ) N.S. 
Table 7.52 Gene frequencies for diabetics and controls tested with 
a b anti-Kp and anti-Kp . 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
O.OO45 0.0177 0.0136 0.0071 
(+.005) (+.006) (+.004) (+.004) 
0.9955 0,9823 O.9864 0.9929 
36z. 
Table 7•53 Phenotype frequencies f o r diabetics and controls tested 
with anti-K,anti-k,anti-Kp and anti-Kp . 
Phenotype Number and frequency ($) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
KKKp^p13 0 3 ( 0 .6) 3 ( 0 .4) 1 ( 0 .2) 
KkKpbKpb 21 ( 9 .5) 44 ( 9 .2) 65 ( 9 .3) 27 ( 6 .4) 
kkKp^p 1 3 2 ( 0 .9) 17 ( 3 .5) 19 ( 2 .7) 6 ( 1.4) 
kkKpbKpb 197 (89.5) 415 (86.6) 612 (87.5) 389 (92.0) 
Totals 220 479 699 423 
3 £ 3 
Table 7.54 Results f o r diabetics and controls tested with anti-Le(a), 
(A and 0 persons only). 
Reaction 
with a n t i -
Le (a) 
Number and frequency (*) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
+ve 41 78 119 30 
(34.2) (34.4) (34.3) (27.8) 
-ve 79 149 228 78 
(65.8) (65.6) (65.7) (72.2) 
Totals 120 227 347 108 
Chi squared ( (3 ) vs. (4 ) ) = 1.59 (d.f. = l ) N.S. 
. 2i8 The Duffy system. 
Table 7.55 shows the phenotype frequencies f o r the 621 
diabetics and 507 controls tested with anti-Fy a. No s i g n i f i c a n t 
differences were found i n the diabetic sample with regard sex,area 
of origin,current age or age at diagnosis. There were no differences 
between oral-hypoglycaemic-treated diabetics and diet-controlled 
diabetics. There are no s i g n i f i c a n t differences between the 
treatment sub-samples and controls and no differences between the 
diabetics as a whole and controls. 
Of these 621 diabetics tested with anti-Fy ,270 were 
also tested with anti-Fy . Their results are given i n table 7»56 , 
with gene frequencies i n table 7»57• Again,the diabetics are 
i n t e r n a l l y consistent with regard to sex,area of origin,age,age 
at diagnosis and treatment and show no s i g n i f i c a n t differences when 
compared with controls. 
7.9 Haptoglobin. 
There were no s i g n i f i c a n t differences between male and 
female diabetics with regard to the haptoglobin phenotype frequencies, 
nor were there any differences with regard to area of o r i g i n . There 
were i n s u f f i c i e n t data f o r analysis i n terms of current age or age 
at diagnosis. 
Phenotype frequencies f o r the system are given i n table 
7.58 with gene frequencies i n table 7•59• There are no s i g n i f i c a n t 
differences between insulin-taking and non-insulin-taking diabetics 
nor between these sub-groups and controls. The entire diabetic 
group does not d i f f e r s i g n i f i c a n t l y from the control group. The 
numbers available were small,especially f o r the comparison between 
355. 
Table 7.55 Results f o r diabetics and controls tested with anti-Fy . 
Phenotype Number and frequency ($) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
+ve 136 263 399 326 
(64.5) (64.1) (64.3) (64.3) 
-ve 75 147 222 181 
(35.5) (35.9) (35.7) (35.7) 
Totals 211 410 621 507 
Table 7.56 Phenotype frequencies f o r diabetics and controls tested with 
a b anti-Fy and anti-Fy . 
•*— - - . -
Phenotype 
• 
Number and frequency ($) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
Fy a 21 50 71 55 
(24.1) (27.3) (26.3) (19.0) 
38 71 109 126 
(43.7) (38.8) (40.4) (43.6) 
Fy b 28 62 90 108 
(32.2) (33.9) (33.3) (37.4) 
Totals 87 183 270 289 
Table 7*57 Gene frequencies f o r diabetics and controls tested with 
a b anti-Fy and anti-Fy . 
Gene 
> 
Frequency (+S.B.) 
Diabetics 
Controls Ins.-taking Non-ins.-taking A l l 
„ a Fy_ 0.4598 0.4672 O.4648 O.4O83 
(+.053) (+.037) (+.030) (+.029) 
Fy_b 0.5402 0.5328 0.5352 0.5917 
3S7. 
Table 7.58 Haptoglobin results,diabetics and controls. 
Phenotype Number and frequency ($) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
1-1 11 24 35 16 
(16.4) (15.5) (15.8) (18.6) 
2-1 26 65 91 44 
(38.8) (41.9) (41.0) (51.2) 
2-2 30 66 96 26 
(44.8) 42.6) (43.2) (30.2) 
Totals 67 155 222 86 
Table 7.59 Gene frequency results f o r the haptoglubin locus,diabetics 
and control. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
0.3582 0.3645 0.3626 0.4419 
(+.059) (+.039) (+.032) (+.054) 
B E 2 0.6418 0.6355 0.6374 0.5581 
. insulin-taking diabetics and controls. 
The f i n d i n g of Ksenofontor (1974) ,that twice as many 
diabetics as controls were heterozygous at both the MN and 
haptoglobin loci,could not be confirmed i n t h i s study. Of the 
222 diabetics investigated f o r haptoglobin 54 (24.3%) were 
heterozygous at both l o c i . I n the control sample 24 (27.9$) 
were of t h i s type. 
7.10 Acid phosphatase. 
Acid phosphatase phenotype frequencies do not d i f f e r 
s i g n i f i c a n t l y i n male and female diabetics. There i s no relationship 
with area of o r i g i n and the trend found with age i n controls i s not 
present i n the diabetics. There i s no r e l a t i o n with age at diagnosis. 
Because of the heterogeneity of the control sample with respect to 
age,comparisons are made between diabetics and non-diabetics matched 
for age. Tables 7.59 and 7.60 show the acid phosphatase phenotype 
frequencies f o r diabetics and controls less than 40 years old and 
greater than 40 years old respectively. The corresponding gene 
frequencies are given i n tables 7.61 and 7 .62. There are i n s u f f i c i e n t 
non-insulin-taking diabetics f o r separate analysis i n the under 40 
group. 
The differences between the groups are not s i g n i f i c a n t . 
7.11 Phosphoglucomutase. 
No si g n i f i c a n t differences i n phosphoglucomutase 
phenotype frequencies could be detected amongst the diabetics with 
regard to sex,area of o r i g i n or age at diagnosis. The trend of 
increasing heterozygote frequency with age,seen i n the controls, 
Table 7.59 Acid phosphatase phenotype results,diabetics and controls 
under 40 years of age. 
Phenotype Number and frequency ($) 
Ins.-taking A l l Controls 
Diabetics Diabetics 
A 12 
(14 .8) 
12 
(12.4) 
5 
( 4 .5) 
BA 39 
(48.1) 
44 
(45.4) 
55 
(49.5) 
B 24 
(29.6) 
33 
(34.0) 
43 
(38.7) 
CA 1 
( 1.2) 
2 
( 2 .1) 
2 
( 1.8) 
CB 5 
( 6.2) 
6 
( 6 .2) 
6 
( 5.4) 
Totals 81 97 111 
Mean age of diabetics = 25,28 (+.97) years 
Mean age of controls = 26.312 (+.62) years 
Table 7.60 Acid phosphatase results,diabetics and controls aged 40 
and over. 
Phenotype Number and frequency (fo) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
A 18 52 70 19 
(14.1) (11.5) (12.1) (16.1) 
BA 47 192 239 56 
(36.7) (42.5) (41.2) (47.5) 
B 51 172 223 37 
(39.8) (38.1) (38.5) (31.4) 
CA 4 11 15 2 
( 3 .1) ( 2 .4) ( 2 .6) ( 1.7) 
CB 7 25 32 4 
( 5.5) ( 5.5) ( 5.5) ( 3.4) 
C 1 0 1 0 
( 0 .8) ( 0 .2) 
Totals 128 452 580 118 
Mean age of diabetics = 63.95 (+.4) years 
Mean age of controls = 62.68 (+1.2) years 
3&I 
Table 7.61 Acid phosphatase gene frequencies f o r diabetics and controls 
aged under 40 years of age. 
Gene Frequency (+S.E.) 
Ins.-taking A l l Controls 
Diabetics Diabetics 
A 0.3951 O.36O8 0.3018 
B 0.5679 0.5979 0.6622 
(+.06) ( ± . 0 5 ) (+.05) 
C 0.0370 0.0413 0.0360 
Table 7«62 Acid phosphatase gene frequencies f o r diabetics and controls 
aged 40 and over 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
A 0.3398 0.3396 0.3397 0.4068 
B 0.6094 0.6206 0.6181 0.5678 
(+.04) (+.02) (+.02) (+.05) 
C 0.0508 0.0398 0.0422 0.0254 
, 
3b* 
.was not present i n the diabetic sample. 
Ideally,because of t h i s trend,the diabetics should have 
been compared with age-matched controls but the size of the control 
sample was i n s u f f i c i e n t to allow f o r t h i s . Table 7.63 shows the 
phenotype frequencies for t h i s system and table 7.64 shows the gene 
frequencies. There are no significant differences i n the diabetics 
with regard to current treatment and the treatment sub-groups are 
not s i g n i f i c a n t l y d i f f e r e n t from the control group. There i s no 
difference between the diabetic group as a whole and the control 
group. 
7.13 Adenylate kinase. 
The results f o r 708 diabetics investigated f o r t h i s 
system are given i n table 7 .65« There were no detectable differences 
between the sexes and none with regard to area of origin,current age 
or age at diagnosis. Oral-hypoglycaemic-treated diabetics and d i e t -
managed diabetics were s t a t i s t i c a l l y indistinguishable from each 
other and have been combined as non-insulin-taking diabetics. The 
gene frequencies f o r t h i s system are given i n table 7.66. 
There are no si g n i f i c a n t differences between i n s u l i n -
taking diabetics and non-insulin-taking diabetics and neither sub-
group d i f f e r s s i g n i f i c a n t l y from the controls. The entire diabetic 
group i s s t a t i s t i c a l l y indistinguishable from the controls. For 
the calculation of chi squared the 2-2 and 2-1 categories have been 
amalgamated. 
7.13 Adenosine deaminase. 
The numbers of diabetics and controls investigated f o r 
Table 7*63 Phosphoglucomutase results,diabetics and controls. 
Phenotype Number and frequency (0 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
1-1 64 151 215 79 
(66.0) (71.9) (70.0) (68.7) 
2-1 31 44 75 32 
(32.0) (20.9) (24.4) (27.8) 
2-2 2 15 17 4 
( 2.1) ( 7.D ( 5.5) ( 3 .5) 
Totals 97 210 307 115 
Table 7.64 Phosphoglucomutase gene frequency results,diabetics and 
controls. 
Gene Frequency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
PGM1 0.8196 0.8238 0.8225 0.8261 
(+.039) (+.026) (+.022) (+.035) 
PGM2 0.1804 0.1762 0.1775 0.1739 
Table 7.65 Adenylate kinase results,controls and diabetics. 
Phenotype Number and frequency ($) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
1-1 210 454 664 363 
(93.8) (93.8) (93.8) (91.9) 
2-1 14 29 43 30 
( 6 .3) ( 6 .0) ( 6 .1) ( 7.6) 
2-2 0 1 1 2 
( 0 .2) ( o.i) ( 0 .5) 
Totals 224 484 708 395 
Table 7.66 Adenylate kinase gene frequencies,controls and diabetics. 
Gene Pre quency (+S.E.) 
Diabetics Controls 
Ins.-taking Non-ins.-taking A l l 
AK1 
AK2 
0.9687 
(+.017) 
0.0313 
0.9680 
(+.008) 
0.0320 
0.9682 
(+.007) 
0.0318 
0.9570 
(+.010) 
0.0430 
. t h i s system are i n s u f f i c i e n t f o r investigation of sex differences 
or those related to area of origin,current age,age at diagnosis or 
treatment. The phenotype frequencies f o r the entire diabetic group 
and the entire control group are given i n table 7«67»"ith gene 
frequencies i n table 7.68. 
There i s a greater frequency of heterozygotes amongst 
the diabetics but t h i s i s not s i g n i f i c a n t . 
7.14 Esterase D. 
The diabetic sample investigated f o r the esterase D 
system showed no s i g n i f i c a n t differences when sub-divided by sex, 
area of origin,current age or age at diagnosis. The non-insulin-
taking diabetics were homogeneous i n t h e i r phenotype frequencies 
and these,together with the frequencies f o r insulin-taking 
diabetics and controls are given i n table 7.69. There are no 
s i g n i f i c a n t differences between insulin-taking and non-insulin-
taking diabetics and neither these,nor the diabetic group as a 
whole,differ s i g n i f i c a n t l y from the control sample. Gene frequencies 
f o r t h i s system are given i n table 7.70. 
7.15 The HLA system. 
The diabetics showed no s i g n i f i c a n t differences when 
HLA phenotype frequencies were compared i n males and females and 
there were no differences with regard area of o r i g i n . The 
comparison between oral-hypoglycaemic-treated diabetics and d i e t -
managed diabetics shows no convincing differences (table 7 » 7 l ) . 
The apparent excess of HLA-A3 positive individuals amongst the 
former group does not stand up to correction f o r the number of 
Table 7.67 Adenosine deaminase phenotype results f o r diabetics and 
controls. 
Phenotype No. & frequency (%) 
A l l A l l 
Diabetics Controls 
1-1 60 96 
(85.7) (94.D 
2-1 10 6 
(14.3) ( 5.9) 
Totals 70 102 
Table 7»68 Gene frequencies f o r diabetics and control,adenosine 
deaminase locus. 
Gene Frequency (+S.E.) 
A l l A l l 
Diabetics Controls 
ADA1 0.9286 0.9706 
(+.031) (+.017) 
ADA2 n n*7i A r\ n i n A 
Table 7.69 Esterase D results,diabetics and controls. 
Phenotype Number and frequency ($>) 
Diabetics (3) A l l 
Diabetics 
(4) A l l 
Controls ( l ) Ins.-taking (2) Non-ins.-taking 
1-1 185 398 583 304 
(81 .9) (81 .4) (81 .5) (77.9) 
2-1 39 86 125 82 
(17.3) (17.6) (17.5) (21.0) 
2-2 2 5 7 4 
( 0.9) ( i .o ) ( i .o ) ( i .o ) 
Totals 226 489 715 390 
Table 7.70 Esterase D gene frequency results,diabetics and controls. 
Gene Frequency (+S.E.) 
Piabetics Controls 
Ins.-taking Non-ins.-taking A l l 
ESP1 
ESP2 
0.9049 
(±.019) 
0.0951 
0.9018 
(+.013) 
0.0982 
0.9028 
(+.011) 
0.0972 
O.8846 
(+.016) 
0.1154 
Table 7.71 HLA Phenotype f r e q u e n c i e s i n o r a l hypoglycaemic t r e a t e d 
d i a b e t i c s and i n d i e t t r e a t e d d i a b e t i c s . 
Number & frequency (%) Chi 
Locus A l l e l e O r a l hypo D i e t sq. P P 
glycaemic 
n=150 n=153 (d.f . = 1) 
x 18 
HLA Al 51 
(34.0) 
62 
(40.5) 
1.11 0.2914 
HLA A2 60 
(40.0) 
68 
(44.4) 
0.44 0.5049 
HLA A3 45 30 3.85 0.0494* 0.8892 
A (30.0) (19.6) 
HLA A9 18 
(12.0) 
28 
(18.3) 
1.87 0.1713 
HLA A10 27 
(18.0) 
25 
(16.3) 
0.05 0.8175 
HLA A l l 12 
( 8.0) 
8 
( 5.2) 
0.55 0.4593 
Blank 4 
( 2.7) 
6 
( 3.9) 
0.08 0.7720 
HLA B5 17 
(11.3) 
20 
(13.1) 
0.08 0.7744 
HLA B7 48 
(32.0) 
40 
(26.1) 
0.99 0.3192 
HLA B8 43 
(28.7) 
43 
(28.1) 
0.00 0.9849 
HLA B12 42 
(28.0) 
48 
(31.4) 
0.27 0.6054 
B HLA B13 10 
( 6.7) 
8 
( 5.2) 
0.08 0.7746 
HLA B14 10 
( 6.7) 
6 
( 3.9) 
0.66 0.4172 
HLA B17 9 
( 6.0) 
8 
( 5.2) 
0.002 0.9665 
HLA B27 12 
( 8.0) 
20 
(13.1) 
1.56 0.2116 
HLA BW15 30 
(20.0) 
24 
(15.7) 
0.69 0.4060 
Blank 7 
( 4.7) 
8 
( 5.2) 
0.002 0.9686 
C HLA CW4 20 + ( n n ) ) 0.51 0.4758 
+ n = 113 A n = 119 
361. 
„ comparisons made (l8),so that t h i s difference may well be due to 
chance. The alight excess of HLA.-Bwl5 positive individuals i n the 
oral-hypoglycaemic-treated group i s worthy of note. This could, 
again,be a chance f i n d i n g , a l t e r n a t i v e l y , i t could be the re s u l t of 
a small number of type I diabetics amongst t h i s group (Irvine,1977). 
Tables 7.72 and 7.73 show separate comparisons between 
controls and oral-hypoglycaemic-treated and diet-controlled 
diabetics respectively. I n the former category there i s an 
apparent excess of HLA-A10 and HLA-Bwl5 positive individuals,whilst 
i n the l a t t e r group there appears to be a d e f i c i t of HLA-A3 
individuals. The r e l a t i v e incidences and chi squared values (Woolf's 
method) for these s p e c i f i c i t i e s are given i n tables 7.74(a) and 
7.74(b). None of these have a s u f f i c i e n t l y low p value to with-
stand the correction for the number of comparisons and,may,therefore 
be the r e s u l t of chance. The possible association between HLA-Bwl5 
and oral-hypoglycaemic-treated diabetes would be worth investigating 
i n another sample of diabetics. 
In the absence of any clear-cut differences between these 
two treatment sub-groups,they have been amalgamated as non-insulin-
taking diabetics. This group i s compared with controls i n table 
7.75. No s i g n i f i c a n t differences are demonstrated. 
Insulin-taking diabetics show several differences when 
compared with non-insulin-taking diabetics (table 7.76) and with 
controls (table 7*77). Relative incidences (insulin-taking diabetics 
vs. controls)of some s p e c i f i c i t i e s and various combinations are 
given i n table 7.78. The starred p values are l e s s than 0.05 even 
af t e r correction for the number of s p e c i f i c i t i e s compared. The 
positive associations with HLA-B8 and HLA-Bwl5 agree with most 
37o. 
Table 7.72 HLA Phenotype f r e q u e n c i e s i n o r a l hypoglycaemic t r e a t e d 
d i a b e t i c s and c o n t r o l s . 
Number & frequency (%) Ch i 
Locus A l l e l e D i a b e t i c s C o n t r o l s sq. P P 
n=150 n=427 (d.f.=1) x l 8 
HLA Al 51 
(34.0) 
147 
(34.4) 
0.00003 0.9957 
HLA A2 60 
(40.0) 
207 
(48.5) 
2.88 0.0898 
HLA A3 45 
(30.0) 
122 
(28.6) 
0.05 0.8202 
A HLA A9 18 
(12.0) 
57 
(13.3) 
0.08 0.7783 
HLA A10 27 
(18.0) 
48 
(11.2) 
3.91 0.0481* .8658 
HLA A l l 12 
( 8.0) 
40 
( 9.4) 
0.11 0.7358 
Blank 4 
( 2.7) 
14 
( 3.3) 
N.A. 
HLA B5 17 
(11.3) 
43 
(10.1) 
0.08 0.7791 
HLA B7 48 
(32.0) 
119 
(27.9) 
0.73 0.3925 
HLA B8 43 
(28.7) 
126 
(29.5) 
0.01 0.9279 
HLA B12 42 
(28.0) 
145 
(34.0) 
1.54 0.2151 
HLA B13 10 
( 6.7) 
17 
( 4.0) 
1.24 0.2649 
HLA B14 10 31 0.003 0.9533 
B ( 6.7) ( 7.3) 
HLA B17 9 
( 6.0) 
32 
( 7.5) 
0.18 0.6686 
HLA B27 12 
( 8.0) 
35 
( 8.2) 
0.01 0.9222 
HLA BW15 30 
(20.0) 
53 
(12.4) 
4.59 0.0321* .5778 
Blank 7 
( 4.7) 
25 
( 5.9) 
0.11 0.7342 
C HLA CW4 2 0 + 
(17.7) 
4 8 A 
(12.9) 
1.30 0.2535 
+ n = 113 A n = 373 
V7I 
Table 7.73 HLA Phenotype f r e q u e n c i e s i n d i e t managed d i a b e t i c s 
and c o n t r o l s . 
Number & frequency (%) C h i 
Locus A l l e l e D i a b e t i c s C o n t r o l s sq. P P 
n=153 n=427 (d.f.=1) x 18 
HLA Al 62 
(40.5) 
147 
(34.4) 
1.56 0.2114 
HLA A2 68 
(44.4) 
207 
(48.5) 
0.58 0.4455 
HLA A7 30 
(19.6) 
122 
(28.6) 
4.23 0.0398* .7164 
A HLA A9 28 
(18.3) 
57 
(13.3) 
1.83 0.1761 
HLA A10 25 
(16.3) 
48 
(11.2) 
2.21 0.1364 
HLA A l l 8 
( 5.2) 
40 
( 9.4) 
2.02 0.1546 
Blank 6 
( 3.9) 
14 
( 3.3) 
0.01 0.9079 
HLA B5 20 
(13.1) 
43 
(10.1) 
0.76 0.3830 
HLA B7 40 
(26.1) 
119 
(27.9) 
0.09 0.7605 
HLA B8 43 
(28.1) 
126 
(29.5) 
0.05 0.8226 
HLA B12 48 
(31.4) 
145 
(34.0) 
0.23 0.6296 
HLA B13 8 
( 5.2) 
17 
( 4.0) 
0.18 0.6745 
HLA B14 6 31 1.58 0.2087 
B ( 3.9) ( 7.3) 
HLA B17 8 
( 5.2 
32 
( 7.5) 
0.58 0.4455 
HLA B27 20 
(13.1) 
35 
( 8.2) 
2.58 0.1084 
HLA BW15 24 
(15.7) 
53 
(12.4) 
0.78 0.3760 
Blank 8 
( 5.2) 
25 
( 5.9) 
0.01 0.9335 
C HLA CW4 16 
(13.4) + 
48 
(12.9) A 
0.00004 0.9949 
+ n = 119 A n = 373 
37z. 
Table 7.74(a) R e l a t i v e i n c i d e n c e s i n oral-hypoglycaemic 
t r e a t e d d i a b e t i c s and c o n t r o l s . 
A l l e l e R e l a t i v e i n c i d e n c e C h i squared 
(d.f.=1) P. 
HLA A10 1.73 4.38 <0.05>0.025 
HLA BW15 1.76 5.06 <0.025>0.01 
Table 7.74(b) R e l a t i v e i n c i d e n c e s i n diet-managed d i a b e t i c s 
and c o n t r o l s . 
A l l e l e R e l a t i v e i n c i d e n c e C h i squared 
(d.f.=1) P. 
HLA-A 3 0.61 4.61 <0.05>0.025 
111 
Table 7.75 HLA Phenotype f r e q u e n c i e s i n n o n - i n s u l i n - t a k i n g 
d i a b e t i c s and c o n t r o l s . 
Number & frequency (%) C h i 
Locus A l l e l e D i a b e t i c s C o n t r o l s sq. P 
n=303 n=427 (d.f.=1) 
HLA-A1 113 147 0.52 0.4723 
(37.3) (34.4) 
HLA-A2 128 207 2.53 0.1118 
(42.2) (48.5) 
HLA-A3 75 122 1.13 0.2888 
(24.8) (28.6) 
A HLA-A9 46 57 0.35 0.5532 
(15.2) (13.3) 
HLA-A10 52 48 4.77 0.0290 
(17.2) (11.2) 
HLA-All 20 40 1.45 0.2284 
( 6.6) ( 9.4) 
Blank 10 14 0.04 0.8458 
( 3.3) ( 3.3) 
HLA-B5 37 43 0.63 0.4282 
(12.2) (10.1) 
HLA-B7 88 119 0.07 0.7922 
(29.0) (27.9) 
HLA-B8 86 126 0.06 0.8047 
(28.4) (29.5) 
HLA-B12 90 145 1.28 0.2576 
(29.7) (34.0) 
B HLA-B13 18 17 1.09 0.2960 
( 5.9) ( 4.0) 
HLA-B14 16 31 0.85 0.3572 
( 5.3) ( 7.3) 
HLA-B17 17 32 0.73 0.3942 
( 5.6) ( 7.5) 
HLA-B27 32 35 0.92 0.3370 
(10.6) ( 8.2) 
HLA-BW15 54 53 3.72 0.0536 
(17.8) (12.4) 
Blank 15 25 0.13 0.7159 
( 5.0) ( 5.9) 
C HLA-CW4 3 6 + 4 8 A 0.63 0.4265 
(15.7) (12.9) 
+ n = 229 A n == 373 
374. 
Table 7.76 HLA Phenotype f r e q u e n c i e s i n i n s u l i n - t a k i n g and 
n o n - i n s u l i n - t a k i n g d i a b e t i c s . 
Number & frequency (%) Chi 
Locus A l l e l e i n s . - t a k i n g 
d i a b e t i c s 
n=179 
non-ins. 
t a k i n g 
d i a b e t i c s 
n=303 
squared P P 
x l 8 
HLA-A1 66 
(36.9) 
113 
(37.3) 
.000 0.9961 
HLA-A2 110 
(61.5) 
128 
(42.2) 
15.85 0.0001* ** .0018 
HLA-A3 30 
(16.8) 
75 
(24.8) 
3.76 0.0524 
A HLA-A9 30 
(16.8) 
46 
(15.2) 
0.11 0.7414 
HLA-A10 23 
(12.8) 
52 
(17.2) 
1.28 0.2576 
HLA-A11 13 
( 7.3) 
20 
( 6.6) 
0.008 0.9272 
Blank 3 
( 1.7) 
10 
( 3.3) 
N.A. 
HLA-B5 13 
( 7.3) 
37 
(12.2) 
2.46 0.1171 
HLA-B7 26 
(14.5) 
88 
(29.0) 
12.34 0.0004* ** .0072 
HLA-B8 81 
(45.3) 
86 
(28.4) 
13.40 0.0003* ** .0054 
HLA-B12 45 
(25.1) 
90 
(29.7) 
0.95 0.3305 
B HLA-B13 9 
( 5.0) 
18 
( 5.9) 
0.05 0.8290 
HLA-B14 10 
( 5.6) 
16 
( 5.3) 
0.004 0.9482 
HLA-B17 3 
( 1.7) 
17 
( 5.6) 
3.45 0.0634 
HLA-B27 15 
( 8.4) 
32 
(10.6) 
0.39 0.5346 
HLA-BW15 48 
(26.8) 
54 
(17.8) 
4.93 0.0264* .4752 
Blank 6 
( 3.4) 
15 
( 5.0) 
0.36 0.5487 
C HLA-CW4 15 + 
(10.9) 
36 A 
(15.7) 
1.15 0.2835 
+ n = 137 A n = 229 
"3-15. 
Table 7.77 HLA Phenotype f r e q u e n c i e s i n i n s u l i n - t a k i n g d i a b e t i c s 
and c o n t r o l s . 
Number & frequency (%) Chi 
Locus A l l e l e D i a b e t i c s C o n t r o l s sq. P P 
n=179 n=427 (d.f.=1) x l 8 
HLA-Al 66 
(36.9) 
147 
(34.4) 
0.23 0.6298 
HLA-A2 110 
(61.5) 
207 
(48.5) 
8.00 0.0047* .0846 
HLA-A3 30 
(16.8) 
122 
(28.6) 
8.75 0.0031* .0558 
A HLA-A9 30 
(16.8) 
57 
(13.3) 
0.93 0.3343 
HLA-A10 23 
(12.8) 
48 
(11.2) 
0.18 0.6723 
HLA-Al1 13 
( 7.3) 
3 
( 1.7) 
40 
( 9.4) 
14 
( 3.3) 
0.46 
N.A. 
0.4970 
HLA-B5 13 
( 7.3) 
43 
(10.1) 
0.87 0.3498 
HLA-B7 26 
(14.5) 
119 
(27.9) 
11.62 0.0007* ** .0126 
HLA-B8 81 
(45.3) 
126 
(29.5) 
13.21 0.0003* ** .0054 
HLA-B12 45 
(25.1) 
145 
(34.0) 
4.16 0.0415* .7470 
B HLA-B13 9 
( 5.0) 
17 
( 4.0) 
0.13 0.7186 
HLA-B14 10 
( 5.6) 
31 
( 7.3) 
0.33 0.5680 
HLA-B17 3 
/ 4 »1 » 
V i- . 1 1 
32 
( 7.5) 
6.81 0.0091* .1638 
HLA-B27 15 
( 8.4) 
35 
( 8.2) 
0.01 0.9306 
HLA-BW15 48 
(26.8) 
53 
(12.4) 
17.82 0.0000* 0.0000** 
6 25 1.15 0.2829 
( 3.4) ( 5.9) 
C HLA-CW4 1 5 + 
(10.9) 
4 8 A 
(12.9) 
0.19 0.6656 
+ n = 137 A n = 373 
Table 7.78 R e l a t i v e i n c i d e n c e s i n i n s u l i n - t a k i n g d i a b e t i c s 
and c o n t r o l s . 
S p e c i f i c i t y R e l a t i v e i n c i d e n c e C h i squared 
(d.f.=1) P. 
HLA-A2 1.69 8.35 <0.005>0.001 
HLA-A3 0.50 9.33 <0.005>0.001 
HLA-B7 0.44 11.90 <0.001>0.0005* 
HLA-B8 1.97 13.60 <0.0005* 
HLA-B12 0.65 4.62 <0.05>0.025 
HLA-B17 0.21 6.53 <0.025>0.01 
HLA-BW15 2.59 18.11 <0.0005* 
Homozygons 
HLA-B7 0.51 2.81 <0.10>0.05 
Homozygons 
B8 2.39 12.55 <0.0005* 
Homozygons 
BW15 2.96 6.68 <0.01 0.005 
Heterozygons 
B7/B8 0.63 1.13 <0.30>0.20 
Heterozygons 
B7/BW15 1.20 0.09 <0.80>0.70 
Heterozygons 
B8/BW15 5.95 12.90 <0.0005* 
n-i 
.previous authors. The negative association with HLA-B7 reported 
by some i s also evident. There i s a large r e l a t i v e incidence of the 
B8/Bwl5 combination. The negative association with HLA-A3 i s 
probably due to the positive linkage disequilibrium that a l l e l e 
shows with HLA-B7,whilst the positive association with HLA-A2 may 
be the r e s u l t of linkage disequilibrium with HLA-Bwl5. The negative 
association with HLA-All reported by Cudworth and Woodrow (1976) 
cannot be demonstrated. The lack of HLA-B17 positive individuals 
amongst the diabetics may be due to chance. 
The 179 insulin-taking diabetics show s i g n i f i c a n t 
differences with regard to age at diagnosis. Subdivided at the 
customary age of 30,the phenotype frequencies i n the two groups 
are shown i n table 7.79. They d i f f e r i n thei r frequency of HLA-
BS and comparison of each sub-group i n turn with controls (tables 
7.80 and 7»8l) shows that the frequency of th i s s p e c i f i c i t y i n 
the l a t e r onset diabetics i s indistinguishable from that i n the 
general population whereas the excess of HLA-Bwl5 positive 
individuals i s highly s i g n i f i c a n t . I n the insulin-taking diabetics 
diagnosed before t h i s age,the reverse i s the case with a highly 
s i g n i f i c a n t excess of the HLA-B8 a l l e l e and only a marginally 
s i g n i f i c a n t excess of HLA-Bwl5 positive individuals. A d e f i c i t of 
the HLA-B7 a l l e l e i s suggested i n both groups. The r e l a t i v e 
incidences are shown i n table 1,82. 
These data are taken to imply that insulin-taking 
diabetics are heterogeneous with regard^associations with a l l e l e s 
at the HLA-B locus. The positive association i s largely confined 
to diabetes diagnosed before about the age of 40 (see figure 7.1(a)) 
but this does not apply to HLA-Bwl5,shown i n figure 7.1(b). 
i t * . 
Table 7.79 HLA Phenotype f r e q u e n c i e s i n i n s u l i n - t a k i n g d i a b e t i c s 
subdivided by age a t d i a g n o s i s . 
Number & frequency (%) Chi 
Locus A l l e l e Diag. <30 Diag. 30+ 
n=101 n=77 
sq. 
(d.f.=1) 
P P 
x l 8 
HLA-A1 40 26 
(39.2) (33.8) 
0.35 0.5540 
HLA-A2 59 51 
(57.8) (66.2) 
0.97 0.3237 
HLA-A3 19 11 
(18.6) (14.3) 
0.32 0.5701 
A HLA-A9 16 14 
(15.7) (18.2) 
0.06 0.8100 
HLA-A10 14 9 
(13.7) (11.7) 
0.03 0.8590 
HLA-A11 6 7 
( 5.9) ( 9.1) 
0.28 0.5974 
Blank 2 1 
( 2.0) ( 1.3) 
0.06 0.8054 
HLA-B5 5 8 
( 4.9) (10.4) 
1.23 0.2671 
HLA-B7 16 10 
(15.7) (13.0) 
0.09 0.7694 
HLA-B8 54 27 
(52.9) (35.1) 
4.96 0.0259* .4662 
HLA-Bl2 28 17 
(27.5) (22.1) 
0.42 0.5180 
B HLA-Bl3 7 2 
( 6.9) ( 2.6) 
0.90 0.3434 
HLA-Bl4 4 6 
( 3.9) ( 7.8) 
0.62 0.4309 
HLA-Bl7 2 1 
( 2.0) ( 1.3) 
0.06 0.8054 
HLA-B27 9 6 
( 8.8) ( 7.8) 
0.00067 0.9794 
HLA-BW15 22 26 
(21.6) (33.8) 
2.73 0.0982 
Blank 2 4 
( 2.0) ( 5.2) 
0.59 0.4408 
C HLA-CW4 * + 5 10 + 
( 6.3) (17.2) 
3.04 0.0811 
*n = 7 8 + n = 58 
3-n. 
Table 7.80 HLA Phenotype frequencies i n insulin-taking diabetics 
diagnosed before age of 30 and in controls. 
Number & frequency (%) Chi 
Locus A l l e l e Diabetics Controls sq. P P 
x l 8 n=102 n=427 (d.f.=1) 
HLA-A1 40 
(39.2) 
147 
(34.4) 
0.63 0.4273 
HLA-A2 59 
(57.8) 
207 
(48.5) 
2.52 0.1120 
HLA-A3 19 
(18.6) 
122 
(28.6) 
3.67 0.0554 
A HLA-A9 16 
(15.7) 
57 
(13.3) 
0.21 0.6490 
HLA-A10 14 
(13.7) 
48 
(11.2) 
0.28 0.5965 
HLA-A11 6 
( 5.9) 
40 
( 9.4) 
0.86 0.3540 
Blank 2 
( 2.0) 
14 
( 3.3) 
N.A. 
HLA-B5 5 
( 4.9) 
43 
(10.1) 
2.08 0.1496 
HLA-B7 16 
(15.7) 
119 
(27.9) 
5.80 0.0160* .2898 
HLA-B8 54 
(52.9) 
126 
(29.5) 
19.11 0.0000* 0.0000 
HLA-B12 28 
(27.5) 
145 
(34.0) 
1.30 0.2538 
B HLA-B13 7 
( 6.9) 
17 
( 4.0) 
0.98 0.3214 
HLA-B14 4 
( 3.9) 
31 
( 7.3) 
0.99 0.3188 
HLA-B17 2 
( 2.0) 
32 
( 7.5) 
3.32 0.0684 
HLA-B27 9 
( 8.8) 
35 
( 8.2) 
0.00004 0.9949 
HLA-BW15 22 
(21.6) 
53 
(12.4) 
4.95 0.0262* .4716 
Blank 2 
( 2.0) 
25 
( 5.9) 
1.84 0.1754 
C HLA-CW4 5 + 
( 6.3) 
48 A 
(12.9) 
2.10 0.1474 
+ n =78 A n = 373 
T a b l e 7.81 HLA P'nenotype f r e q u e n c i e s i n i n s u l i n - t a k i n g d i a b e t i c s 
diagnosed aged 30 or over and i n c o n t r o l s . 
Number & frequency (%) Chi 
Locus A l l e l e D i a b e t i c s 
n=77 
C o n t r o l s 
n=427 
sq. 
(d.f.=1) 
P P 
x 18 
A 
IILA-Al 
HLA-A2 
HLA-A3 
HLA-A9 
HLA-A10 
IILA-Al 1 
Blank 
26 
(33.8) 
51 
(66.2) 
11 
(14.3) 
14 
(10.2) 
9 
(11.7) 
7 
( 9.1) 
1 
( 1.3) 
147 
(34.4) 
207 
(48.5) 
122 
(28.6) 
57 
(13.3) 
43 
(11.2) 
40 
( 9.4) 
14 
( 3.3) 
0.0003 
7.54 
6.14 
0.89 
0.01 
0.02 
0.33 
0.9856 
0.0060* 
0.0132* 
0.3451 
0.9351 
0.0918 
0.5641 
0.1080 
0.2376 
B 
HLA-B5 
HLA--137 
HLA-B8 
HLA-B12 
IILA-B13 
IILA-B14 
HLA-B17 
i 
HLA-B27 
HLA-BW15 
Blank 
8 
(10.4) 
10 
(13.0) 
27 
(35.1) 
17 
(22.1) 
2 
( 2.6) 
6 
( 7.8) 
1 
( 1.3) 
6 
( 7.3) 
26 
(33.8) 
4 
( 5.2) 
43 
(10.1) 
119 
(27.9) 
126 
(29.5) 
145 
(34.0) 
17 
( 4.0) 
31 
( 7.3) 
32 
( 7.5) 
35 
( 8.2) 
53 
(12.4) 
25 
| ( 5.9) 
0.0). 
6.02 
0.71 
3.69 
M.A. 
0.01 
3.14 
0.01 
20.92 
M.A. 
0.9047 
0.0090* 
0.4001 
0.0546 
0.9422 
0.0763 
0.9148 
0.0000* 
i 
0.1G20 
0.0000** 
C HLA-CW4 10 + 
(17.2) (12.D) 
0.49 j 0.--IJ33 
! 
| i i 1 
+ 
n = 50 A n = 373 N.A. = not a p p l i c a b l e . 
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Figure 7. 1(a) Frequency of HLA-B8 i n insulin-taking diabetics 
according to age at diagnosis. 
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Figure 7.1(b) Frequency of HLA-Bwl5 i n insulin-taking diabetics 
according to age at diagnosis. 
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Figure 7.1(c) Frequency of B8/Bwl5 heterozygotes i n insulin-taking 
diabetics. 
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3 * a. 
For the f i r s t four decades of l i f e the frequency of 
HLA-B8 positive diabetics i s s i g n i f i c a n t l y above the mean for the 
population of 29.5$ whereas i n the next three groups i t i s 
indistinguishable from the control value. The frequency of the 
HLA-Bwl5 antigen i s f a r more variable but i n a l l four decades of 
onset except the second the frequency i n diabetics i s above that 
i n the general population. Figure 7.1(c) shows that the number of 
diabetics presenting i n the f i r s t decade of l i f e and heterozygous 
B8/Bwl5 i s fourteen times that i n the general population and i n no 
other decade does the excess frequency approach t h i s . 
These r e s u l t s are at variance with those of Dausset 
(1977) which are given i n figures 7.2(a) and 7.2(b) for the 
purposes of comparison. The numbers of individuals on which these 
conclusions are based are considerably smaller than those of the 
present sample,especially i n the case of diabetics diagnosed over 
the age of 40f(Dausset et a l (1977) - 21 cases,present study - 50). 
I t may be that an increased sample of French diabetics would 
support the present finding of a raised incidence of HLA-Bwl5 
positive individuals prsenting af t e r t h i s age. For HLA-B8,given 
the expected lower frequency of the s p e c i f i c i t y i n the French 
control sample,the pattern of the r e s u l t s i s s i m i l a r . 
The heterogeneity of insulin-dependent diabetics with 
regard to HLA-B8 and HLA-Bwl5 frequencies may explain some of the 
discrepancies i n published r e s u l t s . Singal and Blajchman (1975) 
found a si g n i f i c a n t excess of HLA-Bwl5 positive individuals amongst 
th e i r sample of insulin-taking diabetics but not an excess of HLA-
B8. They used a comparatively old population of diabetics (mean 
59.5 years,range 18 - 84 years) and,although they do not give the 
Figure 7»2(a) Frequency of HLA-B8 i n insulin-taking diabetica 
according to age at diagnosis (from Dausset,1977). 
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Figure 7.2(b) Frequency of HLA-Bwl5 i n insulin-taking diabetics 
according to age at diagnosis (from Dausset,1977). 
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ages at diagnosis of these patients,because of the phenomenon of 
'frequency reduction 1 (see chapter 8 ) , i t i s most l i k e l y that they 
were also of comparatively late age at diagnosis. This may account 
f o r t h e i r r e s u l t . Both Catheli'eau et a l (1975) and Garavoy et a l 
(1977) found the reverse - a sig n i f i c a n t excess of HLA-B8 positive 
individuals amongst insulin-taking diabetics but no excess of HLA-
Bwl5. They both studied a comparatively young population. 
Cathelineau et a l (1975) had only 20 individuals who had presented 
a f t e r the age of 35 years. A l l the patients studied by Garavoy et 
al (1977) were under 20 years of age at diagnosis. 
The findings of Cudworth and Woodrow (1976) d i f f e r from 
a l l these reports and the findings of the present study i n suggesting 
associations with both HLA-B8 and HLA-Bwl5 i n insulin-taking diabetics 
diagnosed before 30 and an association only with HLA-B8 i n diabetics 
diagnosed a f t e r t h i s age. Their data show a suggested increase i n 
HLA-Bwl5 f o r insulin-taking diabetics diagnosed a f t e r the age of 
30 and t h i s may have reached significance with increase of the sample 
size. The effec t on the r e l a t i v e incidence of a certain a l l e l e i n 
a disease of the frequency i n the general population w i l l be 
discussed at the end of t h i s chapter. 
The HLA gene frequencies f o r diabetics of various types 
and f o r controls are given i n table 7*83. Linkage disequilibrium 
(delta) values and haplotype frequencies were computed f o r every 
a l l e l i c combination and f o r each group. The results are not given 
i n f u l l but table 7.84 shows the haplotype frequencies and delta 
values f o r some important haplotypes. 
3«6 
Table 7 .83 HLA gene f r e q u e n c i e s i n d i a b e t i c s and i n c o n t r o l s 
Locus A l l e l e 
I n s . - t a k i n g 
d i a b e t i c s 
d i a g n o s i s 
<30 
I n s . - t a k i n g 
d i a b e t i c s 
d i a g n o s i s 
30+ 
A l l i n s . -
t a k i n g 
d i a b e t i c s 
A l l non-
i n s u l i n -
t a k i n g 
d i a b e t i c s 
A l l 
c o n t r o l s 
HLA-A1 0 .2213 0.1866 0 .2062 0 .2118 0.1882 
HLA-A2 0 .3521 0 .4199 0 .3805 0 .2443 0 .2884 
HLA-A3 0 .983 0 .0743 0.0879 0.1349 0.1547 
A HLA-A9 0.0821 0 .0957 0.0879 0.0804 0.0691 
HLA-A10 0.0775 0.0604 0.0667 0 .0914 0.0585 
HLA-Al1 0 .0300 0 .0464 0 .0371 0 .0342 0.0480 
Blank 0.1447 0 .1167 0 .1337 0.2030 0.1931 
HLA-B5 0 .0256 0 .0548 0.0381 0 .0633 0 .0507 
HLA-B7 0 .0845 0.0690 0.0777 0 .1583 0 .1498 
HLA-B8 0 .3245 0 .1995 0.2679 0 .1544 0.1611 
HLA-B12 0.1532 0 .1205 0 .1388 0.1622 0 .1892 
B HLA-B13 0.0361 0 .0134 0 .0262 0.0303 0 .0199 
HLA-B14 0 .0205 0 .0408 0 .0292 0 .0269 0.0367 
HLA-B17 0.0102 0 .0067 0.0087 0.0286 0.0381 
HLA-B27 0 .0466 0.0408 0 .0441 0.0545 0 .0421 
HLA-BW15 0 .1182 0 .1913 0.1489 0 .0939 0 .0635 
Blank 0 .1806 0 .2632 0.2204 0.2276 0.2489 
as / . 
Table 7*84 HLA haplotype frequencies (upper figure) and delta values 
f o r selected haplotypes i n diabetics and controls. 
Haplotype Diabetics Controls 
I n s u l i n -
taking 
Kon-insulin-
taking 
1-8 0.1645 0.1116 0.1229 
+0.1093 +0.0789 +0.0926 
2-12 0.0848 0.0473 0.0969 
+0.0320 +0.0077 +O.O423 
3-7 0.0068 0.0527 0.0600 
+0.0185 +0.0314 +0.0368 
2-wl5 0.0567 0.0257 0.0358 
+0.0181 +0.0028 +0.0175 
1-5 0 0.0071 0 
-0.0140 -0.0063 -0.0123 
1-12 0.0072 0.0279 0 
-0.0358 -O.OO64 -0.0367 
2-8 0 0.0239 0.0105 
-0.0569 -0.0138 -O.O36O 
3-8 0.0043 O.OO65 0.0097 
-0.0278 -0.0143 -0.0153 
3W-
7..16 Summary and discussion. 
The positive findings i n the analysis of polymorphism 
results i n diabetics and controls are that associations exist i n 
the ABO and HLA systems but not i n any of the others examined. 
The association with the ABO system confirms the findings 
of a large number of previous authors (Craig and Wang,1955;McConnell 
et a l , 1956;Zeytinoglu,1956;Cornil and Pirart,196l;Bibawi and Khatwa, 
196l;Doll et al,196l;Sauer et al,1963;Serra et al,1964;Revai and 
Konig,1968,and Ksenofontor,1974) i n finding an excess of group A 
individuals amongst the diabetics. The present findings that t h i s 
excess i s greater amongst males than amongst females and greater 
amongst the older diabetics than amongst the younger,are also i n 
agreement with some of these authors. 
This association i s suggested to be the result,not of 
any greater predisposition of group A individuals to the disease but 
of an absence of d i f f e r e n t i a l mortality with regard to the ABO 
system i n diabetics,whereas t h i s d i f f e r e n t i a l m o r t a l i t y i s present 
i n non-diabetics. The re s u l t i s that the non-diabetic population 
sees a reduction i n i t s frequency of group A individuals with age, 
whereas the diabetic population does not,giving an apparent excess of 
group A individuals amongst older diabetics. 
Cardiovascular disorders are a l i k e l y candidate f o r t h i s . 
Diabetic individuals suffer from these diseases more frequently and 
more severely than non-diabetics and i t may be that,once diabetic,these 
diseases progress s w i f t l y irrespective of ABO blood group whereas,in 
the non-diabetic the blood group A person i s more severely affected 
as suggested by Mourant et a l . ( l 9 7 l ) . 
The associations between in s u l i n - r e q u i r i n g diabetes and 
the B8 and Bwl5 a l l e l e s of the HLA-B locus found by previous workers 
(f o r example,Nerup et al,1974»Cudworth and Woodrow,1974) have been 
confirmed. A larger number of non-insulin-taking diabetics than has 
been previously reported i s considered here f o r the HLA system. No 
s i g n i f i c a n t associations have been demonstrated though oral hypo-
glycaemic-taking diabetics show an interesting excess of B8 positive 
individuals. Investigation of a larger number of such diabetics 
might reveal that t h i s i s a true association and,if t h i s were the case, 
would be most l i k e l y to be the result of the inclusion of some type I 
diabetics under t h i s heading. 
Heterogeneity with regard to age at diagnosis and HLA 
genotype i s suggested with B8/wl5 heterozygotes presenting predominantly 
i n the f i r s t decade of life,B8 positive individuals presenting i n the 
f i r s t four decades predominantly and the Bwl5 positive individuals 
presenting throughout t h i s time but making the greatest contribution 
to diabetics diagnosed a f t e r the age of 40. This heterogeneity has 
been noted before (Cudworth,personal communication) and i t i s 
suggested that t h i s phenomenon can explain at least part of the 
disagreement between authors on associations between diabetes and 
t h i s sytem. 
The necessity of age matching when conducting an investigation 
of t h i s kind i s emphasised. Comparison of the Rhesus phenotype 
frequencies without age matching,for example,shows a s i g n i f i c a n t 
difference between insulin-taking and non-insulin-taking diabetics 
with an excess of R^ R^  individuals amongst the l a t t e r group (chi 
squared = 12.36,for f i v e degrees of freedom,p*" 0.05 >-0.025). These 
differences disappear when age i s taken into account. 
There seems to be l i t t l e j u s t i f i c a t i o n f o r s t r i c t age 
matching when phenotype frequencies only are considered i n >. the HLA 
system. When gene frequencies or haplotype frequencies are considered, 
however,a case may be made out f o r matching the populations considered 
since the calculation of these frequencies takes in t o account the 
numbers of individuals homozygous f o r each s p e c i f i c i t y and t h i s has 
been shown,at least f o r the HLA-B locus to be related to age. 
L i t t l e attention has been paid to the possible relationship 
between the frequency of an a l l e l e i n the general population and the 
magnitude f o r the r e l a t i v e r i s k of that a l l e l e i n a disease where 
association exists. The r e l a t i v e r i s k f o r the HLA-B8 a l l e l e i n i n s u l i n -
dependent diabetics may be deduced from the data of Dausset(1977)»shown 
i n figure 7 . 2(a) to be 4 . 6 . In the present series t h i s r e l a t i v e r i s k 
i s 2.69 (considering early-onset insulin-dependent diabetes i n both 
cases). This difference may be accounted f o r by the difference i n the 
frequency of t h i s a l l e l e i n the general population i n Prance (about 10?<>) 
and that i n County Durham (29.5 $ ) • Where the population frequency i s 
zero (e.g. Japan) the r e l a t i v e r i s k i s either zero or i n f i n i t y ( i f 
HLA-B8 positive individuals are found amongst diabetics but not amongst 
the non-diabetic controls). 
Chapter 8 
C l i n i c a l diabetes i n the Durham area. 
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Chapter 8 
8 .1 Introduction. 
8.2 Description of the 1975 Dryburn diabetic outpatient population. 
(a) Age of the patients attending. 
(b) Age at diagnosis. 
(c) Duration of the disease, 
(e) Appointments. 
8.5 Newly-diagnosed diabetics i n 1975 and 1976. 
8.4 Retrospective analysis of month of diagnosis. 
8.5 Assessing the prevalence i n the general population. 
(a) Determining the number of c l i n i c a l l y diagnosed diabetic 
i n the population. 
(b) Census s t a t i s t i c s . 
(c) The prevalence of diabetes. 
8.6 Summary. 
8.1 Introduction. 
The epidemiological aspects of t h i s study arose as a 
natural consequence of the genetic investigations. The diabetic 
outpatient c l i n i c s at Dryburn had to be sampled and,to put the sample 
in t o perspective,it was necessary to determine the characteristics of 
the complete outpatient population from which i t was drawn. Since the 
date of onset of diabetes i n each patient had to be ascertained i t was 
a natural extension to investigate retrospectively the pattern of 
occurrence of new cases of diabetes with time. For the analysis of 
family data,an estimate of the prevalence of various types of diabetes 
i n the general population was required and t h i s necessitated i d e n t i f y i n g 
a l l known cases of diabetes i n the area and the use of Census s t a t i s t i c s . 
These three aspects - the characteristics of the outpatient 
population,the pattern of occurrence of new cases and the estimation of 
age-specific prevalence rates f o r the area - constitute the subject 
matter of t h i s chapter. 
8.2 Description of the 1975 Dryburn diabetic outpatient population. 
The advantages of using t h i s particular c l i n i c f o r t h i s 
investigation have been discussed i n chapter 4 and some of the data 
were also given i n that chapter. 
Although diabetics were studied from November,1974 to 
June,1976,the year of 1975 has been chosen as a convenient temporal 
un i t f o r discussion. 
(a) Age of the patients attending. 
Confirmed diabetics being treated as out-patients during t h i s 
period t o t a l l e d 936. Of these,377 (40.3$) were male and 559 (59.7%) 
were female. The ages of a l l patients were calculated as of 1.1.76 
and are given i n tables 8.1(a) (males) and 8.1(b) (females). The mean 
age of the male patients was 56.6 years (standard deviation +17.9),with 
the youngest patient attending being 4.1 years old and the oldest 87.9. 
The mean age of the females was 62.9 years (standard deviation +16.4) 
with a range of 3.1 to 92.2 years. The figures i n tables 8.1(a) and 
(b) are given separately f o r treatment sub-groups. Diagramatic 
representation may be seen i n figures 8.1(a) and 8.1(b). 
(b) Age at diagnosis. 
The date of diagnosis ( i n most cases the date on the i n i t i a l 
r e f e r a l l e t t e r ) of 23 individuals was unknown. For the remaining 913 
the age at diagnosis i n f i v e year age groups i s shown i n tables 8.2(a) 
(males) and 8.2(b) (females). The mean age f o r diagnosis i n males i s 
48.3 years (standard deviation 19.4)»range from 0.2 years to 84.9years. 
The mean age i n females was 54.7 years (standard deviation 17.8) with a 
range of 1.8 years to 90.6 years. 
Figure 8.2 shows the d i s t r i b u t i o n of age at diagnosis f o r 
both sexes combined,the population being divided i n t o diabetics 
currently receiving i n s u l i n and diabetics being treated without i t . 
I n s u l i n therapy i s by no means the exclusive prerogative of diabetics 
diagnosed early i n l i f e . 129 (51.4%) of those on i n s u l i n were 
diagnosed a f t e r the age of 30 although there may be a tendency i n a 
diabetic c l i n i c to review patients on i n s u l i n p r e f e r e n t i a l l y . The 
nine individuals not receiving i n s u l i n and diagnosed before the age of 
30 were discussed i n chapter 5« 
BIG. 
Table 8.1 (a) Breakdown by age (on 1.1.76) and current treatment of 
male diabetics attending Dryburn out-patients i n 1975. 
Age 
(yrs) 
Current treatment A l l 
ales 
Cumulative 
frequency I n s u l i n Tablets Diet m 
0-4 2 ( 1.9*) 0 0 2 ( 0.5*) 0 .5* 
5-9 3 ( 2.3*) 0 0 3 ( 0.8*) 1 .3* 
10-14 5 ( 3.8*) 0 0 5 ( 1.3*) 2 .7* 
15-19 10 ( 7.6*) 0 0 10 ( 2.7*) 5.3* 
20-24 10 ( 7.6*) 1 ( 1.0*) 0 11 ( 2.9*) 8.2* 
25-29 10 ( 7 . # ) 0 0 10 ( 2.7*) 10 .9* 
30-34 9 ( 6.9*) 0 1 ( 0.7*) 10 ( 2.7*) 13 .5* 
35-39 7 ( 5.3*) 1 ( 1.0*) 3 ( 2.1*) 11 ( 2.9*) I6.4* 
40-44 10 ( 7.6*) 4 ( 3.9*) 6 ( 4.2*) 20 ( 5.3*) 21.8* 
45-49 13 ( 9.9*) 9 ( 8.7*) 6 ( 4.2*) 28 ( 7.4*) 29.2* 
50-54 9 ( 6.9*) 8 ( 7.8*) 20 (14.0*) 37 ( 9.8*) 39.0* 
55-59 18 (13 .7*) 8 ( 7.8*) 14 ( 9.8*) 40 (10.6*) 49.6* 
6O-64 7 ( 5.3*) 17 (16.5*) 22 (15.4*) 46 (12.2*) 61.8* 
65-69 8 ( 6.1*) 21 (20.4*) 26 (18.2*) 55 (14.6*) 76 .4* 
70-74 7 ( 5.3*) 15 (14.6*) 21 (14 .7*) 43 (11.4*) 87.8* 
75-79 1 ( 0.8*) 14 (13.6*) 15 (10 .5*) 30 ( 8.0*) 95.8* 
8O-84 1 ( 0.8*) 4 ( 3.9*) 6 ( 4.2*) 11 ( 2.9*) 98 .7* 
85-89 1 / *\ 1 ( l . o f c 3 ( 2.1*) 5 ( 1.3*) 100.0* 
Total 131 103 143 377 
Table 8.1 ("b) Breakdown by age (on 1.1.76) and current treatment of 
female diabetics attending Dryburn out-patients i n 1975. 
Age 
(yrs) 
Current treatment A l l 
•males 
Cumulative 
frequency In s u l i n Tablets Diet fe 
0-4 2 ( 1.7*) 0 0 2 ( 0.4*) 0.4* 
5-9 3 ( 2 .9*) 0 0 3 ( 0.5*) 0.9* 
10-14 6 ( 5.0*) 0 0 6 ( L I * ) 2.0* 
15-19 8 ( 6 .7*) 0 2 ( 1.0*) 10 ( 1.8*) 3.8* 
20-24 11 ( 9.2*) 0 0 11 ( 2.0*) 5.7* 
25-29 2 ( 1.7*) 0 1 ( 0.5*) 3 ( 0.5*) 6.3* 
30-34 6 ( 5.0*) 0 2 ( 1.0*) 8 ( 1.4*) 7.7* 
35-39 6 ( 5.0*) 2 ( 0.9*) 4 ( 1.9*) 12 ( 2.1*) 9.8* 
40-44 10 ( 8.3*) 5 ; 2.1*) 5 ( 2.4*) 20 ( 3.6*) 13 . 4* 
45-49 6 ( 5.0*) 6 : 2.6*) 5 ( 2.4*) 17 ( 3.0*) I6.5* 
50-54 6 ( 5.0*) 9 (3.9*) 8 ( 3.9*) 23 ( 4.1*) 20.6* 
55-59 10 ( 8.3*) 23 [ 9.9*) 16 ( 7.8*) 49 ( 8.8*) 29.3* 
60-64 11 ( 9.2*) 36 [15.5*) 37 (18.0*) 84 (15.0*) 44.4* 
65-69 13 (10.8*) 42 1 [18.0*) 40 (19.4*) 95 (17.0*) 6I.4* 
70-74 7 ( 5.8*) 54 (23.2*) 42 (20.4*) 103 (18 . 4 * ) 79.8* 
75-79 7 ( 5 . # ) 43 (18.5*) 24 (11.7*) 74 (13.2*) 93.0* 
80-84 3 ( 2.5*) 9 ( 3 .9*) 12 ( 5.8*) 24 ( 4.3*) 97.3* 
85-89 3 ( 2.5*) 4 ( 1.7*) 5 (2.4 * ) 12 ( 2.1*) 99.5* 
90-94 0 0 3 ( 1.5*) 3 ( 0.5*) 100.0* 
Total 120 233 206 559 
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Table 8.2 (a) Breakdown by age at diagnosis and current treatment of 
male diabetics attending Dryburn out-patients i n 1975. 
Age at Current treatment A l l Cumulative 
diag. I n s u l i n Tablets Diet males frequency 
(yrs.) 
0-4 11 ( 8.4%) 0 0 11 ( 3.0*) 3 .0* 
5-9 9 ( 6.996) 0 0 9 ( 2 .5*) 5 .9* 
10-14 12 ( 9 .2$) 0 0 12 ( 3.3*) 8 .7* 
15-19 10 ( 7 .6*) 0 0 10 ( 2.7*) 11 .9* 
20-24 13 ( 9 .9*) 1 ( L I * ) 0 14 ( 3.8*) 15 .3* 
25-29 15 (11 .5*) 0 0 15 ( 4 .1*) 19 .4* 
30-34 7 ( 5.3*) 1 ( 1.1*) 4 ( 2 .9*) 12 ( 3.3*) 22 .7* 
35-39 14 (10 .7*) 5 ( 5.3*) 4 ( 2 .9*) 25 ( 6 .3*) 29 .0* 
40-44 8 ( 6 .1*) 8 ; 8.4*) 11 ( 7 .9*) 27 ( 7.4*) 36 .3* 
45-49 7 ( 5.3*) 11 (11.6*) 14 (10 .0*) 32 ( 8.7*) 4 5 . 1 * 
50-54 7 ( 5.3*) 11 (11.6*) 29 (20 .7*) 47 (12 .8*) 57 .9* 
55-59 7 ( 5.3*) 10 (10.5*) 11 ( 7 .9*) 28 ( 7.7*) 65 .6* 
60-64 7 ( 5.3*) 16 (16.8*) 27 (19 .3*) 50 (13 .7*) 7 9 . 2 * 
65-69 3 ( 2 .3$) 14 (14.7*) 23 (16 .4*) 40 (10 .9*) 9 0 . 2 * 
70-74 0 12 (12.6*) 10 ( 7 .1*) 22 ( 6 .0*) 9 6 . 2 * 
75-79 0 6 ( 6 .3*) 4 ( 2 .9*) 10 ( 2.7*) 9 8 . 9 * 
8O-84 X ( 0 .8*) 0 5 4 ( 1.1*) 100.0* 
Total 131 96 140 366 
• 
Table 8.2 (b) Breakdown by age a t diagnosis and current treatment of 
female d i a b e t i c s a t t e n d i n g Dryburn o u t - p a t i e n t s i n 1975• 
Age a t Current treatment A l l Cumulative 
diag. I n s u l i n Tablets Diet females frequency 
( y r s . ) 
0-4 7 ( 5.80) 0 0 7 ( 1.30) 1.30 
5-9 13 (10.80) 0 0 13 ( 2.40) 3.70 
10-14 10 ( 8.30) 0 0 10 ( 1.80) 5.50 
15-19 7 ( 5.80) 0 2 ( 1.00) 9 ( 1.60) 7.10 
20-24 10 ( 8.30) 0 0 10 ( 1.80) 9.00 
25-29 5 ( 4.20) 1 ( 0.40) 5 ( 2.50) 11 ( 2.00) 11.00 
30-34 5 ( 4.20) 4 [ 1.80) 3 ( 1.50) 12 ( 2.20) 13.20 
35-39 10 ( 8.30) 5 1 [ 2.20) 7 ( 3.50) 22 ( 4.00) 17.20 
40-44 7 ( 5.80) 11 1 [ 4.90) 8 ( 4.00) 26 ( 4.80) 21.90 
45-49 6 ( 5.00) 21 I : 9.30) 7 ( 3.50) 34 ( 6.20) 28.20 
50-54 15 (12.50) 32 [14.20) 20 ( 9.90) 67 (12.20) 40.40 
55-59 8 ( 6.70) 31 [13.80) 39 (19.30) 78 (14.30) 54.70 
60-64 7 ( 5.80) 43 [19.10) 38 (18.80) 88 (16.10) 70.70 
65-69 5 ( 4.20) 33 [14.70) 36 (17.80) 74 (13.50) 84.30 
70-74 3 ( 2.50) 20 [ 8.90) 17 ( 8.40) 40 ( 7.30) 91.60 
75-79 2 ( 1.70) 20 ( [ 8.90; 10 ( 5.00) 32 ( 5.90) 97.40 
8O-84 0 3 [ 1.30) 7 ( 3.50) 10 ( 1.80) 99.30 
85-89 0 1 ( k 0.40) 2 ( 1.00) 3 ( 0.50) 99.80 
90-94 0 0 1 ( 0.50) 1 ( 0.20) 100.00 
T o t a l 120 225 202. 547 
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(c) J u r a t i o n of the disease. 
The d u r a t i o n of the disease (measured up u n t i l 1.1.76) 
f o r those i n d i v i d u a l s whose date o f diagnosis was known i s given i n 
tables 8.5(a) and 8.3 ( b ) . The mean d u r a t i o n of diabetes i n males was 
7.9 years (standard d e v i a t i o n 7.3) w i t h a range of 0.05 years t o 47.0. 
The mean d u r a t i o n f o r females was 8.2 years (standard d e v i a t i o n 7.4), 
range 0.05 years t o 40.0 years. The d i s t r i b u t i o n o f d u r a t i o n of 
disease i s skewed t o the r i g h t i n both sexes w i t h the m a j o r i t y having 
been diagnosed as d i a b e t i c s f o r less than seven years. This i s r e l a t e d 
to the phenomenon of 'frequency r e d u c t i o n 1 noted by Darlow et a l (1973) 
t o be enlarged upon l a t e r i n t h i s chapter. 
The e x c e p t i o n a l l y long-established d i a b e t i c s w i t h diagnosis 
of t h e i r disease more than 40 years ago (one male,one female) are 
noteworthy f o r t h e i r l ack of complications. They have both been main-
tained on i n s u l i n since diagnosis. The male patient,diagnosed a t the 
age of 24 ( i n 1928) i s a member of the f a m i l y discussed as being a 
possible example of the M.O.D.Y. type of diabetes i n chapter 5« His 
endogenous i n s u l i n s e c r e t i o n may w e l l have been suppressed by the 
a d m i n i s t r a t i o n of i n s u l i n f o r over 40 years. The female i n t h i s group 
i s one of the i n s u l i n - t a k i n g d i a b e t i c s w i t h the lowest value f o r the 
p r o b a b i l i t y of becoming d i a b e t i c assessed on f a m i l y h i s t o r y and i t 
i s tempting t o c i t e t h i s as supportive of the conclusions made about 
t h i s matter i n chapter 5« 
The phenomenon of frequency r e d u c t i o n i s i l l u s t r a t e d i n 
ta b l e 8.4. This shows a c r o s s t a b u l a t i o n o f curr e n t age ( i n decades) 
against decade of age a t diagnosis. The percentage f i g u r e s i n brackets 
denote the p r o p o r t i o n t h a t number i n any decade of age a t diagnosis 
represents of the t o t a l i n the curr e n t age decade. 
4-0 J . 
Table 8.5 (a) Breakdown by d u r a t i o n of disease (on 1.1.76) and cur r e n t 
treatment o f male d i a b e t i c s a t t e n d i n g Dryburn o u t - p a t i e n t s 
i n 1975. 
Dum. 
( y r s ) 
Current treatment A l l Cumulative 
frequency I n s u l i n Tablets Diet males 
0-4 38 (29.0$) 53 (55.8*) 78 (55.7*) 169 (46.2*) 46.2$ 
5-9 30 (22.9$) 24 (25.3*) 31 (22.1*) 85 (23.2*) 69.4$ 
10^14 18 (13.7$) 12 (12.6*) 24 (17.1*) 54 (14.8*) 84.2* 
15-19 23 (17.6$) 3 ( 3.2*) 6 ( 4.3*) 32 ( 8.7*) 92.9* 
20-24 7 ( 5.396) 3 ( 3.2*) 1 ( 0.7*) 11 ( 3.0*) 95.9* 
25-29 8 ( 6.1$) 0 0 8 ( 2.2*) 98.1* 
30-34 6 ( 4.#) 0 0 6 ( 1.6*) 99.7* 
35-39 0 0 0 0 99.7* 
40-45 0 0 0 0 99.7* 
45-49 1 ( 0.8*) 0 0 1 ( 0.3*) 100.0* 
T o t a l 131 95 140 366 
Table 8.3 (b) Breakdown by d u r a t i o n of disease (on 1.1.76) and 
curren t treatment o f female d i a b e t i c s a t t e n d i n g Dryburn 
o u t - p a t i e n t s i n 1975. 
Sum. 
( y r s ) 
Current treatment A l l 
females 
Cumulative 
frequency I n s u l i n Tablets D i e t 
0-4 31 (25.8/0 94 (41.80) 114 (56.40) 239 (43.70) 43.70 
5-9 27 (22.5/o) 58 (25.80) 42 (20.80) 127 (23-20) 66.90 
10-14 20 (16.7$) 38 (16.90) 29 (14.40) 87 (15.90) 82.80 
15-19 19 (15-80) 18 ( 8.00) 8 ( 4.00) 45 ( Q.20) 91.00 
20-24 9 ( 7.50) 14 ( 6.20) 5 ( 2.50) 28 ( 5.10) 96.20 
25-29 7 ( 5.80) 3 ( 1.30) 3 ( 1.50) 13 ( 2.40) 98.50 
30-34 3 ( 2.50) 0 1 ( 0.50) 4 ( 0.70) 99.30 
35-39 3 ( 2.50) 0 0 3 ( 0.50) 99.80 
40-44 1 ( 0.80) 0 0 1 ( 0.20) 100.00 
T o t a l 120 255 202 547 
Table 8.4 D i s t r i b u t i o n of d i a b e t i c s a t t e n d i n g Dryburn o u t - p a t i e n t s i n 
1975 according t o decade of age and decade of age a t diagnosis 
(age a t diagnosis unknown f o r 22 i n d i v i d u a l s ) . 
Decade of age a t diagnosis 
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99 T o t a l 
10 
(100$) 
10 
10-19 17 
(54.8) 
14 
(45-2) 
31 
20-29 10 
(28.6) 
13 
(37.1) 
12 
(54.3) 
35 
30-39 ( 5^0) 
9 
(22.5) 
18 
(45.0) 
11 
(27.5) 
40 
40-49 
( 1-2) 
4 
( 4.8) 
11 
(13.3) 
28 
(33.7) 
39 
(47.0) 
83 
50-59 
( 0.7) 
7 
( 4.7) 
23 
(15.5) 
48 
(32.4) 
69 (46.6) 
148 
60-69 1 
( 0.4) 
7 
( 2.6) 
23 
( 8.5) 
110 
(40.7) 
129 
(47.8) 
270 
70-79 1 
( 0.4) 
9 
( 3.7) 
39 
(16.0) 
109 
(44.7) 
86 
(35.2) 
244 
80-89 2 
( 4.1) 
14 
(28.0) 
18 
(36.7) 
15 (30.6) 49 
90-99 2 (66.7) (33*3) 
3 
40 41 50 69 119 220 252 104 17 1 
4-efe. 
For any decade of curre n t age a greater number of p a t i e n t s 
were diagnosed w i t h i n t h a t decade than would be expected by chance and 
the frequency,in most cases,becomes reduced as one moves backwards i n 
terms of decade of age a t diagnosis. 
As suggested by Darlow e t a l (1973) t h i s could be the 
r e s u l t higher d e t e c t i o n r a t e s f o r diabetes i n the present decade 
compared w i t h previous decades. A l t e r n a t i v e l y . d i a b e t i c s could be 
moving out of the p o p u l a t i o n once diagnosed. This i s more of a 
p o s s i b i l i t y i n t h i s case than i n the case of the Edinburgh p o p u l a t i o n 
since the f i g u r e s given i n t a b l e 8.5 are f o r an o u t p a t i e n t p o p u l a t i o n . 
Another possible explanation,and perhaps the most l i k e l y , i s t h a t 
frequency r e d u c t i o n i s the r e s u l t o f heavy m o r t a l i t y amongst the 
d i a b e t i c p o p u l a t i o n . 
(e) Appointments. 
Of the 936 confirmed d i a b e t i c s a t t e n d i n g Dryburn h o s p i t a l 
i n 1975»17 (nine males and e i g h t females) were a t t e n d i n g the p a e d i a t r i c 
c l i n i c , t h e remainder a t t e n d i n g the general medical and g e r i a t r i c 
departments. I n a d d i t i o n t o these 919 a d u l t d i a b e t i c s these l a t t e r 
c l i n i c s saw 19 new r e f e r a l s who were found t o have g l y c o s u r i a by t h e i r 
general p r a c t i t i o n e r s or at a r o u t i n e medical examination but who 
were not confirmed as d i a b e t i c on i n v e s t i g a t i o n a t the h o s p i t a l . 
These 938 a d u l t p a t i e n t s had 3»259 booked appointments 
d u r i n g the course of the year. I t i s d i f f i c u l t t o estimate how 
many of them were a c t u a l l y kept since not a l l p a t i e n t s a t t e n d i n g 
the c l i n i c s are recorded as doing so by the medical records department. 
There i s a record o f 2,228 d e f i n i t e attendances i n 1975 so t h a t the 
tru e number o f attendances l i e s somewhere between these f i g u r e s . 
4.0?. 
The d i s t r i b u t i o n of the number of booked appointments per 
i n d i v i d u a l i s shown,for the ad u l t s o n l y , i n t a b l e 8.6. The number of 
such appointments ranges from 16 f o r one i n d i v i d u a l t o one,with a 
modal value of two,or one appointment every s i x months. The consultants' 
work-to-rule i n December of t h a t year make these f i g u r e s somewhat 
a t y p i c a l of the work-load of these c l i n i c s . 
8.3 Newly-diagnosed d i a b e t i c s i n 1975 and 1976. 
During the course of 1975*120 i n d i v i d u a l s were r e f e r e d t o 
the various o u t - p a t i e n t c l i n i c s a t Dryburn w i t h a presumptive diagnosis 
of diabetes. Of these,101 were confirmed as d i a b e t i c a f t e r a glucose 
tolerance t e s t , t h e remaining 19 were labeled as 'renal g l y c o s u r i a 1 or 
'low r e n a l t h r e s h o l d " . I n the f o l l o w i n g year 101 i n d i v i d u a l s were 
re f e r e d to the c l i n i c s , 9 6 being confirmed as d i a b e t i c and 15 regarded 
as having a normal glucose tolerance t e s t w i t h a 'low r e n a l t h r e s h o l d ' . 
I t i s noteworthy t h a t the 197 confirmed d i a b e t i c s r e f e r e d i n these two 
years show an even d i s t r i b u t i o n of the sexes w i t h 97 males and 100 
females whereas,in co n t r a s t , t h e 'low r e n a l t h r e s h o l d ' group show a 
preponderance of males (26 males t o 8 females). Comparison of the new 
d i a b e t i c s and the 'low re n a l t h r e s h o l d 1 group reveals t h a t t h i s d i f f e r e n c e 
i s s i g n i f i c a n t w i t h a c h i squared value of 8.65 ( d . f . = l ) and p<0.005. 
This i n t e r e s t i n g group w i t h 'low r e n a l t h r e s h o l d ' would be 
worthy of & follow-up study i n Durham t o determine how many subsequently 
became confirmed as d i a b e t i c . C e r t a i n l y many o f the curre n t d i a b e t i c s 
i n t h i s p o p u l a t i o n were confirmed as d i a b e t i c a f t e r a f i n d i n g of 
gl y c o s u r i a which was not t h e i r f i r s t . 
Table 8.6 Number of booked appointments a t Dryburn a d u l t d i a b e t i c 
c l i n i c d u r i n g 1975. 
No. appointments No. of i n d i v i d u a l s 
1 139 
2 250 
3 140 
4 168 
5 88 
6 48 
7 40 
8 15 
9 11 
10 7 
11 5 
12 4 
13 2 
14 1 
15 0 
16 1 
T o t a l 919 
The mean age of d i a b e t i c s diagnosed i n 1975 was 56.8 
years,the youngest "being 2.5 years o l d and the ol d e s t 84.0. Of those 
diagnosed i n 1976 the mean age was 54.3 years a t diagnosis,range being 
4.5 years t o 86.1 years. 
The d i s t r i b u t i o n of the ages a t diagnosis of these groups 
are shown i n ta b l e 8.7. 
8.4 Retrospective a n a l y s i s o f month of diagnosis. 
The month of diagnosis of 800 d i a b e t i c s a t t e n d i n g a t Dryburn 
i s shown i n t a b l e 8.8. I n t h a t these data include those diagnosed a f t e r 
the survey was i n i t i a t e d , t h e data are p a r t l y prospective but the m a j o r i t y 
of the i n f o r m a t i o n i s r e t r o s p e c t i v e l y derived and s u f f e r s from the 
defects of such a study. 
The onset of the disease i n n o n - i n s u l i n - t a k i n g d i a b e t i c s 
i s randomly d i s t r i b u t e d throughout the year w i t h 288 (49.4*) presenting 
i n the w i n t e r h a l f o f the year and 295 (50.6*) i n the summer h a l f . 
The 217 cases of insulin-dependent d i a b e t e s , i r r e s p e c t i v e 
o f age at diagnosis,show a s l i g h t p r e d i l i c t i o n f o r diagnosis d u r i n g the 
w i n t e r months (112 or 51.6* diagnosed between October and March), 
although t h i s i s not s t a t i s t i c a l l y s i g n i f i c a n t . 
Tables 8.9 and 8.10 show the months o f diagnosis of i n s u l i n -
dependent diabetes diagnosed before the age of 30 years (8.9) and a f t e r 
t h i s age (8.10). The only s t r i k i n g f e a t u r e i s the peak f o r presentation 
of the under 30 group i n February,a peak which i s not seen i n the 
i n s u l i n - t a k i n g p a t i e n t s w i t h a l a t e r age of onset. 
Table 8.7 Age a t diagnosis of d i a b e t i c s diagnosed i n 1975 and 1976. 
Age 
( y r s ) 
No.& frequency ($) diagnosed i n 
1975 1976 1975 & 1976 
0-4 2 ( 2.0) 1 ( 1.0) 3 ( : 1.5) 
5-9 2 ( 2.0) 1 ( 1.0) 3 ( : 1.5) 
10-14 1 ( 1.0) 4 ( 4.2) 5 1 : 2.5) 
15-19 1 ( 1.0) 2 ( 2.1) 3 I : 1.5) 
20-24 0 6 ( 6.3) 6 { : 3.0) 
25-29 3 ( 3.0) 2 ( 2.1) 5 < : 2.5) 
30-34 0 2 ( 2.1) 2 ( i 1.0) 
35-39 7 ( 6.9) 3 ( 3.1) 10 1 ; 5.1) 
40-44 8 ( 7.9) 4 ( 4.2) 12 1 : 6.1) 
45-49 5 ( 5.0) 6 ( 6.3) 11 ( : 5.6) 
50-54 9 ( 8.9) 9 ( 9.4) 18 : 9.1) 
55-59 7 ( 6.9) 10 (10.4) 17 1 ; 8.6) 
60-64 20 (19.8) 11 (15.5) 31 [15.7) 
65-69 12 (11.9) 15 (15.6) 27 i [13.7) 
70-74 9 ( 8.9) 7 ( 7.3) 16 [ 8.1) 
75-79 12 (11.9) 8 ( 8.3) 20 ( [10.1) 
80-84 3 ( 3.0) 3 ( 3.1) 6 I ; 3.0) 
85-89 0 2 ( 2.1) 2 I ; 1.0) 
Totals 101 96 197 
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Table 8.8 Month of diagnosis of d i a b e t i c s by cur r e n t treatment. 
Number and frequency ($) 
Month of I n s . - t a k i n g Non-ins.-taking 
diagnosis Tablets D i e t T o t a l 
January 18 ( 8.3) 28 (10.6) 26 ( 8.2) 54 ( 9.3) 
February 25 (H.5) 21 ( 7.9) 26 ( 8.2) 47 ( 8.1) 
March 20 ( 9.2) 13 ( 4.9) 30 ( 9.4) 43 ( 7.4) 
A p r i l 23 (10.6) 18 ( 6.8) 26 ( 8.2) 44 ( 7.5) 
May 16 ( 7.4) 23 ( 8.7) 31 ( 9.7) 54 ( 9.3) 
June 20 ( 9.2) 26 ( 9.8) 27 ( 8.5) 53 ( 9.1) 
J u l y 16 ( 7.4) 24 ( 9.1) 26 ( 8.2) 50 ( 8.6) 
August 18 { 8.3) 25 ( 9.4) 20 ( 6.3) 45 ( 7.7) 
September 12 ( 5.5) 20 ( 7.5) 29 ( 9.1) 49 ( 8.4) 
October 17 ( 7.8) 21 ( 7.9) 40 (12.6) 61 (10.5) 
November 19 ( 8.8) 22 ( 8.3) 28 ( 8.8) 50 ( 8.6) 
December 13 ( 6.0) 24 ( 9.1) 9 ( 2.8) 33 ( 5.7) 
T o t a l s 217 265 318 583 
Winter 112 (51.6) 129 (48.7) 159 (50.0) 288 (49.4) 
Summer 105 (48.4) 136 (51.3) 159 (50.0) 295 (50.6) 
4.1 a. 
Table 8.9 Month of diagnosis of i n s u l i n - t a k i n g d i a b e t i c s diagnosed 
before the age of 30. 
Month of diagnosis No. & frequency (fo) 
January 7 ( 6.4) 
February 19 (17.4) 
March 6 ( 5.5) 
A p r i l 11 (10.l) 
May 11 (10.1) 
June 9 ( 8.3) 
J u l y 8 ( 7.3) 
August 12 (11.0) 
September 5 ( 4.6) 
October 7 ( 6.4) 
November 8 ( 7.3) 
December 6 ( 5.5) 
Total: 109 
Winter 53 (48.6) 
Summer 56 (51.4) 
4-13 
Table 8.10 Month of diagnosis of i n s u l i n - t a k i n g d i a b e t i c s diagnosed 
a f t e r the age of 30. 
Month o f diagnosis No. & frequency ($) 
January 11 (10.2) 
February 6 ( 5.5) 
March 14 (13.0) 
A p r i l 12 (11.1) 
May 5 ( 4.6) 
June 11 (10.2) 
J u l y 8 ( 7.4) 
August 6 ( 5.5) 
September 7 ( 6.5) 
October 10 ( 9.3) 
November 11 (10.2) 
December 7 ( 6.5) 
T o t a l 108 
Winter 59 (50.0) 
Summer 59 (50.0) 
The genetic polymorphisms studied were examined f o r 
pa t t e r n s i n the genotypes of i n d i v i d u a l s presenting as d i a b e t i c s 
a t various times of the year ( i n the three-monthly groups,January -
March,April - June,July - September and October - December). No 
s i g n i f i c a n t heterogeneity was detected. The data are not given here 
except f o r the HLA system ( t a b l e s 8.11 and 8.12) f o r i n s u l i n - t a k i n g 
d i a b e t i c s diagnosed before and a f t e r the age of 30. The d i s t r i b u t i o n 
of HLA-B8 i n d i v i d u a l s agrees w i t h the prospective study o f Garavoy e t 
a l (1977) i n t h a t no s i g n i f i c a n t c l u s t e r i n g of HLA-B8 p o s i t i v e 
i n d i v i d u a l s i s seen. 
There i s a suggestion of the c l u s t e r i n g of Bwl5 p o s i t i v e 
i n d i v i d u a l s d u r i n g the second s i x months of the year ( f o r the e a r l y -
onset p a t i e n t s ) and i n the f i r s t three months of the year ( f o r l a t e -
onset p a t i e n t s ) but these are not s i g n i f i c a n t . Cudworth e t a l (1977), 
i n t h e i r prospective study of diabetes i n Merseyside,found a s i g n i f i c a n t 
c l u s t e r i n g of Bwl5 p o s i t i v e i n d i v i d u a l s i n the f i r s t three months of 
1976. 
8.5 Assessing the prevalence i n the general p o p u l a t i o n . 
For comparative purposes i t was necessary to o b t a i n an 
estimate f o r the prevalence of various types of diabetes i n the general 
p o p u l a t i o n l i v i n g i n the Durham area. 
This was performed i n three stages - f i r s t l y a d e t e c t i o n 
survey f o r the enumeration of a l l c l i n i c a l l y diagnosed d i a b e t i c s i n 
the area a t a given time,secondly,the e x t r a c t i o n o f popula t i o n 
4.1'. 
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figures from the Census data and,thirdly,the calculation of age and 
sex specific prevalence rates f o r a l l diabetics and f o r diabetes 
subdivided by treatment. 
(a) Determining the number of c l i n i c a l l y diagnosed diabetics i n 
the population. 
A method f o r i d e n t i f y i n g these individuals was suggested 
by the local Family Practitioner Committee. A l l diabetics are e n t i t l e d 
to claim exemption from prescription charges under category (b) of 
l e a f l e t E.C.91 (Rev. 4/71) as sufferers from a chronic disease. The 
Durham Family Practitioner Committee was able to supply l i s t s of 
the names,addresses,dates of b i r t h and N.H.S. numbers of a l l such 
patients. These l i s t s included,not only diabetics but others who 
can also claim exemption (such as those with myxoedema,hypothyroidism 
and Addison's disease) and many diabetics,either those who have 
not claimed exemption or those who are over 60 or over 65 and who 
are exempt anyway,are not included on the l i s t s . 
To correct f o r these unwanted inclusions and exclusions 
the l i s t s were sent to the appropriate G.P. with a request to delete 
the names of patients who were not diabetic and to insert the names 
and relevant information f o r known diabetics who were not on the l i s t s 
already. 
As a p i l o t project,patients l i v i n g i n the area surrounding 
Durham c i t y were ascertained. This area consists of the Durham 
Rural D i s t r i c t and the parishes of Brandon and Byshottles and New 
Brancepeth. The parishes making up t h i s area are shown i n the map i n 
figure 8.3. 
These patients were derived from nine general practices 
417. 
Key to figure 8.3 Parishes comprising area under study. 
Population (1971) - 82,915 Area - 194 sq kilometers 
Code Parish 
1 Durham 
2 Bearpark 
3 Witton Gilbert 
4 Kimblesworth 
5 Framwellgate Moor 
6 Belmont 
7 West Rainton 
8 P i t t i n g t o n 
9 Sherburn 
10 Shadforth 
11 Sherburn House 
12 Whitwell House 
13 S h i n c l i f f e 
14 Sunderland Bridge 
15 Hett 
16 Cassop-cum-Quarrington 
1 7 Coxhoe 
18 Kelloe 
19 Brandon and Byshottles 
2 0 Brancepeth 
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and returned l i s t s were available f o r a l l but one of them. I t was 
possible to confirm the diagnoses of most of the patients on the 
one outstanding l i s t from the records of Dryburn Hospital but i t 
was not,of course possible to add diabetics known to the practice 
but not on the l i s t and not attending at Dryburn. 
The o r i g i n a l l i s t s f o r these nine practices contained 
278 individuals l i v i n g i n the designated area i n 1975* Of these, 
37 were removed by the practitioners as not being diabetic and 20 
were added,making 261 known diabetics. Of these,145 (55«5$) had 
attended Dryburn at some time during 1975*"the remaining 116 were 
either being reviewed by t h e i r general p r a c t i t i o n e r or being seen 
at another hospital. The records of the diabetic outpatient c l i n i c s 
at Dryburn revealed a further 376 diabetics resident i n t h i s area 
who had not been included on the o r i g i n a l exemption l i s t s and had 
not been added by the general practitioners showing that t h i s 
method i s unacceptable f o r the ascertainment of diabetics without 
the support of another method,since i t only revealed information 
about 41$ of the known diabetics i n the area. 
These diabetics,subdivided by current age and treatment 
are shown i n table 8.I3 (males) and 8.I4 (females). Those with 
unknown treatment come from the general pr a c t i t i o n e r s . 
This method was extended to include the whole of County 
Durham which necessitated c i r c u l a t i n g 92 general practices out of 
which less than half returned the ammended l i s t s . I n consequence, 
the prevalence figures presented here are f o r the area involved i n 
the p i l o t study only. 
The response from General Practitioners was best from 
those p a r t i c u l a r l y interested i n the disease,especially i f they 
47 ft • 
Table 8,13 Numbers of known diabetics i n each treatment group (males). 
Age Treatment Total 
I n s u l i n Tablets Diet Unknown 
0-9 1 0 0 0 1 
10-19 8 0 0 0 8 
20-29 10 1 0 3 14 
30-39 7 1 3 8 19 
40-49 11 9 8 2 30 
50-59 17 10 21 4 52 
60-69 9 23 30 12 74 
70 + 8 26 29 1 64 
Totals 71 70 91 30 262 
Table 8.14 Numbers of known diabetics i n each treatment group (females). 
Age Treatment Total 
I n s u l i n Tablets Diet Unknown 
0-9 3 0 0 1 4 
10-19 6 0 2 0 8 
20-29 9 0 1 1 11 
30-39 7 0 6 4 17 
40-49 11 3 7 2 23 
50-59 6 15 12 8 41 
60-69 15 48 55 9 127 
70 + 14 71 56 3 144 
Totals 71 137 139 28 375 
possessed a diagnostic index of t h e i r patients. From small single-
handed practices with no administrative assistance the response was 
understandably poor with,at best,a l i s t of patients derived from the 
doctors' memories. The numbers of diabetics included i n tables 8.13 
and 8.I4 are underestimates of the t o t a l diabetic population and there 
i s no way of assessing from the data the magnitude of the underestimation. 
(b) Census s t a t i s t i c s . 
The Geography Department of the University of Durham has 
census data which are available to researchers who have obtained 
clearance from the O.P.C.S. These data are stored on the basis of 
1 km g r i d squares so that,for ease of comparison,the s t a t i s t i c s f o r 
diabetes were computerised i n t h i s form also. The area shown i n 
figure 8.3 i s made up of a series of 194 of these squares both f o r 
the general population figures and f o r the detai l s of the places of 
residence of the diabetics. I t was hoped to compare disease 
prevalence figures f o r 1975 with those f o r the p a r t i a l census planned 
f o r 1976 but t h i s census was abandoned at the l a s t minute. Population 
projections on the basis of 1 km squares do not exist so that the disease 
figures f o r 1975 are compared with population figures f o r 1971. The 
estimated home population projection f o r the entire Northern area f o r 
1976 (Registrar General's S t a t i s t i c a l Review f o r 1971,part I I , t a b l e A6) 
shows an increase over the 1971 estimate of home population of .09$ 
(from 3,301,000 to 3,304,000) so that the error produced by t h i s 
imperfect comparison is,hopefully,not large,but must be influencing 
the estimates of prevalence. 
The figures f o r table 8.15 are b u i l t up from data f o r each 
Table 8 .15 1971 Census data for the general population. 
Age Sex Both 
Sexes Males Females 
0-9 6812 6494 13306 
10-19 7039 5843 12882 
20-29 7049 6077 13126 
30-39 5349 4851 10100 
40-49 5176 5129 10305 
50-59 4553 4689 9242 
60-69 3705 4413 8118 
70 + 2244 3592 5836 
Totals 41827 41088 82915 
4 3.3. 
g r i d square do not necessarily correspond exactly with the O.P.C.S. 
A 
s t a t i s t i c s f o r the whole area because of the 'adjustment procedures' 
employed i n the interests of c o n f i d e n t i a l i t y . 
(c) The prevalence of diabetes. 
The prevalence of c l i n i c a l l y diagnosed diabetes i n t h i s 
area i s given,for males only,in table 8.16(a),for females only i n 
table 8.16(b) and,for both sexes together,in table 8.16(c). 
Comparative data from the Edinburgh survey are also given. 
The prevalence of diabetes of a l l types irrespective 
of age and sex i n the Durham sample i s 7*68 per thousand (+0.3) 
compared with 6.26 (+0.l) i n Edinburgh i n 1969. The difference 
i s s i g n i f i c a n t though there i s no way of t e l l i n g whether t h i s i s 
the resu l t of differences i n ascertainment,a difference i n attack 
rate or detection rate i n Durham i n 1975 compared with Edinburgh i n 
1969,or a difference i n the disease characteristics of an urban 
(Edinburgh) and semi-rural (Durham) population. The prevalence 
rates f o r a l l diabetics i n the older age groups are considerably 
higher i n the present sample. The Edinburgh workers admit the 
p o s s i b i l i t y of under-estimation i n these groups,although t h i s i s 
also true of the Durham sample. 
For the calculation of prevalence rates f o r treatment 
sub-groups.it was necessary to assign individuals of unknown treatment 
to p a r t i c u l a r sub-groups. This was done on the same basis as f o r 
affected relatives of unknown treatment (chapter 5)» This i s 
open to c r i t i c i s m since those attending general practitioners 
and not the local hospital might be expected to be predominantly 
non-insulin-taking. 
4,? 
Table 8.l6(oQPrevalence (per thousand) i n males of diabetes. Data from 
Durham area (1975) with comparative data from Edinburgh (1969). 
Age Durham Edinburgh 
I n s u l i n Tablets Diet Total (Total) 
0-9 0.15 0 0 0.15 0.10 
10-19 1.14 0 0 1.14 0.92 
20-29 1.84 0.14 0 1.99 2.09 
30-39 2.29 0.38 0.95 3.62 3.06 
40-49 2.32 1.93 1.55 5.80 6.41 
50-59 3.95 2.42 5.05 11.42 9.95 
60-69 2.97 7.29 9.72 19.97 17.50 
70 + 3.57 12.03 12.92 28.52 19.45 
A l l ages 1.98 1.86 2.46 6.26 5.74 
Table 8.lfcflOPrevalence (per thousand) i n females of diabetes. Data from 
Durham area (1975) with comparative data from Edinburgh. 
Age Durham Edinburgh 
( t o t a l ) I n s u l i n Tablets Diet Total 
0-9 0.62 0 0 0.62 0.16 
10-19 1.03 0 0.34 1.37 0.94 
20-29 1.65 0 0.16 1.81 1.95 
30-39 1.85 0 I.65 3.50 2.59 
40-49 2.34 0.58 1.56 4.48 4.34 
50-59 1.49 4.05 3.20 8.74 8.17 
60-69 3.63 11.78 13.37 28.78 18.80 
70 + 3.90 20.32 15.87 40.09 20.75 
A l l ages 1.90 3.58 3.65 9.13 6.72 
Table 8.16(c)Prevalence (per thousand) of diabetes i n both sexes 
considered together,Durham data and Edinburgh data. 
Age Durham Edinburgh 
I n s u l i n Tablets & Diet* Total 
0-9 0.37 0 0.37 0.13 
10-19 1.09 0.15 I.24 0.93 
20-29 1.75 0.15 1.90 2.02 
30-39 2.08 1.48 3.56 2.82 
40-49 2.33 2 .81 5.14 5.31 
50-59 2 .81 7.25 10.06 8.98 
60-69 3.33 21.43 24.76 18.30 
70 + 3.77 31.87 35.64 19.82 
A l l ages 1.95 5.73 7.68 6.26 
i . e . non-insulin-taking diabetes. 
8.6 Summary. 
This chapter,in many ways a by-product of the genetic 
studies carried out f o r t h i s thesis,does not pretend to give a d e f i n i t i v e 
account of the epidemiology of diabetes mellitus i n the Durham area. 
There are too many methodological imperfections f o r i t to merit that 
description. Rather,an attempt has been made to describe i n d e t a i l a 
diabetic out-patient population i n a,presumably,typical general 
hospital (as opposed to a teaching hospital where the selection of 
patients may be d i f f e r e n t ) , i n the hope that i t w i l l serve as a base-
l i n e f o r the study of future trends i n the constitution of the out-
patient diabetic population of future years. From t h i s changes i n the 
sex-ratio of newly-diagnosed diabetics and of currently known diabetic 
patients may be studied,for example. 
The study of the time of diagnosis of new diabetics i s 
predominantly retrospective i n nature and the results should be seen 
with t h i s i n mind. Despite t h i s , i t confirms the suggestions of previous 
authors that February i s the commonest single month f o r the diagnosis 
of early-onset insulin-dependent diabetes. 
There seems to be l i t t l e information available on the 
number of diabetics i n the non-insulin-taking category who are being 
treated with oral hypoglycaemic agents or diet alone. This study 
w i l l help to f i l l that gap. 
Chapter 9 
Discussion 
The opening chapters of t h i s thesis are concerned with 
a review of previous findings on diabetes which are worthy of re-
i t e r a t i o n before proceding to a f u l l e r discussion of the results of 
the present investigation. 
Segregation analysis,although widely employed i n the 
study of diabetes has f a i l e d to demonstrate a convincing mode of 
inheritance when diabetes i s considered as one disease. The reasons 
f o r t h i s f a i l u r e have been discussed at length,the most important 
being that such a consideration of diabetes as one disease i s 
u n j u s t i f i e d i n the f i r s t place. When diabetes i s subdivided such 
analysis has s t i l l f a i l e d to produce meaningful results except i n 
the case of M.O.D.Y.,where the influence of environmental factors seems 
to be minimal i n contrast to the important role of such non-genetic 
events i n the p r e c i p i t a t i o n of other forms of the disease i n genetically 
susceptible individuals. 
The study of genetic polymorphisms i n established diabetics, 
summarised i n chapter 2,has revealed reproducible associations only 
with the B8 a l l e l e of the HLA system and with the A a l l e l e of the ABO 
system although some workers have f a i l e d to confirm the l a t t e r . Many 
studies have found a positive association between insulin-dependent 
diabetes and the HLA-Bwl5 a l l e l e and a negative association with HLA-
B7 although others have f a i l e d to do so. 
The general conclusions from the reports discussed i n the 
f i r s t two chapters are that diabetes may be divided i n t o two,or 
possibly three categories - type I (roughly equivalent to i n s u l i n -
dependent diabetes),type I I (roughly equivalent to insulin-independent 
diabetes) and a possible type I I I or M.O.D.Y. variety. The aetiologies 
of these sub-types have been shown to be d i f f e r e n t and i t i s t a c i t l y , 
and sometimes e x p l i c i t l y , s t a t e d that the genetic predisposition to 
each i s independent. The evidence discussed i n the preliminary 
sections of chapter 3 by no means convincingly demonstrates t h i s 
f o r type I and type I I diabetes,however. 
The hypothesis expounded i n chapter 3 incorporates the 
notion that genetic factors are involved i n the evolution of the 
cardiovascular changes seen i n the established diabetic. Two 
predictions of t h i s hypothesis are tested by the data - f i r s t l y , t h a t 
i nsulin-taking diabetics should occur i n the families of non-insulin-
taking diabetics (and vice versa) more often than expected by chance 
and that established diabetics should show the more rapid onset of 
cardiovascular complications i f they have a strong family h i s t o r y 
of the disease,irrespective of the type of diabetes t h e i r affected 
r e l a t i v e s have. 
Chapter 5 deals with the analysis of family data and 
t h i s suggests,but does not categorically demonstrate,that both of 
these predictions may be true. The interview-questionnaire method 
employed f o r the examination of families of diabetics and controls 
i s a poor one,it i s time-consuming and i t s potential inaccuracies 
are discussed i n d e t a i l . Current information on f i r s t degree 
rel a t i v e s may be reliable,however,and the analysis of these individuals 
does suggest that insulin-dependent diabetes occurs i n the re l a t i v e s 
of insulin-independent diabetics more often than i n the families of 
controls and more often than i n the general population and that the 
converse i s also true v i z . that insulin-dependent propositi have 
more insulin-independent relatives than expected. This suggests 
that the two forms of diabetes have f a m i l i a l factors i n common (although 
some of these may be non-genetic). Extrapolation of t h i s to type I 
4-VJI 
and type I I diabetes i s unwise i n the present state of knowledge since 
the correspondence between the two modes of c l a s s i f i c a t i o n may not be 
absolute. The study of diabetes subdivided according to the recently 
advocated immunological c r i t e r i a i s advocated. 
Examination of ex i s t i n g and previous cardiovascular 
complications i n insulin-taking diabetics suggests a relationship 
between the strength of family history of the disease and the development 
of these complications,at least i n older individuals. A prospective 
study i s required to evaluate the predictive value of the family 
history of a new diabetic at presentation with regard to the cardio-
vascular pathology he may be expected to develop during the course of 
his disease. 
Detailed examination of the current family history of 
early-onset (defined as under 30 years of age at diagnosis) non-
insulin-taking diabetics confirms previous findings that patterns of 
dominant inheritance are more common i n such individuals than i n 
diabetes of other types. 
The analysis of polymorphism data from non-diabetics 
focuses on two main aspects - comparisons with previously published 
samples of 'normal' individuals and the analysis of the present sample 
for heterogeneity,especially regarding age (chapter 6 ) . 
Data derived from the same region are only available 
f o r the ABO system (Kopec,1970),rhesus (D) (Kope6,1970) and the KLA 
system (Murray et al , 1 9 7 6 ) . The quantitation of regional v a r i a t i o n i n 
t h i s country f o r most polymorphisms i s sparse i n the extreme. I n most 
systems,the phenotype and gene frequencies seem to accord well with 
those found i n the reports considered but where they do not accord, 
i't i s not clear whether the differences are the r e s u l t of geographic 
clines,of sampling d i f f i c u l t i e s or of technical errors. 
Heterogeneity with regard to age i s certain to be 
demonstrated by chance alone i n a certain number of systems when 
several are considered simultaneously. Of those considered here, 
the most convincing demonstration of a trend with age i s that found 
i n the MNSs system where the heterozygote Ss seems at an advantage 
over the homozygote s i n terms of longevity. This f i n d i n g becomes 
convincing when i t i s seen i n the independent analysis of the diabetic 
group (chapter 7). Both male and female controls show an increase i n 
the frequency of the rhesus -ve phenotype with age. This i s not seen 
i n the diabetic group so that i t may be a chance finding o r , a l t e r n a t i v e l y 
that the selective forces acting on t h i s locus are relevant i n non-
diabetics but not i n diabetics. I n the HLA system,heterozygosity at 
the B locus seems a genetic marker f o r longevity and combined hetero-
zygosity at several l o c i may be associated with survival,although a 
much larger population study i s required to confirm t h i s . 
Comparison of controls and diabetic subjects,with matching 
f o r age where necessary (chapter 7) reveals no convincing differences 
i n phenotype frequencies except i n the cases of the ABO and HLA systems. 
I n the former,a s i g n i f i c a n t l y greater number of older male diabetics 
are of the phenotype A^  compared with male controls. Examination of 
the data suggests that t h i s i s primarily the result of a deficiency 
i n older male non-diabetics of t h i s blood group rather than a pure 
excess of group A^ diabetics. That t h i s difference i s the re s u l t of 
d i f f e r e n t i a l mortality i n non-diabetics (with regard to the ABO 
system) which i s not operational i n diabetics i s advocated as an 
explanation of t h i s phenomenon. 
The association with the HLA system confirms the results 
of those authors who found that both HLA-B8 and HLA-Bwl5 are p o s i t i v e l y 
associated with insulin-dependent diabetes and that HLA-B7 shows a 
negative association with t h i s disease. When age at diagnosis i s 
considered,however,HLA-B8 positive individuals and those possessing 
both the B8 and the Bwl5 antigens develop t h e i r disease e a r l i e r than 
Bwl5 positive subjects who are not also B8 positive. This hetero-
geneity i s l i k e l y to have produced the d i s p a r i t y i n published 
reports where the composition of the diabetic groups,with regard to 
age at diagnosis,has d i f f e r e d from author to author. 
Suggested associations with other systems put forward 
by previous workers are considered to be the result of lack of 
attention to age effects i n the control population since s t r i c t 
matching f o r age ( i n the rhesus system,for example) shows that these 
associations are not reproducible. 
The penultimate chapter of the thesis i s not intended 
to be a d e f i n i t i v e account of the epidemiology of diabetes i n the 
Durham area,rather i t contains a detailed account of the structure 
of the diabetic out-patient c l i n i c at Dryburn Hospital with d e t a i l s 
of the months of diagnosis over two successive years of new diabetics 
and a retrospective analysis of the months of diagnosis of exis t i n g 
diabetics at the c l i n i c . The estimate of the prevalence of c l i n i c a l l y 
diagnosed diabetes i n the surrounding area has been undertaken because 
no such estimate considering d i f f e r e n t categories of diabetes sub-
divided by treatment i s available,and t h i s was required f o r comparison 
with the family data. As an estimate of prevalence i t suffers from 
a number of deficiencies. 
Examination of the c l i n i c population reveals that over 
half of those currently being treated with i n s u l i n were diagnosed 
a f t e r the age of 50• Early-onset insulin-taking diabetics were 
diagnosed i n February more often than i n any other single month. 
No convincing relationship between genotype and month of onset can 
be demonstrated i n the retrospective analysis of t h i s diabetic 
population. The prevalence estimates of the disease are higher 
than those presented by previous workers f o r Edinburgh i n 1969 
(see chapter 8 f o r references). No conclusions about the disease 
i n the community and changes i n prevalence may be made from t h i s 
comparison. 
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Appendix A 
Tables giving previously published blood group data 
for the calculation of x ( r e l a t i v e incidence) and giving y ( l o g e x ) f 
2 
w (weight) and wy ,necessary for the calculation of X (weighted mean 
re l a t i v e incidence) and chi squared values for the significance of 
the deviation of X from unity and for the significance of hetero-
geneity amongst the data (Woolf's method). 
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Appendix A. Table 2. ( a l l diabetics combined) 
Ref. X y w 2 wy 
1. 1-12 0-11333 154*8 1-98 
2.(1) 1*12 0-11333 124*4 1-60 
(2) 1-19 0-17395 39*1 1*18 
(3) I ' l l 0-10436 103*3 1*13 
3. 1-03 0-02956 89»6 0*08 
4. 1*28 0.24686 73*3 4*53 
5. I ' l l 0*10436 36*5 0*40 
6. 1*02 0*01980 210*3 0-0B 
7. 1-03 0-02956 173*1 0*15 
8. 0*83 -0*18633 210.5 7*31 
9. 1-30 0*26236 120*8 8.31 
10. 1-34 0-29267 151*0 12*93 
11. 1.20 0*18232 18*1 0*6 
12. 0-97 -0*03046 22*3 0-02 
13. 1.08 0*07-696 309*3 1*83 
14. 0*91 -O.09431 168*9 1*50 
15. 1*34 0.29267 101.5 8.69 
16. 1-02 0*01980 313*1 0*12 
17. 1*04 0*03922 37*1 0-06 
18. 1*08 0.07696 151*5 0*90 
References are as those for Table 1. 
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Appendix A. Table 5« (male diabetics only) 
Ref. X y w 2 wy 
1. 0-95 -0*05129 55.08 0*29 
2.(1) 
(2) 
(5) 
1*32 0*27763 46*33 3-57 
1*61 0*47623 17*00 3-86 
1*25 0*22314 39*68 1*98 
3. 1-23 0*20701 37-45 1*60 
4. 1-13 0*12222 23*16 0*35 
5. 1*09 0*08618 80*28 0*60 
6. 1*01 0*00995 83*59 0*01 
7. 0-79 -0*23572 110*04 0*06 
8. 1-43 0*35767 44-39 5*68 
9. 1-81 0-59333 52*13 18*35 
10. 1-5 6 0*44469 7-90 1*56 
11. 1-09 0*08618 157*14 1-17 
12. 1*60 0*47000 56*46 12*47 
13. 1.04 0*03922 129.92 0*20 
14. 1*09 0*08618 78*19 0*58 
References are as those for Tables 3 and 4. 
4.-7 fe. 
Appendix A. Table 6. (female diabetics only) 
Ref X y w 2 wy 
1. 1*21 0*19062 106*00 3-85 
2.(1) 
(2) 
(3) 
1-03 0.02956 82-75 0*07 
0-97 -0*03046 24*49 0*02 
1«04 0*03922 66*96 0*10 
3. 1-32 0-27763 43-30 3*34 
4. 1.09 0-08618 16.90 0*13 
5. 0*98 -0*02020 134-43 0*05 
6. 1*04 0-3922 119*66 0*18 
7. 0*87 -0-013926 102*51 0*02 
8. 1*24 0-21511 76*36 3-53 
9. 1.15 0-13976 103-43 2*02 
10. 1.00 0-0000 11*22 0*00 
11. 1-06 0-05827 170-90 0*58 
12. 1.19 0-17395 75-19 2*28 
13. 1*01 0-00995 187-60 0*02 
14. 1-07 0-06766 100*11 0*46 
References are as those for Tables 3 and 4. 
4.T7. 
Appendix A. Table 7• (considering / n r a t i o i n a l l diabetics) 
Ref x ( B / Q ) y w 2 wy 
1. 0*92 -0*08338 60-91 0-42 
2.(1) 
(2) 
(3) 
1*25 0*22314 45-22 2-25 
0*52 -0-65393 8-95 3-83 
0-75 -0.28768 25-58 2-12 
3. 1*43 0-35767 36-45 4-66 
4. 1*64 0-49470 31-88 7-8 
5. 1-54 0.43178 21-58 4-02 
6. 1-32 0*27763 78-93 6*08 
7. 1-16 0-14842 93-03 2-05 
8. C79 -0*23572 76-69 4.26 
9. 0-55 -0-59784 41-90 14-98 
10. 0*63 -0-46204 84-22 17-98 
11. 1-39 , 0-32930 7-73 0-84 
12. 0-79 -0.23572 7-59 0-42 
13. 1«03 0-02956 140-17 0-12 
14. 0*92 -0«08338 70-29 0-49 * 
15. 1-19 0-17395 37-23 1-13 
16. 1*19 0-17395 126-91 3-84 
17. 0.87 -0-13926 IO.40 0-20 
18. 1-09 0-08618 62-79 .47 
References are as those for Table 1. 
4-Ttf. 
Appendix A. Table 8. (considering A/not A ra t i o i n a l l diabetics) 
Ref ( A , x vnot A' y w 
2 
wy 
1. 1-13 0*12222 169*41 2*53 
2.(1) 
(2) 
(3) 
1*05 0*04879 140*45 0*33 
1-35 0*30010 42*73 3.85 
1-12 0*11333 115-43 1*48 
3. 0-97 -0*03046 105.15 0*10 
4. 1-13 0*12222 86*28 1*29 
5. 1*00 0.0000 47-3 0*00 
6. 1.00 O'OOOO 234*96 0.00 
7. 1*00 0*0000 220*71 0*00 
8. 0*89 -0*11653 234-27 3.18 
9. 1-21 0*19062 140*56 5-11 
10. 1-37 0*31481 211*54 20*96 
11. 1*05 0*04879 21-53 0*05 
12. 1*04 0*03922 24*29 0-95 
13. 1*05 0*04879 373-64 0*89 
14. 0*94 -0*06188 184*23 0*71 
15. 1*35 0*30010 116*45 10*49 
16. 1*01 0*00995 353-51 0*03 
17. 1*10 0*09531 41*58 0*38 
18. 1*09 0*08618 177*52 1*32 
References are as those for Table 1. 
Appendix A. Table 9. (considering (A+AB]/_ n\ rati o i n a l l diabetics) 
Y A+AB 2 Ref. B+0 y w wy 
1. 1*13 .12222 175*99 2.63 
2.(1) 1-13 •12222 143'45 2.14 
(2) 1*27 •23902 42*83 2-45 
(3) 1*19 •17395 115*97 3-51 
3. 0*96 -0*04082 105*59 0»18 
4. 1-17 0*15700 87-49 2.16 
5. 0*95 -0*05129 48*21 0-13 
6. 0-95 -0*05129 236*65 0.62 
7. 0*96 -0*04082 223-55 0-37 
8, 0*85 -0*16252 239-48 6-33 
9. 1-25 0*22314 140«48 6-99 
10. 1-74 0*055389 213-17 65-40 
11. 1*19 0*17395 21-82 0*66 
12. 0-97 -0*03046 24.63 0*02 
13. 1*07 0*06766 377-86 1-73 
14. 0*90 -0*10536 189*48 2*10 
15. 1»22 0*19885 118.05 4-67 
16. 0-97 -0*03046 357-81 0*33 
17. 1»02 0*01980 41-44 0*02 
18. 1-02 0*01980 179*18 0*07 
References are as those for Table 1. 
Appendix B 
Giving d e t a i l s of the transformation of pedigree data 
in t o a form acceptable f o r computer analysis. 
The following method was devised to store i n computer 
f i l e s the relevant information collected f o r pedigree analysis so 
that the o r i g i n a l pedigree could be reconstructed from the computer 
input and the required analysis could be performed. 
A standard computer punched card has 80 columns i n 
each of which a single character may be punched. These 80 columns 
were used i n the following way:-
Columns 1 - 4 
A four d i g i t numerical label unique to each family, 
r i g h t j u s t i f i e d w i t h i n i t s f i e l d . 
Column 5 
The number of the card w i t h i n the sequence of cards 
used f o r each family,using the d i g i t s 1 to 9 and then repeating. 
Columns 6 - 8 0 
The required information on f i v e members of the family 
per card using 15 columns f o r each person. The following items 
of information were coded i n these 15 columns:-
In the f i r s t seven columns f o r each person ( i . e . columns 
nos. 6 to 12 f o r the f i r s t person on each card) a numerical label 
encapsulating the sex of the individual,the relationship with the 
propositus and the sex of the propositus. 
The codes f o r rel a t i v e s of a male propositus are 
i l l u s t r a t e d i n figure B.l. They are b u i l t up l o g i c a l l y from the 
4-<«il. 
Figure B.l The use of codes i n an i l l u s t r a t i v e family 
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, propositus,who i s coded as '1'. Sons of the propositus have a code 
of '12 1,daughters '15'»father '14' and mother '15'. A grandson, 
related to the propositus v i a a son i s coded as '122',a granddaughter 
related i n a similar fashion has a code of '123',whilst grandsons and 
granddaughters related to the propositus through a daughter are coded 
as '132' and '133' respectively. Paternal grandmothers and grand-
fathers are coded as '145' and '144'»maternal grandmothers and grand-
fathers as '155' and '154'• The code f o r wives i s '11'. 
A complication occurs with sibs because of the necessity 
to distinguish f u l l sibs from half-sibs. The f u l l brother of a male 
propositus i s coded as '162',the f u l l s i s t e r of a male propositus i s 
'165'• A half-brother,related to a male propositus through t h e i r 
father i s '142',when related through the mother,'152'. Half-
s i s t e r s , related through father and mother respectively are coded '143' 
and '153'• By extension of t h i s method,the f u l l brothers of the 
father of a male propositus are a l l coded *1462'. The daughters of 
such individuals ( f i r s t cousins of the propositus) are coded '14623' 
and so on. 
A female proband i s coded as '2' and a l l her r e l a t i v e s 
are coded i n exactly the same way as those of male propositi except 
that the code commences with a '2' i n each case. The seven columns 
devoted to t h i s coding w i l l allow consideration of re l a t i v e s up to 
and including the s i x t h degree. 
Thus,although each r e l a t i v e i n a pedigree may not have 
a unique code,every path relationship from the propositus i s 
designated i n a unique fashion. The number of steps from the 
propositus to an individual i s equal to one less than the number of 
d i g i t s i n the appropriate code fo r that r e l a t i v e and,with the 
4-* 3 
exception of p r o p o s i t i , a l l male relatives have an even code,all 
females an odd coding. These fixe d rules greatly f a c i l i t a t e the 
w r i t i n g of computer programmes f o r the analysis of such data. 
The next column (column no. 13 f o r the f i r s t person on 
each card) i s used to si g n i f y whether the r e l a t i v e i s alive or dead, 
using the codes '1' and '2' respectively. 
The next two columns (nos. 14 and 15 f o r the f i r s t 
person on each card) give the current age or ages at death. The 
codes 1 to 20 are given f o r successive five-year age groupings up 
to 100 years. 
B i r t h order appears i n the next two columns (nos. 16 
and 17 f o r the f i r s t person on each card). 
The l a s t three columns (nos. 18 to 20 f o r the f i r s t 
person on each card) are devoted to details of the a f f e c t i o n 
status of the i n d i v i d u a l . The f i r s t of these three columns uses 
the following codes f o r one of nine possible categories:-
Code Category 
1 Diabetic treated with insulin,diagnosis 
before the age of 30. 
2 Diabetic treated with oral-hypoglycaemic 
agents,diagnosis a f t e r the age of 30. 
3 Diabetic treated with diet alone,diagnosis 
a f t e r the age of 30. 
4 Unaffected. 
5 Diabetic treated with diet alone,diagnosis 
before the age of 30. 
6 Diabetic,treatment unknown,diagnosis 
before the age of 30. 
Code Category 
7 Diabetic,treatment unknown,diagnosis a f t e r 
the age of 30. 
8 Diabetic treated with insulin,diagnosis 
a f t e r the age of 30. 
9 Possible diabetic or 'latent diabetic!. 
The las t of these categories covers a wide range of 
individuals from thos diagnosed as diabetic during pregnancy,and 
now declared not to be diabetic,to those the informant thought 
might have had the disease as part of a terminal i l l n e s s , f o r example. 
I n practice t h i s category was of l i t t l e use and the small number of 
individuals i n i t were ignired i n a l l calculations. 
The second and t h i r d of these l a s t three columns contain 
the age (the appropriate code fo r the five-year age group) at which 
diabetes was diagnosed i n an affected i n d i v i d u a l . 
A missing value f o r current age or age at death was not 
tolerated,the individual was ignored. The reasoning behind t h i s 
was that i f the informant were unsure of a person's age to w i t h i n 
f i v e years then they were u n l i k e l y to be s u f f i c i e n t l y i n contact 
with him to know about his medical status. Similarly f o r the 'alive 
or dead' category. 
The missing value f o r b i r t h order was *99' and also f o r 
the age at diagnosis of diabetes i n an affected i n d i v i d u a l . The 
same code was also used f o r 'does not apply' f o r age at diagnosis 
i n an unaffected i n d i v i d u a l . 
When a pedigree was being coded,each individual i s 
taken i n turn with children following t h e i r parents (except i n the 
case of the propositus and his parents). Successively numbered 
cards are used u n t i l each r e l a t i v e has been dealt with and a blank 
series of columns i s l e f t a f t e r the l a s t r e l a t i v e of each family. 
Information on the families of the 101 control propositi 
was stored i n a l i n e f i l e of 783 l i n e s . The 433 families of diabetic 
propositi were contained i n a f i l e of 2,466 l i n e s . Files of t h i s 
size allowed f o r the storage of information on 3>621 individuals 
i n the case of control families and 14»244 individuals i n the case 
of the families of diabetics. The l a t t e r f i l e was sequentially 
structured so that,for example,the f i r s t 745 lines contained the 
families of propositi treated with i n s u l i n and diagnosed before the 
age of 30• Lines 746 to 1219 contained the families of i n s u l i n -
taking diabetic propositi diagnosed a f t e r t h i s age,so that,reading 
the f i r s t 1,219 lineB of the f i l e enabled the rel a t i v e s of a l l 
insulin-treated diabetics to be analysed. 
Fortran programmes,written s p e c i f i c a l l y f o r the purpose, 
were used to analyse these data. 
Appendix C 
Relatives included i n the calculation of probability 
of becoming diabetic (taken from Smith,1972). 
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Appendix D. 
Electrophoresis methods. 
Haptoglobins and acid phosphatase were examined i n standard 
thickness starch gels. The remaining systems (phosphoglucomutase, 
adenylate kinase,adenosine deaminase,esterase D) were conducted i n 
1mm thick gels. This appendix l i s t s the constituents of tank and gel 
buffers f o r each system,the staining procedures,conditions of the run 
and any special precedures required. 
Haptoglobin. 
Tank buffer: 0.06M NaOH 2.4 g / l 
O.JM Boric acid 18.55 g / l 
Adjusted to pH 8.5 
Gel buffer: O.O76M Tris 9.2 g / l 
0.005M C i t r i c acid 1.05 g / l 
Adjusted to pH 8.65 
The gels are prepared by the addition of 150 mis of gel 
buffer to 100 mis of d i s t i l l e d water and 25 grms of starch per gel. 
The mixture i s heated and pressure boiled. Inserts are f i l t e r paper 
impregnated with Iffo lysate mixed 1:3 with serum. Electrophoresis 
run carried out cathode to anode,constant current 50 mA.. Duration 
of run about 3 hrs. Staining mixture consists of 250 mis of Vfo acetic 
acid mixed with a small amount of benzidine with 3-5 drops of hydrogen 
peroxide. This mixture i s poured on each gel and the bands appear 
rapidly. 
Acid phosphatase. 
Tank buffer: 0.41 M C i t r i c acid 86.16 g / l 
NaOH 45 g / l 
Adjusted to pH 6 . 0 
Gel buffer: 0 .0025 M Succinic acid 0 .2952 g / l 
O.OO46 M Tr i s . 0 .5572 g / l 
Adjusted to pH 6 . 0 
For each gel required,250 mis of gel buffer (to which have 
been added 0 .931 grms of E.D.T.A.) are mixed with 25 grms of starch. 
After heating 1 ml of 2-mercaptoethanol i s added and the mixture i s 
pressure boiled. F i l t e r paper inserts are used and the run i s conducted 
cathode to anode at constant voltage of 115 volts,current about 40mA, 
16 or 17 hour run. 
Incubation buffer: 0.05m C i t r i c acid 10 .50 g / l 
Adjusted to pH 6 .0 
0.005M Phenolphthalein diphosphate ( 0 .2944 grms/ 
100 ml) 
After s l i c i n g the gel 25 mis of the above incubation buffer 
are added to f i l t e r paper placed over each h a l f . The gels are incubated 
fo r 3 hrs at 37*C. After incubation 4 -5 mis of ammonia soln. are added 
per gel. Bands appear immediately. 
Phosphoglucomutase. 
Tank buffer: D i s t i l l e d water 1 l i t r e 
T r i s 12 .11 grms 
Maleic acid 11 .62 grms 
E.D.T.A.(acid) 2 .92 grins 
MgCl2 2 .03 grms 
Adjust to pH 7 .4 with 40$ NaOH 
Gel buffer: Tank buffer d i l u t e d 1:5 
Electrophoresis i s carried out cathode to anode at constant 
voltage (HOv) and at a current of 5-8mA. f o r about 17 hours. 
For t h i s and other t h i n layer methods,40 mis of the gel 
4*1 
buffer ..are mixed with 3.5 grms of 10$ starch,for each gel required. 
Incubation buffer: Trie 7.28 grms 
D i s t i l l e d water 1 l i t r e 
Adjusted to pH 8.0 with cone. HC1,after which 20 mgs 
of MgClg are added per 10 ml of buffer. The following ingredients are 
added to the incubation buffer and the resultant staining mixture placed 
i n the oven at 37*C:-
f o r each 10 mis of incubation buffer 
Glucose 1 phosphate 30 mg 
(containing G 1:6 diphosphate) 
NADP 1.5 mg 
MTT 2.5 mg 
PMS 2.5 mg 
G 6 PDH 20 micro l i t r e 
Agar (2$ soln.) 10 mis 
The incubation buffer containing the f i r s t f i v e ingredients 
i n the above l i s t i s mixed i n t o the agar a f t e r b o i l i n g and cooling to about 
55-60*C. The mixture i s applied to the gels by an overlay method and, 
a f t e r incubation at 37*C f o r 30 minutes the bands should appear. 
Adenylate kinase. 
Tank buffer: C i t r i c acid 28.72 grms 
NaOH 10.6866 grms 
D i s t i l l e d water 1 l i t r e 
Adjusted to pH 4.9. 
Gel buffer Succinic acid 1.89 grms 
Tris 2.226 grms 
D i s t i l l e d water 1 l i t r e 
Adjusted to pH 5.0 
Electrophoresis run i s carried out with specimens running 
from anode to cathode,constant voltage (250v) f o r 4 hrs. 
Staining i s again by the agar overlay method. The following 
ingredients are mixed i n 10 mis of the incubation buffer (see below) 
and the resultant solution i s mixed int o 10 mis of 2fo agar which has 
been boiled and cooled to 55-60*C as f o r phosphoglucomutase above. 
Glucose 18 mg 
Mg C l 2 40 mg 
A.D.P. 4.9 mg 
N.A.D.P. 3.1 mg 
M.T.T. 2.5 mg 
P.M.S. 2.5 mg 
G6PDH 20 m i c r o l i t r e 
Hexokinase 20 mi c r o l i t r e 
Incubation buffer: T r i s 12.12 grms 
D i s t i l l e d water 1 l i t r e 
Adjusted to pH 8.0 using cone HC1. 
Bands appear a f t e r 30 minutes incubation at 37*C. 
Adenosine deaminase. 
Tank buffer: 
Soln. A NaH2P04 46.802 grms 
D i s t i l l e d water 3 l i t r e s 
Soln B Anhydrous Na2H PO^  19.874 grms 
D i s t i l l e d water 1.4 l i t r e s 
Add solution A to solution B and adjust pH to 6.5. 
Gel buffer: Tank buffer diluted 1 i n 10. 
The electrophoresis i s carried out cathode to anode at constant voltage 
(loo v) f o r 4 hours. Staining i s by agar overlay method with following 
incubation buffer and staining mixture:-
Incubation buffer: 
Solution A NaH_P0. 0.195 grms 
D i s t i l l e d water 50 mis 
Solution B Anhydrous Na2HP0^ O.7098 grms 
D i s t i l l e d water 200 mis 
Solution A i s added to solution B and the pH adjusted to 7.5* The 
solution i s diluted 1 i n 4 with d i s t i l l e d water. 
Staining mixture: 
2fo agar solution i n water 10 mis 
Incubation buffer 10 mis 
Adenosine 15 mg 
M.T.T. 2 mg 
P.M.S. 2 mg 
Xanthine oxidase 10 m i c r o l i t r o 
Nucleoside phosphorylaBe 10 m i c r o l i t r e 
The agar solution i s prepared as f o r the above two methods 
and incubation i s f o r 30 minutes at 37*C. Clellands reagent i s added 
to specimens before insertion into gels (see below). 
Esterase D. 
Gel buffer: T r i s I.636 grms 
C i t r i c acid 0.756 grms 
Boric acid 0.272 grms 
Lithium hydroxide 0.016 grms 
D i s t i l l e d water 1 l i t r e 
Adjusted to pH 7.4 (stored at 4*C). For 10 gels 240 ml gel buffer 
are mixed with 240 mis water. 42 grms of starch are mixed with t h i s 
solution f o r 10 gels. 
Tank buffer: Boric acid 108.84 grms 
Lithium hydroxide 6.72 grms 
D i s t i l l e d water 4 l i t r e s 
Adjusted to pH 7.2 and stored at 4'C. 
Before insertion i n t o the gel lysates are diluted with 
one drop of Clelland's reagent (see below) solution i n the gel buffer. 
Electrophoresis carried out cathode to anode f o r 2 hrs at 
constant voltage (300 volts),about 5 raA. 
Incubation buffer: 41 mg. anhydrous sodium acetate (Soln.A) 
10 mis d i s t i l l e d water 
4 mg. 4~n»e'thylumbelliferyl acetate (Soln.B) 
a few drops of acetone 
Prior to incubation,solutions A and B are mixed and the 
gels incubated under f i l t e r paper s t r i p s impregnated with t h i s 
mixture f o r 5 minutes at 37*C. Results are read under u.v. l i g h t . 
Clelland's reagent,for use i n adenosine deaminase and esterase D methods. 
Clelland's reagent ( d i t h i o t h r e i t o l ) i s diluted with the 
appropriate gel buffer f o r that system by adding 37*5 nig to 5 nils of 
gel buffer. This may be stored at 4*C. Addition of t h i s solution to 
the lysate before insertion into the gel i s appropriate f o r specimens 
stored f o r any length of time and reduces the confusing storage bands 
seen with these specimens. 
A l l methods using t h i n layer gels have specimens inserted 
by means of linen thread wicks. 
4*1 
F i c o l l T r i o a i l solution ( f o r use i n the separation of lymphocytes f o r 
HLA determination), 
® 
Soln. A 45 grms of F i c o l l disolved i n 500 mis of d i s t i l l e d water. 
(This solutions requires over-night incubation to disolve). 
® 
Soln.B 100 ml T r i o s i l made up to 225 mis with d i s t i l l e d water, 
well mixed. (Protect from u.v. l i g h t ) . 
Final solution i s made up from 480 mis of soln.A and 200 mis of solution 
B. 
Antisera 
Antisera f o r red c e l l grouping and f o r HLA typing were 
derived from a variety of sources,commercial and private. A l l HLA 
antisera were commercially prepared (Biotest,Searle and Hoescht 
Pharmaceuticals) except f o r HLA-A9,B12 and Bwl5 s p e c i f i c i t i e s which 
were kindly donated by other laboratories (see acknowledgements). 
Red c e l l antisera were derived from the Newcastle Blood 
Transfusion Service (anti-A,anti-B,anti AB,anti-M,all rhesus antisera 
anti-K and some anti-Fy ),from Lancaster Blood Transfusion Service ( a n t i -
P^  and anti-Le (a)),Blood Group Reference Laboratory (anti-N,anti-M) and 
the B r i t i s h Museum of Natural History (anti-Fy a and anti-Kp a). Other 
antisera were commercially derived (Ortho and Biotest). Anti-human 
globulin was from Ortho. 
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